Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Leiomyoma of uterus,A1BG,Alpha-1B-glycoprotein,10353,149,0.53 [0.22-1.25],0.1476298847571925
Chapter II Neoplasms,Leiomyoma of uterus,AAMDC,Mth938 domain-containing protein,10091,145,1.10 [0.81-1.48],0.5386376994606628
Chapter II Neoplasms,Leiomyoma of uterus,AARSD1,Alanyl-tRNA editing protein Aarsd1,11744,167,1.08 [0.84-1.37],0.5489442513484226
Chapter II Neoplasms,Leiomyoma of uterus,ABCA2,ATP-binding cassette sub-family A member 2,10002,147,1.72 [1.20-2.48],0.0033670019967499
Chapter II Neoplasms,Leiomyoma of uterus,ABHD14B,Protein ABHD14B,11689,167,1.03 [0.81-1.31],0.7982393727935515
Chapter II Neoplasms,Leiomyoma of uterus,ABL1,Tyrosine-protein kinase ABL1,11744,167,1.02 [0.83-1.25],0.8636476064722641
Chapter II Neoplasms,Leiomyoma of uterus,ABO,Histo-blood group ABO system transferase,10335,147,1.11 [1.00-1.24],0.0572879009403258
Chapter II Neoplasms,Leiomyoma of uterus,ABRAXAS2,BRISC complex subunit Abraxas 2,10002,147,1.00 [0.78-1.27],0.9909873289188236
Chapter II Neoplasms,Leiomyoma of uterus,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",11526,160,1.11 [0.94-1.31],0.2163339071096454
Chapter II Neoplasms,Leiomyoma of uterus,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",10166,144,0.99 [0.79-1.25],0.964272262024158
Chapter II Neoplasms,Leiomyoma of uterus,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",10334,150,0.95 [0.80-1.14],0.5917462198633696
Chapter II Neoplasms,Leiomyoma of uterus,ACAN,Aggrecan core protein,11691,169,1.04 [0.64-1.70],0.8740720439295641
Chapter II Neoplasms,Leiomyoma of uterus,ACE,Angiotensin-converting enzyme,10335,147,1.30 [0.72-2.33],0.3843237810870532
Chapter II Neoplasms,Leiomyoma of uterus,ACE2,Angiotensin-converting enzyme 2,11560,165,1.20 [0.94-1.55],0.1449832378459827
Chapter II Neoplasms,Leiomyoma of uterus,ACHE,Acetylcholinesterase,10128,146,1.00 [0.61-1.65],0.9928293278287575
Chapter II Neoplasms,Leiomyoma of uterus,ACOT13,Acyl-coenzyme A thioesterase 13,10273,150,0.99 [0.86-1.14],0.9187846762260174
Chapter II Neoplasms,Leiomyoma of uterus,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,11802,169,0.93 [0.70-1.22],0.5832678226260183
Chapter II Neoplasms,Leiomyoma of uterus,ACP1,Low molecular weight phosphotyrosine protein phosphatase,10039,145,0.97 [0.68-1.40],0.8810041546634636
Chapter II Neoplasms,Leiomyoma of uterus,ACP5,Tartrate-resistant acid phosphatase type 5,11861,169,1.40 [0.94-2.08],0.0960924606443998
Chapter II Neoplasms,Leiomyoma of uterus,ACP6,Lysophosphatidic acid phosphatase type 6,11867,169,1.00 [0.82-1.22],0.9957935480737128
Chapter II Neoplasms,Leiomyoma of uterus,ACRBP,Acrosin-binding protein,10278,147,1.16 [0.80-1.68],0.4232986400672351
Chapter II Neoplasms,Leiomyoma of uterus,ACRV1,Acrosomal protein SP-10,10039,145,1.24 [0.80-1.91],0.3405966031865591
Chapter II Neoplasms,Leiomyoma of uterus,ACSL1,Long-chain-fatty-acid--CoA ligase 1,10002,147,1.13 [0.78-1.63],0.5124295763470803
Chapter II Neoplasms,Leiomyoma of uterus,ACTA2,"Actin, aortic smooth muscle",11560,165,1.09 [0.81-1.47],0.5621775222205174
Chapter II Neoplasms,Leiomyoma of uterus,ACTN2,Alpha-actinin-2,10002,147,1.18 [0.90-1.54],0.2349675822298584
Chapter II Neoplasms,Leiomyoma of uterus,ACTN4,Alpha-actinin-4,11555,165,1.25 [0.88-1.78],0.2039011838561346
Chapter II Neoplasms,Leiomyoma of uterus,ACVRL1,Serine/threonine-protein kinase receptor R3,11703,167,1.17 [0.67-2.04],0.5914690102972665
Chapter II Neoplasms,Leiomyoma of uterus,ACY1,Aminoacylase-1,11802,169,0.92 [0.73-1.16],0.5034898877361287
Chapter II Neoplasms,Leiomyoma of uterus,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,10002,147,0.99 [0.74-1.33],0.9702907584962344
Chapter II Neoplasms,Leiomyoma of uterus,ACYP1,Acylphosphatase-1,10086,145,0.97 [0.76-1.24],0.8006693008552486
Chapter II Neoplasms,Leiomyoma of uterus,ADA,Adenosine deaminase,11910,170,1.10 [0.74-1.62],0.6424241087504525
Chapter II Neoplasms,Leiomyoma of uterus,ADA2,Adenosine deaminase 2,11732,167,0.83 [0.60-1.15],0.2709530490193851
Chapter II Neoplasms,Leiomyoma of uterus,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,10039,145,1.51 [0.96-2.37],0.0753612797518185
Chapter II Neoplasms,Leiomyoma of uterus,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,11560,165,0.81 [0.51-1.28],0.3735137809927834
Chapter II Neoplasms,Leiomyoma of uterus,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,11718,168,0.81 [0.55-1.19],0.2846282190939926
Chapter II Neoplasms,Leiomyoma of uterus,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,11910,170,1.21 [0.81-1.80],0.3607677121007917
Chapter II Neoplasms,Leiomyoma of uterus,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,11867,170,1.33 [0.83-2.13],0.242024073193789
Chapter II Neoplasms,Leiomyoma of uterus,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,10273,150,1.40 [0.85-2.31],0.1903573230530366
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,10039,145,1.32 [0.82-2.14],0.2496903563644021
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,11938,171,1.07 [0.60-1.92],0.8192221205101105
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,11744,167,1.08 [0.79-1.47],0.6443037423396942
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,11560,165,1.03 [0.66-1.60],0.9132006890391944
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,10039,145,1.18 [0.76-1.85],0.4609698379994668
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,11855,167,0.97 [0.71-1.32],0.8268653732921981
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTSL2,ADAMTS-like protein 2,10347,149,0.99 [0.60-1.61],0.9574407800975226
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTSL4,ADAMTS-like protein 4,10091,145,1.26 [0.62-2.55],0.5161242662118899
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTSL5,ADAMTS-like protein 5,10334,150,0.93 [0.62-1.40],0.7315620387741284
Chapter II Neoplasms,Leiomyoma of uterus,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,11526,160,0.94 [0.62-1.43],0.7734293034195123
Chapter II Neoplasms,Leiomyoma of uterus,ADD1,Alpha-adducin,10128,146,1.00 [0.80-1.26],0.9857227644006072
Chapter II Neoplasms,Leiomyoma of uterus,ADGRB3,Adhesion G protein-coupled receptor B3,11703,167,0.93 [0.62-1.40],0.7350679544133012
Chapter II Neoplasms,Leiomyoma of uterus,ADGRD1,Adhesion G-protein coupled receptor D1,10128,146,1.00 [0.65-1.56],0.9866285609070468
Chapter II Neoplasms,Leiomyoma of uterus,ADGRE1,Adhesion G protein-coupled receptor E1,10273,150,0.80 [0.60-1.07],0.1282170199360786
Chapter II Neoplasms,Leiomyoma of uterus,ADGRE2,Adhesion G protein-coupled receptor E2,11854,170,0.89 [0.54-1.46],0.6453292267578676
Chapter II Neoplasms,Leiomyoma of uterus,ADGRE5,Adhesion G protein-coupled receptor E5,11893,170,0.90 [0.57-1.42],0.6469843169525398
Chapter II Neoplasms,Leiomyoma of uterus,ADGRF5,Adhesion G protein-coupled receptor F5,10334,150,0.92 [0.54-1.55],0.7430964294502793
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG1,Adhesion G-protein coupled receptor G1,11744,167,1.15 [0.95-1.39],0.1398321448628359
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG2,Adhesion G-protein coupled receptor G2,11802,169,1.26 [0.76-2.09],0.3783408668917346
Chapter II Neoplasms,Leiomyoma of uterus,ADGRV1,Adhesion G-protein coupled receptor V1,9978,146,1.08 [0.87-1.33],0.4740118617061409
Chapter II Neoplasms,Leiomyoma of uterus,ADH1B,All-trans-retinol dehydrogenase,10128,146,1.01 [0.81-1.25],0.9490668983538424
Chapter II Neoplasms,Leiomyoma of uterus,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,11560,165,1.02 [0.87-1.21],0.7838217917119412
Chapter II Neoplasms,Leiomyoma of uterus,ADIPOQ,Adiponectin,10353,149,0.87 [0.69-1.10],0.2393050356235248
Chapter II Neoplasms,Leiomyoma of uterus,ADM,Pro-adrenomedullin,11889,169,1.05 [0.62-1.76],0.8597193664981668
Chapter II Neoplasms,Leiomyoma of uterus,ADRA2A,Alpha-2A adrenergic receptor,10002,147,1.05 [0.85-1.30],0.6654964977856096
Chapter II Neoplasms,Leiomyoma of uterus,AFAP1,Actin filament-associated protein 1,10128,146,0.86 [0.71-1.05],0.1326549598212222
Chapter II Neoplasms,Leiomyoma of uterus,AFM,Afamin,10353,149,1.64 [0.72-3.70],0.2381769561438048
Chapter II Neoplasms,Leiomyoma of uterus,AFP,Alpha-fetoprotein,11682,167,1.01 [0.82-1.23],0.9406786033398016
Chapter II Neoplasms,Leiomyoma of uterus,AGBL2,Cytosolic carboxypeptidase 2,9978,146,1.20 [0.99-1.45],0.0640660259820291
Chapter II Neoplasms,Leiomyoma of uterus,AGER,Advanced glycosylation end product-specific receptor,11778,168,1.14 [0.82-1.58],0.4344952111915118
Chapter II Neoplasms,Leiomyoma of uterus,AGR2,Anterior gradient protein 2 homolog,11406,161,1.08 [0.94-1.23],0.2782795190812639
Chapter II Neoplasms,Leiomyoma of uterus,AGR3,Anterior gradient protein 3,11502,160,1.31 [1.06-1.63],0.011815128674383
Chapter II Neoplasms,Leiomyoma of uterus,AGRN,Agrin,11854,170,1.34 [0.91-1.97],0.1390086607287794
Chapter II Neoplasms,Leiomyoma of uterus,AGRP,Agouti-related protein,11910,170,1.31 [1.01-1.71],0.041122880014934
Chapter II Neoplasms,Leiomyoma of uterus,AGT,Angiotensinogen,10335,147,1.18 [0.61-2.27],0.6292017950595152
Chapter II Neoplasms,Leiomyoma of uterus,AGXT,Serine--pyruvate aminotransferase,11802,169,1.01 [0.84-1.21],0.9350635517321296
Chapter II Neoplasms,Leiomyoma of uterus,AHCY,Adenosylhomocysteinase,11802,169,0.90 [0.74-1.10],0.3139711840110174
Chapter II Neoplasms,Leiomyoma of uterus,AHNAK,Neuroblast differentiation-associated protein AHNAK,10091,145,1.13 [0.69-1.86],0.6247899526812717
Chapter II Neoplasms,Leiomyoma of uterus,AHNAK2,Protein AHNAK2,10091,145,1.01 [0.58-1.79],0.959673073067174
Chapter II Neoplasms,Leiomyoma of uterus,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,10278,147,1.10 [0.89-1.36],0.3988601101835968
Chapter II Neoplasms,Leiomyoma of uterus,AHSG,Alpha-2-HS-glycoprotein,10335,147,1.42 [0.80-2.54],0.2335043883644788
Chapter II Neoplasms,Leiomyoma of uterus,AHSP,Alpha-hemoglobin-stabilizing protein,11790,165,1.05 [0.90-1.23],0.5098477706718577
Chapter II Neoplasms,Leiomyoma of uterus,AIDA,"Axin interactor, dorsalization-associated protein",10056,144,1.01 [0.84-1.22],0.9248056944456
Chapter II Neoplasms,Leiomyoma of uterus,AIF1,Allograft inflammatory factor 1,11526,160,1.03 [0.79-1.35],0.8057205855184362
Chapter II Neoplasms,Leiomyoma of uterus,AIF1L,Allograft inflammatory factor 1-like,10091,145,1.08 [0.83-1.40],0.5685760072051931
Chapter II Neoplasms,Leiomyoma of uterus,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",11725,167,1.00 [0.88-1.14],0.9884005968339296
Chapter II Neoplasms,Leiomyoma of uterus,AK1,Adenylate kinase isoenzyme 1,11802,169,1.00 [0.81-1.24],0.9816088813537082
Chapter II Neoplasms,Leiomyoma of uterus,AK2,"Adenylate kinase 2, mitochondrial",10317,147,1.05 [0.91-1.22],0.4961896671913651
Chapter II Neoplasms,Leiomyoma of uterus,AKAP12,A-kinase anchor protein 12,10128,146,1.08 [0.53-2.17],0.8391267404309924
Chapter II Neoplasms,Leiomyoma of uterus,AKR1B1,Aldo-keto reductase family 1 member B1,11526,160,0.96 [0.79-1.16],0.6821858942334738
Chapter II Neoplasms,Leiomyoma of uterus,AKR1B10,Aldo-keto reductase family 1 member B10,10056,144,0.96 [0.73-1.25],0.7530768759124048
Chapter II Neoplasms,Leiomyoma of uterus,AKR1C4,Aldo-keto reductase family 1 member C4,11560,165,1.01 [0.79-1.29],0.9510516324150262
Chapter II Neoplasms,Leiomyoma of uterus,AKR7L,Aflatoxin B1 aldehyde reductase member 4,10039,145,1.08 [0.87-1.35],0.4857212759524281
Chapter II Neoplasms,Leiomyoma of uterus,AKT1S1,Proline-rich AKT1 substrate 1,11512,163,1.10 [0.89-1.36],0.3762399277766688
Chapter II Neoplasms,Leiomyoma of uterus,AKT2,RAC-beta serine/threonine-protein kinase,10311,147,1.02 [0.90-1.16],0.7713880184600702
Chapter II Neoplasms,Leiomyoma of uterus,AKT3,RAC-gamma serine/threonine-protein kinase,11475,159,0.94 [0.73-1.22],0.6558708431890554
Chapter II Neoplasms,Leiomyoma of uterus,ALCAM,CD166 antigen,11938,171,0.67 [0.33-1.36],0.2687563278688065
Chapter II Neoplasms,Leiomyoma of uterus,ALDH1A1,Retinal dehydrogenase 1,11808,165,1.00 [0.78-1.29],0.9984586674665046
Chapter II Neoplasms,Leiomyoma of uterus,ALDH2,"Aldehyde dehydrogenase, mitochondrial",10278,147,1.18 [0.93-1.50],0.1798075196600058
Chapter II Neoplasms,Leiomyoma of uterus,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",11755,170,1.04 [0.86-1.26],0.6938191527800219
Chapter II Neoplasms,Leiomyoma of uterus,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",10311,147,1.15 [0.84-1.58],0.3895614926877734
Chapter II Neoplasms,Leiomyoma of uterus,ALMS1,Alstrom syndrome protein 1,10166,144,0.74 [0.49-1.12],0.1568182684763716
Chapter II Neoplasms,Leiomyoma of uterus,ALPI,Intestinal-type alkaline phosphatase,10039,145,1.03 [0.91-1.18],0.6323750851049827
Chapter II Neoplasms,Leiomyoma of uterus,ALPP,"Alkaline phosphatase, placental type",11744,167,1.14 [0.99-1.31],0.0695491848827909
Chapter II Neoplasms,Leiomyoma of uterus,AMBN,Ameloblastin,11555,165,1.53 [1.10-2.14],0.0126988817734436
Chapter II Neoplasms,Leiomyoma of uterus,AMBP,Protein AMBP,11869,169,0.63 [0.32-1.23],0.1748778415582266
Chapter II Neoplasms,Leiomyoma of uterus,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,10347,149,1.03 [0.56-1.88],0.9359645428443214
Chapter II Neoplasms,Leiomyoma of uterus,AMFR,E3 ubiquitin-protein ligase AMFR,11512,163,1.05 [0.84-1.30],0.6841195726168384
Chapter II Neoplasms,Leiomyoma of uterus,AMIGO1,Amphoterin-induced protein 1,10056,144,0.95 [0.68-1.32],0.7431025917345524
Chapter II Neoplasms,Leiomyoma of uterus,AMIGO2,Amphoterin-induced protein 2,11744,167,0.92 [0.50-1.68],0.7793550150582181
Chapter II Neoplasms,Leiomyoma of uterus,AMN,Protein amnionless,11555,165,1.11 [0.83-1.49],0.4834785643249909
Chapter II Neoplasms,Leiomyoma of uterus,AMOT,Angiomotin,10128,146,1.24 [0.83-1.84],0.2889738386085642
Chapter II Neoplasms,Leiomyoma of uterus,AMOTL2,Angiomotin-like protein 2,10235,145,1.15 [0.86-1.55],0.3419632641513543
Chapter II Neoplasms,Leiomyoma of uterus,AMPD3,AMP deaminase 3,10317,147,1.03 [0.83-1.28],0.7663614339720677
Chapter II Neoplasms,Leiomyoma of uterus,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,9646,142,1.07 [0.78-1.47],0.6626672347585945
Chapter II Neoplasms,Leiomyoma of uterus,AMY2A,Pancreatic alpha-amylase,11313,163,1.07 [0.80-1.44],0.6538992373326071
Chapter II Neoplasms,Leiomyoma of uterus,AMY2B,Alpha-amylase 2B,10990,160,1.07 [0.80-1.44],0.6356047651221589
Chapter II Neoplasms,Leiomyoma of uterus,ANG,Angiogenin,11774,168,0.88 [0.58-1.32],0.5272867659618724
Chapter II Neoplasms,Leiomyoma of uterus,ANGPT1,Angiopoietin-1,11748,166,0.91 [0.77-1.06],0.2344593328146241
Chapter II Neoplasms,Leiomyoma of uterus,ANGPT2,Angiopoietin-2,11889,169,1.07 [0.74-1.55],0.718078441573919
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL1,Angiopoietin-related protein 1,11643,168,0.84 [0.52-1.34],0.4587242787556463
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL2,Angiopoietin-related protein 2,11817,170,1.00 [0.72-1.40],0.9836977652229448
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL3,Angiopoietin-related protein 3,11807,169,1.15 [0.79-1.68],0.4685710859224563
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL4,Angiopoietin-related protein 4,11831,169,0.97 [0.71-1.32],0.8478405577089785
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL7,Angiopoietin-related protein 7,11889,169,1.04 [0.71-1.51],0.8414779915621609
Chapter II Neoplasms,Leiomyoma of uterus,ANK2,Ankyrin-2,10002,147,1.04 [0.85-1.28],0.688596782980837
Chapter II Neoplasms,Leiomyoma of uterus,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,10039,145,0.97 [0.79-1.19],0.790942824396523
Chapter II Neoplasms,Leiomyoma of uterus,ANKRA2,Ankyrin repeat family A protein 2,9961,142,0.99 [0.74-1.31],0.9346658037951554
Chapter II Neoplasms,Leiomyoma of uterus,ANKRD54,Ankyrin repeat domain-containing protein 54,11526,160,1.07 [0.85-1.36],0.5492606365550798
Chapter II Neoplasms,Leiomyoma of uterus,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,10091,145,1.10 [0.78-1.55],0.5924294775989688
Chapter II Neoplasms,Leiomyoma of uterus,ANPEP,Aminopeptidase N,11840,168,1.28 [0.80-2.04],0.2958648113221986
Chapter II Neoplasms,Leiomyoma of uterus,ANXA1,Annexin A1,10065,145,0.91 [0.62-1.34],0.6348716976065704
Chapter II Neoplasms,Leiomyoma of uterus,ANXA10,Annexin A10,11512,163,1.06 [0.90-1.24],0.4799684890096625
Chapter II Neoplasms,Leiomyoma of uterus,ANXA11,Annexin A11,11764,170,1.05 [0.85-1.28],0.6717054259254694
Chapter II Neoplasms,Leiomyoma of uterus,ANXA2,Annexin A2,9931,143,1.09 [0.88-1.35],0.414044977039004
Chapter II Neoplasms,Leiomyoma of uterus,ANXA3,Annexin A3,11867,170,0.97 [0.80-1.18],0.7563549721391363
Chapter II Neoplasms,Leiomyoma of uterus,ANXA4,Annexin A4,11750,168,0.95 [0.79-1.15],0.6194265471010465
Chapter II Neoplasms,Leiomyoma of uterus,ANXA5,Annexin A5,11482,163,1.50 [0.99-2.28],0.0567286926745647
Chapter II Neoplasms,Leiomyoma of uterus,AOC1,Amiloride-sensitive amine oxidase [copper-containing],11555,165,1.13 [0.93-1.38],0.2078471940630611
Chapter II Neoplasms,Leiomyoma of uterus,AOC3,Membrane primary amine oxidase,11855,169,0.86 [0.55-1.36],0.5256723793728233
Chapter II Neoplasms,Leiomyoma of uterus,AP1G2,AP-1 complex subunit gamma-like 2,10278,147,0.99 [0.82-1.21],0.9416707241987252
Chapter II Neoplasms,Leiomyoma of uterus,AP2B1,AP-2 complex subunit beta,10056,144,0.99 [0.71-1.38],0.9554005898098398
Chapter II Neoplasms,Leiomyoma of uterus,AP3B1,AP-3 complex subunit beta-1,10273,150,0.98 [0.80-1.20],0.8401031399412263
Chapter II Neoplasms,Leiomyoma of uterus,AP3S2,AP-3 complex subunit sigma-2,10317,147,1.04 [0.75-1.45],0.8041011124707735
Chapter II Neoplasms,Leiomyoma of uterus,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,11744,167,1.10 [0.82-1.48],0.5332112070958409
Chapter II Neoplasms,Leiomyoma of uterus,APCS,Serum amyloid P-component,10250,148,0.82 [0.52-1.27],0.3746131622214497
Chapter II Neoplasms,Leiomyoma of uterus,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,11844,169,1.05 [0.83-1.32],0.7071503974780433
Chapter II Neoplasms,Leiomyoma of uterus,APLP1,Amyloid-like protein 1,11802,169,0.93 [0.72-1.22],0.6061758654237897
Chapter II Neoplasms,Leiomyoma of uterus,APOA1,Apolipoprotein A-I,10353,149,1.01 [0.57-1.81],0.9664018863477716
Chapter II Neoplasms,Leiomyoma of uterus,APOA2,Apolipoprotein A-II,10335,147,1.05 [0.76-1.44],0.7736554884727461
Chapter II Neoplasms,Leiomyoma of uterus,APOA4,Apolipoprotein A-IV,10353,149,1.01 [0.65-1.57],0.9576986622564412
Chapter II Neoplasms,Leiomyoma of uterus,APOB,Apolipoprotein B-100,10335,147,1.90 [0.95-3.80],0.0685758855837366
Chapter II Neoplasms,Leiomyoma of uterus,APOBR,Apolipoprotein B receptor,10091,145,0.73 [0.51-1.06],0.0944473067330234
Chapter II Neoplasms,Leiomyoma of uterus,APOC1,Apolipoprotein C-I,10332,149,1.09 [0.70-1.70],0.7049033490994778
Chapter II Neoplasms,Leiomyoma of uterus,APOD,Apolipoprotein D,9891,144,1.10 [0.77-1.57],0.6126633496832911
Chapter II Neoplasms,Leiomyoma of uterus,APOE,Apolipoprotein E,10353,149,1.14 [0.96-1.37],0.1353526767736918
Chapter II Neoplasms,Leiomyoma of uterus,APOF,Apolipoprotein F,10335,147,0.82 [0.47-1.43],0.4811202341498622
Chapter II Neoplasms,Leiomyoma of uterus,APOH,Beta-2-glycoprotein 1,11808,165,1.15 [0.79-1.68],0.4736498426892772
Chapter II Neoplasms,Leiomyoma of uterus,APOL1,Apolipoprotein L1,10335,147,1.02 [0.80-1.30],0.8989426717277796
Chapter II Neoplasms,Leiomyoma of uterus,APOM,Apolipoprotein M,11829,169,0.89 [0.53-1.48],0.6448002598724683
Chapter II Neoplasms,Leiomyoma of uterus,APP,Amyloid-beta precursor protein,11797,165,0.90 [0.73-1.11],0.3149609587302689
Chapter II Neoplasms,Leiomyoma of uterus,APPL2,DCC-interacting protein 13-beta,10128,146,0.98 [0.85-1.13],0.7677532757379586
Chapter II Neoplasms,Leiomyoma of uterus,APRT,Adenine phosphoribosyltransferase,11700,168,1.13 [0.84-1.51],0.4128176108301963
Chapter II Neoplasms,Leiomyoma of uterus,ARAF,Serine/threonine-protein kinase A-Raf,10166,144,1.14 [0.91-1.42],0.2649443389401431
Chapter II Neoplasms,Leiomyoma of uterus,AREG,Amphiregulin,11744,167,1.14 [0.84-1.56],0.3962849769085619
Chapter II Neoplasms,Leiomyoma of uterus,ARF6,ADP-ribosylation factor 6,10273,150,0.97 [0.83-1.12],0.6627753871539634
Chapter II Neoplasms,Leiomyoma of uterus,ARFIP1,Arfaptin-1,10311,147,1.10 [0.87-1.38],0.4351759541842266
Chapter II Neoplasms,Leiomyoma of uterus,ARG1,Arginase-1,11730,166,1.06 [0.82-1.38],0.6374695971451063
Chapter II Neoplasms,Leiomyoma of uterus,ARG2,"Arginase-2, mitochondrial",10278,147,1.11 [0.79-1.54],0.553847570746982
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP1,Rho GTPase-activating protein 1,11526,160,1.10 [0.80-1.50],0.5690487386923185
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP25,Rho GTPase-activating protein 25,11526,160,0.95 [0.74-1.22],0.7059705066510292
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP30,Rho GTPase-activating protein 30,10166,144,1.47 [1.08-2.00],0.014996264184667
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP45,Rho GTPase-activating protein 45,10128,146,0.95 [0.78-1.16],0.6050065997606824
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP5,Rho GTPase-activating protein 5,9961,142,1.07 [0.88-1.29],0.5129001626694685
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF1,Rho guanine nucleotide exchange factor 1,10317,147,1.01 [0.85-1.21],0.9110478214197316
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF10,Rho guanine nucleotide exchange factor 10,10311,147,0.96 [0.81-1.14],0.6644295877229165
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF12,Rho guanine nucleotide exchange factor 12,11777,170,0.95 [0.83-1.08],0.4237808639054907
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF5,Rho guanine nucleotide exchange factor 5,9978,146,0.90 [0.71-1.13],0.3666086959201999
Chapter II Neoplasms,Leiomyoma of uterus,ARID3A,AT-rich interactive domain-containing protein 3A,9978,146,0.97 [0.65-1.45],0.8903302292420001
Chapter II Neoplasms,Leiomyoma of uterus,ARID4B,AT-rich interactive domain-containing protein 4B,11512,163,1.32 [1.05-1.65],0.0186104146282321
Chapter II Neoplasms,Leiomyoma of uterus,ARL13B,ADP-ribosylation factor-like protein 13B,10002,147,1.01 [0.81-1.27],0.8980983717735349
Chapter II Neoplasms,Leiomyoma of uterus,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,10002,147,1.23 [0.84-1.81],0.2829822235886579
Chapter II Neoplasms,Leiomyoma of uterus,ARMCX2,Armadillo repeat-containing X-linked protein 2,9978,146,1.29 [1.08-1.55],0.0061253537793684
Chapter II Neoplasms,Leiomyoma of uterus,ARNT,Aryl hydrocarbon receptor nuclear translocator,11555,165,1.02 [0.70-1.49],0.9017884475906798
Chapter II Neoplasms,Leiomyoma of uterus,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,10002,147,1.14 [0.87-1.49],0.3425945931239593
Chapter II Neoplasms,Leiomyoma of uterus,ARSA,Arylsulfatase A,11808,165,0.85 [0.61-1.16],0.304386107683214
Chapter II Neoplasms,Leiomyoma of uterus,ARSB,Arylsulfatase B,11744,167,0.89 [0.69-1.15],0.3792249097380769
Chapter II Neoplasms,Leiomyoma of uterus,ART3,Ecto-ADP-ribosyltransferase 3,11855,169,0.77 [0.51-1.16],0.2128874971974564
Chapter II Neoplasms,Leiomyoma of uterus,ART5,Ecto-ADP-ribosyltransferase 5,9978,146,1.11 [0.90-1.37],0.3353563994013778
Chapter II Neoplasms,Leiomyoma of uterus,ARTN,Artemin,11555,165,1.03 [0.75-1.41],0.8749722833265113
Chapter II Neoplasms,Leiomyoma of uterus,ASAH1,Acid ceramidase,10231,146,0.84 [0.58-1.21],0.3400770498350594
Chapter II Neoplasms,Leiomyoma of uterus,ASAH2,Neutral ceramidase,11718,168,1.15 [0.87-1.52],0.3188852262280735
Chapter II Neoplasms,Leiomyoma of uterus,ASGR1,Asialoglycoprotein receptor 1,11718,168,1.22 [0.76-1.93],0.4095359996182321
Chapter II Neoplasms,Leiomyoma of uterus,ASGR2,Asialoglycoprotein receptor 2,10335,147,1.70 [0.97-2.99],0.0641809439754523
Chapter II Neoplasms,Leiomyoma of uterus,ASPN,Asporin,10334,150,1.35 [0.79-2.29],0.2700534462599604
Chapter II Neoplasms,Leiomyoma of uterus,ASPSCR1,Tether containing UBX domain for GLUT4,10311,147,1.11 [0.88-1.40],0.3920646533843769
Chapter II Neoplasms,Leiomyoma of uterus,ASRGL1,Isoaspartyl peptidase/L-asparaginase,10091,145,0.93 [0.79-1.09],0.3625739208140585
Chapter II Neoplasms,Leiomyoma of uterus,ASS1,Argininosuccinate synthase,10002,147,1.03 [0.84-1.26],0.7771615327000172
Chapter II Neoplasms,Leiomyoma of uterus,ATF2,Cyclic AMP-dependent transcription factor ATF-2,11512,163,0.95 [0.76-1.18],0.6587280986576511
Chapter II Neoplasms,Leiomyoma of uterus,ATF4,Cyclic AMP-dependent transcription factor ATF-4,9961,142,1.18 [0.77-1.81],0.4564771225519415
Chapter II Neoplasms,Leiomyoma of uterus,ATG16L1,Autophagy-related protein 16-1,10273,150,1.05 [0.87-1.27],0.6221357464063106
Chapter II Neoplasms,Leiomyoma of uterus,ATG4A,Cysteine protease ATG4A,11526,160,0.99 [0.78-1.26],0.9516201173387926
Chapter II Neoplasms,Leiomyoma of uterus,ATOX1,Copper transport protein ATOX1,11855,167,0.96 [0.79-1.17],0.6747213445509868
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,10002,147,1.08 [0.80-1.44],0.6160249293132838
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,10002,147,1.17 [0.75-1.84],0.490500354587231
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,10002,147,1.12 [0.77-1.63],0.5598326285881146
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B4,Protein ATP1B4,9961,142,1.32 [0.96-1.82],0.0907674507470599
Chapter II Neoplasms,Leiomyoma of uterus,ATP2B4,Plasma membrane calcium-transporting ATPase 4,10002,147,1.21 [0.98-1.50],0.0793234261082902
Chapter II Neoplasms,Leiomyoma of uterus,ATP5F1D,"ATP synthase subunit delta, mitochondrial",10002,147,1.05 [0.79-1.41],0.7174136425914797
Chapter II Neoplasms,Leiomyoma of uterus,ATP5IF1,"ATPase inhibitor, mitochondrial",11854,170,0.92 [0.82-1.04],0.1866593069880477
Chapter II Neoplasms,Leiomyoma of uterus,ATP5PO,"ATP synthase subunit O, mitochondrial",11512,163,0.97 [0.69-1.37],0.8656995927869087
Chapter II Neoplasms,Leiomyoma of uterus,ATP6AP2,Renin receptor,11526,160,1.12 [0.81-1.54],0.5000833256401509
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1D,V-type proton ATPase subunit D,11744,167,1.02 [0.62-1.70],0.9313910098740498
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1F,V-type proton ATPase subunit F,11493,162,1.19 [0.97-1.45],0.0996298643516416
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1G1,V-type proton ATPase subunit G 1,10091,145,1.11 [0.89-1.38],0.3611319145993794
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1G2,V-type proton ATPase subunit G 2,10002,147,0.97 [0.83-1.14],0.7191599689311816
Chapter II Neoplasms,Leiomyoma of uterus,ATRAID,All-trans retinoic acid-induced differentiation factor,10273,150,1.16 [0.67-1.99],0.6014635813198108
Chapter II Neoplasms,Leiomyoma of uterus,ATRN,"Attractin, Isoform 2",10353,149,1.13 [0.44-2.91],0.8072976715476706
Chapter II Neoplasms,Leiomyoma of uterus,ATXN10,Ataxin-10,11512,163,0.96 [0.79-1.17],0.715853583198772
Chapter II Neoplasms,Leiomyoma of uterus,ATXN2,Ataxin-2,9978,146,1.04 [0.91-1.19],0.5194860574252964
Chapter II Neoplasms,Leiomyoma of uterus,ATXN2L,Ataxin-2-like protein,10311,147,1.06 [0.77-1.47],0.7210210119665688
Chapter II Neoplasms,Leiomyoma of uterus,ATXN3,Ataxin-3,10317,147,1.10 [0.86-1.41],0.4560121246103599
Chapter II Neoplasms,Leiomyoma of uterus,AXIN1,Axin-1,11777,170,0.98 [0.85-1.13],0.7950786353740947
Chapter II Neoplasms,Leiomyoma of uterus,AXL,Tyrosine-protein kinase receptor UFO,11855,169,1.05 [0.64-1.73],0.8515662976727596
Chapter II Neoplasms,Leiomyoma of uterus,AZI2,5-azacytidine-induced protein 2,10311,147,0.92 [0.69-1.23],0.5616541037629814
Chapter II Neoplasms,Leiomyoma of uterus,AZU1,Azurocidin,11426,167,0.88 [0.73-1.07],0.1914365196648563
Chapter II Neoplasms,Leiomyoma of uterus,B2M,Beta-2-microglobulin,10353,149,1.49 [1.10-2.00],0.009108455573617
Chapter II Neoplasms,Leiomyoma of uterus,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,10002,147,1.56 [0.83-2.96],0.1708380735539895
Chapter II Neoplasms,Leiomyoma of uterus,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",10091,145,0.98 [0.63-1.53],0.9297556971526082
Chapter II Neoplasms,Leiomyoma of uterus,B4GALT1,"Beta-1,4-galactosyltransferase 1",11854,170,1.53 [0.95-2.48],0.0831246011921998
Chapter II Neoplasms,Leiomyoma of uterus,B4GAT1,"Beta-1,4-glucuronyltransferase 1",11808,165,0.51 [0.29-0.92],0.0247107984849435
Chapter II Neoplasms,Leiomyoma of uterus,BABAM1,BRISC and BRCA1-A complex member 1,10039,145,0.92 [0.52-1.62],0.7725326996186285
Chapter II Neoplasms,Leiomyoma of uterus,BACH1,Transcription regulator protein BACH1,11777,170,0.94 [0.78-1.14],0.5393757949371798
Chapter II Neoplasms,Leiomyoma of uterus,BAG3,BAG family molecular chaperone regulator 3,11703,167,0.92 [0.66-1.29],0.6282731131961402
Chapter II Neoplasms,Leiomyoma of uterus,BAG4,BAG family molecular chaperone regulator 4,10039,145,1.18 [0.86-1.61],0.2973454684149249
Chapter II Neoplasms,Leiomyoma of uterus,BAG6,Large proline-rich protein BAG6,11560,165,0.77 [0.51-1.15],0.1949504541701204
Chapter II Neoplasms,Leiomyoma of uterus,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,11526,160,1.09 [0.88-1.36],0.4107320607881195
Chapter II Neoplasms,Leiomyoma of uterus,BAMBI,BMP and activin membrane-bound inhibitor homolog,11526,160,1.23 [0.78-1.96],0.3707041012149629
Chapter II Neoplasms,Leiomyoma of uterus,BANK1,B-cell scaffold protein with ankyrin repeats,11777,170,0.99 [0.87-1.12],0.8436241667327414
Chapter II Neoplasms,Leiomyoma of uterus,BAP18,Chromatin complexes subunit BAP18,10317,147,1.11 [0.90-1.38],0.3258855636262835
Chapter II Neoplasms,Leiomyoma of uterus,BATF,Basic leucine zipper transcriptional factor ATF-like,10056,144,0.85 [0.68-1.06],0.1541496367790837
Chapter II Neoplasms,Leiomyoma of uterus,BAX,Apoptosis regulator BAX,11496,163,1.00 [0.85-1.18],0.9579781428422726
Chapter II Neoplasms,Leiomyoma of uterus,BCAM,Basal cell adhesion molecule,11808,165,1.07 [0.60-1.91],0.8218708012895921
Chapter II Neoplasms,Leiomyoma of uterus,BCAN,Brevican core protein,11718,168,0.82 [0.55-1.23],0.3380953096429582
Chapter II Neoplasms,Leiomyoma of uterus,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",10334,150,1.26 [0.79-2.03],0.3359301463129072
Chapter II Neoplasms,Leiomyoma of uterus,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",9978,146,1.12 [0.85-1.46],0.4235137508233241
Chapter II Neoplasms,Leiomyoma of uterus,BCHE,Cholinesterase,10155,147,0.69 [0.45-1.05],0.085143366192429
Chapter II Neoplasms,Leiomyoma of uterus,BCL2,Apoptosis regulator Bcl-2,10273,150,1.15 [0.91-1.46],0.2512834415878265
Chapter II Neoplasms,Leiomyoma of uterus,BCL2L1,Bcl-2-like protein 1,10317,147,1.00 [0.85-1.17],0.9892611898245098
Chapter II Neoplasms,Leiomyoma of uterus,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",11777,170,0.84 [0.63-1.13],0.2494759519192247
Chapter II Neoplasms,Leiomyoma of uterus,BCL2L15,Bcl-2-like protein 15,10039,145,1.01 [0.77-1.32],0.9552019545462916
Chapter II Neoplasms,Leiomyoma of uterus,BCL7A,B-cell CLL/lymphoma 7 protein family member A,9961,142,1.04 [0.81-1.32],0.7776365749454841
Chapter II Neoplasms,Leiomyoma of uterus,BCL7B,B-cell CLL/lymphoma 7 protein family member B,10278,147,1.37 [1.03-1.82],0.0286181485232534
Chapter II Neoplasms,Leiomyoma of uterus,BCR,Breakpoint cluster region protein,11777,170,0.95 [0.81-1.10],0.4897124373093693
Chapter II Neoplasms,Leiomyoma of uterus,BDNF,Brain-derived neurotrophic factor,10347,149,1.03 [0.85-1.24],0.7912167353451682
Chapter II Neoplasms,Leiomyoma of uterus,BECN1,Beclin-1,10091,145,1.14 [0.88-1.48],0.3084122614427624
Chapter II Neoplasms,Leiomyoma of uterus,BEX3,Protein BEX3,9961,142,1.28 [0.99-1.65],0.0578055436163781
Chapter II Neoplasms,Leiomyoma of uterus,BGLAP,Osteocalcin,10347,149,1.11 [0.93-1.31],0.2525318218598653
Chapter II Neoplasms,Leiomyoma of uterus,BGN,Biglycan,11499,160,0.99 [0.88-1.11],0.8894727668884443
Chapter II Neoplasms,Leiomyoma of uterus,BHLHE40,Class E basic helix-loop-helix protein 40,9978,146,1.18 [0.97-1.44],0.0973803054182763
Chapter II Neoplasms,Leiomyoma of uterus,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,10002,147,1.68 [0.90-3.16],0.1062032261837589
Chapter II Neoplasms,Leiomyoma of uterus,BID,BH3-interacting domain death agonist,11777,170,1.05 [0.87-1.28],0.6058547832811274
Chapter II Neoplasms,Leiomyoma of uterus,BIN2,Bridging integrator 2,11808,165,0.94 [0.81-1.10],0.4436852454243611
Chapter II Neoplasms,Leiomyoma of uterus,BIRC2,Baculoviral IAP repeat-containing protein 2,11526,160,1.16 [0.93-1.44],0.2024537209344202
Chapter II Neoplasms,Leiomyoma of uterus,BLMH,Bleomycin hydrolase,11938,171,0.68 [0.48-0.97],0.0357696675440211
Chapter II Neoplasms,Leiomyoma of uterus,BLNK,B-cell linker protein,10039,145,1.22 [0.85-1.73],0.2778321197375555
Chapter II Neoplasms,Leiomyoma of uterus,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,9978,146,1.09 [0.90-1.33],0.3785195901349562
Chapter II Neoplasms,Leiomyoma of uterus,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,10317,147,0.90 [0.60-1.35],0.6231551190402103
Chapter II Neoplasms,Leiomyoma of uterus,BLVRB,Flavin reductase,11808,165,1.07 [0.88-1.31],0.4810055397750572
Chapter II Neoplasms,Leiomyoma of uterus,BMP10,Bone morphogenetic protein 10,10128,146,1.33 [0.75-2.34],0.3252654470220185
Chapter II Neoplasms,Leiomyoma of uterus,BMP4,Bone morphogenetic protein 4,11703,167,0.79 [0.58-1.09],0.1516695851500422
Chapter II Neoplasms,Leiomyoma of uterus,BMP6,Bone morphogenetic protein 6,11544,164,1.30 [0.92-1.81],0.13258678990331
Chapter II Neoplasms,Leiomyoma of uterus,BMPER,BMP-binding endothelial regulator protein,10128,146,0.99 [0.48-2.02],0.9739919066383764
Chapter II Neoplasms,Leiomyoma of uterus,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,10334,150,1.36 [0.91-2.04],0.1303922010889981
Chapter II Neoplasms,Leiomyoma of uterus,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,10039,145,1.25 [0.89-1.77],0.199726830017269
Chapter II Neoplasms,Leiomyoma of uterus,BOC,Brother of CDO,11560,165,1.05 [0.57-1.90],0.8845954997540363
Chapter II Neoplasms,Leiomyoma of uterus,BOLA1,BolA-like protein 1,9978,146,1.09 [0.82-1.45],0.5321805324806749
Chapter II Neoplasms,Leiomyoma of uterus,BOLA2_BOLA2B,BolA-like protein 2,10091,145,1.13 [0.84-1.51],0.4111755415938735
Chapter II Neoplasms,Leiomyoma of uterus,BPIFA2,BPI fold-containing family A member 2,9715,143,0.96 [0.83-1.11],0.5952285283786128
Chapter II Neoplasms,Leiomyoma of uterus,BPIFB1,BPI fold-containing family B member 1,11751,168,1.04 [0.83-1.31],0.7099696099986776
Chapter II Neoplasms,Leiomyoma of uterus,BPIFB2,BPI fold-containing family B member 2,10311,150,0.93 [0.74-1.16],0.5110217982796081
Chapter II Neoplasms,Leiomyoma of uterus,BRAP,BRCA1-associated protein,10176,150,1.02 [0.88-1.19],0.7651623742821079
Chapter II Neoplasms,Leiomyoma of uterus,BRD1,Bromodomain-containing protein 1,10166,144,0.99 [0.59-1.65],0.9702609682562764
Chapter II Neoplasms,Leiomyoma of uterus,BRD2,Bromodomain-containing protein 2,9978,146,1.09 [0.71-1.67],0.7080562072557073
Chapter II Neoplasms,Leiomyoma of uterus,BRD3,Bromodomain-containing protein 3,10002,147,1.03 [0.75-1.42],0.8568601758583925
Chapter II Neoplasms,Leiomyoma of uterus,BRDT,Bromodomain testis-specific protein,10002,147,0.77 [0.49-1.21],0.2581159246311987
Chapter II Neoplasms,Leiomyoma of uterus,BRK1,Protein BRICK1,11512,163,0.86 [0.62-1.19],0.3608879499619229
Chapter II Neoplasms,Leiomyoma of uterus,BRME1,Break repair meiotic recombinase recruitment factor 1,9978,146,1.00 [0.69-1.44],0.9791954146967756
Chapter II Neoplasms,Leiomyoma of uterus,BRSK2,Serine/threonine-protein kinase BRSK2,10311,147,1.34 [0.94-1.90],0.1023974533153636
Chapter II Neoplasms,Leiomyoma of uterus,BSG,Basigin,11894,170,1.03 [0.54-1.97],0.929171109182752
Chapter II Neoplasms,Leiomyoma of uterus,BSND,Barttin,9961,142,1.00 [0.62-1.61],0.9839166297828033
Chapter II Neoplasms,Leiomyoma of uterus,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,11892,170,0.98 [0.74-1.30],0.8959833723084484
Chapter II Neoplasms,Leiomyoma of uterus,BST2,Bone marrow stromal antigen 2,11892,170,1.12 [0.88-1.43],0.3664981978159709
Chapter II Neoplasms,Leiomyoma of uterus,BTC,Probetacellulin,11526,160,1.15 [0.97-1.37],0.0967044891736601
Chapter II Neoplasms,Leiomyoma of uterus,BTD,Biotinidase,10353,149,1.04 [0.49-2.24],0.9113061472787458
Chapter II Neoplasms,Leiomyoma of uterus,BTLA,B- and T-lymphocyte attenuator,9961,142,1.08 [0.92-1.27],0.3649831212012855
Chapter II Neoplasms,Leiomyoma of uterus,BTN1A1,Butyrophilin subfamily 1 member A1,10257,147,1.21 [0.90-1.63],0.2052797295248372
Chapter II Neoplasms,Leiomyoma of uterus,BTN2A1,Butyrophilin subfamily 2 member A1,11854,170,1.08 [0.64-1.80],0.7835582009333468
Chapter II Neoplasms,Leiomyoma of uterus,BTN3A2,Butyrophilin subfamily 3 member A2,11777,170,1.49 [1.07-2.08],0.0181523873943146
Chapter II Neoplasms,Leiomyoma of uterus,BTNL10,Butyrophilin-like protein 10,9961,142,0.90 [0.59-1.37],0.611534573975077
Chapter II Neoplasms,Leiomyoma of uterus,C19orf12,Protein C19orf12,11512,163,1.01 [0.82-1.26],0.9065930659913424
Chapter II Neoplasms,Leiomyoma of uterus,C1GALT1C1,C1GALT1-specific chaperone 1,10002,147,0.78 [0.46-1.32],0.3571030710310304
Chapter II Neoplasms,Leiomyoma of uterus,C1QA,Complement C1q subcomponent subunit A,11852,169,0.76 [0.40-1.42],0.3884342552332988
Chapter II Neoplasms,Leiomyoma of uterus,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",10311,147,0.89 [0.69-1.15],0.3650475783227288
Chapter II Neoplasms,Leiomyoma of uterus,C1QL2,Complement C1q-like protein 2,10039,145,1.14 [0.81-1.60],0.4617007800558559
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,11855,169,0.81 [0.59-1.12],0.2093406419386888
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,10128,146,0.71 [0.49-1.04],0.0811696694147521
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,10311,147,1.23 [0.78-1.92],0.3693906145422048
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,10106,146,0.77 [0.56-1.04],0.0883878899744804
Chapter II Neoplasms,Leiomyoma of uterus,C1R,Complement C1r subcomponent,10353,149,1.32 [0.63-2.74],0.4621134463982002
Chapter II Neoplasms,Leiomyoma of uterus,C1RL,Complement C1r subcomponent-like protein,10337,149,0.65 [0.30-1.40],0.2687978732933094
Chapter II Neoplasms,Leiomyoma of uterus,C1S,Complement C1s subcomponent,10353,149,1.31 [0.62-2.79],0.4843632700034559
Chapter II Neoplasms,Leiomyoma of uterus,C2,Complement C2,11829,169,0.51 [0.33-0.78],0.0022776074190231
Chapter II Neoplasms,Leiomyoma of uterus,C2CD2L,Phospholipid transfer protein C2CD2L,11493,162,1.33 [1.01-1.74],0.0392494979042037
Chapter II Neoplasms,Leiomyoma of uterus,C2orf69,UPF0565 protein C2orf69,10056,144,0.99 [0.74-1.30],0.920269562590454
Chapter II Neoplasms,Leiomyoma of uterus,C3,Complement C3,9806,143,1.08 [0.77-1.53],0.6491733591412392
Chapter II Neoplasms,Leiomyoma of uterus,C4BPB,C4b-binding protein beta chain,11855,167,0.67 [0.48-0.94],0.0198804365478863
Chapter II Neoplasms,Leiomyoma of uterus,C5,Complement C5,10353,149,1.07 [0.38-2.99],0.9008701099382695
Chapter II Neoplasms,Leiomyoma of uterus,C7,Complement component C7,10095,146,1.97 [1.18-3.28],0.0097527987042166
Chapter II Neoplasms,Leiomyoma of uterus,C7orf50,Uncharacterized protein C7orf50,10317,147,1.34 [0.77-2.34],0.301938438238544
Chapter II Neoplasms,Leiomyoma of uterus,C8B,Complement component C8 beta chain,10353,149,0.59 [0.35-0.98],0.0408546249200469
Chapter II Neoplasms,Leiomyoma of uterus,C9,Complement component C9,10335,147,0.76 [0.56-1.03],0.0783597251072527
Chapter II Neoplasms,Leiomyoma of uterus,C9orf40,Uncharacterized protein C9orf40,10273,150,1.07 [0.89-1.29],0.4460044728186944
Chapter II Neoplasms,Leiomyoma of uterus,CA1,Carbonic anhydrase 1,11543,168,1.00 [0.80-1.23],0.9636558342453354
Chapter II Neoplasms,Leiomyoma of uterus,CA11,Carbonic anhydrase-related protein 11,11526,160,1.14 [0.79-1.63],0.494470476785431
Chapter II Neoplasms,Leiomyoma of uterus,CA12,Carbonic anhydrase 12,11744,167,1.28 [0.84-1.94],0.2466914167440362
Chapter II Neoplasms,Leiomyoma of uterus,CA13,Carbonic anhydrase 13,11699,169,0.99 [0.86-1.13],0.830559664854304
Chapter II Neoplasms,Leiomyoma of uterus,CA14,Carbonic anhydrase 14,11889,169,1.24 [0.84-1.83],0.2846824932149263
Chapter II Neoplasms,Leiomyoma of uterus,CA2,Carbonic anhydrase 2,11764,165,0.99 [0.82-1.19],0.8941170754027123
Chapter II Neoplasms,Leiomyoma of uterus,CA3,Carbonic anhydrase 3,11918,171,1.08 [0.87-1.34],0.4975796739323239
Chapter II Neoplasms,Leiomyoma of uterus,CA4,Carbonic anhydrase 4,11938,171,1.17 [0.66-2.08],0.5856261413817745
Chapter II Neoplasms,Leiomyoma of uterus,CA5A,"Carbonic anhydrase 5A, mitochondrial",11560,165,1.09 [0.94-1.26],0.2712641974679464
Chapter II Neoplasms,Leiomyoma of uterus,CA6,Carbonic anhydrase 6,11767,165,0.80 [0.64-1.00],0.0487118939960721
Chapter II Neoplasms,Leiomyoma of uterus,CA7,Carbonic anhydrase 7,10166,144,0.57 [0.34-0.96],0.035904772038661
Chapter II Neoplasms,Leiomyoma of uterus,CA8,Carbonic anhydrase-related protein,10039,145,0.85 [0.44-1.64],0.6255585262608456
Chapter II Neoplasms,Leiomyoma of uterus,CA9,Carbonic anhydrase 9,11889,169,1.16 [0.88-1.53],0.2901272964149205
Chapter II Neoplasms,Leiomyoma of uterus,CABP2,Calcium-binding protein 2,10056,144,0.98 [0.76-1.25],0.8509181806592319
Chapter II Neoplasms,Leiomyoma of uterus,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,9978,146,1.28 [0.85-1.93],0.24151093188591
Chapter II Neoplasms,Leiomyoma of uterus,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,10002,147,1.01 [0.78-1.31],0.9119154623799706
Chapter II Neoplasms,Leiomyoma of uterus,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,9978,146,1.19 [0.94-1.51],0.1415527600005934
Chapter II Neoplasms,Leiomyoma of uterus,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,10311,147,1.10 [0.91-1.32],0.3378674405649373
Chapter II Neoplasms,Leiomyoma of uterus,CACYBP,Calcyclin-binding protein,10112,145,0.99 [0.85-1.16],0.9114308756452472
Chapter II Neoplasms,Leiomyoma of uterus,CADPS,Calcium-dependent secretion activator 1,10056,144,1.35 [1.01-1.79],0.0411710009849156
Chapter II Neoplasms,Leiomyoma of uterus,CALB1,Calbindin,11744,167,0.87 [0.64-1.17],0.3493321025534847
Chapter II Neoplasms,Leiomyoma of uterus,CALB2,Calretinin,11512,163,1.17 [0.81-1.68],0.4022506138632415
Chapter II Neoplasms,Leiomyoma of uterus,CALCA,Calcitonin,11699,167,1.03 [0.81-1.33],0.7904266413034103
Chapter II Neoplasms,Leiomyoma of uterus,CALCB,Calcitonin gene-related peptide 2,10317,147,1.17 [0.81-1.68],0.3938487005843384
Chapter II Neoplasms,Leiomyoma of uterus,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,11848,168,0.95 [0.83-1.08],0.4391579211655099
Chapter II Neoplasms,Leiomyoma of uterus,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,10091,145,1.01 [0.82-1.25],0.910880303893164
Chapter II Neoplasms,Leiomyoma of uterus,CALY,Neuron-specific vesicular protein calcyon,10002,147,0.98 [0.65-1.48],0.9212588080089952
Chapter II Neoplasms,Leiomyoma of uterus,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,11526,160,0.96 [0.69-1.34],0.8247866393826762
Chapter II Neoplasms,Leiomyoma of uterus,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,10056,144,0.85 [0.62-1.17],0.321686926711422
Chapter II Neoplasms,Leiomyoma of uterus,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,10311,147,1.01 [0.87-1.17],0.9102847716879194
Chapter II Neoplasms,Leiomyoma of uterus,CANT1,Soluble calcium-activated nucleotidase 1,11761,169,0.81 [0.42-1.59],0.549664112623247
Chapter II Neoplasms,Leiomyoma of uterus,CAPG,Macrophage-capping protein,11687,166,1.23 [0.98-1.54],0.0733482223322995
Chapter II Neoplasms,Leiomyoma of uterus,CAPN3,Calpain-3,10278,147,0.98 [0.64-1.49],0.9185311987439608
Chapter II Neoplasms,Leiomyoma of uterus,CAPS,Calcyphosin,10317,147,1.02 [0.88-1.18],0.7886710978314576
Chapter II Neoplasms,Leiomyoma of uterus,CARHSP1,Calcium-regulated heat-stable protein 1,11512,163,1.18 [0.92-1.52],0.1848105270478308
Chapter II Neoplasms,Leiomyoma of uterus,CASC3,Protein CASC3,10056,144,1.08 [0.74-1.59],0.688785354041341
Chapter II Neoplasms,Leiomyoma of uterus,CASP1,Caspase-1,11512,163,1.12 [0.93-1.35],0.234345851319608
Chapter II Neoplasms,Leiomyoma of uterus,CASP10,Caspase-10,11512,163,1.08 [0.88-1.31],0.4641033933716171
Chapter II Neoplasms,Leiomyoma of uterus,CASP2,Caspase-2,11777,170,0.99 [0.81-1.21],0.908053877811099
Chapter II Neoplasms,Leiomyoma of uterus,CASP3,Caspase-3,11938,171,0.98 [0.84-1.15],0.8206128067105313
Chapter II Neoplasms,Leiomyoma of uterus,CASP4,Caspase-4,10166,144,0.97 [0.88-1.07],0.5122480343209013
Chapter II Neoplasms,Leiomyoma of uterus,CASP7,Caspase-7,10317,147,0.97 [0.80-1.17],0.7379280749911885
Chapter II Neoplasms,Leiomyoma of uterus,CASP8,Caspase-8,11847,169,0.98 [0.78-1.22],0.8330073841143897
Chapter II Neoplasms,Leiomyoma of uterus,CASP9,Caspase-9,10039,145,0.97 [0.74-1.26],0.7989750287741091
Chapter II Neoplasms,Leiomyoma of uterus,CASQ2,Calsequestrin-2,10002,147,0.86 [0.59-1.24],0.4080559141904488
Chapter II Neoplasms,Leiomyoma of uterus,CAT,Catalase,10181,145,1.16 [0.88-1.53],0.29101867518617
Chapter II Neoplasms,Leiomyoma of uterus,CBLIF,Cobalamin binding intrinsic factor,11779,169,1.11 [0.93-1.33],0.2458556985695233
Chapter II Neoplasms,Leiomyoma of uterus,CBLN1,Cerebellin-1,9978,146,1.07 [0.93-1.24],0.3492129662461338
Chapter II Neoplasms,Leiomyoma of uterus,CBLN4,Cerebellin-4,11889,169,0.95 [0.62-1.46],0.8294711708369189
Chapter II Neoplasms,Leiomyoma of uterus,CBS,Cystathionine beta-synthase,10091,145,1.04 [0.77-1.41],0.792919717361927
Chapter II Neoplasms,Leiomyoma of uterus,CBX2,Chromobox protein homolog 2,10002,147,1.02 [0.69-1.50],0.9180115745841873
Chapter II Neoplasms,Leiomyoma of uterus,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,11718,168,1.04 [0.87-1.25],0.6648624065110498
Chapter II Neoplasms,Leiomyoma of uterus,CCAR2,Cell cycle and apoptosis regulator protein 2,10317,147,1.15 [0.91-1.45],0.242892145665726
Chapter II Neoplasms,Leiomyoma of uterus,CCDC134,Coiled-coil domain-containing protein 134,10278,147,1.15 [0.85-1.56],0.3741347331697657
Chapter II Neoplasms,Leiomyoma of uterus,CCDC28A,Coiled-coil domain-containing protein 28A,10056,144,0.72 [0.42-1.25],0.2435781249585076
Chapter II Neoplasms,Leiomyoma of uterus,CCDC50,Coiled-coil domain-containing protein 50,10311,147,1.13 [0.94-1.35],0.1833948068642265
Chapter II Neoplasms,Leiomyoma of uterus,CCDC80,Coiled-coil domain-containing protein 80,11802,169,1.12 [0.78-1.61],0.5349805637613679
Chapter II Neoplasms,Leiomyoma of uterus,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,10091,145,1.01 [0.78-1.30],0.9629048012539416
Chapter II Neoplasms,Leiomyoma of uterus,CCL11,Eotaxin,11910,170,0.86 [0.59-1.25],0.4351407142221566
Chapter II Neoplasms,Leiomyoma of uterus,CCL13,C-C motif chemokine 13,11887,170,0.92 [0.75-1.12],0.385527885881517
Chapter II Neoplasms,Leiomyoma of uterus,CCL14,C-C motif chemokine 14,11774,168,1.10 [0.78-1.54],0.5971044272389674
Chapter II Neoplasms,Leiomyoma of uterus,CCL15,C-C motif chemokine 15,11938,171,1.16 [0.86-1.55],0.3372314599736519
Chapter II Neoplasms,Leiomyoma of uterus,CCL16,C-C motif chemokine 16,11938,171,1.00 [0.77-1.29],0.9927380741368006
Chapter II Neoplasms,Leiomyoma of uterus,CCL17,C-C motif chemokine 17,11784,168,0.93 [0.80-1.08],0.338298248956982
Chapter II Neoplasms,Leiomyoma of uterus,CCL18,C-C motif chemokine 18,11636,167,0.78 [0.63-0.97],0.0286478106046694
Chapter II Neoplasms,Leiomyoma of uterus,CCL19,C-C motif chemokine 19,11892,170,1.00 [0.91-1.10],0.9870340125744824
Chapter II Neoplasms,Leiomyoma of uterus,CCL2,C-C motif chemokine 2,11703,167,0.89 [0.69-1.15],0.3734110931856308
Chapter II Neoplasms,Leiomyoma of uterus,CCL20,C-C motif chemokine 20,11910,170,0.98 [0.85-1.14],0.8186389839526359
Chapter II Neoplasms,Leiomyoma of uterus,CCL21,C-C motif chemokine 21,11854,170,1.03 [0.76-1.38],0.8620554683914999
Chapter II Neoplasms,Leiomyoma of uterus,CCL22,C-C motif chemokine 22,11704,167,0.94 [0.72-1.22],0.6295646422516288
Chapter II Neoplasms,Leiomyoma of uterus,CCL23,C-C motif chemokine 23,11854,170,1.22 [0.89-1.69],0.223041328067194
Chapter II Neoplasms,Leiomyoma of uterus,CCL24,C-C motif chemokine 24,11831,169,1.01 [0.86-1.19],0.9248720404416428
Chapter II Neoplasms,Leiomyoma of uterus,CCL25,C-C motif chemokine 25,11910,170,1.10 [0.83-1.47],0.4983155885564952
Chapter II Neoplasms,Leiomyoma of uterus,CCL26,C-C motif chemokine 26,11777,170,0.90 [0.77-1.06],0.2086319351873927
Chapter II Neoplasms,Leiomyoma of uterus,CCL27,C-C motif chemokine 27,11802,169,1.23 [0.97-1.56],0.0855726021476459
Chapter II Neoplasms,Leiomyoma of uterus,CCL28,C-C motif chemokine 28,11734,169,0.95 [0.75-1.20],0.6593455832288128
Chapter II Neoplasms,Leiomyoma of uterus,CCL3,C-C motif chemokine 3,11777,170,1.03 [0.82-1.29],0.8058188162122992
Chapter II Neoplasms,Leiomyoma of uterus,CCL4,C-C motif chemokine 4,11821,169,1.02 [0.84-1.22],0.8693492544073317
Chapter II Neoplasms,Leiomyoma of uterus,CCL5,C-C motif chemokine 5,11855,169,0.92 [0.80-1.05],0.22578107244317
Chapter II Neoplasms,Leiomyoma of uterus,CCL7,C-C motif chemokine 7,11777,170,0.92 [0.72-1.16],0.4791079269117356
Chapter II Neoplasms,Leiomyoma of uterus,CCL8,C-C motif chemokine 8,11869,169,0.89 [0.72-1.11],0.310498206093133
Chapter II Neoplasms,Leiomyoma of uterus,CCN1,CCN family member 1,11717,167,1.16 [0.96-1.39],0.1284443023371654
Chapter II Neoplasms,Leiomyoma of uterus,CCN2,CCN family member 2,11782,167,0.93 [0.73-1.19],0.5690432787547336
Chapter II Neoplasms,Leiomyoma of uterus,CCN3,CCN family member 3,11919,171,0.93 [0.62-1.38],0.7006240881986845
Chapter II Neoplasms,Leiomyoma of uterus,CCN4,CCN family member 4,11889,169,1.25 [0.91-1.72],0.1619196254269677
Chapter II Neoplasms,Leiomyoma of uterus,CCN5,CCN family member 5,11808,165,1.16 [0.81-1.65],0.4235200229344446
Chapter II Neoplasms,Leiomyoma of uterus,CCND2,G1/S-specific cyclin-D2,10166,144,0.72 [0.48-1.09],0.1170601924105282
Chapter II Neoplasms,Leiomyoma of uterus,CCNE1,G1/S-specific cyclin-E1,10039,145,1.11 [0.96-1.29],0.1710545338903057
Chapter II Neoplasms,Leiomyoma of uterus,CCS,Copper chaperone for superoxide dismutase,11718,168,1.03 [0.78-1.37],0.8130375653758195
Chapter II Neoplasms,Leiomyoma of uterus,CCT5,T-complex protein 1 subunit epsilon,11526,160,0.99 [0.73-1.36],0.9681514098809152
Chapter II Neoplasms,Leiomyoma of uterus,CD101,Immunoglobulin superfamily member 2,10273,150,0.93 [0.65-1.34],0.713409332605595
Chapter II Neoplasms,Leiomyoma of uterus,CD109,CD109 antigen,11808,165,1.02 [0.67-1.54],0.939683816059614
Chapter II Neoplasms,Leiomyoma of uterus,CD14,Monocyte differentiation antigen CD14,11573,168,0.82 [0.58-1.15],0.2419183265993934
Chapter II Neoplasms,Leiomyoma of uterus,CD160,CD160 antigen,11910,170,1.13 [0.86-1.50],0.3800676642387675
Chapter II Neoplasms,Leiomyoma of uterus,CD163,Scavenger receptor cysteine-rich type 1 protein M130,11855,169,0.92 [0.67-1.28],0.6318795279849102
Chapter II Neoplasms,Leiomyoma of uterus,CD164,Sialomucin core protein 24,11808,165,0.79 [0.45-1.40],0.4168594240962422
Chapter II Neoplasms,Leiomyoma of uterus,CD164L2,CD164 sialomucin-like 2 protein,10056,144,0.82 [0.52-1.30],0.4042145969125396
Chapter II Neoplasms,Leiomyoma of uterus,CD177,CD177 antigen,11792,164,0.97 [0.88-1.08],0.6341528829526286
Chapter II Neoplasms,Leiomyoma of uterus,CD1C,T-cell surface glycoprotein CD1c,11855,167,0.86 [0.49-1.49],0.5825897374395725
Chapter II Neoplasms,Leiomyoma of uterus,CD2,T-cell surface antigen CD2,10002,147,0.76 [0.47-1.22],0.2544495098716224
Chapter II Neoplasms,Leiomyoma of uterus,CD200,OX-2 membrane glycoprotein,11777,170,0.87 [0.51-1.46],0.5871221783030561
Chapter II Neoplasms,Leiomyoma of uterus,CD200R1,Cell surface glycoprotein CD200 receptor 1,11740,170,0.90 [0.60-1.33],0.5867373647772733
Chapter II Neoplasms,Leiomyoma of uterus,CD207,C-type lectin domain family 4 member K,11525,161,1.11 [0.78-1.60],0.5602495201219626
Chapter II Neoplasms,Leiomyoma of uterus,CD209,CD209 antigen,11829,170,1.01 [0.71-1.42],0.970161275828596
Chapter II Neoplasms,Leiomyoma of uterus,CD22,B-cell receptor CD22,11910,170,1.00 [0.73-1.39],0.9760065102807108
Chapter II Neoplasms,Leiomyoma of uterus,CD226,CD226 antigen,10039,145,0.94 [0.64-1.38],0.7515958170334825
Chapter II Neoplasms,Leiomyoma of uterus,CD244,Natural killer cell receptor 2B4,11910,170,1.05 [0.63-1.75],0.8444118985060294
Chapter II Neoplasms,Leiomyoma of uterus,CD248,Endosialin,10347,149,0.96 [0.65-1.42],0.848604715661119
Chapter II Neoplasms,Leiomyoma of uterus,CD27,CD27 antigen,11855,167,1.16 [0.84-1.60],0.3686536547188144
Chapter II Neoplasms,Leiomyoma of uterus,CD274,Programmed cell death 1 ligand 1,11718,168,0.88 [0.59-1.33],0.5476825622693403
Chapter II Neoplasms,Leiomyoma of uterus,CD276,CD276 antigen,11797,169,0.86 [0.59-1.25],0.4156588047507624
Chapter II Neoplasms,Leiomyoma of uterus,CD28,T-cell-specific surface glycoprotein CD28,11526,160,0.93 [0.63-1.37],0.7037173526853027
Chapter II Neoplasms,Leiomyoma of uterus,CD2AP,CD2-associated protein,11802,169,0.90 [0.72-1.11],0.3107434598063818
Chapter II Neoplasms,Leiomyoma of uterus,CD300A,CMRF35-like molecule 8,10128,146,1.13 [0.67-1.90],0.6534092953722443
Chapter II Neoplasms,Leiomyoma of uterus,CD300C,CMRF35-like molecule 6,11892,170,1.13 [0.77-1.66],0.5420427976751093
Chapter II Neoplasms,Leiomyoma of uterus,CD300E,CMRF35-like molecule 2,11839,167,1.07 [0.77-1.50],0.6703970943691973
Chapter II Neoplasms,Leiomyoma of uterus,CD300LF,CMRF35-like molecule 1,11889,169,0.88 [0.72-1.09],0.252992434611794
Chapter II Neoplasms,Leiomyoma of uterus,CD300LG,CMRF35-like molecule 9,11808,165,1.02 [0.70-1.47],0.9303632190479404
Chapter II Neoplasms,Leiomyoma of uterus,CD302,CD302 antigen,11744,167,1.44 [0.93-2.22],0.0986598732016955
Chapter II Neoplasms,Leiomyoma of uterus,CD33,Myeloid cell surface antigen CD33,11855,167,0.91 [0.77-1.07],0.2658676151594056
Chapter II Neoplasms,Leiomyoma of uterus,CD34,Hematopoietic progenitor cell antigen CD34,11864,169,1.07 [0.61-1.89],0.8102489065046838
Chapter II Neoplasms,Leiomyoma of uterus,CD36,Platelet glycoprotein 4,10039,145,1.01 [0.70-1.45],0.9622928116068896
Chapter II Neoplasms,Leiomyoma of uterus,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,11744,167,1.09 [0.71-1.69],0.6829120471958212
Chapter II Neoplasms,Leiomyoma of uterus,CD3D,T-cell surface glycoprotein CD3 delta chain,9978,146,1.45 [1.01-2.10],0.0456427522630174
Chapter II Neoplasms,Leiomyoma of uterus,CD3E,T-cell surface glycoprotein CD3 epsilon chain,10166,144,0.84 [0.52-1.36],0.4739316730754924
Chapter II Neoplasms,Leiomyoma of uterus,CD3G,T-cell surface glycoprotein CD3 gamma chain,10039,145,1.05 [0.89-1.24],0.5952503978903795
Chapter II Neoplasms,Leiomyoma of uterus,CD4,T-cell surface glycoprotein CD4,11756,169,1.35 [0.92-2.00],0.1276613306971576
Chapter II Neoplasms,Leiomyoma of uterus,CD40,Tumor necrosis factor receptor superfamily member 5,11798,168,0.85 [0.64-1.14],0.277200200895244
Chapter II Neoplasms,Leiomyoma of uterus,CD40LG,CD40 ligand,11910,170,0.93 [0.78-1.11],0.4515628107131852
Chapter II Neoplasms,Leiomyoma of uterus,CD46,Membrane cofactor protein,11736,167,0.71 [0.42-1.17],0.1786642363446401
Chapter II Neoplasms,Leiomyoma of uterus,CD48,CD48 antigen,11831,169,0.96 [0.61-1.52],0.8782099667278662
Chapter II Neoplasms,Leiomyoma of uterus,CD5,T-cell surface glycoprotein CD5,11869,169,0.87 [0.58-1.30],0.4896857566781106
Chapter II Neoplasms,Leiomyoma of uterus,CD55,Complement decay-accelerating factor,11393,163,1.12 [0.66-1.92],0.6659898124209025
Chapter II Neoplasms,Leiomyoma of uterus,CD58,Lymphocyte function-associated antigen 3,11786,169,0.83 [0.39-1.79],0.640023447168681
Chapter II Neoplasms,Leiomyoma of uterus,CD59,CD59 glycoprotein,11386,163,1.17 [0.64-2.13],0.6057682180994644
Chapter II Neoplasms,Leiomyoma of uterus,CD5L,CD5 antigen-like,10288,149,1.29 [0.93-1.80],0.1315889548720137
Chapter II Neoplasms,Leiomyoma of uterus,CD6,T-cell differentiation antigen CD6,11894,170,0.81 [0.63-1.05],0.1132178793688993
Chapter II Neoplasms,Leiomyoma of uterus,CD63,CD63 antigen,11703,167,0.83 [0.64-1.08],0.1702023454931119
Chapter II Neoplasms,Leiomyoma of uterus,CD69,Early activation antigen CD69,11754,168,0.91 [0.78-1.06],0.2264789857064416
Chapter II Neoplasms,Leiomyoma of uterus,CD7,T-cell antigen CD7,10012,145,1.23 [0.86-1.76],0.2494475667280524
Chapter II Neoplasms,Leiomyoma of uterus,CD70,CD70 antigen,11777,170,0.81 [0.58-1.12],0.1949328044237381
Chapter II Neoplasms,Leiomyoma of uterus,CD72,B-cell differentiation antigen CD72,10128,146,1.27 [0.89-1.81],0.1943627806721283
Chapter II Neoplasms,Leiomyoma of uterus,CD74,HLA class II histocompatibility antigen gamma chain,11892,170,1.08 [0.74-1.59],0.6778490660135794
Chapter II Neoplasms,Leiomyoma of uterus,CD79B,B-cell antigen receptor complex-associated protein beta chain,11910,170,0.97 [0.72-1.31],0.8457988416946844
Chapter II Neoplasms,Leiomyoma of uterus,CD80,T-lymphocyte activation antigen CD80,10334,150,1.26 [0.81-1.97],0.3042483238935771
Chapter II Neoplasms,Leiomyoma of uterus,CD82,CD82 antigen,10166,144,0.97 [0.66-1.42],0.8837174343905874
Chapter II Neoplasms,Leiomyoma of uterus,CD83,CD83 antigen,11777,170,0.98 [0.66-1.46],0.9255975169496414
Chapter II Neoplasms,Leiomyoma of uterus,CD84,SLAM family member 5,11777,170,0.78 [0.50-1.21],0.266056402390779
Chapter II Neoplasms,Leiomyoma of uterus,CD86,T-lymphocyte activation antigen CD86,10273,150,0.59 [0.35-1.01],0.0528229257990204
Chapter II Neoplasms,Leiomyoma of uterus,CD8A,T-cell surface glycoprotein CD8 alpha chain,11892,170,0.90 [0.68-1.17],0.4238530803090323
Chapter II Neoplasms,Leiomyoma of uterus,CD93,Complement component C1q receptor,11355,165,0.94 [0.60-1.48],0.7973802545619035
Chapter II Neoplasms,Leiomyoma of uterus,CD99,CD99 antigen,11808,165,1.01 [0.50-2.07],0.9726569593564846
Chapter II Neoplasms,Leiomyoma of uterus,CD99L2,CD99 antigen-like protein 2,11808,165,0.91 [0.50-1.65],0.7581907929757478
Chapter II Neoplasms,Leiomyoma of uterus,CDA,Cytidine deaminase,10308,150,1.03 [0.74-1.43],0.8720070067368942
Chapter II Neoplasms,Leiomyoma of uterus,CDAN1,Codanin-1,10317,147,1.32 [0.78-2.23],0.3044327858111361
Chapter II Neoplasms,Leiomyoma of uterus,CDC123,Cell division cycle protein 123 homolog,9961,142,0.89 [0.67-1.17],0.3860084540118461
Chapter II Neoplasms,Leiomyoma of uterus,CDC25A,M-phase inducer phosphatase 1,9961,142,0.94 [0.62-1.42],0.7765979332041555
Chapter II Neoplasms,Leiomyoma of uterus,CDC26,Anaphase-promoting complex subunit CDC26,10250,149,1.07 [0.85-1.34],0.5718532349686632
Chapter II Neoplasms,Leiomyoma of uterus,CDC27,Cell division cycle protein 27 homolog,11526,160,1.08 [0.87-1.36],0.4845806338139757
Chapter II Neoplasms,Leiomyoma of uterus,CDC37,Hsp90 co-chaperone Cdc37,11855,167,1.00 [0.85-1.18],0.9942474500235376
Chapter II Neoplasms,Leiomyoma of uterus,CDC42BPB,Serine/threonine-protein kinase MRCK beta,10273,150,0.98 [0.85-1.15],0.8440392908510251
Chapter II Neoplasms,Leiomyoma of uterus,CDCP1,CUB domain-containing protein 1,11718,168,0.96 [0.73-1.26],0.7600151147298077
Chapter II Neoplasms,Leiomyoma of uterus,CDH1,Cadherin-1,11431,165,0.95 [0.66-1.37],0.7829847644035643
Chapter II Neoplasms,Leiomyoma of uterus,CDH15,Cadherin-15,11873,169,1.26 [0.98-1.62],0.0683465486083541
Chapter II Neoplasms,Leiomyoma of uterus,CDH17,Cadherin-17,11802,169,0.94 [0.77-1.15],0.5678765972004676
Chapter II Neoplasms,Leiomyoma of uterus,CDH2,Cadherin-2,11802,169,0.92 [0.63-1.35],0.6697684790371051
Chapter II Neoplasms,Leiomyoma of uterus,CDH22,Cadherin-22,10166,144,1.12 [0.66-1.89],0.6839522450958291
Chapter II Neoplasms,Leiomyoma of uterus,CDH23,Cadherin-23,10317,147,1.76 [1.04-2.98],0.0347758039535411
Chapter II Neoplasms,Leiomyoma of uterus,CDH3,Cadherin-3,11892,170,2.36 [1.73-3.20],4.3808780469635043e-08
Chapter II Neoplasms,Leiomyoma of uterus,CDH4,Cadherin-4,9978,146,1.12 [0.83-1.52],0.4620744431020313
Chapter II Neoplasms,Leiomyoma of uterus,CDH5,Cadherin-5,11938,171,1.05 [0.68-1.64],0.8203349908484003
Chapter II Neoplasms,Leiomyoma of uterus,CDH6,Cadherin-6,11802,169,1.00 [0.69-1.43],0.9860819750906328
Chapter II Neoplasms,Leiomyoma of uterus,CDHR1,Cadherin-related family member 1,11512,163,1.11 [0.83-1.50],0.4803274173318448
Chapter II Neoplasms,Leiomyoma of uterus,CDHR2,Cadherin-related family member 2,11744,167,1.06 [0.88-1.27],0.5373380069206326
Chapter II Neoplasms,Leiomyoma of uterus,CDHR5,Cadherin-related family member 5,11802,169,1.00 [0.70-1.41],0.9816077322812516
Chapter II Neoplasms,Leiomyoma of uterus,CDK1,Cyclin-dependent kinase 1,9961,142,1.26 [0.82-1.96],0.2947759568510535
Chapter II Neoplasms,Leiomyoma of uterus,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,10311,147,0.97 [0.73-1.28],0.8133837530030592
Chapter II Neoplasms,Leiomyoma of uterus,CDKL5,Cyclin-dependent kinase-like 5,9978,146,1.40 [1.16-1.69],0.0005261334535034
Chapter II Neoplasms,Leiomyoma of uterus,CDKN1A,Cyclin-dependent kinase inhibitor 1,11744,167,1.02 [0.89-1.16],0.7769254069464203
Chapter II Neoplasms,Leiomyoma of uterus,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,11744,167,0.97 [0.83-1.12],0.6465176045308809
Chapter II Neoplasms,Leiomyoma of uterus,CDNF,Cerebral dopamine neurotrophic factor,11744,167,1.21 [0.80-1.81],0.3619997538390817
Chapter II Neoplasms,Leiomyoma of uterus,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,11817,169,0.97 [0.57-1.65],0.9187082620685894
Chapter II Neoplasms,Leiomyoma of uterus,CDSN,Corneodesmosin,11869,169,0.88 [0.64-1.20],0.4203994473603062
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,11834,167,0.81 [0.44-1.47],0.4889051517170214
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,10273,150,0.70 [0.58-0.86],0.0006822600143673
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,10166,144,0.76 [0.56-1.03],0.0781562095787448
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,10273,150,1.33 [0.90-1.95],0.1529415309024481
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,10166,144,0.72 [0.47-1.08],0.1112864347384097
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,11777,170,0.92 [0.78-1.08],0.3157531938143101
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,11526,160,0.88 [0.65-1.20],0.4170805751600221
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,11385,159,0.93 [0.75-1.16],0.5209690129673874
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,10347,149,0.85 [0.55-1.31],0.464182567096259
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,11560,165,0.99 [0.75-1.31],0.9337510412207868
Chapter II Neoplasms,Leiomyoma of uterus,CEBPA,CCAAT/enhancer-binding protein alpha,10039,145,1.29 [0.94-1.78],0.1179219811557975
Chapter II Neoplasms,Leiomyoma of uterus,CEBPB,CCAAT/enhancer-binding protein beta,11560,165,0.78 [0.53-1.15],0.2130011869026143
Chapter II Neoplasms,Leiomyoma of uterus,CELA2A,Chymotrypsin-like elastase family member 2A,10347,149,0.97 [0.75-1.26],0.8045958933070987
Chapter II Neoplasms,Leiomyoma of uterus,CELA3A,Chymotrypsin-like elastase family member 3A,11916,171,1.07 [0.84-1.35],0.5962989023230767
Chapter II Neoplasms,Leiomyoma of uterus,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,10128,146,1.07 [0.62-1.83],0.8053153682299257
Chapter II Neoplasms,Leiomyoma of uterus,CEMIP2,Cell surface hyaluronidase,10039,145,1.58 [1.22-2.05],0.0005568759097677
Chapter II Neoplasms,Leiomyoma of uterus,CEND1,Cell cycle exit and neuronal differentiation protein 1,9978,146,1.14 [0.90-1.44],0.2765286036292868
Chapter II Neoplasms,Leiomyoma of uterus,CENPF,Centromere protein F,10166,144,1.01 [0.76-1.35],0.9495204753236788
Chapter II Neoplasms,Leiomyoma of uterus,CENPJ,Centromere protein J,10166,144,1.12 [0.91-1.38],0.2791025753674731
Chapter II Neoplasms,Leiomyoma of uterus,CEP112,Centrosomal protein of 112 kDa,10002,147,1.10 [0.78-1.53],0.5960230882313433
Chapter II Neoplasms,Leiomyoma of uterus,CEP152,Centrosomal protein of 152 kDa,9961,142,1.05 [0.73-1.53],0.780507905885931
Chapter II Neoplasms,Leiomyoma of uterus,CEP164,Centrosomal protein of 164 kDa,11555,165,0.94 [0.75-1.18],0.5831324358181489
Chapter II Neoplasms,Leiomyoma of uterus,CEP170,Centrosomal protein of 170 kDa,10091,145,1.01 [0.82-1.24],0.9561863086627862
Chapter II Neoplasms,Leiomyoma of uterus,CEP20,Centrosomal protein 20,11526,160,1.05 [0.87-1.27],0.6008426424478478
Chapter II Neoplasms,Leiomyoma of uterus,CEP290,Centrosomal protein of 290 kDa,10166,144,0.79 [0.56-1.12],0.1860746457285771
Chapter II Neoplasms,Leiomyoma of uterus,CEP350,Centrosome-associated protein 350,9961,142,1.04 [0.68-1.57],0.8640788062288751
Chapter II Neoplasms,Leiomyoma of uterus,CEP43,Centrosomal protein 43,11468,165,1.03 [0.84-1.26],0.762208930422188
Chapter II Neoplasms,Leiomyoma of uterus,CEP85,Centrosomal protein of 85 kDa,11526,160,0.97 [0.78-1.21],0.777134067586228
Chapter II Neoplasms,Leiomyoma of uterus,CERT,Ceramide transfer protein,11512,163,1.03 [0.82-1.29],0.8217130096682581
Chapter II Neoplasms,Leiomyoma of uterus,CES1,Liver carboxylesterase 1,11840,170,1.00 [0.84-1.19],0.9864222756052896
Chapter II Neoplasms,Leiomyoma of uterus,CES2,Cocaine esterase,11744,167,1.07 [0.84-1.38],0.5713452169582132
Chapter II Neoplasms,Leiomyoma of uterus,CES3,Carboxylesterase 3,11744,167,1.15 [0.96-1.37],0.118909409846315
Chapter II Neoplasms,Leiomyoma of uterus,CETN2,Centrin-2,11512,163,1.06 [0.86-1.30],0.598953113067402
Chapter II Neoplasms,Leiomyoma of uterus,CETN3,Centrin-3,10273,150,1.07 [0.87-1.32],0.496394562449691
Chapter II Neoplasms,Leiomyoma of uterus,CFB,Complement factor B,10154,147,0.76 [0.46-1.25],0.2756598989927825
Chapter II Neoplasms,Leiomyoma of uterus,CFC1,Cryptic protein,11526,160,1.14 [0.84-1.54],0.394122098379595
Chapter II Neoplasms,Leiomyoma of uterus,CFD,Complement factor D,10353,149,1.85 [0.91-3.76],0.0895077984052394
Chapter II Neoplasms,Leiomyoma of uterus,CFH,Complement factor H,9712,140,0.72 [0.35-1.49],0.3773815383227143
Chapter II Neoplasms,Leiomyoma of uterus,CFHR2,Complement factor H-related protein 2,10267,148,0.97 [0.74-1.27],0.8373531582480158
Chapter II Neoplasms,Leiomyoma of uterus,CFHR4,Complement factor H-related protein 4,10334,148,0.98 [0.79-1.21],0.8378596057263954
Chapter II Neoplasms,Leiomyoma of uterus,CFHR5,Complement factor H-related protein 5,10184,144,0.89 [0.61-1.29],0.5364064623545439
Chapter II Neoplasms,Leiomyoma of uterus,CFI,Complement factor I,10353,149,0.86 [0.39-1.91],0.7148995686154913
Chapter II Neoplasms,Leiomyoma of uterus,CFP,Properdin,10353,149,1.11 [0.53-2.31],0.7873996331683957
Chapter II Neoplasms,Leiomyoma of uterus,CGA,Glycoprotein hormones alpha chain,11808,165,1.02 [0.81-1.29],0.8415172987468987
Chapter II Neoplasms,Leiomyoma of uterus,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,10335,147,0.78 [0.52-1.18],0.24191041043982
Chapter II Neoplasms,Leiomyoma of uterus,CGN,Cingulin,10056,144,1.17 [0.85-1.61],0.3258463180071205
Chapter II Neoplasms,Leiomyoma of uterus,CGREF1,Cell growth regulator with EF hand domain protein 1,11802,169,1.18 [0.86-1.62],0.3096095493404651
Chapter II Neoplasms,Leiomyoma of uterus,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,11526,160,0.91 [0.72-1.16],0.4594462661992671
Chapter II Neoplasms,Leiomyoma of uterus,CHAD,Chondroadherin,10128,146,1.00 [0.74-1.34],0.982637679344778
Chapter II Neoplasms,Leiomyoma of uterus,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",10317,147,1.38 [0.95-1.99],0.0882673339510132
Chapter II Neoplasms,Leiomyoma of uterus,CHCHD6,MICOS complex subunit MIC25,10278,147,1.74 [1.17-2.59],0.0058764773699625
Chapter II Neoplasms,Leiomyoma of uterus,CHEK2,Serine/threonine-protein kinase Chk2,11560,165,1.30 [0.88-1.91],0.1863323168334696
Chapter II Neoplasms,Leiomyoma of uterus,CHGA,Chromogranin-A,10347,149,1.08 [0.93-1.25],0.3216374932480511
Chapter II Neoplasms,Leiomyoma of uterus,CHGB,Secretogranin-1,11855,169,1.07 [0.77-1.49],0.6874219898744942
Chapter II Neoplasms,Leiomyoma of uterus,CHI3L1,Chitinase-3-like protein 1,11555,163,0.95 [0.79-1.14],0.5810610191378446
Chapter II Neoplasms,Leiomyoma of uterus,CHIT1,Chitotriosidase-1,11849,170,1.00 [0.92-1.10],0.9322972129421844
Chapter II Neoplasms,Leiomyoma of uterus,CHL1,Neural cell adhesion molecule L1-like protein,11839,169,0.92 [0.59-1.45],0.7312560700664998
Chapter II Neoplasms,Leiomyoma of uterus,CHM,Rab proteins geranylgeranyltransferase component A 1,10056,144,1.08 [0.84-1.40],0.5404114861321961
Chapter II Neoplasms,Leiomyoma of uterus,CHMP1A,Charged multivesicular body protein 1a,11718,168,1.03 [0.86-1.22],0.7620581590185074
Chapter II Neoplasms,Leiomyoma of uterus,CHMP6,Charged multivesicular body protein 6,10334,150,1.02 [0.77-1.36],0.8888765914390541
Chapter II Neoplasms,Leiomyoma of uterus,CHP1,Calcineurin B homologous protein 1,9978,146,0.95 [0.76-1.19],0.6463848505396445
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL1,Chordin-like protein 1,11831,169,1.26 [0.81-1.97],0.3088561012002878
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL2,Chordin-like protein 2,11802,169,2.53 [1.96-3.26],9.070588832674137e-13
Chapter II Neoplasms,Leiomyoma of uterus,CHRM1,Muscarinic acetylcholine receptor M1,10056,144,1.26 [0.88-1.82],0.2045971189673487
Chapter II Neoplasms,Leiomyoma of uterus,CIAPIN1,Anamorsin,11855,167,1.01 [0.81-1.26],0.9329901120327349
Chapter II Neoplasms,Leiomyoma of uterus,CILP,Cartilage intermediate layer protein 1,10347,149,1.06 [0.79-1.42],0.6920562337403795
Chapter II Neoplasms,Leiomyoma of uterus,CINP,Cyclin-dependent kinase 2-interacting protein,10166,144,1.32 [1.00-1.75],0.0505841525598207
Chapter II Neoplasms,Leiomyoma of uterus,CIRBP,Cold-inducible RNA-binding protein,10273,150,1.02 [0.86-1.20],0.8412511134052498
Chapter II Neoplasms,Leiomyoma of uterus,CIT,Citron Rho-interacting kinase,10056,144,1.19 [0.86-1.64],0.2913590375618889
Chapter II Neoplasms,Leiomyoma of uterus,CKAP4,Cytoskeleton-associated protein 4,11862,169,1.22 [0.75-1.97],0.429852156906344
Chapter II Neoplasms,Leiomyoma of uterus,CKB,Creatine kinase B-type,10347,149,1.03 [0.80-1.34],0.8094061165709138
Chapter II Neoplasms,Leiomyoma of uterus,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",11767,168,0.96 [0.80-1.16],0.6953947999418767
Chapter II Neoplasms,Leiomyoma of uterus,CLASP1,CLIP-associating protein 1,9961,142,1.23 [1.01-1.48],0.0360044660943292
Chapter II Neoplasms,Leiomyoma of uterus,CLC,Galectin-10,11781,169,0.98 [0.80-1.20],0.8439268187442119
Chapter II Neoplasms,Leiomyoma of uterus,CLEC10A,C-type lectin domain family 10 member A,11718,168,0.76 [0.52-1.11],0.161846930991416
Chapter II Neoplasms,Leiomyoma of uterus,CLEC11A,C-type lectin domain family 11 member A,11789,164,1.01 [0.76-1.34],0.924916061017641
Chapter II Neoplasms,Leiomyoma of uterus,CLEC12A,C-type lectin domain family 12 member A,10039,145,0.85 [0.39-1.86],0.6869423736786762
Chapter II Neoplasms,Leiomyoma of uterus,CLEC14A,C-type lectin domain family 14 member A,11808,165,0.85 [0.55-1.31],0.4584151431368231
Chapter II Neoplasms,Leiomyoma of uterus,CLEC1A,C-type lectin domain family 1 member A,11560,165,1.23 [0.82-1.86],0.3187449315796247
Chapter II Neoplasms,Leiomyoma of uterus,CLEC1B,C-type lectin domain family 1 member B,11892,170,0.93 [0.81-1.07],0.3191756084217101
Chapter II Neoplasms,Leiomyoma of uterus,CLEC2L,C-type lectin domain family 2 member L,10056,144,1.25 [0.97-1.62],0.0811870150807536
Chapter II Neoplasms,Leiomyoma of uterus,CLEC3B,Tetranectin,10089,147,1.31 [0.63-2.73],0.4715358459965724
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4A,C-type lectin domain family 4 member A,11777,170,0.79 [0.54-1.17],0.2365031387874482
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4C,C-type lectin domain family 4 member C,11777,170,0.89 [0.67-1.19],0.4334499601331864
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4D,C-type lectin domain family 4 member D,11777,170,0.99 [0.80-1.24],0.9528292605283316
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4G,C-type lectin domain family 4 member G,11777,170,0.98 [0.64-1.48],0.9129767238650855
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4M,C-type lectin domain family 4 member M,10330,149,1.08 [0.78-1.48],0.6395618192994267
Chapter II Neoplasms,Leiomyoma of uterus,CLEC5A,C-type lectin domain family 5 member A,11770,168,0.75 [0.46-1.20],0.23016453949699
Chapter II Neoplasms,Leiomyoma of uterus,CLEC6A,C-type lectin domain family 6 member A,11526,160,1.03 [0.77-1.39],0.837067715420538
Chapter II Neoplasms,Leiomyoma of uterus,CLEC7A,C-type lectin domain family 7 member A,11910,170,0.91 [0.74-1.11],0.3513012618197216
Chapter II Neoplasms,Leiomyoma of uterus,CLGN,Calmegin,10056,144,0.90 [0.62-1.30],0.5633653120471754
Chapter II Neoplasms,Leiomyoma of uterus,CLIC5,Chloride intracellular channel protein 5,10056,144,0.59 [0.33-1.06],0.079678997078612
Chapter II Neoplasms,Leiomyoma of uterus,CLINT1,Clathrin interactor 1,9961,142,1.24 [0.94-1.63],0.1352740536343203
Chapter II Neoplasms,Leiomyoma of uterus,CLIP2,CAP-Gly domain-containing linker protein 2,11777,170,1.00 [0.89-1.13],0.9973556235618204
Chapter II Neoplasms,Leiomyoma of uterus,CLMP,CXADR-like membrane protein,11889,169,1.00 [0.51-1.96],0.997053896552008
Chapter II Neoplasms,Leiomyoma of uterus,CLNS1A,Methylosome subunit pICln,10056,144,1.02 [0.63-1.65],0.9289613802534368
Chapter II Neoplasms,Leiomyoma of uterus,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",11699,167,0.94 [0.82-1.09],0.4333967754796328
Chapter II Neoplasms,Leiomyoma of uterus,CLPS,Colipase,11790,165,1.16 [0.95-1.42],0.1392157367306946
Chapter II Neoplasms,Leiomyoma of uterus,CLSPN,Claspin,11493,162,1.01 [0.66-1.55],0.9484055016421256
Chapter II Neoplasms,Leiomyoma of uterus,CLSTN1,Calsyntenin-1,11512,163,1.07 [0.84-1.38],0.5689809519730813
Chapter II Neoplasms,Leiomyoma of uterus,CLSTN2,Calsyntenin-2,11910,170,0.99 [0.70-1.41],0.96774033812706
Chapter II Neoplasms,Leiomyoma of uterus,CLSTN3,Calsyntenin-3,10317,147,1.14 [0.68-1.91],0.6142967101032704
Chapter II Neoplasms,Leiomyoma of uterus,CLTA,Clathrin light chain A,11560,165,0.99 [0.75-1.32],0.9631687800353572
Chapter II Neoplasms,Leiomyoma of uterus,CLU,Clusterin,10353,149,1.29 [0.89-1.87],0.1860004639347727
Chapter II Neoplasms,Leiomyoma of uterus,CLUL1,Clusterin-like protein 1,11783,169,1.07 [0.79-1.44],0.6620275574051248
Chapter II Neoplasms,Leiomyoma of uterus,CMC1,COX assembly mitochondrial protein homolog,10334,150,0.98 [0.82-1.17],0.8176779515098282
Chapter II Neoplasms,Leiomyoma of uterus,CMIP,C-Maf-inducing protein,10278,147,1.03 [0.85-1.25],0.7589347369631223
Chapter II Neoplasms,Leiomyoma of uterus,CNDP1,Beta-Ala-His dipeptidase,11855,169,0.89 [0.66-1.19],0.4174274087117673
Chapter II Neoplasms,Leiomyoma of uterus,CNGB3,Cyclic nucleotide-gated cation channel beta-3,9978,146,0.94 [0.69-1.28],0.69611114455898
Chapter II Neoplasms,Leiomyoma of uterus,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",10072,145,1.03 [0.84-1.26],0.7805020918841998
Chapter II Neoplasms,Leiomyoma of uterus,CNPY2,Protein canopy homolog 2,11560,165,0.79 [0.60-1.04],0.0919929803468894
Chapter II Neoplasms,Leiomyoma of uterus,CNPY4,Protein canopy homolog 4,11744,167,0.96 [0.80-1.16],0.6947808348372457
Chapter II Neoplasms,Leiomyoma of uterus,CNST,Consortin,11802,169,0.90 [0.79-1.02],0.1083524311891623
Chapter II Neoplasms,Leiomyoma of uterus,CNTF,Ciliary neurotrophic factor,9978,146,1.47 [0.92-2.36],0.1105590645978485
Chapter II Neoplasms,Leiomyoma of uterus,CNTN1,Contactin-1,11938,171,1.01 [0.62-1.63],0.9760393621251912
Chapter II Neoplasms,Leiomyoma of uterus,CNTN2,Contactin-2,11889,169,0.76 [0.56-1.04],0.0855169446781577
Chapter II Neoplasms,Leiomyoma of uterus,CNTN3,Contactin-3,11808,165,0.95 [0.64-1.42],0.7978265415972291
Chapter II Neoplasms,Leiomyoma of uterus,CNTN4,Contactin-4,11808,165,0.63 [0.35-1.11],0.1118819882139499
Chapter II Neoplasms,Leiomyoma of uterus,CNTN5,Contactin-5,11828,169,0.93 [0.65-1.33],0.6903126220214209
Chapter II Neoplasms,Leiomyoma of uterus,CNTNAP2,Contactin-associated protein-like 2,11777,170,1.20 [0.86-1.68],0.2792662968570959
Chapter II Neoplasms,Leiomyoma of uterus,CNTNAP4,Contactin-associated protein-like 4,10056,144,1.08 [0.94-1.25],0.2508627323316195
Chapter II Neoplasms,Leiomyoma of uterus,COCH,Cochlin,10334,150,0.97 [0.70-1.36],0.8786092417326984
Chapter II Neoplasms,Leiomyoma of uterus,COL15A1,Collagen alpha-1(XV) chain,10347,149,1.84 [1.05-3.22],0.0327380674187629
Chapter II Neoplasms,Leiomyoma of uterus,COL18A1,Collagen alpha-1(XVIII) chain,11852,170,0.95 [0.53-1.71],0.8613288013913452
Chapter II Neoplasms,Leiomyoma of uterus,COL1A1,Collagen alpha-1(I) chain,11938,171,1.26 [0.75-2.10],0.380930445158236
Chapter II Neoplasms,Leiomyoma of uterus,COL24A1,Collagen alpha-1(XXIV) chain,10273,150,1.02 [0.77-1.36],0.8912640375379043
Chapter II Neoplasms,Leiomyoma of uterus,COL28A1,Collagen alpha-1(XXVIII) chain,10056,144,0.88 [0.70-1.10],0.2712516675055264
Chapter II Neoplasms,Leiomyoma of uterus,COL2A1,Collagen alpha-1(II) chain,10091,145,1.05 [0.86-1.27],0.6564057015790097
Chapter II Neoplasms,Leiomyoma of uterus,COL3A1,Collagen alpha-1(III) chain,10347,149,1.16 [0.59-2.30],0.6700913151279595
Chapter II Neoplasms,Leiomyoma of uterus,COL4A1,Collagen alpha-1(IV) chain,11802,169,1.05 [0.75-1.48],0.7740672829943109
Chapter II Neoplasms,Leiomyoma of uterus,COL4A4,Collagen alpha-4(IV) chain,10148,144,1.33 [0.96-1.83],0.0872113893248359
Chapter II Neoplasms,Leiomyoma of uterus,COL5A1,Collagen alpha-1(V) chain,10128,146,1.23 [0.84-1.81],0.2945641539634018
Chapter II Neoplasms,Leiomyoma of uterus,COL6A3,Collagen alpha-3(VI) chain,11938,171,1.32 [0.91-1.92],0.141128656378182
Chapter II Neoplasms,Leiomyoma of uterus,COL9A1,Collagen alpha-1(IX) chain,11777,170,0.99 [0.76-1.29],0.9337277555597
Chapter II Neoplasms,Leiomyoma of uterus,COL9A2,Collagen alpha-2(IX) chain,10166,144,1.26 [0.96-1.65],0.0986607009383206
Chapter II Neoplasms,Leiomyoma of uterus,COLEC12,Collectin-12,11797,169,1.44 [0.86-2.40],0.1669533892058707
Chapter II Neoplasms,Leiomyoma of uterus,COMMD1,COMM domain-containing protein 1,10091,145,1.09 [0.84-1.41],0.533078425037568
Chapter II Neoplasms,Leiomyoma of uterus,COMMD9,COMM domain-containing protein 9,10278,147,0.87 [0.57-1.32],0.5014855489750659
Chapter II Neoplasms,Leiomyoma of uterus,COMP,Cartilage oligomeric matrix protein,11676,167,0.72 [0.48-1.09],0.122428041488409
Chapter II Neoplasms,Leiomyoma of uterus,COMT,Catechol O-methyltransferase,11445,165,1.01 [0.85-1.19],0.930073553990526
Chapter II Neoplasms,Leiomyoma of uterus,COPB2,Coatomer subunit beta',10002,147,0.87 [0.59-1.28],0.4843613565600364
Chapter II Neoplasms,Leiomyoma of uterus,COPE,Coatomer subunit epsilon,11512,163,1.13 [0.87-1.47],0.3698965931874707
Chapter II Neoplasms,Leiomyoma of uterus,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",10091,145,0.90 [0.62-1.32],0.603432563707702
Chapter II Neoplasms,Leiomyoma of uterus,CORO1A,Coronin-1A,11546,166,0.87 [0.74-1.03],0.0982260326941462
Chapter II Neoplasms,Leiomyoma of uterus,CORO6,Coronin-6,9978,146,1.56 [1.10-2.20],0.0118159384725993
Chapter II Neoplasms,Leiomyoma of uterus,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",11744,167,1.12 [0.93-1.36],0.2322575558415869
Chapter II Neoplasms,Leiomyoma of uterus,COX6B1,Cytochrome c oxidase subunit 6B1,10334,150,1.17 [0.73-1.85],0.5136070633648305
Chapter II Neoplasms,Leiomyoma of uterus,CPA1,Carboxypeptidase A1,11938,171,1.03 [0.82-1.30],0.8062125580986523
Chapter II Neoplasms,Leiomyoma of uterus,CPA2,Carboxypeptidase A2,11856,169,1.02 [0.83-1.26],0.8245579913005443
Chapter II Neoplasms,Leiomyoma of uterus,CPA4,Carboxypeptidase A4,9926,143,0.97 [0.67-1.40],0.8620590775489405
Chapter II Neoplasms,Leiomyoma of uterus,CPB1,Carboxypeptidase B,11938,171,1.14 [0.91-1.44],0.2513168828070898
Chapter II Neoplasms,Leiomyoma of uterus,CPB2,Carboxypeptidase B2,10332,149,1.38 [0.67-2.83],0.378496182172635
Chapter II Neoplasms,Leiomyoma of uterus,CPE,Carboxypeptidase E,11791,168,0.77 [0.55-1.08],0.1297110139274033
Chapter II Neoplasms,Leiomyoma of uterus,CPLX2,Complexin-2,9961,142,0.86 [0.50-1.47],0.5887469855347873
Chapter II Neoplasms,Leiomyoma of uterus,CPM,Carboxypeptidase M,11832,170,0.83 [0.55-1.24],0.3528611372494381
Chapter II Neoplasms,Leiomyoma of uterus,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",10039,145,0.97 [0.55-1.73],0.9272667528330786
Chapter II Neoplasms,Leiomyoma of uterus,CPPED1,Serine/threonine-protein phosphatase CPPED1,11892,170,1.00 [0.81-1.22],0.9841694103405468
Chapter II Neoplasms,Leiomyoma of uterus,CPQ,Carboxypeptidase Q,10321,148,0.89 [0.58-1.38],0.6120398600097685
Chapter II Neoplasms,Leiomyoma of uterus,CPTP,Ceramide-1-phosphate transfer protein,10002,147,1.08 [0.73-1.59],0.691804604152423
Chapter II Neoplasms,Leiomyoma of uterus,CPVL,Probable serine carboxypeptidase CPVL,11876,169,0.88 [0.63-1.23],0.4533604951682018
Chapter II Neoplasms,Leiomyoma of uterus,CPXM1,Probable carboxypeptidase X1,11855,167,0.99 [0.82-1.20],0.9125604235731416
Chapter II Neoplasms,Leiomyoma of uterus,CPXM2,Inactive carboxypeptidase-like protein X2,10334,150,1.56 [0.91-2.65],0.1046632853275036
Chapter II Neoplasms,Leiomyoma of uterus,CR1,Complement receptor type 1,10295,147,1.19 [0.76-1.86],0.443337803256344
Chapter II Neoplasms,Leiomyoma of uterus,CR2,Complement receptor type 2,11855,169,1.23 [0.93-1.64],0.1519588278462266
Chapter II Neoplasms,Leiomyoma of uterus,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,11526,160,0.95 [0.80-1.12],0.5184141822924974
Chapter II Neoplasms,Leiomyoma of uterus,CRADD,Death domain-containing protein CRADD,11699,167,1.00 [0.84-1.21],0.959079438160315
Chapter II Neoplasms,Leiomyoma of uterus,CREB3,Cyclic AMP-responsive element-binding protein 3,9961,142,1.07 [0.81-1.41],0.6450000197083807
Chapter II Neoplasms,Leiomyoma of uterus,CREBZF,CREB/ATF bZIP transcription factor,9961,142,1.35 [0.75-2.41],0.3138658401087755
Chapter II Neoplasms,Leiomyoma of uterus,CREG1,Protein CREG1,11662,164,1.10 [0.75-1.61],0.6211909414226727
Chapter II Neoplasms,Leiomyoma of uterus,CRELD1,Protein disulfide isomerase CRELD1,10128,146,0.95 [0.62-1.45],0.8142888320645008
Chapter II Neoplasms,Leiomyoma of uterus,CRELD2,Protein disulfide isomerase CRELD2,11831,169,0.96 [0.74-1.24],0.7372064458987286
Chapter II Neoplasms,Leiomyoma of uterus,CRH,Corticoliberin,11506,160,0.88 [0.74-1.04],0.1245524574996267
Chapter II Neoplasms,Leiomyoma of uterus,CRHBP,Corticotropin-releasing factor-binding protein,11797,169,1.07 [0.65-1.75],0.7995813839067561
Chapter II Neoplasms,Leiomyoma of uterus,CRHR1,Corticotropin-releasing factor receptor 1,11560,165,1.04 [0.84-1.30],0.6987106490234776
Chapter II Neoplasms,Leiomyoma of uterus,CRIM1,Cysteine-rich motor neuron 1 protein,11854,170,0.92 [0.47-1.80],0.8084542067442414
Chapter II Neoplasms,Leiomyoma of uterus,CRIP2,Cysteine-rich protein 2,11718,168,1.48 [1.07-2.06],0.0177504943923722
Chapter II Neoplasms,Leiomyoma of uterus,CRISP2,Cysteine-rich secretory protein 2,11889,169,0.91 [0.74-1.13],0.3957667463041723
Chapter II Neoplasms,Leiomyoma of uterus,CRISP3,Cysteine-rich secretory protein 3,10248,145,0.83 [0.47-1.49],0.5347796634516006
Chapter II Neoplasms,Leiomyoma of uterus,CRKL,Crk-like protein,11820,169,1.02 [0.89-1.16],0.8091028039504821
Chapter II Neoplasms,Leiomyoma of uterus,CRLF1,Cytokine receptor-like factor 1,11854,170,1.44 [0.83-2.48],0.1933060056056191
Chapter II Neoplasms,Leiomyoma of uterus,CRNN,Cornulin,11473,164,1.11 [0.91-1.36],0.3145007316983971
Chapter II Neoplasms,Leiomyoma of uterus,CRTAC1,Cartilage acidic protein 1,11938,171,1.15 [0.72-1.84],0.5621663217210422
Chapter II Neoplasms,Leiomyoma of uterus,CRTAM,Cytotoxic and regulatory T-cell molecule,11718,168,1.00 [0.76-1.30],0.9906341383455788
Chapter II Neoplasms,Leiomyoma of uterus,CRTAP,Cartilage-associated protein,10056,144,1.14 [0.84-1.53],0.402246350816538
Chapter II Neoplasms,Leiomyoma of uterus,CRX,Cone-rod homeobox protein,11560,165,0.98 [0.85-1.11],0.7182831452455646
Chapter II Neoplasms,Leiomyoma of uterus,CRYBB1,Beta-crystallin B1,10334,150,1.02 [0.80-1.31],0.8694261382796189
Chapter II Neoplasms,Leiomyoma of uterus,CRYBB2,Beta-crystallin B2,10317,147,1.06 [0.89-1.26],0.5224914801841996
Chapter II Neoplasms,Leiomyoma of uterus,CRYGD,Gamma-crystallin D,10317,147,0.99 [0.84-1.16],0.8925680456422616
Chapter II Neoplasms,Leiomyoma of uterus,CRYM,Ketimine reductase mu-crystallin,9978,146,1.09 [0.90-1.33],0.3895625088572795
Chapter II Neoplasms,Leiomyoma of uterus,CRYZL1,Quinone oxidoreductase-like protein 1,10091,145,1.02 [0.86-1.22],0.8205169828671448
Chapter II Neoplasms,Leiomyoma of uterus,CSDE1,Cold shock domain-containing protein E1,10002,147,1.16 [1.03-1.30],0.0116195649091306
Chapter II Neoplasms,Leiomyoma of uterus,CSF1,Macrophage colony-stimulating factor 1,11854,170,1.19 [0.73-1.94],0.4914167906729912
Chapter II Neoplasms,Leiomyoma of uterus,CSF1R,Macrophage colony-stimulating factor 1 receptor,10335,147,0.98 [0.65-1.46],0.9056114691548452
Chapter II Neoplasms,Leiomyoma of uterus,CSF2,Granulocyte-macrophage colony-stimulating factor,10002,147,1.17 [0.75-1.82],0.4947997911525053
Chapter II Neoplasms,Leiomyoma of uterus,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,11718,168,0.88 [0.70-1.11],0.2820719366114853
Chapter II Neoplasms,Leiomyoma of uterus,CSF2RB,Cytokine receptor common subunit beta,10039,145,1.00 [0.69-1.44],0.9830908548737716
Chapter II Neoplasms,Leiomyoma of uterus,CSF3,Granulocyte colony-stimulating factor,11555,165,0.69 [0.51-0.92],0.0126330354965661
Chapter II Neoplasms,Leiomyoma of uterus,CSF3R,Granulocyte colony-stimulating factor receptor,10039,145,1.38 [0.86-2.21],0.1823184323982442
Chapter II Neoplasms,Leiomyoma of uterus,CSH1,Chorionic somatomammotropin hormone 1,10335,147,0.78 [0.45-1.35],0.3699404493950375
Chapter II Neoplasms,Leiomyoma of uterus,CSNK1D,Casein kinase I isoform delta,10039,145,1.17 [0.92-1.48],0.1958644321589457
Chapter II Neoplasms,Leiomyoma of uterus,CSNK2A1,Casein kinase II subunit alpha,10311,147,0.95 [0.67-1.35],0.7591882488761234
Chapter II Neoplasms,Leiomyoma of uterus,CSPG4,Chondroitin sulfate proteoglycan 4,10347,149,1.09 [0.67-1.76],0.7378554771131283
Chapter II Neoplasms,Leiomyoma of uterus,CSPG5,Chondroitin sulfate proteoglycan 5,9978,146,1.22 [0.92-1.61],0.1634601561272611
Chapter II Neoplasms,Leiomyoma of uterus,CSRP3,Cysteine and glycine-rich protein 3,10002,147,1.04 [0.89-1.22],0.590988708442426
Chapter II Neoplasms,Leiomyoma of uterus,CST1,Cystatin-SN,8984,139,1.03 [0.88-1.21],0.7036600581108541
Chapter II Neoplasms,Leiomyoma of uterus,CST3,Cystatin-C,11838,169,1.09 [0.67-1.75],0.7350089949776626
Chapter II Neoplasms,Leiomyoma of uterus,CST5,Cystatin-D,11602,167,0.92 [0.72-1.18],0.5258808592890505
Chapter II Neoplasms,Leiomyoma of uterus,CST6,Cystatin-M,11473,161,1.06 [0.80-1.43],0.672852263115796
Chapter II Neoplasms,Leiomyoma of uterus,CST7,Cystatin-F,11821,169,1.01 [0.87-1.16],0.9068222376297624
Chapter II Neoplasms,Leiomyoma of uterus,CSTB,Cystatin-B,11645,166,1.19 [0.86-1.66],0.2923558875219937
Chapter II Neoplasms,Leiomyoma of uterus,CTAG1A_CTAG1B,Cancer/testis antigen 1,10146,144,1.15 [0.84-1.56],0.3767544126066435
Chapter II Neoplasms,Leiomyoma of uterus,CTBS,Di-N-acetylchitobiase,10173,143,1.12 [0.61-2.06],0.7157289017948352
Chapter II Neoplasms,Leiomyoma of uterus,CTF1,Cardiotrophin-1,11560,165,0.98 [0.82-1.15],0.7672735006244858
Chapter II Neoplasms,Leiomyoma of uterus,CTHRC1,Collagen triple helix repeat-containing protein 1,10347,149,0.80 [0.46-1.39],0.4302083287207379
Chapter II Neoplasms,Leiomyoma of uterus,CTLA4,Cytotoxic T-lymphocyte protein 4,10347,149,0.90 [0.53-1.53],0.6916341497800405
Chapter II Neoplasms,Leiomyoma of uterus,CTNNA1,Catenin alpha-1,9978,146,1.27 [0.91-1.78],0.1608217329794716
Chapter II Neoplasms,Leiomyoma of uterus,CTRB1,Chymotrypsinogen B,11808,165,1.02 [0.79-1.32],0.8663003484477618
Chapter II Neoplasms,Leiomyoma of uterus,CTRC,Chymotrypsin-C,11802,169,1.08 [0.87-1.33],0.4810730830751605
Chapter II Neoplasms,Leiomyoma of uterus,CTRL,Chymotrypsin-like protease CTRL-1,10317,147,1.10 [0.87-1.39],0.4194777310305231
Chapter II Neoplasms,Leiomyoma of uterus,CTSB,Cathepsin B,11825,170,1.27 [1.00-1.60],0.0505782741548644
Chapter II Neoplasms,Leiomyoma of uterus,CTSC,Dipeptidyl peptidase 1,11780,168,0.73 [0.53-1.02],0.0645747894739773
Chapter II Neoplasms,Leiomyoma of uterus,CTSD,Cathepsin D,11063,155,0.95 [0.66-1.38],0.7943263856543059
Chapter II Neoplasms,Leiomyoma of uterus,CTSE,Cathepsin E,10128,146,1.50 [1.10-2.04],0.0100769114645471
Chapter II Neoplasms,Leiomyoma of uterus,CTSF,Cathepsin F,11855,167,0.99 [0.70-1.41],0.963647373199076
Chapter II Neoplasms,Leiomyoma of uterus,CTSH,Pro-cathepsin H,11527,165,1.06 [0.88-1.28],0.5323423129203778
Chapter II Neoplasms,Leiomyoma of uterus,CTSL,Cathepsin L1,11802,169,0.80 [0.45-1.41],0.4387166110026116
Chapter II Neoplasms,Leiomyoma of uterus,CTSO,Cathepsin O,11910,170,0.98 [0.62-1.55],0.943287192023895
Chapter II Neoplasms,Leiomyoma of uterus,CTSS,Cathepsin S,9186,131,0.94 [0.46-1.91],0.8609234842008752
Chapter II Neoplasms,Leiomyoma of uterus,CTSV,Cathepsin L2,11854,168,0.93 [0.66-1.29],0.6451022943593603
Chapter II Neoplasms,Leiomyoma of uterus,CTSZ,Cathepsin Z,11826,168,0.98 [0.63-1.51],0.9194752476519809
Chapter II Neoplasms,Leiomyoma of uterus,CUZD1,CUB and zona pellucida-like domain-containing protein 1,10056,144,1.35 [0.97-1.88],0.0776385131662607
Chapter II Neoplasms,Leiomyoma of uterus,CWC15,Spliceosome-associated protein CWC15 homolog,10208,150,1.29 [1.05-1.58],0.0152064603237391
Chapter II Neoplasms,Leiomyoma of uterus,CX3CL1,Fractalkine,11718,168,1.10 [0.74-1.64],0.6393371787093644
Chapter II Neoplasms,Leiomyoma of uterus,CXADR,Coxsackievirus and adenovirus receptor,11777,170,0.83 [0.64-1.09],0.1764338465949552
Chapter II Neoplasms,Leiomyoma of uterus,CXCL1,Growth-regulated alpha protein,11786,169,0.98 [0.85-1.13],0.7878514119994038
Chapter II Neoplasms,Leiomyoma of uterus,CXCL10,C-X-C motif chemokine 10,11854,170,1.08 [0.90-1.31],0.4085490241840074
Chapter II Neoplasms,Leiomyoma of uterus,CXCL11,C-X-C motif chemokine 11,11892,170,0.94 [0.79-1.12],0.5175602619926389
Chapter II Neoplasms,Leiomyoma of uterus,CXCL12,Stromal cell-derived factor 1,11555,165,1.10 [0.78-1.55],0.5885199336068603
Chapter II Neoplasms,Leiomyoma of uterus,CXCL13,C-X-C motif chemokine 13,11892,170,1.04 [0.84-1.28],0.7337584494228808
Chapter II Neoplasms,Leiomyoma of uterus,CXCL14,C-X-C motif chemokine 14,11555,165,0.94 [0.74-1.20],0.6454117107053949
Chapter II Neoplasms,Leiomyoma of uterus,CXCL16,C-X-C motif chemokine 16,11922,170,0.94 [0.53-1.66],0.8275907598252917
Chapter II Neoplasms,Leiomyoma of uterus,CXCL17,C-X-C motif chemokine 17,11910,170,0.94 [0.66-1.34],0.7337342269007323
Chapter II Neoplasms,Leiomyoma of uterus,CXCL3,C-X-C motif chemokine 3,11798,168,1.02 [0.88-1.18],0.7717336759330822
Chapter II Neoplasms,Leiomyoma of uterus,CXCL5,C-X-C motif chemokine 5,11768,168,1.03 [0.92-1.16],0.6218990798471711
Chapter II Neoplasms,Leiomyoma of uterus,CXCL6,C-X-C motif chemokine 6,11910,170,1.04 [0.87-1.24],0.6666306533804651
Chapter II Neoplasms,Leiomyoma of uterus,CXCL8,Interleukin-8,11706,167,0.87 [0.70-1.07],0.1920462898734613
Chapter II Neoplasms,Leiomyoma of uterus,CXCL9,C-X-C motif chemokine 9,11854,170,1.07 [0.88-1.30],0.4970032046987808
Chapter II Neoplasms,Leiomyoma of uterus,CYB5A,Cytochrome b5,9961,142,1.17 [0.97-1.41],0.0926053891454021
Chapter II Neoplasms,Leiomyoma of uterus,CYB5R2,NADH-cytochrome b5 reductase 2,10154,149,1.12 [0.85-1.47],0.4114957917753017
Chapter II Neoplasms,Leiomyoma of uterus,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",10002,147,1.02 [0.85-1.22],0.8228172849107164
Chapter II Neoplasms,Leiomyoma of uterus,CYTH3,Cytohesin-3,9961,142,1.24 [1.04-1.49],0.0192945985397837
Chapter II Neoplasms,Leiomyoma of uterus,CYTL1,Cytokine-like protein 1,10347,149,1.29 [0.67-2.49],0.4408067661048557
Chapter II Neoplasms,Leiomyoma of uterus,DAAM1,Disheveled-associated activator of morphogenesis 1,10128,146,0.86 [0.71-1.05],0.1312795368871742
Chapter II Neoplasms,Leiomyoma of uterus,DAB2,Disabled homolog 2,11889,169,1.02 [0.90-1.15],0.7929719546631533
Chapter II Neoplasms,Leiomyoma of uterus,DAG1,Dystroglycan,11854,170,0.87 [0.65-1.17],0.3586970276673494
Chapter II Neoplasms,Leiomyoma of uterus,DAND5,DAN domain family member 5,10039,145,0.98 [0.73-1.33],0.9111272677004758
Chapter II Neoplasms,Leiomyoma of uterus,DAPK2,Death-associated protein kinase 2,10039,145,1.10 [0.84-1.45],0.4798740017356381
Chapter II Neoplasms,Leiomyoma of uterus,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,11777,170,1.04 [0.92-1.17],0.5554091658809633
Chapter II Neoplasms,Leiomyoma of uterus,DARS1,"Aspartate--tRNA ligase, cytoplasmic",11699,167,0.98 [0.81-1.19],0.8454987008729402
Chapter II Neoplasms,Leiomyoma of uterus,DBH,Dopamine beta-hydroxylase,10309,147,1.17 [0.98-1.39],0.0753595557728628
Chapter II Neoplasms,Leiomyoma of uterus,DBI,Acyl-CoA-binding protein,11755,163,0.99 [0.82-1.18],0.8839260821558006
Chapter II Neoplasms,Leiomyoma of uterus,DBN1,Drebrin,10039,145,1.11 [0.81-1.51],0.5288415764556664
Chapter II Neoplasms,Leiomyoma of uterus,DBNL,Drebrin-like protein,11854,170,1.01 [0.87-1.17],0.93395972476434
Chapter II Neoplasms,Leiomyoma of uterus,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",11855,167,0.97 [0.66-1.43],0.8757889959012793
Chapter II Neoplasms,Leiomyoma of uterus,DCC,Netrin receptor DCC,10056,144,1.33 [0.77-2.28],0.3073016479565559
Chapter II Neoplasms,Leiomyoma of uterus,DCDC2C,Doublecortin domain-containing protein 2C,9961,142,1.19 [0.96-1.48],0.1053649853191721
Chapter II Neoplasms,Leiomyoma of uterus,DCLRE1C,Protein artemis,9961,142,1.08 [0.64-1.80],0.7817287768331895
Chapter II Neoplasms,Leiomyoma of uterus,DCN,Decorin,11560,165,0.93 [0.51-1.70],0.8133636216091407
Chapter II Neoplasms,Leiomyoma of uterus,DCTD,Deoxycytidylate deaminase,10128,146,0.96 [0.80-1.13],0.60090711665591
Chapter II Neoplasms,Leiomyoma of uterus,DCTN1,Dynactin subunit 1,11889,169,0.96 [0.78-1.18],0.6925206277117268
Chapter II Neoplasms,Leiomyoma of uterus,DCTN2,Dynactin subunit 2,11744,167,0.99 [0.86-1.15],0.9451196423260076
Chapter II Neoplasms,Leiomyoma of uterus,DCTN6,Dynactin subunit 6,11512,163,0.99 [0.82-1.21],0.9586930727862812
Chapter II Neoplasms,Leiomyoma of uterus,DCTPP1,dCTP pyrophosphatase 1,11802,169,0.79 [0.51-1.23],0.3044239092958749
Chapter II Neoplasms,Leiomyoma of uterus,DCUN1D1,DCN1-like protein 1,9978,146,1.17 [0.98-1.40],0.0763110998649832
Chapter II Neoplasms,Leiomyoma of uterus,DCUN1D2,DCN1-like protein 2,9961,142,1.17 [0.99-1.38],0.0641214059872465
Chapter II Neoplasms,Leiomyoma of uterus,DCXR,L-xylulose reductase,11855,167,1.13 [0.87-1.46],0.3486065996372183
Chapter II Neoplasms,Leiomyoma of uterus,DDA1,DET1- and DDB1-associated protein 1,10002,147,1.49 [1.17-1.89],0.0011984470323782
Chapter II Neoplasms,Leiomyoma of uterus,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",11744,167,1.05 [0.78-1.43],0.7310125332879449
Chapter II Neoplasms,Leiomyoma of uterus,DDC,Aromatic-L-amino-acid decarboxylase,11779,169,0.95 [0.71-1.26],0.72343941364941
Chapter II Neoplasms,Leiomyoma of uterus,DDHD2,Phospholipase DDHD2,10311,147,1.03 [0.81-1.31],0.8001921093774937
Chapter II Neoplasms,Leiomyoma of uterus,DDI2,Protein DDI1 homolog 2,10128,146,1.07 [0.88-1.30],0.5099339943185022
Chapter II Neoplasms,Leiomyoma of uterus,DDR1,Epithelial discoidin domain-containing receptor 1,11892,170,1.29 [0.71-2.35],0.3984382787916997
Chapter II Neoplasms,Leiomyoma of uterus,DDT,D-dopachrome decarboxylase,10347,149,1.17 [0.82-1.68],0.3738914715172552
Chapter II Neoplasms,Leiomyoma of uterus,DDX1,ATP-dependent RNA helicase DDX1,10273,150,1.24 [0.95-1.60],0.1077503416836291
Chapter II Neoplasms,Leiomyoma of uterus,DDX25,ATP-dependent RNA helicase DDX25,10056,144,0.99 [0.66-1.50],0.9719639296132638
Chapter II Neoplasms,Leiomyoma of uterus,DDX39A,ATP-dependent RNA helicase DDX39A,10039,145,0.66 [0.30-1.41],0.2790667480640309
Chapter II Neoplasms,Leiomyoma of uterus,DDX4,Probable ATP-dependent RNA helicase DDX4,10039,145,1.22 [0.95-1.57],0.1210421040644873
Chapter II Neoplasms,Leiomyoma of uterus,DDX53,Probable ATP-dependent RNA helicase DDX53,10056,144,0.98 [0.63-1.54],0.9416635661933308
Chapter II Neoplasms,Leiomyoma of uterus,DDX58,Antiviral innate immune response receptor RIG-I,11526,160,1.04 [0.82-1.33],0.7242886979747336
Chapter II Neoplasms,Leiomyoma of uterus,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",11777,170,0.98 [0.85-1.13],0.7905480905829887
Chapter II Neoplasms,Leiomyoma of uterus,DEFA1_DEFA1B,Neutrophil defensin 1,11570,164,0.97 [0.75-1.26],0.8333637556609211
Chapter II Neoplasms,Leiomyoma of uterus,DEFB103A_DEFB103B,Beta-defensin 103,9956,145,0.92 [0.60-1.41],0.6996043286938041
Chapter II Neoplasms,Leiomyoma of uterus,DEFB104A_DEFB104B,Beta-defensin 104,9978,146,1.08 [0.82-1.43],0.576704389355479
Chapter II Neoplasms,Leiomyoma of uterus,DEFB116,Beta-defensin 116,9978,146,1.06 [0.88-1.29],0.5323924383328857
Chapter II Neoplasms,Leiomyoma of uterus,DEFB118,Beta-defensin 118,9978,146,1.20 [0.97-1.48],0.0978753554645073
Chapter II Neoplasms,Leiomyoma of uterus,DEFB4A_DEFB4B,Beta-defensin 4A,11642,166,0.98 [0.89-1.07],0.648633338114736
Chapter II Neoplasms,Leiomyoma of uterus,DENND2B,DENN domain-containing protein 2B,10002,147,1.07 [0.80-1.44],0.6459553814767025
Chapter II Neoplasms,Leiomyoma of uterus,DENR,Density-regulated protein,10039,145,1.11 [0.84-1.47],0.4507062896758371
Chapter II Neoplasms,Leiomyoma of uterus,DFFA,DNA fragmentation factor subunit alpha,11910,170,1.00 [0.82-1.22],0.982228632158838
Chapter II Neoplasms,Leiomyoma of uterus,DGCR6,Protein DGCR6,9978,146,1.13 [0.83-1.53],0.4362132018471705
Chapter II Neoplasms,Leiomyoma of uterus,DGKA,Diacylglycerol kinase alpha,10039,145,1.09 [0.82-1.46],0.5536427107942666
Chapter II Neoplasms,Leiomyoma of uterus,DGKZ,Diacylglycerol kinase zeta,11555,165,0.86 [0.57-1.30],0.4799799556835359
Chapter II Neoplasms,Leiomyoma of uterus,DHODH,Dihydroorotate dehydrogenase,10002,147,1.22 [0.93-1.59],0.1515689059965197
Chapter II Neoplasms,Leiomyoma of uterus,DHPS,Deoxyhypusine synthase,10278,147,1.28 [0.95-1.72],0.107636104303834
Chapter II Neoplasms,Leiomyoma of uterus,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,10317,147,1.02 [0.73-1.43],0.8947170091375375
Chapter II Neoplasms,Leiomyoma of uterus,DIABLO,"Diablo homolog, mitochondrial",11770,168,0.95 [0.84-1.08],0.425188982955798
Chapter II Neoplasms,Leiomyoma of uterus,DIPK1C,Divergent protein kinase domain 1C,10056,144,0.86 [0.57-1.28],0.4575059862637666
Chapter II Neoplasms,Leiomyoma of uterus,DIPK2B,Divergent protein kinase domain 2B,10128,146,1.19 [0.66-2.16],0.5620102438784147
Chapter II Neoplasms,Leiomyoma of uterus,DKK1,Dickkopf-related protein 1,11892,170,0.90 [0.71-1.13],0.3488848200873966
Chapter II Neoplasms,Leiomyoma of uterus,DKK3,Dickkopf-related protein 3,11938,171,0.86 [0.54-1.34],0.4987160135663051
Chapter II Neoplasms,Leiomyoma of uterus,DKK4,Dickkopf-related protein 4,11708,168,1.18 [0.89-1.58],0.2440662935160181
Chapter II Neoplasms,Leiomyoma of uterus,DKKL1,Dickkopf-like protein 1,11744,167,1.01 [0.87-1.18],0.860226854044098
Chapter II Neoplasms,Leiomyoma of uterus,DLG4,Disks large homolog 4,10317,147,1.10 [0.88-1.36],0.4097907082124162
Chapter II Neoplasms,Leiomyoma of uterus,DLGAP5,Disks large-associated protein 5,10311,147,1.08 [0.82-1.43],0.5687770278653592
Chapter II Neoplasms,Leiomyoma of uterus,DLK1,Protein delta homolog 1,11938,171,0.91 [0.70-1.17],0.4584654274277483
Chapter II Neoplasms,Leiomyoma of uterus,DLL1,Delta-like protein 1,11855,167,1.21 [0.77-1.89],0.4158349828498412
Chapter II Neoplasms,Leiomyoma of uterus,DLL4,Delta-like protein 4,10091,145,1.09 [0.95-1.25],0.2240337679884562
Chapter II Neoplasms,Leiomyoma of uterus,DMD,Dystrophin,10091,145,0.84 [0.59-1.18],0.3065624343483396
Chapter II Neoplasms,Leiomyoma of uterus,DMP1,Dentin matrix acidic phosphoprotein 1,10091,145,1.16 [0.89-1.51],0.2702247593931384
Chapter II Neoplasms,Leiomyoma of uterus,DNAJA1,DnaJ homolog subfamily A member 1,9961,142,1.38 [1.06-1.80],0.0175881351931509
Chapter II Neoplasms,Leiomyoma of uterus,DNAJA2,DnaJ homolog subfamily A member 2,11878,169,0.99 [0.84-1.17],0.9236879787326638
Chapter II Neoplasms,Leiomyoma of uterus,DNAJA4,DnaJ homolog subfamily A member 4,10317,147,1.10 [0.89-1.36],0.3855771929729059
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB1,DnaJ homolog subfamily B member 1,11744,167,1.06 [0.91-1.24],0.4451919110381596
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB14,DnaJ homolog subfamily B member 14,10273,150,0.99 [0.77-1.26],0.9175142298662604
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB2,DnaJ homolog subfamily B member 2,10128,146,1.12 [0.84-1.49],0.442786845912666
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB6,DnaJ homolog subfamily B member 6,10033,144,0.99 [0.82-1.20],0.9146396721340172
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB8,DnaJ homolog subfamily B member 8,11560,165,1.20 [0.99-1.46],0.0563460240915562
Chapter II Neoplasms,Leiomyoma of uterus,DNAJC21,DnaJ homolog subfamily C member 21,10317,147,1.17 [0.79-1.75],0.4313383387040532
Chapter II Neoplasms,Leiomyoma of uterus,DNAJC6,Putative tyrosine-protein phosphatase auxilin,10091,145,1.05 [0.87-1.28],0.5862860996084318
Chapter II Neoplasms,Leiomyoma of uterus,DNAJC9,DnaJ homolog subfamily C member 9,10273,150,1.08 [0.88-1.33],0.4570021503194879
Chapter II Neoplasms,Leiomyoma of uterus,DNER,Delta and Notch-like epidermal growth factor-related receptor,11780,169,0.80 [0.46-1.42],0.4488559424869678
Chapter II Neoplasms,Leiomyoma of uterus,DNLZ,DNL-type zinc finger protein,9978,146,1.01 [0.86-1.20],0.8690352739239837
Chapter II Neoplasms,Leiomyoma of uterus,DNM1,Dynamin-1,10273,150,1.00 [0.87-1.15],0.9691521088923402
Chapter II Neoplasms,Leiomyoma of uterus,DNM3,Dynamin-3,10311,147,1.13 [0.86-1.50],0.3832389272021594
Chapter II Neoplasms,Leiomyoma of uterus,DNMBP,Dynamin-binding protein,11718,168,0.95 [0.76-1.19],0.6643875712859426
Chapter II Neoplasms,Leiomyoma of uterus,DNPEP,Aspartyl aminopeptidase,10317,147,0.98 [0.74-1.29],0.8737297544580137
Chapter II Neoplasms,Leiomyoma of uterus,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,11843,170,1.08 [0.84-1.40],0.5495161507676283
Chapter II Neoplasms,Leiomyoma of uterus,DOC2B,Double C2-like domain-containing protein beta,10056,144,1.27 [0.87-1.87],0.2181016621965401
Chapter II Neoplasms,Leiomyoma of uterus,DOCK9,Dedicator of cytokinesis protein 9,9978,146,1.12 [1.00-1.25],0.0594055560024492
Chapter II Neoplasms,Leiomyoma of uterus,DOK1,Docking protein 1,10317,147,1.01 [0.90-1.14],0.80674553897414
Chapter II Neoplasms,Leiomyoma of uterus,DOK2,Docking protein 2,11802,169,0.96 [0.86-1.07],0.4560452515063991
Chapter II Neoplasms,Leiomyoma of uterus,DPEP1,Dipeptidase 1,11699,167,0.80 [0.62-1.03],0.0884748178137594
Chapter II Neoplasms,Leiomyoma of uterus,DPEP2,Dipeptidase 2,11744,167,0.67 [0.41-1.10],0.1119179785644077
Chapter II Neoplasms,Leiomyoma of uterus,DPP10,Inactive dipeptidyl peptidase 10,11777,170,0.76 [0.50-1.14],0.1878082360254563
Chapter II Neoplasms,Leiomyoma of uterus,DPP4,Dipeptidyl peptidase 4,11594,166,0.77 [0.47-1.25],0.289841248368537
Chapter II Neoplasms,Leiomyoma of uterus,DPP6,Dipeptidyl aminopeptidase-like protein 6,11744,167,0.81 [0.53-1.22],0.3127368682955938
Chapter II Neoplasms,Leiomyoma of uterus,DPP7,Dipeptidyl peptidase 2,11708,168,0.91 [0.72-1.16],0.4548896945928637
Chapter II Neoplasms,Leiomyoma of uterus,DPT,Dermatopontin,11938,171,0.86 [0.51-1.46],0.5855368426435998
Chapter II Neoplasms,Leiomyoma of uterus,DPY30,Protein dpy-30 homolog,11844,169,1.10 [0.88-1.37],0.4115966778385512
Chapter II Neoplasms,Leiomyoma of uterus,DRAXIN,Draxin,11718,168,1.00 [0.73-1.37],0.9973344090848696
Chapter II Neoplasms,Leiomyoma of uterus,DRG2,Developmentally-regulated GTP-binding protein 2,11744,167,0.92 [0.72-1.18],0.5188494909987216
Chapter II Neoplasms,Leiomyoma of uterus,DSC2,Desmocollin-2,11692,164,1.21 [0.81-1.82],0.35747368800971
Chapter II Neoplasms,Leiomyoma of uterus,DSCAM,Down syndrome cell adhesion molecule,10311,147,1.19 [0.76-1.85],0.4457793635202478
Chapter II Neoplasms,Leiomyoma of uterus,DSG2,Desmoglein-2,11808,165,1.08 [0.65-1.80],0.7596420226817805
Chapter II Neoplasms,Leiomyoma of uterus,DSG3,Desmoglein-3,11847,168,1.09 [0.73-1.63],0.6813267599541767
Chapter II Neoplasms,Leiomyoma of uterus,DSG4,Desmoglein-4,11716,167,1.06 [0.81-1.38],0.6661487789931446
Chapter II Neoplasms,Leiomyoma of uterus,DTD1,D-aminoacyl-tRNA deacylase 1,10128,146,1.06 [0.88-1.27],0.5577301844930309
Chapter II Neoplasms,Leiomyoma of uterus,DTNB,Dystrobrevin beta,10255,146,1.16 [0.80-1.69],0.444354643941493
Chapter II Neoplasms,Leiomyoma of uterus,DTX2,Probable E3 ubiquitin-protein ligase DTX2,10056,144,0.89 [0.68-1.17],0.419988449265894
Chapter II Neoplasms,Leiomyoma of uterus,DTX3,Probable E3 ubiquitin-protein ligase DTX3,11744,167,1.21 [0.69-2.11],0.5116904701357374
Chapter II Neoplasms,Leiomyoma of uterus,DTYMK,Thymidylate kinase,10334,150,1.18 [0.94-1.48],0.1475060227795558
Chapter II Neoplasms,Leiomyoma of uterus,DUOX2,Dual oxidase 2,11560,165,1.02 [0.85-1.23],0.824428719559134
Chapter II Neoplasms,Leiomyoma of uterus,DUSP13,Dual specificity protein phosphatase 13 isoform A,10278,147,1.27 [0.90-1.80],0.1755828699552376
Chapter II Neoplasms,Leiomyoma of uterus,DUSP29,Dual specificity phosphatase 29,10056,144,1.01 [0.79-1.29],0.9273999861578116
Chapter II Neoplasms,Leiomyoma of uterus,DUSP3,Dual specificity protein phosphatase 3,11512,163,1.03 [0.88-1.20],0.7472120831594875
Chapter II Neoplasms,Leiomyoma of uterus,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",10273,150,0.97 [0.83-1.13],0.6904761798329984
Chapter II Neoplasms,Leiomyoma of uterus,DXO,Decapping and exoribonuclease protein,10317,147,1.02 [0.72-1.45],0.910766709881336
Chapter II Neoplasms,Leiomyoma of uterus,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,10278,147,0.86 [0.60-1.25],0.4292361618489523
Chapter II Neoplasms,Leiomyoma of uterus,DYNLT1,Dynein light chain Tctex-type 1,10056,144,0.87 [0.70-1.07],0.1926797987077745
Chapter II Neoplasms,Leiomyoma of uterus,DYNLT3,Dynein light chain Tctex-type 3,10278,147,1.02 [0.71-1.46],0.9128843353886154
Chapter II Neoplasms,Leiomyoma of uterus,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,11718,168,0.96 [0.83-1.12],0.6239653113946668
Chapter II Neoplasms,Leiomyoma of uterus,EBI3_IL27,Interleukin-27,11867,169,0.56 [0.35-0.89],0.013590907045778
Chapter II Neoplasms,Leiomyoma of uterus,ECE1,Endothelin-converting enzyme 1,11512,163,0.97 [0.65-1.44],0.8831080910320843
Chapter II Neoplasms,Leiomyoma of uterus,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",10334,150,1.05 [0.85-1.29],0.6784631865427548
Chapter II Neoplasms,Leiomyoma of uterus,ECHS1,"Enoyl-CoA hydratase, mitochondrial",10091,145,1.00 [0.84-1.18],0.9795411294801802
Chapter II Neoplasms,Leiomyoma of uterus,ECI2,Enoyl-CoA delta isomerase 2,10002,147,0.95 [0.73-1.23],0.6884300034308419
Chapter II Neoplasms,Leiomyoma of uterus,ECM1,Extracellular matrix protein 1,10064,149,1.28 [0.82-2.01],0.2812952302115562
Chapter II Neoplasms,Leiomyoma of uterus,ECSCR,Endothelial cell-specific chemotaxis regulator,9978,146,1.13 [0.86-1.48],0.3729911048718007
Chapter II Neoplasms,Leiomyoma of uterus,EDA2R,Tumor necrosis factor receptor superfamily member 27,11889,169,0.90 [0.62-1.32],0.5950888720604954
Chapter II Neoplasms,Leiomyoma of uterus,EDAR,Tumor necrosis factor receptor superfamily member EDAR,11777,170,0.96 [0.82-1.11],0.5547366556822685
Chapter II Neoplasms,Leiomyoma of uterus,EDDM3B,Epididymal secretory protein E3-beta,10278,147,1.39 [1.01-1.90],0.042846155684102
Chapter II Neoplasms,Leiomyoma of uterus,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,10002,147,1.29 [0.90-1.83],0.1605460824653649
Chapter II Neoplasms,Leiomyoma of uterus,EDF1,Endothelial differentiation-related factor 1,10311,147,0.91 [0.71-1.16],0.4423677631650139
Chapter II Neoplasms,Leiomyoma of uterus,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,11560,165,0.91 [0.60-1.39],0.6686670422400331
Chapter II Neoplasms,Leiomyoma of uterus,EDN1,Endothelin-1,10091,145,1.23 [0.71-2.13],0.4500317139454896
Chapter II Neoplasms,Leiomyoma of uterus,EDNRB,Endothelin receptor type B,10039,145,1.29 [0.98-1.70],0.0650400252193062
Chapter II Neoplasms,Leiomyoma of uterus,EEF1D,Elongation factor 1-delta,10334,150,0.98 [0.83-1.16],0.8180187275475459
Chapter II Neoplasms,Leiomyoma of uterus,EFCAB14,EF-hand calcium-binding domain-containing protein 14,10273,150,1.48 [0.89-2.44],0.1310303176360684
Chapter II Neoplasms,Leiomyoma of uterus,EFCAB2,Dynein regulatory complex protein 8,10166,144,1.15 [0.74-1.78],0.543893907181751
Chapter II Neoplasms,Leiomyoma of uterus,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,11839,168,0.70 [0.45-1.10],0.1251244761831716
Chapter II Neoplasms,Leiomyoma of uterus,EFHD1,EF-hand domain-containing protein D1,10311,147,1.38 [0.93-2.05],0.1126270508502824
Chapter II Neoplasms,Leiomyoma of uterus,EFNA1,Ephrin-A1,11794,164,1.04 [0.63-1.71],0.8908449710121912
Chapter II Neoplasms,Leiomyoma of uterus,EFNA4,Ephrin-A4,11703,167,1.32 [0.86-2.03],0.2023503780445241
Chapter II Neoplasms,Leiomyoma of uterus,EFNB2,Ephrin-B2,10056,144,1.11 [0.85-1.44],0.4498604145441504
Chapter II Neoplasms,Leiomyoma of uterus,EGF,Pro-epidermal growth factor,11782,169,0.94 [0.83-1.08],0.3798445158400454
Chapter II Neoplasms,Leiomyoma of uterus,EGFL7,Epidermal growth factor-like protein 7,11526,160,0.97 [0.68-1.37],0.8464135796321287
Chapter II Neoplasms,Leiomyoma of uterus,EGFLAM,Pikachurin,10273,150,0.61 [0.36-1.05],0.076215517322612
Chapter II Neoplasms,Leiomyoma of uterus,EGFR,Epidermal growth factor receptor,11938,171,0.59 [0.26-1.35],0.2125595195682228
Chapter II Neoplasms,Leiomyoma of uterus,EGLN1,Egl nine homolog 1,11777,170,1.03 [0.81-1.31],0.8187731638837626
Chapter II Neoplasms,Leiomyoma of uterus,EHBP1,EH domain-binding protein 1,10334,150,1.02 [0.83-1.26],0.8472945464806831
Chapter II Neoplasms,Leiomyoma of uterus,EHD3,EH domain-containing protein 3,10091,145,1.06 [0.92-1.23],0.3871864777939333
Chapter II Neoplasms,Leiomyoma of uterus,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",10317,147,1.22 [0.96-1.56],0.1053248828298349
Chapter II Neoplasms,Leiomyoma of uterus,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",10225,148,1.06 [0.92-1.22],0.4413364669927642
Chapter II Neoplasms,Leiomyoma of uterus,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,10002,147,0.82 [0.64-1.06],0.1363020763156339
Chapter II Neoplasms,Leiomyoma of uterus,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,10091,145,1.46 [1.05-2.02],0.0246106709528046
Chapter II Neoplasms,Leiomyoma of uterus,EIF4B,Eukaryotic translation initiation factor 4B,11718,168,1.09 [0.86-1.39],0.4678507521563434
Chapter II Neoplasms,Leiomyoma of uterus,EIF4E,Eukaryotic translation initiation factor 4E,10039,145,1.06 [0.89-1.27],0.5127621286431696
Chapter II Neoplasms,Leiomyoma of uterus,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,11802,169,1.05 [0.85-1.29],0.6327336440187532
Chapter II Neoplasms,Leiomyoma of uterus,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,11910,170,1.00 [0.87-1.15],0.9897441415771424
Chapter II Neoplasms,Leiomyoma of uterus,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,10311,147,0.98 [0.77-1.25],0.8800957516702267
Chapter II Neoplasms,Leiomyoma of uterus,EIF5,Eukaryotic translation initiation factor 5,10002,147,0.85 [0.58-1.25],0.408916359248514
Chapter II Neoplasms,Leiomyoma of uterus,EIF5A,Eukaryotic translation initiation factor 5A-1,11555,165,0.99 [0.61-1.60],0.9634729591714598
Chapter II Neoplasms,Leiomyoma of uterus,ELAC1,Zinc phosphodiesterase ELAC protein 1,10311,147,1.09 [0.90-1.32],0.3574613097538639
Chapter II Neoplasms,Leiomyoma of uterus,ELAVL4,ELAV-like protein 4,9978,146,1.16 [0.98-1.37],0.0887102166653555
Chapter II Neoplasms,Leiomyoma of uterus,ELN,Elastin,10334,150,1.16 [0.76-1.78],0.4823566792928072
Chapter II Neoplasms,Leiomyoma of uterus,ELOA,Elongin-A,11744,167,1.10 [0.88-1.39],0.4026175585233507
Chapter II Neoplasms,Leiomyoma of uterus,ELOB,Elongin-B,10002,147,0.95 [0.62-1.45],0.8149354006265417
Chapter II Neoplasms,Leiomyoma of uterus,ENAH,Protein enabled homolog,11555,165,1.19 [0.89-1.58],0.2373778345953957
Chapter II Neoplasms,Leiomyoma of uterus,ENDOU,Poly(U)-specific endoribonuclease,9524,147,0.97 [0.70-1.35],0.8671946088328375
Chapter II Neoplasms,Leiomyoma of uterus,ENG,Endoglin,11938,171,0.85 [0.39-1.88],0.6931625086208215
Chapter II Neoplasms,Leiomyoma of uterus,ENO1,Alpha-enolase,11787,169,0.94 [0.79-1.12],0.4922354938363139
Chapter II Neoplasms,Leiomyoma of uterus,ENO2,Gamma-enolase,11892,170,0.97 [0.78-1.19],0.7552946666197735
Chapter II Neoplasms,Leiomyoma of uterus,ENO3,Beta-enolase,10091,145,1.21 [0.93-1.57],0.1646276799815577
Chapter II Neoplasms,Leiomyoma of uterus,ENOPH1,Enolase-phosphatase E1,10278,147,1.09 [0.85-1.41],0.4878227976621815
Chapter II Neoplasms,Leiomyoma of uterus,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,10002,147,1.32 [0.77-2.27],0.3069345774237793
Chapter II Neoplasms,Leiomyoma of uterus,ENPEP,Glutamyl aminopeptidase,10002,147,1.17 [0.88-1.56],0.2699634817270321
Chapter II Neoplasms,Leiomyoma of uterus,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,11938,171,0.89 [0.56-1.42],0.6227396432391142
Chapter II Neoplasms,Leiomyoma of uterus,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,11854,170,1.02 [0.72-1.43],0.9292306584181524
Chapter II Neoplasms,Leiomyoma of uterus,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,10091,145,1.31 [0.84-2.04],0.2287209796972442
Chapter II Neoplasms,Leiomyoma of uterus,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,11395,164,1.07 [0.91-1.25],0.4316180461970887
Chapter II Neoplasms,Leiomyoma of uterus,ENSA,Alpha-endosulfine,10278,147,1.18 [0.90-1.55],0.231767904263841
Chapter II Neoplasms,Leiomyoma of uterus,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,11526,160,1.21 [0.89-1.65],0.2140432194101232
Chapter II Neoplasms,Leiomyoma of uterus,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,11560,165,0.90 [0.46-1.76],0.7641007835474241
Chapter II Neoplasms,Leiomyoma of uterus,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,11560,165,0.97 [0.59-1.60],0.920365773449274
Chapter II Neoplasms,Leiomyoma of uterus,ENTR1,Endosome-associated-trafficking regulator 1,10091,145,0.78 [0.58-1.07],0.1214751003499437
Chapter II Neoplasms,Leiomyoma of uterus,EP300,Histone acetyltransferase p300,10039,145,1.23 [0.78-1.92],0.370060554718401
Chapter II Neoplasms,Leiomyoma of uterus,EPB41L5,Band 4.1-like protein 5,10056,144,1.28 [1.04-1.57],0.0200213633517931
Chapter II Neoplasms,Leiomyoma of uterus,EPCAM,Epithelial cell adhesion molecule,11796,169,0.88 [0.77-1.00],0.0542908963750499
Chapter II Neoplasms,Leiomyoma of uterus,EPGN,Epigen,10278,147,1.29 [1.00-1.66],0.0504847816239374
Chapter II Neoplasms,Leiomyoma of uterus,EPHA1,Ephrin type-A receptor 1,11843,170,1.32 [0.88-1.98],0.1765646049660661
Chapter II Neoplasms,Leiomyoma of uterus,EPHA10,Ephrin type-A receptor 10,11512,163,1.08 [0.89-1.31],0.4570724155175809
Chapter II Neoplasms,Leiomyoma of uterus,EPHA2,Ephrin type-A receptor 2,11373,158,1.15 [0.74-1.79],0.5420699677944996
Chapter II Neoplasms,Leiomyoma of uterus,EPHA4,Ephrin type-A receptor 4,10128,146,1.26 [0.72-2.21],0.4200724708965246
Chapter II Neoplasms,Leiomyoma of uterus,EPHB4,Ephrin type-B receptor 4,11938,171,1.41 [0.84-2.37],0.192469762359504
Chapter II Neoplasms,Leiomyoma of uterus,EPHB6,Ephrin type-B receptor 6,11699,167,0.83 [0.53-1.28],0.3899099784026462
Chapter II Neoplasms,Leiomyoma of uterus,EPHX2,Bifunctional epoxide hydrolase 2,11560,165,1.06 [0.86-1.31],0.5666954422254693
Chapter II Neoplasms,Leiomyoma of uterus,EPN1,Epsin-1,10166,144,1.02 [0.70-1.46],0.9352721669222644
Chapter II Neoplasms,Leiomyoma of uterus,EPO,Erythropoietin,11777,170,1.00 [0.83-1.20],0.9780042903187212
Chapter II Neoplasms,Leiomyoma of uterus,EPPK1,Epiplakin,10091,145,1.11 [0.89-1.38],0.3526825251266012
Chapter II Neoplasms,Leiomyoma of uterus,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,11866,169,0.84 [0.53-1.33],0.4464289851198307
Chapter II Neoplasms,Leiomyoma of uterus,ERBB2,Receptor tyrosine-protein kinase erbB-2,11855,167,1.01 [0.56-1.82],0.9633428908274756
Chapter II Neoplasms,Leiomyoma of uterus,ERBB3,Receptor tyrosine-protein kinase erbB-3,11773,168,1.20 [0.58-2.52],0.6212315914812738
Chapter II Neoplasms,Leiomyoma of uterus,ERBB4,Receptor tyrosine-protein kinase erbB-4,11855,167,0.96 [0.54-1.69],0.8831385134051402
Chapter II Neoplasms,Leiomyoma of uterus,ERBIN,Erbin,11744,167,1.00 [0.87-1.14],0.9506174584330978
Chapter II Neoplasms,Leiomyoma of uterus,ERC2,ERC protein 2,10056,144,1.02 [0.83-1.26],0.8547550035692204
Chapter II Neoplasms,Leiomyoma of uterus,ERCC1,DNA excision repair protein ERCC-1,9961,142,1.50 [1.04-2.16],0.0309025072290664
Chapter II Neoplasms,Leiomyoma of uterus,EREG,Proepiregulin,11699,167,1.02 [0.86-1.21],0.8460864139820903
Chapter II Neoplasms,Leiomyoma of uterus,ERI1,3'-5' exoribonuclease 1,10166,144,1.20 [0.77-1.87],0.4181849639258177
Chapter II Neoplasms,Leiomyoma of uterus,ERMAP,Erythroid membrane-associated protein,10039,145,1.09 [0.76-1.56],0.6519589783359934
Chapter II Neoplasms,Leiomyoma of uterus,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,10278,147,0.98 [0.65-1.48],0.9384857228617152
Chapter II Neoplasms,Leiomyoma of uterus,ERP29,Endoplasmic reticulum resident protein 29,10128,146,0.99 [0.86-1.13],0.8644432982215472
Chapter II Neoplasms,Leiomyoma of uterus,ERP44,Endoplasmic reticulum resident protein 44,11717,167,0.98 [0.57-1.68],0.9464885824907524
Chapter II Neoplasms,Leiomyoma of uterus,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,10002,147,0.82 [0.55-1.21],0.3195195806272574
Chapter II Neoplasms,Leiomyoma of uterus,ESAM,Endothelial cell-selective adhesion molecule,11938,171,0.98 [0.64-1.51],0.9408032067779962
Chapter II Neoplasms,Leiomyoma of uterus,ESM1,Endothelial cell-specific molecule 1,11797,169,0.97 [0.65-1.45],0.8845609411152042
Chapter II Neoplasms,Leiomyoma of uterus,ESPL1,Separin,9961,142,0.91 [0.67-1.23],0.5421748571278955
Chapter II Neoplasms,Leiomyoma of uterus,ESR1,Estrogen receptor,10039,145,1.28 [1.02-1.59],0.0301240340148538
Chapter II Neoplasms,Leiomyoma of uterus,ESYT2,Extended synaptotagmin-2,10317,147,0.99 [0.81-1.20],0.9132001203026148
Chapter II Neoplasms,Leiomyoma of uterus,EVI2B,Protein EVI2B,9961,142,1.11 [0.76-1.61],0.5871667935294731
Chapter II Neoplasms,Leiomyoma of uterus,EVI5,Ecotropic viral integration site 5 protein homolog,10039,145,1.07 [0.89-1.28],0.4829416132652863
Chapter II Neoplasms,Leiomyoma of uterus,EVPL,Envoplakin,10166,144,0.80 [0.48-1.31],0.369677887944339
Chapter II Neoplasms,Leiomyoma of uterus,EXOSC10,Exosome component 10,10002,147,0.93 [0.71-1.23],0.6231174361202032
Chapter II Neoplasms,Leiomyoma of uterus,EXTL1,Exostosin-like 1,10002,147,0.74 [0.50-1.09],0.1294253054808381
Chapter II Neoplasms,Leiomyoma of uterus,EZR,Ezrin,11892,170,1.05 [0.59-1.86],0.8694091521899352
Chapter II Neoplasms,Leiomyoma of uterus,F10,Coagulation factor X,10335,147,0.71 [0.39-1.27],0.2443056657357765
Chapter II Neoplasms,Leiomyoma of uterus,F11,Coagulation factor XI,10198,148,0.91 [0.52-1.59],0.7409810366419635
Chapter II Neoplasms,Leiomyoma of uterus,F11R,Junctional adhesion molecule A,11808,165,0.92 [0.72-1.18],0.5218520600396384
Chapter II Neoplasms,Leiomyoma of uterus,F12,Coagulation factor XII,10353,149,1.07 [0.74-1.55],0.719107996052736
Chapter II Neoplasms,Leiomyoma of uterus,F13B,Coagulation factor XIII B chain,10288,149,0.87 [0.47-1.62],0.664202169417277
Chapter II Neoplasms,Leiomyoma of uterus,F2,Prothrombin,10353,149,0.86 [0.31-2.43],0.7829359242169256
Chapter II Neoplasms,Leiomyoma of uterus,F2R,Proteinase-activated receptor 1,11831,169,0.95 [0.75-1.21],0.6753346264358842
Chapter II Neoplasms,Leiomyoma of uterus,F3,Tissue factor,11825,167,0.63 [0.38-1.04],0.0700186912907572
Chapter II Neoplasms,Leiomyoma of uterus,F7,Coagulation factor VII,11838,169,0.88 [0.56-1.40],0.5986286001000323
Chapter II Neoplasms,Leiomyoma of uterus,F9,Coagulation factor IX,11829,169,0.68 [0.31-1.45],0.3143408783366062
Chapter II Neoplasms,Leiomyoma of uterus,FABP1,"Fatty acid-binding protein, liver",11797,169,0.98 [0.84-1.14],0.7847100873772257
Chapter II Neoplasms,Leiomyoma of uterus,FABP2,"Fatty acid-binding protein, intestinal",11802,169,0.89 [0.74-1.07],0.2035115854850531
Chapter II Neoplasms,Leiomyoma of uterus,FABP3,"Fatty acid-binding protein, heart",10334,150,1.41 [1.06-1.87],0.0168164287836653
Chapter II Neoplasms,Leiomyoma of uterus,FABP4,"Fatty acid-binding protein, adipocyte",11938,171,1.11 [0.85-1.45],0.4397725483754063
Chapter II Neoplasms,Leiomyoma of uterus,FABP5,Fatty acid-binding protein 5,11848,170,1.00 [0.82-1.22],0.9675908367756908
Chapter II Neoplasms,Leiomyoma of uterus,FABP6,Gastrotropin,11537,165,0.94 [0.74-1.21],0.6417869845313167
Chapter II Neoplasms,Leiomyoma of uterus,FABP9,Fatty acid-binding protein 9,11777,170,0.91 [0.72-1.16],0.4632469127484638
Chapter II Neoplasms,Leiomyoma of uterus,FADD,FAS-associated death domain protein,11802,169,0.97 [0.81-1.16],0.7257860066341455
Chapter II Neoplasms,Leiomyoma of uterus,FAM13A,Protein FAM13A,10273,150,1.01 [0.80-1.28],0.9027100474281764
Chapter II Neoplasms,Leiomyoma of uterus,FAM171A2,Protein FAM171A2,10311,147,1.02 [0.92-1.12],0.7289977737250309
Chapter II Neoplasms,Leiomyoma of uterus,FAM171B,Protein FAM171B,10278,147,1.07 [0.62-1.86],0.7955839192880138
Chapter II Neoplasms,Leiomyoma of uterus,FAM172A,Cotranscriptional regulator FAM172A,10091,145,1.00 [0.77-1.30],0.983995313520965
Chapter II Neoplasms,Leiomyoma of uterus,FAM20A,Pseudokinase FAM20A,10334,150,0.80 [0.45-1.42],0.4443135007963182
Chapter II Neoplasms,Leiomyoma of uterus,FAM3B,Protein FAM3B,11744,167,1.67 [1.12-2.51],0.0125775221581796
Chapter II Neoplasms,Leiomyoma of uterus,FAM3C,Protein FAM3C,11779,169,1.34 [0.85-2.11],0.200522749665285
Chapter II Neoplasms,Leiomyoma of uterus,FAM3D,Protein FAM3D,10273,150,1.07 [0.89-1.29],0.4934084265379197
Chapter II Neoplasms,Leiomyoma of uterus,FAP,Prolyl endopeptidase FAP,11938,171,0.98 [0.59-1.61],0.924083445400118
Chapter II Neoplasms,Leiomyoma of uterus,FARSA,Phenylalanine--tRNA ligase alpha subunit,10056,144,0.87 [0.68-1.12],0.2888781663653319
Chapter II Neoplasms,Leiomyoma of uterus,FAS,Tumor necrosis factor receptor superfamily member 6,11905,170,0.93 [0.60-1.44],0.7411079643897914
Chapter II Neoplasms,Leiomyoma of uterus,FASLG,Tumor necrosis factor ligand superfamily member 6,11910,170,1.35 [0.93-1.95],0.1156153961440479
Chapter II Neoplasms,Leiomyoma of uterus,FBLN2,Fibulin-2,10347,149,1.14 [0.70-1.87],0.5900445150602545
Chapter II Neoplasms,Leiomyoma of uterus,FBN2,Fibrillin-2,10056,144,0.99 [0.76-1.30],0.9592981601936688
Chapter II Neoplasms,Leiomyoma of uterus,FBP1,"Fructose-1,6-bisphosphatase 1",11802,169,0.93 [0.77-1.12],0.4600127188534419
Chapter II Neoplasms,Leiomyoma of uterus,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,10334,150,1.12 [0.91-1.38],0.2925865492280093
Chapter II Neoplasms,Leiomyoma of uterus,FCAR,Immunoglobulin alpha Fc receptor,11777,170,0.83 [0.62-1.10],0.2021376984490814
Chapter II Neoplasms,Leiomyoma of uterus,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,10311,147,1.58 [0.86-2.90],0.1435816151107621
Chapter II Neoplasms,Leiomyoma of uterus,FCER2,Low affinity immunoglobulin epsilon Fc receptor,11808,165,0.91 [0.69-1.21],0.5187015818547245
Chapter II Neoplasms,Leiomyoma of uterus,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,11755,168,1.05 [0.83-1.33],0.6754017321554484
Chapter II Neoplasms,Leiomyoma of uterus,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,11526,160,0.85 [0.66-1.09],0.1937789770969413
Chapter II Neoplasms,Leiomyoma of uterus,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,11818,169,0.88 [0.67-1.14],0.3253204900826306
Chapter II Neoplasms,Leiomyoma of uterus,FCN1,Ficolin-1,10309,147,1.12 [0.84-1.51],0.4326595897956641
Chapter II Neoplasms,Leiomyoma of uterus,FCN2,Ficolin-2,11751,168,1.12 [0.79-1.59],0.5244617429372778
Chapter II Neoplasms,Leiomyoma of uterus,FCRL1,Fc receptor-like protein 1,11802,169,1.21 [0.91-1.62],0.1951573258408775
Chapter II Neoplasms,Leiomyoma of uterus,FCRL2,Fc receptor-like protein 2,11854,170,1.14 [0.89-1.47],0.2879293290874248
Chapter II Neoplasms,Leiomyoma of uterus,FCRL3,Fc receptor-like protein 3,11555,165,1.30 [1.02-1.64],0.0317289548238643
Chapter II Neoplasms,Leiomyoma of uterus,FCRL5,Fc receptor-like protein 5,11808,165,0.76 [0.60-0.97],0.0272380114625817
Chapter II Neoplasms,Leiomyoma of uterus,FCRL6,Fc receptor-like protein 6,11777,170,0.94 [0.78-1.14],0.5516451680569338
Chapter II Neoplasms,Leiomyoma of uterus,FCRLB,Fc receptor-like B,11526,160,1.15 [0.94-1.41],0.1884006026314675
Chapter II Neoplasms,Leiomyoma of uterus,FDX1,"Adrenodoxin, mitochondrial",10002,147,1.02 [0.79-1.31],0.9020474963285412
Chapter II Neoplasms,Leiomyoma of uterus,FDX2,"Ferredoxin-2, mitochondrial",10002,147,1.17 [0.91-1.50],0.2111862595792915
Chapter II Neoplasms,Leiomyoma of uterus,FEN1,Flap endonuclease 1,11526,160,1.07 [0.87-1.30],0.5372356859845726
Chapter II Neoplasms,Leiomyoma of uterus,FES,Tyrosine-protein kinase Fes/Fps,11526,160,0.94 [0.69-1.27],0.6720060094883552
Chapter II Neoplasms,Leiomyoma of uterus,FETUB,Fetuin-B,11829,169,1.05 [0.68-1.61],0.8273146188014912
Chapter II Neoplasms,Leiomyoma of uterus,FGA,Fibrinogen alpha chain,10101,145,0.80 [0.47-1.35],0.3942146504156533
Chapter II Neoplasms,Leiomyoma of uterus,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",10311,147,1.11 [0.91-1.35],0.2993744366402274
Chapter II Neoplasms,Leiomyoma of uterus,FGF12,Fibroblast growth factor 12,10039,145,0.75 [0.47-1.19],0.2265945301025927
Chapter II Neoplasms,Leiomyoma of uterus,FGF16,Fibroblast growth factor 16,10039,145,1.14 [0.85-1.54],0.3825172762774063
Chapter II Neoplasms,Leiomyoma of uterus,FGF19,Fibroblast growth factor 19,11854,170,1.01 [0.85-1.21],0.8956297921020585
Chapter II Neoplasms,Leiomyoma of uterus,FGF2,Fibroblast growth factor 2,11777,170,0.94 [0.77-1.16],0.573067533581722
Chapter II Neoplasms,Leiomyoma of uterus,FGF20,Fibroblast growth factor 20,10039,145,0.98 [0.69-1.41],0.9200065770097988
Chapter II Neoplasms,Leiomyoma of uterus,FGF21,Fibroblast growth factor 21,11867,169,0.95 [0.84-1.07],0.3977991753975493
Chapter II Neoplasms,Leiomyoma of uterus,FGF23,Fibroblast growth factor 23,11871,169,1.22 [0.97-1.54],0.0860659364456167
Chapter II Neoplasms,Leiomyoma of uterus,FGF3,Fibroblast growth factor 3,10039,145,0.68 [0.36-1.29],0.2361171402220209
Chapter II Neoplasms,Leiomyoma of uterus,FGF5,Fibroblast growth factor 5,11555,165,0.95 [0.62-1.48],0.8349515684178054
Chapter II Neoplasms,Leiomyoma of uterus,FGF6,Fibroblast growth factor 6,10039,145,0.93 [0.63-1.39],0.7270357341029334
Chapter II Neoplasms,Leiomyoma of uterus,FGF7,Fibroblast growth factor 7,9961,142,0.88 [0.70-1.11],0.2878783397837734
Chapter II Neoplasms,Leiomyoma of uterus,FGF9,Fibroblast growth factor 9,9943,142,0.94 [0.64-1.39],0.7502338341312975
Chapter II Neoplasms,Leiomyoma of uterus,FGFBP1,Fibroblast growth factor-binding protein 1,11855,167,0.84 [0.54-1.29],0.422785790860148
Chapter II Neoplasms,Leiomyoma of uterus,FGFBP2,Fibroblast growth factor-binding protein 2,10347,149,1.14 [0.84-1.56],0.3959933029793222
Chapter II Neoplasms,Leiomyoma of uterus,FGFBP3,Fibroblast growth factor-binding protein 3,10317,147,0.70 [0.45-1.08],0.1068964693731793
Chapter II Neoplasms,Leiomyoma of uterus,FGFR2,Fibroblast growth factor receptor 2,11855,167,1.25 [0.67-2.34],0.4802866222033307
Chapter II Neoplasms,Leiomyoma of uterus,FGFR4,Fibroblast growth factor receptor 4,10128,146,1.00 [0.74-1.34],0.9946946225866398
Chapter II Neoplasms,Leiomyoma of uterus,FGL1,Fibrinogen-like protein 1,10335,147,0.90 [0.71-1.14],0.3698488009691811
Chapter II Neoplasms,Leiomyoma of uterus,FGR,Tyrosine-protein kinase Fgr,11512,163,1.12 [0.91-1.39],0.2861035697316287
Chapter II Neoplasms,Leiomyoma of uterus,FH,"Fumarate hydratase, mitochondrial",9978,146,1.09 [0.93-1.29],0.29034776405382
Chapter II Neoplasms,Leiomyoma of uterus,FHIP2A,FHF complex subunit HOOK interacting protein 2A,10002,147,1.07 [0.79-1.46],0.645237302043151
Chapter II Neoplasms,Leiomyoma of uterus,FHIT,Bis(5'-adenosyl)-triphosphatase,11512,163,1.02 [0.85-1.24],0.8166475495839598
Chapter II Neoplasms,Leiomyoma of uterus,FIS1,Mitochondrial fission 1 protein,11810,169,0.94 [0.79-1.13],0.5241220410475431
Chapter II Neoplasms,Leiomyoma of uterus,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,10311,147,1.00 [0.85-1.18],0.9784311604142802
Chapter II Neoplasms,Leiomyoma of uterus,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,11818,169,0.99 [0.87-1.12],0.86766808871798
Chapter II Neoplasms,Leiomyoma of uterus,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,11718,168,1.15 [0.84-1.57],0.3884643370638383
Chapter II Neoplasms,Leiomyoma of uterus,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,11718,168,1.00 [0.86-1.16],0.994297406811864
Chapter II Neoplasms,Leiomyoma of uterus,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,11493,162,1.02 [0.76-1.36],0.8969683176401324
Chapter II Neoplasms,Leiomyoma of uterus,FKBPL,FK506-binding protein-like,10273,150,1.15 [0.88-1.50],0.3162205807990156
Chapter II Neoplasms,Leiomyoma of uterus,FLI1,Friend leukemia integration 1 transcription factor,11526,160,1.04 [0.91-1.18],0.5678688920786705
Chapter II Neoplasms,Leiomyoma of uterus,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,11718,168,0.87 [0.53-1.42],0.5762810247289366
Chapter II Neoplasms,Leiomyoma of uterus,FLT1,Vascular endothelial growth factor receptor 1,11731,166,1.04 [0.54-2.03],0.8976324823941573
Chapter II Neoplasms,Leiomyoma of uterus,FLT3,Receptor-type tyrosine-protein kinase FLT3,11526,160,1.06 [0.68-1.65],0.8055876397122994
Chapter II Neoplasms,Leiomyoma of uterus,FLT3LG,Fms-related tyrosine kinase 3 ligand,11910,170,0.76 [0.50-1.15],0.1984953779241656
Chapter II Neoplasms,Leiomyoma of uterus,FLT4,Vascular endothelial growth factor receptor 3,11855,167,0.96 [0.63-1.45],0.8417072104217529
Chapter II Neoplasms,Leiomyoma of uterus,FMNL1,Formin-like protein 1,11512,163,1.11 [0.91-1.34],0.3003103886892959
Chapter II Neoplasms,Leiomyoma of uterus,FMR1,Synaptic functional regulator FMR1,11526,160,0.85 [0.57-1.28],0.4393118784420602
Chapter II Neoplasms,Leiomyoma of uterus,FN1,Fibronectin,10353,149,1.08 [0.60-1.97],0.7936330592466608
Chapter II Neoplasms,Leiomyoma of uterus,FNDC1,Fibronectin type III domain-containing protein 1,10317,147,1.11 [0.78-1.57],0.568679461168627
Chapter II Neoplasms,Leiomyoma of uterus,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,10278,147,1.19 [0.78-1.80],0.4167445077447316
Chapter II Neoplasms,Leiomyoma of uterus,FOLH1,Glutamate carboxypeptidase 2,10039,145,1.08 [0.94-1.24],0.2496574795307974
Chapter II Neoplasms,Leiomyoma of uterus,FOLR1,Folate receptor alpha,11803,165,1.41 [0.88-2.25],0.1511954697282825
Chapter II Neoplasms,Leiomyoma of uterus,FOLR2,Folate receptor beta,11892,170,1.23 [0.78-1.93],0.3791236895077515
Chapter II Neoplasms,Leiomyoma of uterus,FOLR3,Folate receptor gamma,11819,167,1.08 [1.01-1.15],0.0161150908525283
Chapter II Neoplasms,Leiomyoma of uterus,FOS,Proto-oncogene c-Fos,9943,142,1.11 [0.71-1.73],0.6569411012435413
Chapter II Neoplasms,Leiomyoma of uterus,FOSB,Protein fosB,11512,163,1.20 [0.89-1.62],0.2289110584269726
Chapter II Neoplasms,Leiomyoma of uterus,FOXJ3,Forkhead box protein J3,10039,145,1.08 [0.76-1.53],0.6626928337757718
Chapter II Neoplasms,Leiomyoma of uterus,FOXO1,Forkhead box protein O1,11777,170,1.01 [0.86-1.19],0.8792696449679545
Chapter II Neoplasms,Leiomyoma of uterus,FOXO3,Forkhead box protein O3,11526,160,1.08 [0.94-1.25],0.2904630520015858
Chapter II Neoplasms,Leiomyoma of uterus,FRMD4B,FERM domain-containing protein 4B,10002,147,0.96 [0.76-1.20],0.7119960385728326
Chapter II Neoplasms,Leiomyoma of uterus,FRMD7,FERM domain-containing protein 7,10056,144,1.04 [0.64-1.68],0.8855742175898258
Chapter II Neoplasms,Leiomyoma of uterus,FRZB,Secreted frizzled-related protein 3,11684,167,0.71 [0.42-1.19],0.1971150356536185
Chapter II Neoplasms,Leiomyoma of uterus,FSHB,Follitropin subunit beta,10091,145,0.75 [0.58-0.97],0.0268625961699135
Chapter II Neoplasms,Leiomyoma of uterus,FST,Follistatin,11831,169,0.75 [0.57-1.00],0.04645318314288
Chapter II Neoplasms,Leiomyoma of uterus,FSTL1,Follistatin-related protein 1,10091,145,0.84 [0.41-1.75],0.6416080098583178
Chapter II Neoplasms,Leiomyoma of uterus,FSTL3,Follistatin-related protein 3,11780,168,1.03 [0.67-1.58],0.902767903389556
Chapter II Neoplasms,Leiomyoma of uterus,FTCD,Formimidoyltransferase-cyclodeaminase,10294,146,1.07 [0.89-1.28],0.4701124900704827
Chapter II Neoplasms,Leiomyoma of uterus,FUCA1,Tissue alpha-L-fucosidase,11880,170,1.14 [0.96-1.35],0.145012044206361
Chapter II Neoplasms,Leiomyoma of uterus,FUOM,Fucose mutarotase,10128,146,1.04 [0.81-1.33],0.77062590784528
Chapter II Neoplasms,Leiomyoma of uterus,FURIN,Furin,11855,167,1.12 [0.74-1.69],0.6042037083678674
Chapter II Neoplasms,Leiomyoma of uterus,FUS,RNA-binding protein FUS,11509,160,1.04 [0.73-1.49],0.820551520221328
Chapter II Neoplasms,Leiomyoma of uterus,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",10141,144,1.28 [1.04-1.57],0.0194918844054319
Chapter II Neoplasms,Leiomyoma of uterus,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,11892,170,1.06 [0.79-1.42],0.6911822263301675
Chapter II Neoplasms,Leiomyoma of uterus,FUT8,"Alpha-(1,6)-fucosyltransferase",11718,168,1.04 [0.83-1.32],0.7235785312036245
Chapter II Neoplasms,Leiomyoma of uterus,FXN,"Frataxin, mitochondrial",11889,169,0.93 [0.77-1.12],0.4170114951965594
Chapter II Neoplasms,Leiomyoma of uterus,FXYD5,FXYD domain-containing ion transport regulator 5,11555,165,1.06 [0.85-1.30],0.6154500027220142
Chapter II Neoplasms,Leiomyoma of uterus,FYB1,FYN-binding protein 1,11790,165,0.98 [0.84-1.14],0.803795846977362
Chapter II Neoplasms,Leiomyoma of uterus,FZD10,Frizzled-10,10056,144,1.08 [0.85-1.38],0.518911194127581
Chapter II Neoplasms,Leiomyoma of uterus,FZD8,Frizzled-8,9978,146,1.05 [0.74-1.50],0.789500137813284
Chapter II Neoplasms,Leiomyoma of uterus,GABARAP,Gamma-aminobutyric acid receptor-associated protein,10278,147,1.24 [0.95-1.63],0.1120514873984545
Chapter II Neoplasms,Leiomyoma of uterus,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,10166,144,1.26 [1.04-1.52],0.0166793147360524
Chapter II Neoplasms,Leiomyoma of uterus,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,9978,146,1.15 [0.92-1.43],0.2115436399985924
Chapter II Neoplasms,Leiomyoma of uterus,GAD1,Glutamate decarboxylase 1,9961,142,1.39 [0.74-2.58],0.304042295969007
Chapter II Neoplasms,Leiomyoma of uterus,GAD2,Glutamate decarboxylase 2,10039,145,0.77 [0.51-1.15],0.2040886712279926
Chapter II Neoplasms,Leiomyoma of uterus,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,10166,144,0.88 [0.61-1.27],0.4998201290258126
Chapter II Neoplasms,Leiomyoma of uterus,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,10091,145,0.97 [0.71-1.33],0.8655262722997749
Chapter II Neoplasms,Leiomyoma of uterus,GAGE2A,G antigen 2A,9961,142,1.14 [0.93-1.40],0.2123522092360315
Chapter II Neoplasms,Leiomyoma of uterus,GAL,Galanin peptides,11854,170,0.89 [0.71-1.11],0.3072326013063642
Chapter II Neoplasms,Leiomyoma of uterus,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,11744,167,1.68 [1.02-2.75],0.0405497378285246
Chapter II Neoplasms,Leiomyoma of uterus,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,11889,169,1.36 [0.81-2.27],0.2474789421401384
Chapter II Neoplasms,Leiomyoma of uterus,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,11555,165,1.33 [0.96-1.84],0.0813847315695283
Chapter II Neoplasms,Leiomyoma of uterus,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,10334,150,1.35 [0.78-2.31],0.2794342281593346
Chapter II Neoplasms,Leiomyoma of uterus,GALNT7,N-acetylgalactosaminyltransferase 7,11744,167,1.15 [0.60-2.20],0.6770310123258371
Chapter II Neoplasms,Leiomyoma of uterus,GAMT,Guanidinoacetate N-methyltransferase,10002,147,1.27 [0.92-1.75],0.1502361216748432
Chapter II Neoplasms,Leiomyoma of uterus,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,9906,143,1.11 [0.68-1.83],0.6706059287050264
Chapter II Neoplasms,Leiomyoma of uterus,GART,Trifunctional purine biosynthetic protein adenosine-3,10311,147,0.98 [0.55-1.74],0.9383734173288656
Chapter II Neoplasms,Leiomyoma of uterus,GAS2,Growth arrest-specific protein 2,10166,144,1.03 [0.76-1.39],0.8565305152150887
Chapter II Neoplasms,Leiomyoma of uterus,GAS6,Growth arrest-specific protein 6,11866,169,0.73 [0.42-1.24],0.2447266672848899
Chapter II Neoplasms,Leiomyoma of uterus,GASK1A,Golgi-associated kinase 1A,10002,147,1.20 [0.84-1.73],0.3145061995543654
Chapter II Neoplasms,Leiomyoma of uterus,GAST,Gastrin,10317,147,1.00 [0.89-1.11],0.9380934215848252
Chapter II Neoplasms,Leiomyoma of uterus,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,9961,142,1.37 [0.76-2.47],0.3015458628709358
Chapter II Neoplasms,Leiomyoma of uterus,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",10091,145,1.09 [0.89-1.34],0.4022403081607236
Chapter II Neoplasms,Leiomyoma of uterus,GBA,Lysosomal acid glucosylceramidase,10056,144,0.83 [0.61-1.12],0.2157644041311937
Chapter II Neoplasms,Leiomyoma of uterus,GBP1,Guanylate-binding protein 1,10301,146,1.14 [0.90-1.44],0.286494872215487
Chapter II Neoplasms,Leiomyoma of uterus,GBP2,Guanylate-binding protein 2,11555,165,1.19 [0.96-1.49],0.1128742120333634
Chapter II Neoplasms,Leiomyoma of uterus,GBP4,Guanylate-binding protein 4,11512,163,1.09 [0.82-1.44],0.5631572670945442
Chapter II Neoplasms,Leiomyoma of uterus,GBP6,Guanylate-binding protein 6,10002,147,0.88 [0.60-1.29],0.50504199820309
Chapter II Neoplasms,Leiomyoma of uterus,GC,Vitamin D-binding protein,10353,149,0.48 [0.26-0.89],0.0203283383872676
Chapter II Neoplasms,Leiomyoma of uterus,GCC1,GRIP and coiled-coil domain-containing protein 1,10317,147,0.99 [0.85-1.15],0.906610042642036
Chapter II Neoplasms,Leiomyoma of uterus,GCG,Pro-glucagon,11526,160,1.12 [1.01-1.26],0.0394279783608404
Chapter II Neoplasms,Leiomyoma of uterus,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,9895,143,1.06 [0.77-1.47],0.7140928173022458
Chapter II Neoplasms,Leiomyoma of uterus,GCLM,Glutamate--cysteine ligase regulatory subunit,10002,147,0.94 [0.67-1.33],0.7367800414237893
Chapter II Neoplasms,Leiomyoma of uterus,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",11744,167,0.99 [0.67-1.46],0.9472650940545552
Chapter II Neoplasms,Leiomyoma of uterus,GDF15,Growth/differentiation factor 15,11938,171,1.08 [0.79-1.48],0.6411087152972124
Chapter II Neoplasms,Leiomyoma of uterus,GDF2,Growth/differentiation factor 2,11802,169,1.11 [0.76-1.63],0.5856789492687359
Chapter II Neoplasms,Leiomyoma of uterus,GDNF,Glial cell line-derived neurotrophic factor,11512,163,1.24 [0.88-1.74],0.2206771245956062
Chapter II Neoplasms,Leiomyoma of uterus,GET3,ATPase GET3,10334,150,1.19 [0.92-1.54],0.1745496280106104
Chapter II Neoplasms,Leiomyoma of uterus,GFAP,Glial fibrillary acidic protein,11505,159,0.97 [0.73-1.30],0.8642897667232773
Chapter II Neoplasms,Leiomyoma of uterus,GFER,FAD-linked sulfhydryl oxidase ALR,11526,160,1.06 [0.85-1.33],0.5867322593892803
Chapter II Neoplasms,Leiomyoma of uterus,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,11526,160,1.07 [0.97-1.18],0.1927739599817732
Chapter II Neoplasms,Leiomyoma of uterus,GFRA1,GDNF family receptor alpha-1,11867,169,0.86 [0.53-1.40],0.553624596310013
Chapter II Neoplasms,Leiomyoma of uterus,GFRA2,GDNF family receptor alpha-2,11744,167,1.56 [0.83-2.96],0.168767691987268
Chapter II Neoplasms,Leiomyoma of uterus,GFRA3,GDNF family receptor alpha-3,11681,168,0.95 [0.59-1.53],0.8265292223434134
Chapter II Neoplasms,Leiomyoma of uterus,GFRAL,GDNF family receptor alpha-like,9992,144,0.94 [0.72-1.23],0.6556905552564247
Chapter II Neoplasms,Leiomyoma of uterus,GGA1,ADP-ribosylation factor-binding protein GGA1,11512,163,0.98 [0.79-1.22],0.8789302259107616
Chapter II Neoplasms,Leiomyoma of uterus,GGACT,Gamma-glutamylaminecyclotransferase,10334,150,1.17 [0.94-1.45],0.1636141636222886
Chapter II Neoplasms,Leiomyoma of uterus,GGCT,Gamma-glutamylcyclotransferase,10308,149,1.19 [0.86-1.64],0.289158443881033
Chapter II Neoplasms,Leiomyoma of uterus,GGH,Gamma-glutamyl hydrolase,11613,164,0.65 [0.43-0.98],0.0412789559972409
Chapter II Neoplasms,Leiomyoma of uterus,GGT1,Glutathione hydrolase 1 proenzyme,11794,164,0.98 [0.74-1.31],0.9053579002354488
Chapter II Neoplasms,Leiomyoma of uterus,GGT5,Glutathione hydrolase 5 proenzyme,11718,168,1.30 [0.71-2.38],0.3895119698699715
Chapter II Neoplasms,Leiomyoma of uterus,GH1,Somatotropin,11779,169,1.00 [0.93-1.09],0.936716836426488
Chapter II Neoplasms,Leiomyoma of uterus,GH2,Growth hormone variant,11526,160,1.02 [0.94-1.10],0.6498777138905489
Chapter II Neoplasms,Leiomyoma of uterus,GHR,Growth hormone receptor,10128,146,1.03 [0.58-1.82],0.916510729771826
Chapter II Neoplasms,Leiomyoma of uterus,GHRHR,Growth hormone-releasing hormone receptor,11512,163,0.89 [0.67-1.17],0.3933344032675445
Chapter II Neoplasms,Leiomyoma of uterus,GHRL,Appetite-regulating hormone,11802,169,1.24 [1.05-1.47],0.0104893008230995
Chapter II Neoplasms,Leiomyoma of uterus,GID8,Glucose-induced degradation protein 8 homolog,10311,147,1.07 [0.67-1.72],0.7642641091424774
Chapter II Neoplasms,Leiomyoma of uterus,GIGYF2,GRB10-interacting GYF protein 2,10311,147,0.96 [0.78-1.18],0.6973330974634748
Chapter II Neoplasms,Leiomyoma of uterus,GIMAP7,GTPase IMAP family member 7,10128,146,0.86 [0.51-1.44],0.5706917071320174
Chapter II Neoplasms,Leiomyoma of uterus,GIMAP8,GTPase IMAP family member 8,9961,142,1.10 [0.82-1.46],0.5262446082234109
Chapter II Neoplasms,Leiomyoma of uterus,GIP,Gastric inhibitory polypeptide,10091,145,0.97 [0.74-1.27],0.8216429042648905
Chapter II Neoplasms,Leiomyoma of uterus,GIPC2,PDZ domain-containing protein GIPC2,10317,147,1.79 [1.09-2.94],0.0215846934428069
Chapter II Neoplasms,Leiomyoma of uterus,GIPC3,PDZ domain-containing protein GIPC3,10273,150,1.02 [0.87-1.20],0.8185286231953187
Chapter II Neoplasms,Leiomyoma of uterus,GIPR,Gastric inhibitory polypeptide receptor,10039,145,0.74 [0.50-1.10],0.1337066393071408
Chapter II Neoplasms,Leiomyoma of uterus,GIT1,ARF GTPase-activating protein GIT1,10039,145,1.00 [0.85-1.18],0.996404584529884
Chapter II Neoplasms,Leiomyoma of uterus,GJA8,Gap junction alpha-8 protein,9961,142,1.21 [0.99-1.48],0.0640511576884448
Chapter II Neoplasms,Leiomyoma of uterus,GKN1,Gastrokine-1,11287,162,1.24 [0.75-2.04],0.4107765957120822
Chapter II Neoplasms,Leiomyoma of uterus,GLA,Alpha-galactosidase A,10112,145,1.21 [0.79-1.87],0.383632532229366
Chapter II Neoplasms,Leiomyoma of uterus,GLB1,Beta-galactosidase,11718,168,0.81 [0.57-1.15],0.2391011950032403
Chapter II Neoplasms,Leiomyoma of uterus,GLI2,Zinc finger protein GLI2,10039,145,1.32 [0.86-2.01],0.2001383476449008
Chapter II Neoplasms,Leiomyoma of uterus,GLO1,Lactoylglutathione lyase,11560,165,0.89 [0.70-1.13],0.3375595543293036
Chapter II Neoplasms,Leiomyoma of uterus,GLOD4,Glyoxalase domain-containing protein 4,11787,168,1.04 [0.71-1.53],0.8459674747586721
Chapter II Neoplasms,Leiomyoma of uterus,GLP1R,Glucagon-like peptide 1 receptor,9978,146,1.23 [0.86-1.78],0.2599497018787634
Chapter II Neoplasms,Leiomyoma of uterus,GLRX,Glutaredoxin-1,11712,169,0.93 [0.73-1.18],0.5459829651851446
Chapter II Neoplasms,Leiomyoma of uterus,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",10128,146,0.95 [0.79-1.14],0.6069993989454481
Chapter II Neoplasms,Leiomyoma of uterus,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,11512,163,1.13 [0.86-1.48],0.3758357634843694
Chapter II Neoplasms,Leiomyoma of uterus,GLYR1,Putative oxidoreductase GLYR1,10278,147,1.02 [0.78-1.33],0.903814402818614
Chapter II Neoplasms,Leiomyoma of uterus,GM2A,Ganglioside GM2 activator,10069,143,1.11 [0.77-1.62],0.5682435728017905
Chapter II Neoplasms,Leiomyoma of uterus,GMFG,Glia maturation factor gamma,10334,150,1.07 [0.86-1.33],0.5489280867502802
Chapter II Neoplasms,Leiomyoma of uterus,GMPR,GMP reductase 1,11910,170,1.04 [0.80-1.36],0.7556540334061614
Chapter II Neoplasms,Leiomyoma of uterus,GMPR2,GMP reductase 2,10128,146,1.04 [0.82-1.32],0.7295763546491342
Chapter II Neoplasms,Leiomyoma of uterus,GNAS,Neuroendocrine secretory protein 55,10311,147,1.07 [0.90-1.27],0.4554136025824074
Chapter II Neoplasms,Leiomyoma of uterus,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,11526,160,0.96 [0.77-1.20],0.7333905158832736
Chapter II Neoplasms,Leiomyoma of uterus,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,10056,144,0.95 [0.69-1.32],0.769071656228014
Chapter II Neoplasms,Leiomyoma of uterus,GNLY,Granulysin,11808,165,0.90 [0.69-1.18],0.4635143217237628
Chapter II Neoplasms,Leiomyoma of uterus,GNPDA1,Glucosamine-6-phosphate isomerase 1,10091,145,1.00 [0.61-1.62],0.986387509856667
Chapter II Neoplasms,Leiomyoma of uterus,GNPDA2,Glucosamine-6-phosphate isomerase 2,10128,146,0.82 [0.52-1.28],0.3790141124835022
Chapter II Neoplasms,Leiomyoma of uterus,GOLGA3,Golgin subfamily A member 3,10311,147,1.02 [0.83-1.25],0.8547338672968299
Chapter II Neoplasms,Leiomyoma of uterus,GOLM2,Protein GOLM2,11892,170,0.95 [0.51-1.75],0.8678432615099123
Chapter II Neoplasms,Leiomyoma of uterus,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,11777,170,0.95 [0.83-1.09],0.4908376140228638
Chapter II Neoplasms,Leiomyoma of uterus,GORASP2,Golgi reassembly-stacking protein 2,10273,150,1.26 [0.91-1.73],0.1662903644197591
Chapter II Neoplasms,Leiomyoma of uterus,GOT1,"Aspartate aminotransferase, cytoplasmic",10347,149,1.14 [0.78-1.66],0.5010456770418406
Chapter II Neoplasms,Leiomyoma of uterus,GP1BA,Platelet glycoprotein Ib alpha chain,11747,169,0.82 [0.53-1.25],0.3513074453422125
Chapter II Neoplasms,Leiomyoma of uterus,GP1BB,Platelet glycoprotein Ib beta chain,10002,147,0.88 [0.70-1.12],0.312895039302112
Chapter II Neoplasms,Leiomyoma of uterus,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,11416,162,1.17 [1.01-1.36],0.0348091612045675
Chapter II Neoplasms,Leiomyoma of uterus,GP5,Platelet glycoprotein V,10128,146,0.81 [0.52-1.25],0.3302042157028534
Chapter II Neoplasms,Leiomyoma of uterus,GP6,Platelet glycoprotein VI,11790,165,0.95 [0.81-1.11],0.5133599845944223
Chapter II Neoplasms,Leiomyoma of uterus,GPA33,Cell surface A33 antigen,11744,167,0.90 [0.81-0.99],0.0284008780634778
Chapter II Neoplasms,Leiomyoma of uterus,GPC1,Glypican-1,11889,169,0.77 [0.49-1.23],0.2754433329964025
Chapter II Neoplasms,Leiomyoma of uterus,GPC5,Glypican-5,11718,168,1.09 [0.85-1.39],0.5125478647005115
Chapter II Neoplasms,Leiomyoma of uterus,GPD1,Glycerol-3-phosphate dehydrogenase,10278,147,1.21 [0.90-1.62],0.2016985760989929
Chapter II Neoplasms,Leiomyoma of uterus,GPHA2,Glycoprotein hormone alpha-2,10273,150,1.41 [1.11-1.79],0.0046761541338753
Chapter II Neoplasms,Leiomyoma of uterus,GPI,Glucose-6-phosphate isomerase,10335,147,1.09 [0.78-1.52],0.616611945011948
Chapter II Neoplasms,Leiomyoma of uterus,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,10273,150,0.84 [0.68-1.03],0.0913707478157758
Chapter II Neoplasms,Leiomyoma of uterus,GPKOW,G-patch domain and KOW motifs-containing protein,11512,163,1.36 [0.92-2.01],0.1207533541795921
Chapter II Neoplasms,Leiomyoma of uterus,GPNMB,Transmembrane glycoprotein NMB,11479,163,0.79 [0.48-1.30],0.3507369177728459
Chapter II Neoplasms,Leiomyoma of uterus,GPR101,Probable G-protein coupled receptor 101,9978,146,1.00 [0.77-1.29],0.9766988479689191
Chapter II Neoplasms,Leiomyoma of uterus,GPR158,Probable G-protein coupled receptor 158,10311,147,1.09 [0.72-1.65],0.678376367771564
Chapter II Neoplasms,Leiomyoma of uterus,GPR15L,Protein GPR15L,10273,150,1.19 [0.92-1.54],0.1744725319289563
Chapter II Neoplasms,Leiomyoma of uterus,GPR37,Prosaposin receptor GPR37,11560,165,1.10 [0.90-1.35],0.3577214444244423
Chapter II Neoplasms,Leiomyoma of uterus,GPRC5C,G-protein coupled receptor family C group 5 member C,10278,147,1.17 [0.91-1.51],0.2139287882040968
Chapter II Neoplasms,Leiomyoma of uterus,GRAP2,GRB2-related adapter protein 2,11802,169,0.99 [0.89-1.11],0.9249624136275578
Chapter II Neoplasms,Leiomyoma of uterus,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,10334,150,1.22 [0.96-1.56],0.1072291878145293
Chapter II Neoplasms,Leiomyoma of uterus,GRIK2,"Glutamate receptor ionotropic, kainate 2",10311,147,0.89 [0.61-1.29],0.5311678744098993
Chapter II Neoplasms,Leiomyoma of uterus,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",9978,146,1.06 [0.82-1.37],0.6400869081824544
Chapter II Neoplasms,Leiomyoma of uterus,GRK5,G protein-coupled receptor kinase 5,11560,165,0.93 [0.70-1.24],0.6309155610925012
Chapter II Neoplasms,Leiomyoma of uterus,GRN,Progranulin,11761,163,0.74 [0.41-1.33],0.3086328286567208
Chapter II Neoplasms,Leiomyoma of uterus,GRP,Gastrin-releasing peptide,10091,145,1.12 [0.84-1.49],0.4284242797499581
Chapter II Neoplasms,Leiomyoma of uterus,GRPEL1,"GrpE protein homolog 1, mitochondrial",11744,167,1.02 [0.81-1.29],0.8482228642139757
Chapter II Neoplasms,Leiomyoma of uterus,GRSF1,G-rich sequence factor 1,9907,142,1.07 [0.88-1.30],0.5131177433855368
Chapter II Neoplasms,Leiomyoma of uterus,GSAP,Gamma-secretase-activating protein,11526,160,0.94 [0.79-1.12],0.5171267892262947
Chapter II Neoplasms,Leiomyoma of uterus,GSN,Gelsolin,10306,146,1.45 [0.63-3.31],0.3797898438582643
Chapter II Neoplasms,Leiomyoma of uterus,GSR,"Glutathione reductase, mitochondrial",10272,146,0.87 [0.43-1.77],0.7077854500014552
Chapter II Neoplasms,Leiomyoma of uterus,GSTA1,Glutathione S-transferase A1,11781,169,1.04 [0.88-1.22],0.6500260790324742
Chapter II Neoplasms,Leiomyoma of uterus,GSTA3,Glutathione S-transferase A3,11526,160,1.06 [0.88-1.26],0.5551236674879613
Chapter II Neoplasms,Leiomyoma of uterus,GSTM4,Glutathione S-transferase Mu 4,10002,147,0.93 [0.74-1.18],0.5486287404655921
Chapter II Neoplasms,Leiomyoma of uterus,GSTP1,Glutathione S-transferase P,11436,162,1.06 [0.87-1.29],0.5833786043635567
Chapter II Neoplasms,Leiomyoma of uterus,GSTT2B,Glutathione S-transferase theta-2B,10317,147,1.02 [0.95-1.09],0.578371723072307
Chapter II Neoplasms,Leiomyoma of uterus,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,10166,144,1.08 [0.89-1.32],0.4408599591669454
Chapter II Neoplasms,Leiomyoma of uterus,GTPBP2,GTP-binding protein 2,10056,144,0.97 [0.79-1.19],0.7953106746797459
Chapter II Neoplasms,Leiomyoma of uterus,GUCA2A,Guanylin,11754,164,1.20 [0.80-1.80],0.382600407378959
Chapter II Neoplasms,Leiomyoma of uterus,GUCY2C,Heat-stable enterotoxin receptor,10166,144,1.06 [0.88-1.27],0.5395254224518944
Chapter II Neoplasms,Leiomyoma of uterus,GUK1,Guanylate kinase,10002,147,0.96 [0.62-1.47],0.8414954280121325
Chapter II Neoplasms,Leiomyoma of uterus,GUSB,Beta-glucuronidase,11861,169,0.85 [0.67-1.06],0.1544273105062819
Chapter II Neoplasms,Leiomyoma of uterus,GYS1,"Glycogen [starch] synthase, muscle",11560,165,0.96 [0.83-1.12],0.6271882712611299
Chapter II Neoplasms,Leiomyoma of uterus,GZMA,Granzyme A,11910,170,0.90 [0.62-1.32],0.6015609605221135
Chapter II Neoplasms,Leiomyoma of uterus,GZMB,Granzyme B,11777,170,1.02 [0.82-1.26],0.8569371400067455
Chapter II Neoplasms,Leiomyoma of uterus,GZMH,Granzyme H,11560,165,1.04 [0.87-1.24],0.6717099210025044
Chapter II Neoplasms,Leiomyoma of uterus,H2AP,Huntingtin-interacting protein M,9961,142,1.17 [0.91-1.50],0.2110636048338529
Chapter II Neoplasms,Leiomyoma of uterus,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",10002,147,0.96 [0.75-1.23],0.765135768175386
Chapter II Neoplasms,Leiomyoma of uterus,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",11847,169,1.07 [0.89-1.28],0.4628062370204886
Chapter II Neoplasms,Leiomyoma of uterus,HAO1,Hydroxyacid oxidase 1,11889,169,0.99 [0.89-1.10],0.8452562917028533
Chapter II Neoplasms,Leiomyoma of uterus,HARS1,"Histidine--tRNA ligase, cytoplasmic",11808,165,0.99 [0.83-1.19],0.9136151997668216
Chapter II Neoplasms,Leiomyoma of uterus,HAVCR1,Hepatitis A virus cellular receptor 1,11869,169,0.99 [0.79-1.23],0.898179738904983
Chapter II Neoplasms,Leiomyoma of uterus,HAVCR2,Hepatitis A virus cellular receptor 2,11808,165,1.02 [0.69-1.51],0.923907892286598
Chapter II Neoplasms,Leiomyoma of uterus,HBEGF,Proheparin-binding EGF-like growth factor,11847,169,0.95 [0.79-1.14],0.5839393480865156
Chapter II Neoplasms,Leiomyoma of uterus,HBQ1,Hemoglobin subunit theta-1,11889,169,1.02 [0.82-1.28],0.8343822803321765
Chapter II Neoplasms,Leiomyoma of uterus,HBZ,Hemoglobin subunit zeta,10334,150,1.06 [0.92-1.23],0.4057515228550263
Chapter II Neoplasms,Leiomyoma of uterus,HCG22,Protein PBMUCL2,10002,147,0.91 [0.65-1.28],0.5838619666541961
Chapter II Neoplasms,Leiomyoma of uterus,HCLS1,Hematopoietic lineage cell-specific protein,11910,170,1.11 [0.87-1.43],0.3951540541159076
Chapter II Neoplasms,Leiomyoma of uterus,HDAC8,Histone deacetylase 8,10039,145,1.19 [0.96-1.48],0.1111509468929251
Chapter II Neoplasms,Leiomyoma of uterus,HDAC9,Histone deacetylase 9,9978,146,1.25 [1.04-1.50],0.019408762192556
Chapter II Neoplasms,Leiomyoma of uterus,HDDC2,5'-deoxynucleotidase HDDC2,10273,150,0.87 [0.60-1.24],0.4396244727937149
Chapter II Neoplasms,Leiomyoma of uterus,HDGF,Hepatoma-derived growth factor,11872,169,0.95 [0.82-1.10],0.4752487012658485
Chapter II Neoplasms,Leiomyoma of uterus,HDGFL2,Hepatoma-derived growth factor-related protein 2,10317,147,1.04 [0.81-1.33],0.7744124822826017
Chapter II Neoplasms,Leiomyoma of uterus,HEBP1,Heme-binding protein 1,11560,165,1.14 [0.91-1.42],0.2511500130922736
Chapter II Neoplasms,Leiomyoma of uterus,HEG1,Protein HEG homolog 1,10128,146,0.70 [0.38-1.29],0.2468761300313202
Chapter II Neoplasms,Leiomyoma of uterus,HEPACAM2,HEPACAM family member 2,10317,147,1.26 [0.85-1.85],0.244677502016905
Chapter II Neoplasms,Leiomyoma of uterus,HEPH,Hephaestin,10334,150,1.28 [0.68-2.41],0.4484626818215932
Chapter II Neoplasms,Leiomyoma of uterus,HEXIM1,Protein HEXIM1,11777,170,0.96 [0.81-1.14],0.6425262512707615
Chapter II Neoplasms,Leiomyoma of uterus,HGF,Hepatocyte growth factor,11910,170,0.84 [0.56-1.26],0.4091372701492474
Chapter II Neoplasms,Leiomyoma of uterus,HGFAC,Hepatocyte growth factor activator,10227,147,0.81 [0.52-1.26],0.35063716280446
Chapter II Neoplasms,Leiomyoma of uterus,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,11526,160,1.01 [0.84-1.21],0.9405170717113764
Chapter II Neoplasms,Leiomyoma of uterus,HHEX,Hematopoietically-expressed homeobox protein HHEX,10317,147,1.02 [0.82-1.26],0.8634064799677639
Chapter II Neoplasms,Leiomyoma of uterus,HIF1A,Hypoxia-inducible factor 1-alpha,10039,145,1.14 [0.93-1.39],0.2092654647100803
Chapter II Neoplasms,Leiomyoma of uterus,HIP1,Huntingtin-interacting protein 1,10002,147,1.12 [0.71-1.77],0.6255568382639476
Chapter II Neoplasms,Leiomyoma of uterus,HIP1R,Huntingtin-interacting protein 1-related protein,10292,147,1.08 [0.76-1.53],0.6832270439168664
Chapter II Neoplasms,Leiomyoma of uterus,HJV,Hemojuvelin,10311,147,1.27 [0.97-1.67],0.0807602613283621
Chapter II Neoplasms,Leiomyoma of uterus,HK2,Hexokinase-2,11560,165,1.04 [0.64-1.69],0.8837619889521742
Chapter II Neoplasms,Leiomyoma of uterus,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",10311,147,1.24 [0.76-2.01],0.3918704510193459
Chapter II Neoplasms,Leiomyoma of uterus,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",11748,170,0.68 [0.46-0.99],0.0469012294813579
Chapter II Neoplasms,Leiomyoma of uterus,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",11777,170,1.23 [0.79-1.93],0.3614736793753997
Chapter II Neoplasms,Leiomyoma of uterus,HMBS,Porphobilinogen deaminase,11889,169,1.09 [0.81-1.47],0.5571625403274532
Chapter II Neoplasms,Leiomyoma of uterus,HMCN2,Hemicentin-2,10111,146,0.87 [0.66-1.15],0.3227488669203502
Chapter II Neoplasms,Leiomyoma of uterus,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",10091,145,1.07 [0.78-1.47],0.6767035156028305
Chapter II Neoplasms,Leiomyoma of uterus,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",10002,147,1.05 [0.73-1.49],0.8057676815483853
Chapter II Neoplasms,Leiomyoma of uterus,HMMR,Hyaluronan mediated motility receptor,9939,141,0.97 [0.70-1.35],0.8638887218202065
Chapter II Neoplasms,Leiomyoma of uterus,HMOX1,Heme oxygenase 1,11662,168,1.31 [0.99-1.73],0.059245183174808
Chapter II Neoplasms,Leiomyoma of uterus,HMOX2,Heme oxygenase 2,11512,163,1.24 [0.95-1.63],0.1128476513059135
Chapter II Neoplasms,Leiomyoma of uterus,HNF1A,Hepatocyte nuclear factor 1-alpha,10056,144,0.91 [0.71-1.17],0.4629225137015936
Chapter II Neoplasms,Leiomyoma of uterus,HNMT,Histamine N-methyltransferase,11666,166,1.02 [0.76-1.37],0.8926185667600962
Chapter II Neoplasms,Leiomyoma of uterus,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,11531,164,0.99 [0.83-1.19],0.9546313685916208
Chapter II Neoplasms,Leiomyoma of uterus,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,10311,147,1.09 [0.80-1.50],0.5853706453070342
Chapter II Neoplasms,Leiomyoma of uterus,HPCAL1,Hippocalcin-like protein 1,11910,170,0.95 [0.79-1.15],0.6049027759054864
Chapter II Neoplasms,Leiomyoma of uterus,HPGDS,Hematopoietic prostaglandin D synthase,11526,160,1.07 [0.74-1.56],0.7186130176318992
Chapter II Neoplasms,Leiomyoma of uterus,HPSE,Heparanase,10200,147,0.98 [0.82-1.16],0.7782944847969445
Chapter II Neoplasms,Leiomyoma of uterus,HRAS,GTPase Hras,10138,143,0.86 [0.71-1.05],0.14341894048086
Chapter II Neoplasms,Leiomyoma of uterus,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,10091,145,1.08 [0.71-1.65],0.7104555846016004
Chapter II Neoplasms,Leiomyoma of uterus,HRG,Histidine-rich glycoprotein,10288,149,1.20 [0.73-1.98],0.4786983212905273
Chapter II Neoplasms,Leiomyoma of uterus,HS1BP3,HCLS1-binding protein 3,10091,145,1.04 [0.87-1.25],0.6570958084983893
Chapter II Neoplasms,Leiomyoma of uterus,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,11744,167,0.87 [0.61-1.25],0.4553997194012302
Chapter II Neoplasms,Leiomyoma of uterus,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,11889,169,1.15 [0.78-1.71],0.4690736974380589
Chapter II Neoplasms,Leiomyoma of uterus,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,10039,145,1.11 [0.67-1.86],0.686838559774333
Chapter II Neoplasms,Leiomyoma of uterus,HSBP1,Heat shock factor-binding protein 1,10091,145,1.01 [0.85-1.19],0.9306761374090328
Chapter II Neoplasms,Leiomyoma of uterus,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,11777,170,1.08 [0.76-1.52],0.6726823989063836
Chapter II Neoplasms,Leiomyoma of uterus,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,10317,147,1.14 [0.89-1.46],0.3017181466149743
Chapter II Neoplasms,Leiomyoma of uterus,HSD17B3,Testosterone 17-beta-dehydrogenase 3,10002,147,1.01 [0.73-1.40],0.9519175915124284
Chapter II Neoplasms,Leiomyoma of uterus,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,10091,145,1.06 [0.76-1.48],0.7398021350495978
Chapter II Neoplasms,Leiomyoma of uterus,HSP90B1,Endoplasmin,11455,162,1.18 [1.00-1.39],0.0467337621305992
Chapter II Neoplasms,Leiomyoma of uterus,HSPA1A,Heat shock 70 kDa protein 1A,11843,170,0.97 [0.80-1.17],0.725512328178292
Chapter II Neoplasms,Leiomyoma of uterus,HSPA2,Heat shock-related 70 kDa protein 2,10278,147,1.11 [0.71-1.75],0.6461576325118994
Chapter II Neoplasms,Leiomyoma of uterus,HSPB1,Heat shock protein beta-1,11615,164,0.88 [0.72-1.08],0.2299584307430512
Chapter II Neoplasms,Leiomyoma of uterus,HSPB6,Heat shock protein beta-6,11889,169,1.31 [0.92-1.87],0.1394970961582298
Chapter II Neoplasms,Leiomyoma of uterus,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,11722,167,1.23 [0.73-2.07],0.4336128031935771
Chapter II Neoplasms,Leiomyoma of uterus,HTR1A,5-hydroxytryptamine receptor 1A,9978,146,1.04 [0.86-1.25],0.6955949807459852
Chapter II Neoplasms,Leiomyoma of uterus,HTR1B,5-hydroxytryptamine receptor 1B,9978,146,1.13 [0.81-1.58],0.4619745302440688
Chapter II Neoplasms,Leiomyoma of uterus,HTRA2,"Serine protease HTRA2, mitochondrial",11855,167,1.02 [0.81-1.27],0.8810511045796772
Chapter II Neoplasms,Leiomyoma of uterus,HYAL1,Hyaluronidase-1,11741,167,0.88 [0.48-1.61],0.6852150200263143
Chapter II Neoplasms,Leiomyoma of uterus,HYOU1,Hypoxia up-regulated protein 1,11938,171,0.91 [0.50-1.68],0.7738236644520049
Chapter II Neoplasms,Leiomyoma of uterus,ICA1,Islet cell autoantigen 1,11555,165,1.04 [0.87-1.24],0.6393608245209499
Chapter II Neoplasms,Leiomyoma of uterus,ICAM1,Intercellular adhesion molecule 1,11747,168,0.66 [0.40-1.08],0.1000390742672174
Chapter II Neoplasms,Leiomyoma of uterus,ICAM2,Intercellular adhesion molecule 2,11938,171,0.85 [0.56-1.30],0.4579644196076221
Chapter II Neoplasms,Leiomyoma of uterus,ICAM3,Intercellular adhesion molecule 3,11938,171,0.77 [0.46-1.31],0.3390530639647458
Chapter II Neoplasms,Leiomyoma of uterus,ICAM4,Intercellular adhesion molecule 4,11777,170,1.03 [0.80-1.33],0.821531536346978
Chapter II Neoplasms,Leiomyoma of uterus,ICAM5,Intercellular adhesion molecule 5,11802,169,0.88 [0.65-1.20],0.4317632222001291
Chapter II Neoplasms,Leiomyoma of uterus,ICOSLG,ICOS ligand,11744,167,0.74 [0.36-1.52],0.4142610912467077
Chapter II Neoplasms,Leiomyoma of uterus,ID4,DNA-binding protein inhibitor ID-4,10166,144,0.82 [0.54-1.25],0.3613268643236639
Chapter II Neoplasms,Leiomyoma of uterus,IDI2,Isopentenyl-diphosphate delta-isomerase 2,11512,163,1.11 [0.84-1.48],0.4554171499959996
Chapter II Neoplasms,Leiomyoma of uterus,IDO1,"Indoleamine 2,3-dioxygenase 1",10091,145,1.11 [0.88-1.40],0.3790934540179181
Chapter II Neoplasms,Leiomyoma of uterus,IDS,Iduronate 2-sulfatase,11910,170,0.43 [0.10-1.93],0.2734278469118527
Chapter II Neoplasms,Leiomyoma of uterus,IDUA,Alpha-L-iduronidase,11889,169,1.05 [0.78-1.41],0.7531080133048382
Chapter II Neoplasms,Leiomyoma of uterus,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,10011,148,1.21 [0.81-1.81],0.3416610017211583
Chapter II Neoplasms,Leiomyoma of uterus,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,10166,144,1.07 [0.81-1.43],0.6202983032879295
Chapter II Neoplasms,Leiomyoma of uterus,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,10166,144,1.00 [0.66-1.53],0.9895689883442006
Chapter II Neoplasms,Leiomyoma of uterus,IFNAR1,Interferon alpha/beta receptor 1,10273,150,0.70 [0.37-1.34],0.2841659164043142
Chapter II Neoplasms,Leiomyoma of uterus,IFNG,Interferon gamma,11555,165,0.93 [0.82-1.05],0.2551568821644239
Chapter II Neoplasms,Leiomyoma of uterus,IFNGR1,Interferon gamma receptor 1,11854,170,0.89 [0.46-1.72],0.7295493328324114
Chapter II Neoplasms,Leiomyoma of uterus,IFNGR2,Interferon gamma receptor 2,11718,168,1.13 [0.87-1.46],0.3498914151230268
Chapter II Neoplasms,Leiomyoma of uterus,IFNL1,Interferon lambda-1,11512,163,1.04 [0.77-1.42],0.7855691887685348
Chapter II Neoplasms,Leiomyoma of uterus,IFNL2,Interferon lambda-2,9978,146,1.24 [1.02-1.51],0.027397772716269
Chapter II Neoplasms,Leiomyoma of uterus,IFNLR1,Interferon lambda receptor 1,11777,170,0.66 [0.44-1.00],0.0477914171777122
Chapter II Neoplasms,Leiomyoma of uterus,IFNW1,Interferon omega-1,10002,147,1.06 [0.70-1.61],0.791819348033606
Chapter II Neoplasms,Leiomyoma of uterus,IFT20,Intraflagellar transport protein 20 homolog,10056,144,0.99 [0.68-1.43],0.9627848828255752
Chapter II Neoplasms,Leiomyoma of uterus,IGBP1,Immunoglobulin-binding protein 1,10311,147,1.17 [0.91-1.51],0.2098101080263038
Chapter II Neoplasms,Leiomyoma of uterus,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,9978,146,1.00 [0.72-1.38],0.9822119551990104
Chapter II Neoplasms,Leiomyoma of uterus,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,10347,149,0.94 [0.51-1.72],0.8391521699704492
Chapter II Neoplasms,Leiomyoma of uterus,IGF1R,Insulin-like growth factor 1 receptor,11744,167,0.94 [0.48-1.81],0.8468843788291269
Chapter II Neoplasms,Leiomyoma of uterus,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,10002,147,0.81 [0.55-1.19],0.2765523909367618
Chapter II Neoplasms,Leiomyoma of uterus,IGF2R,Cation-independent mannose-6-phosphate receptor,11808,165,0.71 [0.39-1.31],0.2776009686185177
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP1,Insulin-like growth factor-binding protein 1,11918,171,0.88 [0.78-0.99],0.0306191178280134
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP2,Insulin-like growth factor-binding protein 2,11926,171,1.04 [0.84-1.29],0.7125274349810287
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP3,Insulin-like growth factor-binding protein 3,11855,169,0.99 [0.61-1.60],0.9691617928348296
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP4,Insulin-like growth factor-binding protein 4,11654,164,1.37 [1.01-1.85],0.0401536736281649
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP6,Insulin-like growth factor-binding protein 6,11750,168,1.06 [0.67-1.68],0.8051944090589345
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP7,Insulin-like growth factor-binding protein 7,11938,171,1.28 [0.83-1.96],0.2649295319019906
Chapter II Neoplasms,Leiomyoma of uterus,IGFBPL1,Insulin-like growth factor-binding protein-like 1,11802,169,1.24 [0.84-1.84],0.281367313478017
Chapter II Neoplasms,Leiomyoma of uterus,IGFL4,Insulin growth factor-like family member 4,10039,145,0.83 [0.64-1.08],0.1703705339834552
Chapter II Neoplasms,Leiomyoma of uterus,IGHMBP2,DNA-binding protein SMUBP-2,10002,147,1.33 [1.05-1.69],0.0190818444604824
Chapter II Neoplasms,Leiomyoma of uterus,IGLC2,Immunoglobulin lambda constant 2,10326,149,0.98 [0.53-1.82],0.9518272012443616
Chapter II Neoplasms,Leiomyoma of uterus,IGLON5,IgLON family member 5,9961,142,1.05 [0.89-1.23],0.5587346154207744
Chapter II Neoplasms,Leiomyoma of uterus,IGSF21,Immunoglobulin superfamily member 21,10091,145,0.89 [0.58-1.39],0.6135029742449759
Chapter II Neoplasms,Leiomyoma of uterus,IGSF3,Immunoglobulin superfamily member 3,11744,167,0.89 [0.58-1.35],0.5755130010359053
Chapter II Neoplasms,Leiomyoma of uterus,IGSF8,Immunoglobulin superfamily member 8,11802,169,0.98 [0.62-1.56],0.9414179033949576
Chapter II Neoplasms,Leiomyoma of uterus,IGSF9,Protein turtle homolog A,10334,150,0.97 [0.80-1.18],0.7803886934025408
Chapter II Neoplasms,Leiomyoma of uterus,IKBKG,NF-kappa-B essential modulator,11777,170,0.96 [0.82-1.12],0.5956350144153784
Chapter II Neoplasms,Leiomyoma of uterus,IKZF2,Zinc finger protein Helios,11526,160,1.09 [0.95-1.26],0.2182197737718406
Chapter II Neoplasms,Leiomyoma of uterus,IL10,Interleukin-10,11555,165,0.95 [0.80-1.12],0.537749609257245
Chapter II Neoplasms,Leiomyoma of uterus,IL10RA,Interleukin-10 receptor subunit alpha,11555,165,0.89 [0.69-1.16],0.4077147847454566
Chapter II Neoplasms,Leiomyoma of uterus,IL10RB,Interleukin-10 receptor subunit beta,11854,170,1.03 [0.64-1.65],0.9046383937322852
Chapter II Neoplasms,Leiomyoma of uterus,IL11,Interleukin-11,11555,165,1.00 [0.81-1.24],0.977844520400643
Chapter II Neoplasms,Leiomyoma of uterus,IL12A_IL12B,Interleukin-12,11744,167,1.10 [0.94-1.30],0.2407486085552617
Chapter II Neoplasms,Leiomyoma of uterus,IL12B,Interleukin-12 subunit beta,11910,170,1.19 [0.93-1.52],0.1573084176797985
Chapter II Neoplasms,Leiomyoma of uterus,IL12RB1,Interleukin-12 receptor subunit beta-1,11555,165,0.83 [0.57-1.20],0.3200797946686649
Chapter II Neoplasms,Leiomyoma of uterus,IL12RB2,Interleukin-12 receptor subunit beta-2,10039,145,1.06 [0.72-1.55],0.7685711487041139
Chapter II Neoplasms,Leiomyoma of uterus,IL13,Interleukin-13,11555,165,1.00 [0.75-1.34],0.9953718195497716
Chapter II Neoplasms,Leiomyoma of uterus,IL13RA1,Interleukin-13 receptor subunit alpha-1,11671,164,1.61 [0.82-3.17],0.1660980895489019
Chapter II Neoplasms,Leiomyoma of uterus,IL13RA2,Interleukin-13 receptor subunit alpha-2,9978,146,1.47 [0.85-2.54],0.1655213892375676
Chapter II Neoplasms,Leiomyoma of uterus,IL15,Interleukin-15,11777,170,0.88 [0.58-1.34],0.5615649176798778
Chapter II Neoplasms,Leiomyoma of uterus,IL15RA,Interleukin-15 receptor subunit alpha,11555,165,1.08 [0.73-1.59],0.7070182518314516
Chapter II Neoplasms,Leiomyoma of uterus,IL16,Pro-interleukin-16,11910,170,1.12 [0.82-1.54],0.4727725687027972
Chapter II Neoplasms,Leiomyoma of uterus,IL17A,Interleukin-17A,11540,165,0.91 [0.66-1.27],0.5901001209167263
Chapter II Neoplasms,Leiomyoma of uterus,IL17C,Interleukin-17C,11555,165,0.85 [0.69-1.04],0.1212766252640567
Chapter II Neoplasms,Leiomyoma of uterus,IL17D,Interleukin-17D,11555,165,1.03 [0.68-1.55],0.8880035383066582
Chapter II Neoplasms,Leiomyoma of uterus,IL17F,Interleukin-17F,11555,165,0.97 [0.81-1.17],0.7699448255525242
Chapter II Neoplasms,Leiomyoma of uterus,IL17RA,Interleukin-17 receptor A,11808,165,1.01 [0.74-1.37],0.9737794710890382
Chapter II Neoplasms,Leiomyoma of uterus,IL17RB,Interleukin-17 receptor B,11634,168,0.98 [0.75-1.28],0.8895161767095753
Chapter II Neoplasms,Leiomyoma of uterus,IL18,Interleukin-18,11765,168,0.97 [0.73-1.28],0.8097877557765693
Chapter II Neoplasms,Leiomyoma of uterus,IL18BP,Interleukin-18-binding protein,11855,169,0.92 [0.59-1.43],0.7072565781169498
Chapter II Neoplasms,Leiomyoma of uterus,IL18R1,Interleukin-18 receptor 1,11910,170,0.97 [0.64-1.46],0.8815973885227182
Chapter II Neoplasms,Leiomyoma of uterus,IL18RAP,Interleukin-18 receptor accessory protein,11651,166,0.95 [0.87-1.03],0.2004770969988059
Chapter II Neoplasms,Leiomyoma of uterus,IL19,Interleukin-19,11506,164,1.12 [0.92-1.36],0.2441310282614822
Chapter II Neoplasms,Leiomyoma of uterus,IL1A,Interleukin-1 alpha,11555,165,1.14 [0.93-1.40],0.2139806789365394
Chapter II Neoplasms,Leiomyoma of uterus,IL1B,Interleukin-1 beta,11503,162,0.92 [0.71-1.19],0.52846959985925
Chapter II Neoplasms,Leiomyoma of uterus,IL1R1,Interleukin-1 receptor type 1,11794,164,0.98 [0.53-1.80],0.9500816502234284
Chapter II Neoplasms,Leiomyoma of uterus,IL1R2,Interleukin-1 receptor type 2,11780,169,0.65 [0.33-1.30],0.2248314218100268
Chapter II Neoplasms,Leiomyoma of uterus,IL1RAP,Interleukin-1 receptor accessory protein,11808,165,0.75 [0.55-1.04],0.0880460246192323
Chapter II Neoplasms,Leiomyoma of uterus,IL1RL1,Interleukin-1 receptor-like 1,11905,170,0.84 [0.62-1.14],0.2687859692963996
Chapter II Neoplasms,Leiomyoma of uterus,IL1RL2,Interleukin-1 receptor-like 2,11555,165,0.68 [0.48-0.98],0.0361211671008851
Chapter II Neoplasms,Leiomyoma of uterus,IL1RN,Interleukin-1 receptor antagonist protein,11788,169,1.10 [0.87-1.38],0.4241222780348868
Chapter II Neoplasms,Leiomyoma of uterus,IL2,Interleukin-2,11555,165,0.72 [0.46-1.11],0.1355883885168494
Chapter II Neoplasms,Leiomyoma of uterus,IL20,Interleukin-20,11555,165,0.95 [0.72-1.26],0.7413692012550107
Chapter II Neoplasms,Leiomyoma of uterus,IL20RA,Interleukin-20 receptor subunit alpha,11555,165,0.92 [0.66-1.27],0.6139231997320754
Chapter II Neoplasms,Leiomyoma of uterus,IL20RB,Interleukin-20 receptor subunit beta,10039,145,1.08 [0.73-1.58],0.7000772395582553
Chapter II Neoplasms,Leiomyoma of uterus,IL21R,Interleukin-21 receptor,10039,145,0.62 [0.42-0.93],0.02122067535912
Chapter II Neoplasms,Leiomyoma of uterus,IL22,Interleukin-22,10278,147,0.99 [0.78-1.25],0.9225689664194427
Chapter II Neoplasms,Leiomyoma of uterus,IL22RA1,Interleukin-22 receptor subunit alpha-1,11555,165,1.03 [0.75-1.41],0.8760386995549012
Chapter II Neoplasms,Leiomyoma of uterus,IL24,Interleukin-24,11555,165,1.10 [0.85-1.42],0.4661634761254726
Chapter II Neoplasms,Leiomyoma of uterus,IL25,Interleukin-25,9926,142,0.61 [0.38-0.96],0.0335027937528803
Chapter II Neoplasms,Leiomyoma of uterus,IL2RA,Interleukin-2 receptor subunit alpha,11699,166,1.13 [0.81-1.57],0.4760642820210559
Chapter II Neoplasms,Leiomyoma of uterus,IL2RB,Interleukin-2 receptor subunit beta,11555,165,1.16 [0.85-1.59],0.3397194275185327
Chapter II Neoplasms,Leiomyoma of uterus,IL2RG,Cytokine receptor common subunit gamma,10278,147,1.16 [0.82-1.64],0.3985750101678554
Chapter II Neoplasms,Leiomyoma of uterus,IL3,Interleukin-3,9961,142,1.01 [0.77-1.33],0.9362961267736044
Chapter II Neoplasms,Leiomyoma of uterus,IL31,Interleukin-31,10039,145,1.16 [0.91-1.49],0.22637812080334
Chapter II Neoplasms,Leiomyoma of uterus,IL31RA,Interleukin-31 receptor subunit alpha,9995,145,0.67 [0.44-1.01],0.0580851788535334
Chapter II Neoplasms,Leiomyoma of uterus,IL32,Interleukin-32,11777,170,0.79 [0.57-1.10],0.1711586032835435
Chapter II Neoplasms,Leiomyoma of uterus,IL33,Interleukin-33,11555,165,1.60 [1.12-2.29],0.0106534898849132
Chapter II Neoplasms,Leiomyoma of uterus,IL34,Interleukin-34,11496,163,1.24 [0.83-1.83],0.2923433413034039
Chapter II Neoplasms,Leiomyoma of uterus,IL36A,Interleukin-36 alpha,10039,145,1.28 [1.03-1.60],0.0280868289682358
Chapter II Neoplasms,Leiomyoma of uterus,IL36G,Interleukin-36 gamma,9989,145,0.95 [0.74-1.22],0.6950034646097972
Chapter II Neoplasms,Leiomyoma of uterus,IL3RA,Interleukin-3 receptor subunit alpha,11555,165,0.82 [0.53-1.27],0.3741187851155861
Chapter II Neoplasms,Leiomyoma of uterus,IL4,Interleukin-4,11555,165,1.08 [0.92-1.28],0.3502066863848849
Chapter II Neoplasms,Leiomyoma of uterus,IL4R,Interleukin-4 receptor subunit alpha,11777,170,0.97 [0.67-1.42],0.8841969286070277
Chapter II Neoplasms,Leiomyoma of uterus,IL5,Interleukin-5,11555,165,0.98 [0.89-1.09],0.7467885361883946
Chapter II Neoplasms,Leiomyoma of uterus,IL5RA,Interleukin-5 receptor subunit alpha,11777,170,0.73 [0.57-0.94],0.0145782527793201
Chapter II Neoplasms,Leiomyoma of uterus,IL6,Interleukin-6,11744,167,1.05 [0.88-1.25],0.6191413948425804
Chapter II Neoplasms,Leiomyoma of uterus,IL6R,Interleukin-6 receptor subunit alpha,11733,168,1.08 [0.72-1.61],0.7095294865141505
Chapter II Neoplasms,Leiomyoma of uterus,IL6ST,Interleukin-6 receptor subunit beta,11802,169,0.58 [0.26-1.29],0.1804076415559455
Chapter II Neoplasms,Leiomyoma of uterus,IL7,Interleukin-7,11777,170,0.85 [0.68-1.05],0.1376060479247808
Chapter II Neoplasms,Leiomyoma of uterus,IL7R,Interleukin-7 receptor subunit alpha,11808,165,0.78 [0.60-1.01],0.0571577868671829
Chapter II Neoplasms,Leiomyoma of uterus,IL9,Interleukin-9,10166,144,0.89 [0.65-1.23],0.4873833234195711
Chapter II Neoplasms,Leiomyoma of uterus,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,11493,163,1.24 [0.99-1.56],0.0642141516667228
Chapter II Neoplasms,Leiomyoma of uterus,IMMT,MICOS complex subunit MIC60,10278,147,1.13 [0.80-1.59],0.4998376203761498
Chapter II Neoplasms,Leiomyoma of uterus,IMPA1,Inositol monophosphatase 1,11718,168,0.98 [0.78-1.23],0.8358665193465016
Chapter II Neoplasms,Leiomyoma of uterus,IMPACT,Protein IMPACT,10317,147,1.10 [0.83-1.45],0.5106113285028422
Chapter II Neoplasms,Leiomyoma of uterus,IMPG1,Interphotoreceptor matrix proteoglycan 1,9978,146,1.64 [1.16-2.33],0.005417655595807
Chapter II Neoplasms,Leiomyoma of uterus,ING1,Inhibitor of growth protein 1,11493,162,1.32 [1.02-1.70],0.0321732314008046
Chapter II Neoplasms,Leiomyoma of uterus,INHBB,Inhibin beta B chain,10128,146,1.34 [1.00-1.79],0.0471610184715764
Chapter II Neoplasms,Leiomyoma of uterus,INHBC,Inhibin beta C chain,11808,165,1.00 [0.73-1.39],0.982654464184896
Chapter II Neoplasms,Leiomyoma of uterus,INPP1,Inositol polyphosphate 1-phosphatase,11744,167,0.98 [0.76-1.26],0.873612831914889
Chapter II Neoplasms,Leiomyoma of uterus,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",10091,145,1.03 [0.78-1.37],0.8268078324702619
Chapter II Neoplasms,Leiomyoma of uterus,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",10311,147,1.30 [0.98-1.73],0.0729532827020066
Chapter II Neoplasms,Leiomyoma of uterus,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",11744,167,0.98 [0.85-1.13],0.8071007521222172
Chapter II Neoplasms,Leiomyoma of uterus,INSL3,Insulin-like 3,10317,147,1.22 [0.91-1.63],0.1845647248728877
Chapter II Neoplasms,Leiomyoma of uterus,INSL4,Early placenta insulin-like peptide,10278,147,1.13 [0.85-1.51],0.3917179973863163
Chapter II Neoplasms,Leiomyoma of uterus,INSL5,Insulin-like peptide INSL5,10273,150,1.03 [0.87-1.22],0.7144065060682887
Chapter II Neoplasms,Leiomyoma of uterus,INSR,Insulin receptor,10039,145,1.04 [0.40-2.71],0.9321952782116598
Chapter II Neoplasms,Leiomyoma of uterus,IPCEF1,Interactor protein for cytohesin exchange factors 1,11703,167,1.05 [0.90-1.23],0.5194021013340857
Chapter II Neoplasms,Leiomyoma of uterus,IQGAP2,Ras GTPase-activating-like protein IQGAP2,11744,167,0.94 [0.73-1.21],0.6411145909349756
Chapter II Neoplasms,Leiomyoma of uterus,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",11560,165,0.91 [0.77-1.07],0.2611256281258826
Chapter II Neoplasms,Leiomyoma of uterus,IRAK1,Interleukin-1 receptor-associated kinase 1,11555,165,1.01 [0.82-1.24],0.9054775909799
Chapter II Neoplasms,Leiomyoma of uterus,IRAK4,Interleukin-1 receptor-associated kinase 4,11777,170,1.00 [0.88-1.14],0.9949265775718829
Chapter II Neoplasms,Leiomyoma of uterus,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,11365,162,0.94 [0.64-1.38],0.7376731697489172
Chapter II Neoplasms,Leiomyoma of uterus,ISM1,Isthmin-1,11777,170,0.87 [0.61-1.24],0.4523465934607356
Chapter II Neoplasms,Leiomyoma of uterus,ISM2,Isthmin-2,10347,149,1.05 [0.75-1.49],0.7677288159184992
Chapter II Neoplasms,Leiomyoma of uterus,IST1,IST1 homolog,10194,149,0.98 [0.84-1.15],0.8159792757287111
Chapter II Neoplasms,Leiomyoma of uterus,ITGA11,Integrin alpha-11,11777,170,0.89 [0.60-1.34],0.5875709354916103
Chapter II Neoplasms,Leiomyoma of uterus,ITGA2,Integrin alpha-2,10128,146,0.62 [0.39-0.99],0.0453038754827854
Chapter II Neoplasms,Leiomyoma of uterus,ITGA5,Integrin alpha-5,11808,165,0.55 [0.31-0.96],0.0363189182318734
Chapter II Neoplasms,Leiomyoma of uterus,ITGA6,Integrin alpha-6,11777,170,0.84 [0.64-1.10],0.2093904185016777
Chapter II Neoplasms,Leiomyoma of uterus,ITGAL,Integrin alpha-L,10039,145,1.58 [1.08-2.32],0.0197073797179244
Chapter II Neoplasms,Leiomyoma of uterus,ITGAM,Integrin alpha-M,11808,165,0.95 [0.62-1.48],0.8350962020978858
Chapter II Neoplasms,Leiomyoma of uterus,ITGAV,Integrin alpha-V,11889,169,0.46 [0.20-1.08],0.0740951970130252
Chapter II Neoplasms,Leiomyoma of uterus,ITGAX,Integrin alpha-X,10166,144,0.81 [0.58-1.14],0.227451375619154
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1,Integrin beta-1,11795,167,0.73 [0.38-1.41],0.3488105433152307
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1BP1,Integrin beta-1-binding protein 1,11526,160,0.84 [0.61-1.18],0.3222297186370977
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1BP2,Integrin beta-1-binding protein 2,11560,165,1.02 [0.90-1.16],0.7743960728475634
Chapter II Neoplasms,Leiomyoma of uterus,ITGB2,Integrin beta-2,11731,168,0.85 [0.52-1.39],0.5226525146814293
Chapter II Neoplasms,Leiomyoma of uterus,ITGB5,Integrin beta-5,11855,167,0.71 [0.48-1.04],0.0796617674127912
Chapter II Neoplasms,Leiomyoma of uterus,ITGB6,Integrin beta-6,11555,165,1.00 [0.63-1.60],0.9893338426684736
Chapter II Neoplasms,Leiomyoma of uterus,ITGB7,Integrin beta-7,11889,169,0.97 [0.72-1.31],0.8250237964782932
Chapter II Neoplasms,Leiomyoma of uterus,ITGBL1,Integrin beta-like protein 1,10347,149,1.38 [0.91-2.09],0.1328155374761243
Chapter II Neoplasms,Leiomyoma of uterus,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,10353,149,1.03 [0.45-2.35],0.9427481164586548
Chapter II Neoplasms,Leiomyoma of uterus,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,11855,169,0.90 [0.63-1.28],0.5515324766348253
Chapter II Neoplasms,Leiomyoma of uterus,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,10353,149,1.01 [0.56-1.81],0.9763373302306456
Chapter II Neoplasms,Leiomyoma of uterus,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,10278,147,1.24 [0.90-1.69],0.1852557969904475
Chapter II Neoplasms,Leiomyoma of uterus,ITM2A,Integral membrane protein 2A,11777,170,1.01 [0.81-1.27],0.9030867005400232
Chapter II Neoplasms,Leiomyoma of uterus,ITPA,Inosine triphosphate pyrophosphatase,10002,147,1.03 [0.81-1.30],0.804363946079396
Chapter II Neoplasms,Leiomyoma of uterus,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",10091,145,0.95 [0.75-1.21],0.6698656249455319
Chapter II Neoplasms,Leiomyoma of uterus,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",9978,146,1.22 [0.88-1.67],0.2315995867394763
Chapter II Neoplasms,Leiomyoma of uterus,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",11512,163,1.22 [0.95-1.58],0.1218123344728704
Chapter II Neoplasms,Leiomyoma of uterus,IZUMO1,Izumo sperm-egg fusion protein 1,9961,142,1.24 [0.94-1.63],0.124435982743471
Chapter II Neoplasms,Leiomyoma of uterus,JAM2,Junctional adhesion molecule B,11892,170,1.19 [0.71-1.98],0.5053462404431424
Chapter II Neoplasms,Leiomyoma of uterus,JAM3,Junctional adhesion molecule C,10128,146,1.15 [0.84-1.57],0.384730792427266
Chapter II Neoplasms,Leiomyoma of uterus,JCHAIN,Immunoglobulin J chain,11555,165,1.08 [0.87-1.34],0.5003679868335349
Chapter II Neoplasms,Leiomyoma of uterus,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,9961,142,1.21 [0.96-1.53],0.1065608360599721
Chapter II Neoplasms,Leiomyoma of uterus,JPT2,Jupiter microtubule associated homolog 2,10273,150,1.04 [0.87-1.25],0.6666545205973586
Chapter II Neoplasms,Leiomyoma of uterus,JUN,Transcription factor AP-1,11555,165,1.10 [0.85-1.42],0.4606370950279016
Chapter II Neoplasms,Leiomyoma of uterus,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,11744,167,1.11 [0.81-1.51],0.5148353160334529
Chapter II Neoplasms,Leiomyoma of uterus,KAZN,Kazrin,10273,150,0.98 [0.84-1.14],0.8011254824281127
Chapter II Neoplasms,Leiomyoma of uterus,KCNC4,Potassium voltage-gated channel subfamily C member 4,9978,146,0.96 [0.71-1.28],0.7591979507895743
Chapter II Neoplasms,Leiomyoma of uterus,KCNH2,Potassium voltage-gated channel subfamily H member 2,10056,144,1.11 [0.93-1.34],0.2556975514002637
Chapter II Neoplasms,Leiomyoma of uterus,KCNIP4,Kv channel-interacting protein 4,11512,163,0.94 [0.70-1.26],0.6859451316011675
Chapter II Neoplasms,Leiomyoma of uterus,KCTD5,BTB/POZ domain-containing protein KCTD5,10123,145,1.09 [0.76-1.55],0.6483402804210672
Chapter II Neoplasms,Leiomyoma of uterus,KDM3A,Lysine-specific demethylase 3A,10039,145,1.08 [0.92-1.28],0.3278203618062179
Chapter II Neoplasms,Leiomyoma of uterus,KDR,Vascular endothelial growth factor receptor 2,11855,167,1.27 [0.72-2.23],0.411841045152538
Chapter II Neoplasms,Leiomyoma of uterus,KEL,Kell blood group glycoprotein,11512,163,1.43 [0.97-2.11],0.0724021467357975
Chapter II Neoplasms,Leiomyoma of uterus,KHDC3L,KH domain-containing protein 3,9961,142,0.94 [0.73-1.21],0.631954079014488
Chapter II Neoplasms,Leiomyoma of uterus,KHK,Ketohexokinase,10091,145,1.10 [0.85-1.42],0.4530837610649076
Chapter II Neoplasms,Leiomyoma of uterus,KIAA0319,Dyslexia-associated protein KIAA0319,10317,147,0.90 [0.53-1.52],0.6954014419189047
Chapter II Neoplasms,Leiomyoma of uterus,KIAA1549,UPF0606 protein KIAA1549,10166,144,0.81 [0.65-1.01],0.0580059848029296
Chapter II Neoplasms,Leiomyoma of uterus,KIAA1549L,UPF0606 protein KIAA1549L,10166,144,1.23 [0.74-2.05],0.4229740472108017
Chapter II Neoplasms,Leiomyoma of uterus,KIAA2013,Uncharacterized protein KIAA2013,10278,147,1.12 [0.87-1.43],0.3787864756697282
Chapter II Neoplasms,Leiomyoma of uterus,KIF1C,Kinesin-like protein KIF1C,10002,147,1.17 [0.79-1.76],0.4337119845017625
Chapter II Neoplasms,Leiomyoma of uterus,KIF20B,Kinesin-like protein KIF20B,9978,146,1.06 [0.88-1.29],0.5205472486132634
Chapter II Neoplasms,Leiomyoma of uterus,KIF22,Kinesin-like protein KIF22,10002,147,1.00 [0.88-1.14],0.9764714481229128
Chapter II Neoplasms,Leiomyoma of uterus,KIFBP,KIF-binding protein,11744,167,0.99 [0.84-1.17],0.9070179013409122
Chapter II Neoplasms,Leiomyoma of uterus,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,10278,147,1.02 [0.86-1.22],0.8174399885858877
Chapter II Neoplasms,Leiomyoma of uterus,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,11526,160,1.07 [0.90-1.27],0.4569922593993651
Chapter II Neoplasms,Leiomyoma of uterus,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,10273,150,0.89 [0.81-0.98],0.0179293378049922
Chapter II Neoplasms,Leiomyoma of uterus,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,11526,160,0.98 [0.87-1.09],0.6814548610765581
Chapter II Neoplasms,Leiomyoma of uterus,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,9961,142,1.04 [0.86-1.25],0.6939201764644939
Chapter II Neoplasms,Leiomyoma of uterus,KIRREL1,Kin of IRRE-like protein 1,9978,146,1.10 [0.86-1.40],0.466802443312174
Chapter II Neoplasms,Leiomyoma of uterus,KIRREL2,Kin of IRRE-like protein 2,11512,163,1.43 [1.05-1.93],0.0213195577794275
Chapter II Neoplasms,Leiomyoma of uterus,KIT,Mast/stem cell growth factor receptor Kit,11829,169,1.08 [0.69-1.70],0.7312570872189084
Chapter II Neoplasms,Leiomyoma of uterus,KITLG,Kit ligand,11802,169,0.80 [0.55-1.15],0.2291453582477113
Chapter II Neoplasms,Leiomyoma of uterus,KLB,Beta-klotho,11512,163,0.95 [0.78-1.15],0.596106034979446
Chapter II Neoplasms,Leiomyoma of uterus,KLF4,Krueppel-like factor 4,9978,146,1.29 [0.88-1.89],0.1852489210584093
Chapter II Neoplasms,Leiomyoma of uterus,KLHL41,Kelch-like protein 41,10311,147,1.07 [0.77-1.48],0.6756953423851517
Chapter II Neoplasms,Leiomyoma of uterus,KLK1,Kallikrein-1,11690,165,1.06 [0.96-1.18],0.2536562443763051
Chapter II Neoplasms,Leiomyoma of uterus,KLK10,Kallikrein-10,11811,167,1.02 [0.72-1.43],0.9307583172954724
Chapter II Neoplasms,Leiomyoma of uterus,KLK11,Kallikrein-11,11752,164,1.31 [0.87-1.98],0.1981312191728618
Chapter II Neoplasms,Leiomyoma of uterus,KLK12,Kallikrein-12,11526,160,1.04 [0.94-1.15],0.4737584291038172
Chapter II Neoplasms,Leiomyoma of uterus,KLK13,Kallikrein-13,11537,164,0.87 [0.64-1.18],0.3678202737420989
Chapter II Neoplasms,Leiomyoma of uterus,KLK14,Kallikrein-14,11889,169,0.96 [0.71-1.28],0.7749462835989558
Chapter II Neoplasms,Leiomyoma of uterus,KLK15,Kallikrein-15,10258,147,1.03 [0.76-1.38],0.8694114434312078
Chapter II Neoplasms,Leiomyoma of uterus,KLK3,Prostate-specific antigen,10347,149,1.08 [0.83-1.40],0.5822255937672391
Chapter II Neoplasms,Leiomyoma of uterus,KLK4,Kallikrein-4,11889,169,1.58 [1.31-1.92],2.6096006968109857e-06
Chapter II Neoplasms,Leiomyoma of uterus,KLK6,Kallikrein-6,11831,167,1.06 [0.68-1.64],0.8057302275008115
Chapter II Neoplasms,Leiomyoma of uterus,KLK7,Kallikrein-7,9871,140,0.89 [0.58-1.38],0.6169871106131104
Chapter II Neoplasms,Leiomyoma of uterus,KLK8,Kallikrein-8,11418,158,1.10 [0.74-1.64],0.6225850456891006
Chapter II Neoplasms,Leiomyoma of uterus,KLKB1,Plasma kallikrein,10136,147,1.00 [0.53-1.91],0.9931558707049628
Chapter II Neoplasms,Leiomyoma of uterus,KLRB1,Killer cell lectin-like receptor subfamily B member 1,11910,170,1.18 [0.83-1.67],0.3514036005374885
Chapter II Neoplasms,Leiomyoma of uterus,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,9978,146,1.12 [0.89-1.41],0.3412032578905163
Chapter II Neoplasms,Leiomyoma of uterus,KLRD1,Natural killer cells antigen CD94,11910,170,1.23 [0.92-1.65],0.1630798087809024
Chapter II Neoplasms,Leiomyoma of uterus,KLRF1,Killer cell lectin-like receptor subfamily F member 1,10039,145,1.33 [1.01-1.73],0.0386725473380834
Chapter II Neoplasms,Leiomyoma of uterus,KLRK1,NKG2-D type II integral membrane protein,10317,147,1.08 [0.77-1.50],0.6677705860496651
Chapter II Neoplasms,Leiomyoma of uterus,KRT14,"Keratin, type I cytoskeletal 14",11140,156,1.37 [0.92-2.03],0.1202152622062846
Chapter II Neoplasms,Leiomyoma of uterus,KRT17,"Keratin, type I cytoskeletal 17",10002,147,1.31 [0.87-1.98],0.19412355103921
Chapter II Neoplasms,Leiomyoma of uterus,KRT18,"Keratin, type I cytoskeletal 18",11744,167,1.03 [0.86-1.22],0.75715622352915
Chapter II Neoplasms,Leiomyoma of uterus,KRT19,"Keratin, type I cytoskeletal 19",11755,170,1.04 [0.86-1.27],0.6757575945164579
Chapter II Neoplasms,Leiomyoma of uterus,KRT5,"Keratin, type II cytoskeletal 5",11512,163,1.45 [1.12-1.86],0.0045639267635382
Chapter II Neoplasms,Leiomyoma of uterus,KRT6C,"Keratin, type II cytoskeletal 6C",10002,147,1.11 [0.74-1.65],0.6192377613842486
Chapter II Neoplasms,Leiomyoma of uterus,KRT8,"Keratin, type II cytoskeletal 8",9978,146,0.96 [0.76-1.22],0.7277156407203207
Chapter II Neoplasms,Leiomyoma of uterus,KYAT1,Kynurenine--oxoglutarate transaminase 1,11786,168,0.97 [0.76-1.23],0.7797929488365144
Chapter II Neoplasms,Leiomyoma of uterus,KYNU,Kynureninase,11910,170,1.04 [0.77-1.41],0.7929680063905106
Chapter II Neoplasms,Leiomyoma of uterus,L1CAM,Neural cell adhesion molecule L1,11855,167,0.84 [0.52-1.36],0.4741334541331522
Chapter II Neoplasms,Leiomyoma of uterus,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,10334,150,1.00 [0.84-1.19],0.9964932451208852
Chapter II Neoplasms,Leiomyoma of uterus,LACRT,Extracellular glycoprotein lacritin,10255,146,0.93 [0.68-1.26],0.6320396811553217
Chapter II Neoplasms,Leiomyoma of uterus,LACTB2,Endoribonuclease LACTB2,11802,169,0.97 [0.78-1.19],0.7480037248069707
Chapter II Neoplasms,Leiomyoma of uterus,LAG3,Lymphocyte activation gene 3 protein,11744,167,1.01 [0.72-1.41],0.9763690813307266
Chapter II Neoplasms,Leiomyoma of uterus,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,11797,169,1.13 [0.79-1.61],0.5024902181941604
Chapter II Neoplasms,Leiomyoma of uterus,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,11718,168,1.12 [0.98-1.29],0.1057826211537343
Chapter II Neoplasms,Leiomyoma of uterus,LAMA1,Laminin subunit alpha-1,10002,147,1.04 [0.79-1.37],0.7668229502079933
Chapter II Neoplasms,Leiomyoma of uterus,LAMA4,Laminin subunit alpha-4,11854,170,1.27 [0.84-1.92],0.2659835075305578
Chapter II Neoplasms,Leiomyoma of uterus,LAMB1,Laminin subunit beta-1,10091,145,0.78 [0.45-1.35],0.3739657811398159
Chapter II Neoplasms,Leiomyoma of uterus,LAMP1,Lysosome-associated membrane glycoprotein 1,10035,145,0.98 [0.55-1.74],0.9473714804538528
Chapter II Neoplasms,Leiomyoma of uterus,LAMP2,Lysosome-associated membrane glycoprotein 2,11441,167,1.44 [0.68-3.09],0.3433309704336599
Chapter II Neoplasms,Leiomyoma of uterus,LAMP3,Lysosome-associated membrane glycoprotein 3,11894,170,1.07 [0.82-1.40],0.6126997015131148
Chapter II Neoplasms,Leiomyoma of uterus,LAMTOR5,Ragulator complex protein LAMTOR5,10278,147,0.90 [0.60-1.33],0.5870269564718138
Chapter II Neoplasms,Leiomyoma of uterus,LAP3,Cytosol aminopeptidase,11555,165,0.99 [0.74-1.33],0.9388989664381036
Chapter II Neoplasms,Leiomyoma of uterus,LARP1,La-related protein 1,10278,147,1.26 [1.02-1.55],0.0330198564313342
Chapter II Neoplasms,Leiomyoma of uterus,LAT,Linker for activation of T-cells family member 1,11910,170,0.97 [0.81-1.16],0.7342767942338582
Chapter II Neoplasms,Leiomyoma of uterus,LAT2,Linker for activation of T-cells family member 2,11744,167,1.02 [0.91-1.14],0.745396241798661
Chapter II Neoplasms,Leiomyoma of uterus,LATS1,Serine/threonine-protein kinase LATS1,10039,145,1.11 [0.92-1.34],0.2935545542270424
Chapter II Neoplasms,Leiomyoma of uterus,LAYN,Layilin,11699,167,1.37 [0.94-2.00],0.0999951625571873
Chapter II Neoplasms,Leiomyoma of uterus,LBP,Lipopolysaccharide-binding protein,11855,169,1.01 [0.80-1.28],0.9415658959486168
Chapter II Neoplasms,Leiomyoma of uterus,LBR,Delta(14)-sterol reductase LBR,11892,170,1.03 [0.85-1.26],0.7330378914542592
Chapter II Neoplasms,Leiomyoma of uterus,LCAT,Phosphatidylcholine-sterol acyltransferase,10335,147,0.72 [0.39-1.34],0.3049771923893962
Chapter II Neoplasms,Leiomyoma of uterus,LCN15,Lipocalin-15,10311,147,1.22 [0.99-1.52],0.0674835961841276
Chapter II Neoplasms,Leiomyoma of uterus,LCN2,Neutrophil gelatinase-associated lipocalin,11475,165,1.00 [0.70-1.43],0.9869055706836388
Chapter II Neoplasms,Leiomyoma of uterus,LCP1,Plastin-2,10347,149,0.98 [0.70-1.37],0.89030572167961
Chapter II Neoplasms,Leiomyoma of uterus,LDLR,Low-density lipoprotein receptor,11821,169,1.08 [0.83-1.40],0.5753384173318222
Chapter II Neoplasms,Leiomyoma of uterus,LDLRAP1,Low density lipoprotein receptor adapter protein 1,10311,147,1.00 [0.85-1.17],0.9667289313114898
Chapter II Neoplasms,Leiomyoma of uterus,LECT2,Leukocyte cell-derived chemotaxin-2,10334,150,1.14 [0.90-1.44],0.267742679606188
Chapter II Neoplasms,Leiomyoma of uterus,LEFTY2,Left-right determination factor 2,11867,169,1.33 [1.00-1.78],0.0535874005121348
Chapter II Neoplasms,Leiomyoma of uterus,LEG1,Protein LEG1 homolog,9772,144,0.95 [0.75-1.21],0.6889647261225851
Chapter II Neoplasms,Leiomyoma of uterus,LELP1,Late cornified envelope-like proline-rich protein 1,9978,146,1.08 [0.89-1.30],0.4552235492044212
Chapter II Neoplasms,Leiomyoma of uterus,LEO1,RNA polymerase-associated protein LEO1,10311,147,1.08 [0.70-1.66],0.7282595296985999
Chapter II Neoplasms,Leiomyoma of uterus,LEP,Leptin,11802,169,0.88 [0.71-1.09],0.2373158189957113
Chapter II Neoplasms,Leiomyoma of uterus,LEPR,Leptin receptor,11802,169,0.86 [0.54-1.36],0.5232187678124502
Chapter II Neoplasms,Leiomyoma of uterus,LETM1,Mitochondrial proton/calcium exchanger protein,10311,147,1.20 [0.90-1.61],0.2062211824591512
Chapter II Neoplasms,Leiomyoma of uterus,LGALS1,Galectin-1,11802,169,1.19 [0.80-1.76],0.3971031800141587
Chapter II Neoplasms,Leiomyoma of uterus,LGALS3,Galectin-3,11818,168,0.98 [0.62-1.55],0.9199371439365444
Chapter II Neoplasms,Leiomyoma of uterus,LGALS3BP,Galectin-3-binding protein,10353,149,1.12 [0.68-1.85],0.653122664286083
Chapter II Neoplasms,Leiomyoma of uterus,LGALS4,Galectin-4,11797,169,0.90 [0.70-1.16],0.4239246795538084
Chapter II Neoplasms,Leiomyoma of uterus,LGALS7_LGALS7B,Galectin-7,11745,166,0.95 [0.68-1.35],0.7865631274792861
Chapter II Neoplasms,Leiomyoma of uterus,LGALS8,Galectin-8,11892,170,0.94 [0.75-1.18],0.5925677934039704
Chapter II Neoplasms,Leiomyoma of uterus,LGALS9,Galectin-9,11798,168,1.39 [0.92-2.10],0.1163226630485668
Chapter II Neoplasms,Leiomyoma of uterus,LGMN,Legumain,11854,170,1.08 [0.74-1.57],0.7064296752845516
Chapter II Neoplasms,Leiomyoma of uterus,LHB,Lutropin subunit beta,11526,160,0.92 [0.76-1.11],0.3734311092770901
Chapter II Neoplasms,Leiomyoma of uterus,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,11821,170,1.04 [0.83-1.30],0.7607591083523868
Chapter II Neoplasms,Leiomyoma of uterus,LIF,Leukemia inhibitory factor,11512,163,1.15 [0.92-1.45],0.2141736384525649
Chapter II Neoplasms,Leiomyoma of uterus,LIFR,Leukemia inhibitory factor receptor,11777,170,0.82 [0.46-1.46],0.5085251630394227
Chapter II Neoplasms,Leiomyoma of uterus,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,11808,165,0.99 [0.67-1.47],0.9794935558967176
Chapter II Neoplasms,Leiomyoma of uterus,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,10347,149,0.97 [0.87-1.07],0.5519172394620395
Chapter II Neoplasms,Leiomyoma of uterus,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,10002,147,1.10 [0.82-1.47],0.520969215012469
Chapter II Neoplasms,Leiomyoma of uterus,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,11779,169,0.67 [0.43-1.02],0.0620818555098806
Chapter II Neoplasms,Leiomyoma of uterus,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,10334,150,0.94 [0.76-1.16],0.5850333205797253
Chapter II Neoplasms,Leiomyoma of uterus,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,11938,171,0.73 [0.45-1.20],0.2166967588373657
Chapter II Neoplasms,Leiomyoma of uterus,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,11893,170,0.94 [0.63-1.38],0.7429582511957121
Chapter II Neoplasms,Leiomyoma of uterus,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,11555,165,1.20 [0.88-1.64],0.2389663936446086
Chapter II Neoplasms,Leiomyoma of uterus,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,11938,171,1.05 [0.87-1.27],0.6127318599570786
Chapter II Neoplasms,Leiomyoma of uterus,LIPF,Gastric triacylglycerol lipase,10091,145,1.13 [0.88-1.46],0.3337475197762982
Chapter II Neoplasms,Leiomyoma of uterus,LMNB1,Lamin-B1,10252,150,1.04 [0.81-1.34],0.7617105669668616
Chapter II Neoplasms,Leiomyoma of uterus,LMNB2,Lamin-B2,10317,147,1.47 [0.87-2.50],0.1544942159380986
Chapter II Neoplasms,Leiomyoma of uterus,LMOD1,Leiomodin-1,10311,147,1.30 [0.89-1.91],0.1788739765562585
Chapter II Neoplasms,Leiomyoma of uterus,LMOD2,Leiomodin-2,9978,146,1.05 [0.82-1.35],0.6971740578946355
Chapter II Neoplasms,Leiomyoma of uterus,LONP1,"Lon protease homolog, mitochondrial",10091,145,1.01 [0.83-1.21],0.9571930195569625
Chapter II Neoplasms,Leiomyoma of uterus,LPA,Apolipoprotein(a),10101,145,0.96 [0.88-1.05],0.3658607344911069
Chapter II Neoplasms,Leiomyoma of uterus,LPCAT2,Lysophosphatidylcholine acyltransferase 2,11744,167,1.24 [0.96-1.59],0.0956010441615507
Chapter II Neoplasms,Leiomyoma of uterus,LPL,Lipoprotein lipase,11802,169,1.02 [0.76-1.37],0.9124105060298208
Chapter II Neoplasms,Leiomyoma of uterus,LPO,Lactoperoxidase,11430,167,0.99 [0.79-1.25],0.9489751007614332
Chapter II Neoplasms,Leiomyoma of uterus,LPP,Lipoma-preferred partner,10002,147,1.19 [0.93-1.52],0.1579821057188255
Chapter II Neoplasms,Leiomyoma of uterus,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,10002,147,1.10 [0.88-1.39],0.3976137009688061
Chapter II Neoplasms,Leiomyoma of uterus,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,10056,144,0.90 [0.63-1.29],0.565448002640219
Chapter II Neoplasms,Leiomyoma of uterus,LRG1,Leucine-rich alpha-2-glycoprotein,10353,149,0.98 [0.54-1.78],0.9467905391093618
Chapter II Neoplasms,Leiomyoma of uterus,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,11847,169,1.05 [0.70-1.57],0.8068020927263321
Chapter II Neoplasms,Leiomyoma of uterus,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,10000,145,1.50 [0.96-2.34],0.0784555688634762
Chapter II Neoplasms,Leiomyoma of uterus,LRP1,Prolow-density lipoprotein receptor-related protein 1,11744,167,1.34 [0.81-2.22],0.2606464326641651
Chapter II Neoplasms,Leiomyoma of uterus,LRP11,Low-density lipoprotein receptor-related protein 11,11802,169,1.08 [0.74-1.58],0.6788120207622848
Chapter II Neoplasms,Leiomyoma of uterus,LRP2,Low-density lipoprotein receptor-related protein 2,10056,144,0.67 [0.41-1.09],0.1087463144002647
Chapter II Neoplasms,Leiomyoma of uterus,LRP2BP,LRP2-binding protein,10056,144,1.02 [0.85-1.21],0.8492156464848327
Chapter II Neoplasms,Leiomyoma of uterus,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,11892,170,1.16 [0.94-1.42],0.1586350112256992
Chapter II Neoplasms,Leiomyoma of uterus,LRRC25,Leucine-rich repeat-containing protein 25,11744,167,0.96 [0.67-1.38],0.8278682960595602
Chapter II Neoplasms,Leiomyoma of uterus,LRRC37A2,Leucine-rich repeat-containing protein 37A2,10273,150,1.34 [0.93-1.94],0.1143176497105251
Chapter II Neoplasms,Leiomyoma of uterus,LRRC38,Leucine-rich repeat-containing protein 38,10056,144,0.97 [0.70-1.36],0.8764769215849739
Chapter II Neoplasms,Leiomyoma of uterus,LRRC59,Leucine-rich repeat-containing protein 59,10334,150,1.04 [0.76-1.43],0.787773862310175
Chapter II Neoplasms,Leiomyoma of uterus,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,10278,147,1.00 [0.72-1.39],0.9978069609514076
Chapter II Neoplasms,Leiomyoma of uterus,LRRN1,Leucine-rich repeat neuronal protein 1,11555,165,1.17 [0.81-1.68],0.4125379643548837
Chapter II Neoplasms,Leiomyoma of uterus,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,10056,144,0.95 [0.64-1.43],0.8227511138113042
Chapter II Neoplasms,Leiomyoma of uterus,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,10311,147,0.88 [0.48-1.62],0.6811068851640477
Chapter II Neoplasms,Leiomyoma of uterus,LSM1,U6 snRNA-associated Sm-like protein LSm1,11526,160,1.14 [0.92-1.42],0.2247224180856599
Chapter II Neoplasms,Leiomyoma of uterus,LSM8,U6 snRNA-associated Sm-like protein LSm8,10166,144,1.11 [0.95-1.29],0.1803320390312255
Chapter II Neoplasms,Leiomyoma of uterus,LSP1,Lymphocyte-specific protein 1,11777,170,0.94 [0.66-1.33],0.7201102392374106
Chapter II Neoplasms,Leiomyoma of uterus,LTA,Lymphotoxin-alpha,11777,170,0.90 [0.64-1.26],0.5265177289585965
Chapter II Neoplasms,Leiomyoma of uterus,LTA4H,Leukotriene A-4 hydrolase,11889,169,1.12 [0.88-1.42],0.3706214459439423
Chapter II Neoplasms,Leiomyoma of uterus,LTB,Lymphotoxin-beta,10278,147,1.14 [0.76-1.71],0.5268773767939017
Chapter II Neoplasms,Leiomyoma of uterus,LTBP2,Latent-transforming growth factor beta-binding protein 2,11938,171,0.93 [0.61-1.42],0.7316925850471249
Chapter II Neoplasms,Leiomyoma of uterus,LTBP3,Latent-transforming growth factor beta-binding protein 3,11526,160,0.98 [0.75-1.28],0.8620008104117461
Chapter II Neoplasms,Leiomyoma of uterus,LTBR,Tumor necrosis factor receptor superfamily member 3,11753,168,1.41 [0.89-2.25],0.144981288462644
Chapter II Neoplasms,Leiomyoma of uterus,LTO1,Protein LTO1 homolog,11555,165,1.06 [0.77-1.45],0.7404833236617654
Chapter II Neoplasms,Leiomyoma of uterus,LUZP2,Leucine zipper protein 2,10278,147,1.45 [1.13-1.87],0.0035905317846004
Chapter II Neoplasms,Leiomyoma of uterus,LXN,Latexin,11669,167,0.95 [0.77-1.18],0.6592834486709312
Chapter II Neoplasms,Leiomyoma of uterus,LY6D,Lymphocyte antigen 6D,11756,169,1.16 [0.81-1.65],0.4137128482457773
Chapter II Neoplasms,Leiomyoma of uterus,LY75,Lymphocyte antigen 75,11777,170,1.00 [0.71-1.43],0.9781908030353796
Chapter II Neoplasms,Leiomyoma of uterus,LY9,T-lymphocyte surface antigen Ly-9,11668,167,0.83 [0.52-1.32],0.4364151410836365
Chapter II Neoplasms,Leiomyoma of uterus,LY96,Lymphocyte antigen 96,11718,168,0.73 [0.49-1.10],0.1335076082105469
Chapter II Neoplasms,Leiomyoma of uterus,LYAR,Cell growth-regulating nucleolar protein,11526,160,1.05 [0.81-1.35],0.7305741991187338
Chapter II Neoplasms,Leiomyoma of uterus,LYN,Tyrosine-protein kinase Lyn,11744,167,1.03 [0.87-1.21],0.7430099649160451
Chapter II Neoplasms,Leiomyoma of uterus,LYPD1,Ly6/PLAUR domain-containing protein 1,11512,163,0.87 [0.67-1.13],0.2838272554092246
Chapter II Neoplasms,Leiomyoma of uterus,LYPD3,Ly6/PLAUR domain-containing protein 3,11756,166,1.30 [0.87-1.94],0.2037607798019957
Chapter II Neoplasms,Leiomyoma of uterus,LYPD8,Ly6/PLAUR domain-containing protein 8,11526,160,0.89 [0.67-1.19],0.4295126937352926
Chapter II Neoplasms,Leiomyoma of uterus,LYPLA2,Acyl-protein thioesterase 2,9978,146,1.03 [0.89-1.18],0.7278303318175197
Chapter II Neoplasms,Leiomyoma of uterus,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,10056,144,0.87 [0.73-1.03],0.1020197697768121
Chapter II Neoplasms,Leiomyoma of uterus,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,10353,149,0.60 [0.28-1.31],0.2024761630561162
Chapter II Neoplasms,Leiomyoma of uterus,LYZL2,Lysozyme-like protein 2,9961,142,1.33 [0.89-1.99],0.167549044206132
Chapter II Neoplasms,Leiomyoma of uterus,LZTFL1,Leucine zipper transcription factor-like protein 1,10128,146,0.98 [0.78-1.24],0.888955105938384
Chapter II Neoplasms,Leiomyoma of uterus,M6PR,Cation-dependent mannose-6-phosphate receptor,10091,145,1.03 [0.70-1.51],0.8808727640113014
Chapter II Neoplasms,Leiomyoma of uterus,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,11676,167,1.11 [0.86-1.44],0.4217590592846683
Chapter II Neoplasms,Leiomyoma of uterus,MAEA,E3 ubiquitin-protein transferase MAEA,11526,160,0.93 [0.64-1.33],0.6829034867525893
Chapter II Neoplasms,Leiomyoma of uterus,MAG,Myelin-associated glycoprotein,10056,144,0.77 [0.55-1.08],0.1355859998389641
Chapter II Neoplasms,Leiomyoma of uterus,MAGEA3,Melanoma-associated antigen 3,10166,144,1.10 [0.90-1.35],0.3330511810106908
Chapter II Neoplasms,Leiomyoma of uterus,MAGED1,Melanoma-associated antigen D1,11526,160,0.91 [0.67-1.23],0.5317659170648814
Chapter II Neoplasms,Leiomyoma of uterus,MAMDC2,MAM domain-containing protein 2,10334,150,1.07 [0.69-1.67],0.7590314615680754
Chapter II Neoplasms,Leiomyoma of uterus,MAMDC4,Apical endosomal glycoprotein,10278,147,1.03 [0.77-1.39],0.8299255803480107
Chapter II Neoplasms,Leiomyoma of uterus,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",10091,145,1.17 [0.61-2.23],0.6329754205971085
Chapter II Neoplasms,Leiomyoma of uterus,MAN2B2,Epididymis-specific alpha-mannosidase,10334,150,1.06 [0.82-1.38],0.6483404433169971
Chapter II Neoplasms,Leiomyoma of uterus,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",9961,142,1.06 [0.77-1.45],0.7276240152275288
Chapter II Neoplasms,Leiomyoma of uterus,MANF,Mesencephalic astrocyte-derived neurotrophic factor,11854,170,0.98 [0.87-1.10],0.735698289031963
Chapter II Neoplasms,Leiomyoma of uterus,MANSC1,MANSC domain-containing protein 1,11855,167,0.89 [0.54-1.48],0.6572291898299049
Chapter II Neoplasms,Leiomyoma of uterus,MANSC4,MANSC domain-containing protein 4,10002,147,0.90 [0.71-1.13],0.3570993707515859
Chapter II Neoplasms,Leiomyoma of uterus,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,9978,146,1.12 [0.67-1.86],0.6700189150439276
Chapter II Neoplasms,Leiomyoma of uterus,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,10002,147,0.99 [0.77-1.26],0.92309781180171
Chapter II Neoplasms,Leiomyoma of uterus,MAP2,Microtubule-associated protein 2,10317,147,0.98 [0.69-1.38],0.8901169885927573
Chapter II Neoplasms,Leiomyoma of uterus,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,10273,150,1.01 [0.78-1.29],0.9599040935869122
Chapter II Neoplasms,Leiomyoma of uterus,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,11777,170,0.97 [0.85-1.11],0.6605116685018803
Chapter II Neoplasms,Leiomyoma of uterus,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,11526,160,0.93 [0.80-1.08],0.3498151961358576
Chapter II Neoplasms,Leiomyoma of uterus,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,11699,167,1.03 [0.91-1.17],0.6585537900623142
Chapter II Neoplasms,Leiomyoma of uterus,MAPK13,Mitogen-activated protein kinase 13,9961,142,0.85 [0.57-1.26],0.4123534355406516
Chapter II Neoplasms,Leiomyoma of uterus,MAPK9,Mitogen-activated protein kinase 9,11777,170,0.69 [0.50-0.94],0.0201774239805887
Chapter II Neoplasms,Leiomyoma of uterus,MAPKAPK2,MAP kinase-activated protein kinase 2,10166,144,1.07 [0.86-1.33],0.5469356896534933
Chapter II Neoplasms,Leiomyoma of uterus,MAPRE3,Microtubule-associated protein RP/EB family member 3,9961,142,1.10 [1.00-1.21],0.0447083640966535
Chapter II Neoplasms,Leiomyoma of uterus,MAPT,Microtubule-associated protein tau,11512,163,1.14 [0.88-1.50],0.3251860920007616
Chapter II Neoplasms,Leiomyoma of uterus,MARCO,Macrophage receptor MARCO,11802,169,0.89 [0.53-1.49],0.6443141824548597
Chapter II Neoplasms,Leiomyoma of uterus,MARS1,"Methionine--tRNA ligase, cytoplasmic",10112,145,1.01 [0.84-1.23],0.8794345287228342
Chapter II Neoplasms,Leiomyoma of uterus,MASP1,Mannan-binding lectin serine protease 1,11699,167,1.32 [0.73-2.38],0.3639864413496602
Chapter II Neoplasms,Leiomyoma of uterus,MATN2,Matrilin-2,11817,169,0.85 [0.53-1.36],0.4985471881033141
Chapter II Neoplasms,Leiomyoma of uterus,MATN3,Matrilin-3,11703,167,1.16 [0.75-1.80],0.5131534251305262
Chapter II Neoplasms,Leiomyoma of uterus,MAVS,Mitochondrial antiviral-signaling protein,11526,160,0.97 [0.84-1.14],0.7434490460058274
Chapter II Neoplasms,Leiomyoma of uterus,MAX,Protein max,11512,163,1.01 [0.89-1.16],0.8468461211856977
Chapter II Neoplasms,Leiomyoma of uterus,MB,Myoglobin,11938,171,1.12 [0.86-1.45],0.3945753302680844
Chapter II Neoplasms,Leiomyoma of uterus,MBL2,Mannose-binding protein C,10199,148,1.26 [1.08-1.47],0.0032659345268506
Chapter II Neoplasms,Leiomyoma of uterus,MCAM,Cell surface glycoprotein MUC18,11855,169,0.75 [0.50-1.13],0.1680327644089796
Chapter II Neoplasms,Leiomyoma of uterus,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",10311,147,1.21 [0.87-1.68],0.2555120715615597
Chapter II Neoplasms,Leiomyoma of uterus,MCEMP1,Mast cell-expressed membrane protein 1,10039,145,1.03 [0.87-1.23],0.7039102004171285
Chapter II Neoplasms,Leiomyoma of uterus,MCFD2,Multiple coagulation factor deficiency protein 2,11742,169,1.05 [0.76-1.44],0.7839292379687576
Chapter II Neoplasms,Leiomyoma of uterus,MCTS1,Malignant T-cell-amplified sequence 1,10273,150,1.19 [0.70-2.03],0.5260236993373406
Chapter II Neoplasms,Leiomyoma of uterus,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,11718,168,0.90 [0.74-1.10],0.3113526567335018
Chapter II Neoplasms,Leiomyoma of uterus,MDH1,"Malate dehydrogenase, cytoplasmic",10272,146,1.11 [0.75-1.63],0.6059094165011745
Chapter II Neoplasms,Leiomyoma of uterus,MDK,Midkine,11826,165,1.11 [0.86-1.41],0.4222566017276083
Chapter II Neoplasms,Leiomyoma of uterus,MDM1,Nuclear protein MDM1,10056,144,0.85 [0.50-1.42],0.5237467164957723
Chapter II Neoplasms,Leiomyoma of uterus,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",10091,145,1.00 [0.84-1.19],0.9954751390741556
Chapter II Neoplasms,Leiomyoma of uterus,MED18,Mediator of RNA polymerase II transcription subunit 18,11526,160,1.05 [0.87-1.27],0.6142571264977738
Chapter II Neoplasms,Leiomyoma of uterus,MED21,Mediator of RNA polymerase II transcription subunit 21,10002,147,1.26 [0.98-1.63],0.0752589919934219
Chapter II Neoplasms,Leiomyoma of uterus,MEGF10,Multiple epidermal growth factor-like domains protein 10,11797,169,1.10 [0.76-1.59],0.6227944588864882
Chapter II Neoplasms,Leiomyoma of uterus,MEGF11,Multiple epidermal growth factor-like domains protein 11,10002,147,0.94 [0.58-1.52],0.7956773811367455
Chapter II Neoplasms,Leiomyoma of uterus,MEGF9,Multiple epidermal growth factor-like domains protein 9,11905,170,0.80 [0.40-1.60],0.5278152708024362
Chapter II Neoplasms,Leiomyoma of uterus,MELTF,Melanotransferrin,10334,150,0.73 [0.42-1.26],0.2562884019550042
Chapter II Neoplasms,Leiomyoma of uterus,MENT,Protein MENT,10128,146,0.42 [0.21-0.84],0.0137410085767736
Chapter II Neoplasms,Leiomyoma of uterus,MEP1A,Meprin A subunit alpha,10273,150,1.01 [0.81-1.27],0.912941933425853
Chapter II Neoplasms,Leiomyoma of uterus,MEP1B,Meprin A subunit beta,11802,169,0.98 [0.88-1.10],0.7424628958679862
Chapter II Neoplasms,Leiomyoma of uterus,MEPE,Matrix extracellular phosphoglycoprotein,11797,169,1.45 [0.86-2.46],0.1601640326751622
Chapter II Neoplasms,Leiomyoma of uterus,MERTK,Tyrosine-protein kinase Mer,11910,170,1.07 [0.63-1.81],0.7999306874210069
Chapter II Neoplasms,Leiomyoma of uterus,MESD,LRP chaperone MESD,11808,165,0.99 [0.88-1.11],0.815117942173486
Chapter II Neoplasms,Leiomyoma of uterus,MET,Hepatocyte growth factor receptor,11827,171,0.75 [0.39-1.47],0.4075113683777835
Chapter II Neoplasms,Leiomyoma of uterus,METAP1,Methionine aminopeptidase 1,11512,163,1.16 [0.74-1.82],0.5107590472909582
Chapter II Neoplasms,Leiomyoma of uterus,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",11777,170,0.97 [0.82-1.15],0.7367778537774442
Chapter II Neoplasms,Leiomyoma of uterus,METAP2,Methionine aminopeptidase 2,11867,169,1.02 [0.80-1.29],0.8746226110126107
Chapter II Neoplasms,Leiomyoma of uterus,MFAP3,Microfibril-associated glycoprotein 3,11560,165,1.21 [0.95-1.54],0.1267436450467066
Chapter II Neoplasms,Leiomyoma of uterus,MFAP3L,Microfibrillar-associated protein 3-like,10056,144,1.06 [0.85-1.33],0.6092720510028309
Chapter II Neoplasms,Leiomyoma of uterus,MFAP4,Microfibril-associated glycoprotein 4,10128,146,1.17 [0.71-1.93],0.5453639696824241
Chapter II Neoplasms,Leiomyoma of uterus,MFAP5,Microfibrillar-associated protein 5,11938,171,1.25 [0.89-1.75],0.1977785743734242
Chapter II Neoplasms,Leiomyoma of uterus,MFGE8,Lactadherin,11808,165,1.26 [0.91-1.73],0.1579075251749334
Chapter II Neoplasms,Leiomyoma of uterus,MGLL,Monoglyceride lipase,11831,169,0.98 [0.84-1.15],0.8297326537346796
Chapter II Neoplasms,Leiomyoma of uterus,MGMT,Methylated-DNA--protein-cysteine methyltransferase,11777,170,0.96 [0.86-1.07],0.4898244399821673
Chapter II Neoplasms,Leiomyoma of uterus,MIA,Melanoma-derived growth regulatory protein,11855,167,1.03 [0.71-1.49],0.8684407814787799
Chapter II Neoplasms,Leiomyoma of uterus,MICALL2,MICAL-like protein 2,10056,144,1.01 [0.80-1.27],0.913435059673785
Chapter II Neoplasms,Leiomyoma of uterus,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,11777,170,0.98 [0.90-1.07],0.6768492779494053
Chapter II Neoplasms,Leiomyoma of uterus,MIF,Macrophage migration inhibitory factor,11793,165,1.03 [0.84-1.26],0.812180053551273
Chapter II Neoplasms,Leiomyoma of uterus,MILR1,Allergin-1,11555,165,0.93 [0.71-1.23],0.611052680301365
Chapter II Neoplasms,Leiomyoma of uterus,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,10278,147,0.96 [0.83-1.11],0.5492833683302895
Chapter II Neoplasms,Leiomyoma of uterus,MINK1,Misshapen-like kinase 1,10317,147,1.06 [0.89-1.26],0.5183795325045367
Chapter II Neoplasms,Leiomyoma of uterus,MITD1,MIT domain-containing protein 1,11718,168,1.02 [0.89-1.18],0.7453819778284101
Chapter II Neoplasms,Leiomyoma of uterus,MKI67,Proliferation marker protein Ki-67,10039,145,1.29 [0.93-1.79],0.1287262433719719
Chapter II Neoplasms,Leiomyoma of uterus,MLLT1,Protein ENL,9961,142,1.11 [0.89-1.39],0.3382237255542391
Chapter II Neoplasms,Leiomyoma of uterus,MLN,Promotilin,11777,170,1.02 [0.88-1.19],0.7866397259056753
Chapter II Neoplasms,Leiomyoma of uterus,MME,Neprilysin,11744,167,0.88 [0.74-1.05],0.1586017888767728
Chapter II Neoplasms,Leiomyoma of uterus,MMP1,Interstitial collagenase,11333,158,1.04 [0.89-1.22],0.5884253147149856
Chapter II Neoplasms,Leiomyoma of uterus,MMP10,Stromelysin-2,11768,167,1.11 [0.88-1.40],0.3779559562090491
Chapter II Neoplasms,Leiomyoma of uterus,MMP12,Macrophage metalloelastase,11791,168,1.01 [0.78-1.31],0.941675863712887
Chapter II Neoplasms,Leiomyoma of uterus,MMP13,Collagenase 3,11512,163,1.32 [0.87-2.00],0.19026173220576
Chapter II Neoplasms,Leiomyoma of uterus,MMP15,Matrix metalloproteinase-15,10334,150,1.05 [0.78-1.41],0.7325251180321666
Chapter II Neoplasms,Leiomyoma of uterus,MMP3,Stromelysin-1,11808,165,1.09 [0.83-1.44],0.541183086272089
Chapter II Neoplasms,Leiomyoma of uterus,MMP7,Matrilysin,11540,165,1.15 [0.86-1.55],0.3453089612789601
Chapter II Neoplasms,Leiomyoma of uterus,MMP8,Neutrophil collagenase,11867,170,1.04 [0.87-1.25],0.6438197429104564
Chapter II Neoplasms,Leiomyoma of uterus,MMP9,Matrix metalloproteinase-9,11782,165,1.01 [0.81-1.28],0.9047280846277556
Chapter II Neoplasms,Leiomyoma of uterus,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",10002,147,1.03 [0.75-1.43],0.8447616772881991
Chapter II Neoplasms,Leiomyoma of uterus,MN1,Transcriptional activator MN1,10056,144,1.24 [0.99-1.56],0.0567051089329617
Chapter II Neoplasms,Leiomyoma of uterus,MNAT1,CDK-activating kinase assembly factor MAT1,10166,144,1.29 [0.94-1.78],0.1130974658701288
Chapter II Neoplasms,Leiomyoma of uterus,MNDA,Myeloid cell nuclear differentiation antigen,11781,169,1.00 [0.88-1.15],0.949160552217032
Chapter II Neoplasms,Leiomyoma of uterus,MOCS2,Molybdopterin synthase catalytic subunit,10128,146,0.91 [0.71-1.16],0.440931365005587
Chapter II Neoplasms,Leiomyoma of uterus,MOG,Myelin-oligodendrocyte glycoprotein,11889,169,1.00 [0.66-1.51],0.9967528460055586
Chapter II Neoplasms,Leiomyoma of uterus,MORC3,MORC family CW-type zinc finger protein 3,10317,147,1.07 [0.62-1.84],0.8116330811831022
Chapter II Neoplasms,Leiomyoma of uterus,MORF4L1,Mortality factor 4-like protein 1,10166,144,1.17 [0.83-1.65],0.3646817066349693
Chapter II Neoplasms,Leiomyoma of uterus,MORF4L2,Mortality factor 4-like protein 2,9961,142,1.40 [0.99-1.99],0.0549501134827654
Chapter II Neoplasms,Leiomyoma of uterus,MORN4,MORN repeat-containing protein 4,9961,142,1.05 [0.86-1.29],0.6243019123006126
Chapter II Neoplasms,Leiomyoma of uterus,MPHOSPH8,M-phase phosphoprotein 8,11560,165,0.96 [0.80-1.16],0.6966966754783168
Chapter II Neoplasms,Leiomyoma of uterus,MPI,Mannose-6-phosphate isomerase,11744,167,1.00 [0.85-1.18],0.99688461857043
Chapter II Neoplasms,Leiomyoma of uterus,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,11831,169,0.90 [0.75-1.07],0.2339412074715259
Chapter II Neoplasms,Leiomyoma of uterus,MPO,Myeloperoxidase,11808,165,0.89 [0.66-1.19],0.427570183391448
Chapter II Neoplasms,Leiomyoma of uterus,MPRIP,Myosin phosphatase Rho-interacting protein,10253,147,1.03 [0.72-1.49],0.8545111051064673
Chapter II Neoplasms,Leiomyoma of uterus,MRC1,Macrophage mannose receptor 1,10335,147,0.68 [0.40-1.16],0.159718103016017
Chapter II Neoplasms,Leiomyoma of uterus,MRI1,Methylthioribose-1-phosphate isomerase,10056,144,1.02 [0.80-1.29],0.891205370614543
Chapter II Neoplasms,Leiomyoma of uterus,MRPL24,"39S ribosomal protein L24, mitochondrial",10002,147,0.96 [0.62-1.47],0.8365714855388334
Chapter II Neoplasms,Leiomyoma of uterus,MRPL28,"39S ribosomal protein L28, mitochondrial",10311,147,1.28 [0.94-1.75],0.1183236320797104
Chapter II Neoplasms,Leiomyoma of uterus,MRPL46,"39S ribosomal protein L46, mitochondrial",11512,163,0.93 [0.56-1.55],0.7771064294854786
Chapter II Neoplasms,Leiomyoma of uterus,MRPL52,"39S ribosomal protein L52, mitochondrial",9939,141,0.85 [0.45-1.63],0.6301589106666817
Chapter II Neoplasms,Leiomyoma of uterus,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",10311,147,0.86 [0.68-1.10],0.2410292248195159
Chapter II Neoplasms,Leiomyoma of uterus,MRPS16,"28S ribosomal protein S16, mitochondrial",10039,145,1.32 [0.82-2.10],0.2502745368936978
Chapter II Neoplasms,Leiomyoma of uterus,MSLN,Mesothelin,11719,166,1.12 [0.88-1.42],0.3604362489754809
Chapter II Neoplasms,Leiomyoma of uterus,MSLNL,Mesothelin-like protein,10056,144,0.70 [0.44-1.10],0.1232050350458675
Chapter II Neoplasms,Leiomyoma of uterus,MSMB,Beta-microseminoprotein,11753,170,1.09 [0.90-1.32],0.3952860229695866
Chapter II Neoplasms,Leiomyoma of uterus,MSR1,Macrophage scavenger receptor types I and II,11892,170,0.87 [0.64-1.18],0.3780135288848966
Chapter II Neoplasms,Leiomyoma of uterus,MSRA,Mitochondrial peptide methionine sulfoxide reductase,11855,167,0.98 [0.81-1.18],0.8132562734505069
Chapter II Neoplasms,Leiomyoma of uterus,MST1,Hepatocyte growth factor-like protein,10172,146,1.00 [0.78-1.28],0.9873328959037504
Chapter II Neoplasms,Leiomyoma of uterus,MSTN,Growth/differentiation factor 8,11560,165,1.03 [0.78-1.35],0.848204228381778
Chapter II Neoplasms,Leiomyoma of uterus,MTDH,Protein LYRIC,10039,145,0.97 [0.81-1.15],0.6997904714246543
Chapter II Neoplasms,Leiomyoma of uterus,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",10317,147,1.22 [0.75-1.98],0.4153087050736882
Chapter II Neoplasms,Leiomyoma of uterus,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,10166,144,0.92 [0.79-1.06],0.2472879319881852
Chapter II Neoplasms,Leiomyoma of uterus,MTIF3,"Translation initiation factor IF-3, mitochondrial",10273,150,1.01 [0.84-1.20],0.9475617326462134
Chapter II Neoplasms,Leiomyoma of uterus,MTPN,Myotrophin,11560,165,0.88 [0.56-1.37],0.5675646849746754
Chapter II Neoplasms,Leiomyoma of uterus,MTR,Methionine synthase,10002,147,1.30 [1.09-1.55],0.0030466338925306
Chapter II Neoplasms,Leiomyoma of uterus,MTSS1,Protein MTSS 1,10273,150,1.02 [0.89-1.18],0.7757922563206269
Chapter II Neoplasms,Leiomyoma of uterus,MTSS2,Protein MTSS 2,10278,147,1.10 [0.94-1.30],0.24524604582558
Chapter II Neoplasms,Leiomyoma of uterus,MTUS1,Microtubule-associated tumor suppressor 1,10166,144,1.17 [0.89-1.53],0.2520632228940491
Chapter II Neoplasms,Leiomyoma of uterus,MUC13,Mucin-13,11512,163,1.05 [0.79-1.39],0.7348359178254975
Chapter II Neoplasms,Leiomyoma of uterus,MUC16,Mucin-16,11744,167,0.99 [0.92-1.06],0.709324433129065
Chapter II Neoplasms,Leiomyoma of uterus,MUC2,Mucin-2,10347,149,1.02 [0.86-1.21],0.8112517418555485
Chapter II Neoplasms,Leiomyoma of uterus,MUCL3,Mucin-like protein 3,9961,142,1.19 [0.87-1.63],0.2676148876894126
Chapter II Neoplasms,Leiomyoma of uterus,MVK,Mevalonate kinase,11555,165,1.06 [0.89-1.27],0.4876098737245935
Chapter II Neoplasms,Leiomyoma of uterus,MXRA8,Matrix remodeling-associated protein 8,10128,146,0.74 [0.44-1.24],0.2490963048526327
Chapter II Neoplasms,Leiomyoma of uterus,MYBPC1,"Myosin-binding protein C, slow-type",10334,150,1.12 [0.89-1.40],0.3457984413867117
Chapter II Neoplasms,Leiomyoma of uterus,MYBPC2,"Myosin-binding protein C, fast-type",10091,145,1.03 [0.86-1.24],0.7365179080438924
Chapter II Neoplasms,Leiomyoma of uterus,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,10311,147,1.01 [0.79-1.27],0.9650463848597176
Chapter II Neoplasms,Leiomyoma of uterus,MYDGF,Myeloid-derived growth factor,10334,150,1.03 [0.88-1.21],0.6849287594677321
Chapter II Neoplasms,Leiomyoma of uterus,MYH4,Myosin-4,10002,147,1.27 [0.96-1.67],0.0965404865632013
Chapter II Neoplasms,Leiomyoma of uterus,MYH7B,Myosin-7B,9961,142,0.82 [0.55-1.22],0.3164727259018166
Chapter II Neoplasms,Leiomyoma of uterus,MYH9,Myosin-9,10347,149,0.94 [0.82-1.08],0.3818150222062445
Chapter II Neoplasms,Leiomyoma of uterus,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",10002,147,1.02 [0.70-1.48],0.93483762392963
Chapter II Neoplasms,Leiomyoma of uterus,MYL3,Myosin light chain 3,10091,145,1.06 [0.84-1.34],0.6129193049676576
Chapter II Neoplasms,Leiomyoma of uterus,MYL4,Myosin light chain 4,10091,145,1.02 [0.76-1.38],0.8824579744575701
Chapter II Neoplasms,Leiomyoma of uterus,MYL6B,Myosin light chain 6B,10056,144,1.23 [1.07-1.41],0.0035063807956619
Chapter II Neoplasms,Leiomyoma of uterus,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",10056,144,1.24 [0.92-1.68],0.1598230909201693
Chapter II Neoplasms,Leiomyoma of uterus,MYO6,Unconventional myosin-VI,10311,147,0.97 [0.62-1.53],0.9072234818039836
Chapter II Neoplasms,Leiomyoma of uterus,MYO9B,Unconventional myosin-IXb,11555,165,1.03 [0.84-1.26],0.7704051701173744
Chapter II Neoplasms,Leiomyoma of uterus,MYOC,Myocilin,11808,165,0.70 [0.52-0.94],0.019295731465896
Chapter II Neoplasms,Leiomyoma of uterus,MYOM1,Myomesin-1,9978,146,1.00 [0.72-1.38],0.9902457874521856
Chapter II Neoplasms,Leiomyoma of uterus,MYOM2,Myomesin-2,10002,147,1.33 [0.97-1.81],0.0743228984072903
Chapter II Neoplasms,Leiomyoma of uterus,MYOM3,Myomesin-3,10128,146,1.10 [0.92-1.31],0.2878980266260096
Chapter II Neoplasms,Leiomyoma of uterus,MZB1,Marginal zone B- and B1-cell-specific protein,11840,170,0.81 [0.62-1.05],0.1147097884893367
Chapter II Neoplasms,Leiomyoma of uterus,MZT1,Mitotic-spindle organizing protein 1,11526,160,0.94 [0.71-1.25],0.6811115179887162
Chapter II Neoplasms,Leiomyoma of uterus,NAA10,N-alpha-acetyltransferase 10,10002,147,1.16 [0.85-1.58],0.3570675174291635
Chapter II Neoplasms,Leiomyoma of uterus,NAA80,N-alpha-acetyltransferase 80,10056,144,1.04 [0.90-1.19],0.6181750715126326
Chapter II Neoplasms,Leiomyoma of uterus,NAAA,N-acylethanolamine-hydrolyzing acid amidase,11664,168,0.81 [0.64-1.04],0.1036417742186522
Chapter II Neoplasms,Leiomyoma of uterus,NACC1,Nucleus accumbens-associated protein 1,10278,147,1.02 [0.77-1.36],0.8827727207968631
Chapter II Neoplasms,Leiomyoma of uterus,NADK,NAD kinase,11802,169,0.90 [0.69-1.16],0.3979096458093052
Chapter II Neoplasms,Leiomyoma of uterus,NAGA,Alpha-N-acetylgalactosaminidase,10012,145,1.24 [0.99-1.56],0.06212418968523
Chapter II Neoplasms,Leiomyoma of uterus,NAGK,N-acetyl-D-glucosamine kinase,10072,145,0.97 [0.72-1.29],0.8212447717396808
Chapter II Neoplasms,Leiomyoma of uterus,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,10128,146,0.79 [0.37-1.67],0.5375364528192281
Chapter II Neoplasms,Leiomyoma of uterus,NAMPT,Nicotinamide phosphoribosyltransferase,11526,160,1.13 [0.90-1.42],0.2772096769205521
Chapter II Neoplasms,Leiomyoma of uterus,NAP1L4,Nucleosome assembly protein 1-like 4,10250,149,1.10 [0.75-1.63],0.6255999378358231
Chapter II Neoplasms,Leiomyoma of uterus,NAPRT,Nicotinate phosphoribosyltransferase,10317,147,1.51 [1.03-2.22],0.0338994778675571
Chapter II Neoplasms,Leiomyoma of uterus,NARS1,"Asparagine--tRNA ligase, cytoplasmic",10311,147,1.20 [0.86-1.69],0.2862855794227746
Chapter II Neoplasms,Leiomyoma of uterus,NBL1,Neuroblastoma suppressor of tumorigenicity 1,11855,167,1.45 [0.88-2.40],0.1465421036037162
Chapter II Neoplasms,Leiomyoma of uterus,NBN,Nibrin,11555,165,1.07 [0.84-1.36],0.6012192347902385
Chapter II Neoplasms,Leiomyoma of uterus,NCAM1,Neural cell adhesion molecule 1,11855,169,1.23 [0.76-1.99],0.3916821416347873
Chapter II Neoplasms,Leiomyoma of uterus,NCAM2,Neural cell adhesion molecule 2,11808,165,1.29 [0.78-2.13],0.3303641259430306
Chapter II Neoplasms,Leiomyoma of uterus,NCAN,Neurocan core protein,11892,170,0.85 [0.59-1.22],0.3717686161108813
Chapter II Neoplasms,Leiomyoma of uterus,NCF2,Neutrophil cytosol factor 2,11763,170,0.97 [0.83-1.15],0.7409194153557525
Chapter II Neoplasms,Leiomyoma of uterus,NCK2,Cytoplasmic protein NCK2,11854,170,1.04 [0.91-1.18],0.5779381146040772
Chapter II Neoplasms,Leiomyoma of uterus,NCLN,Nicalin,11555,165,0.98 [0.74-1.30],0.9070459180716388
Chapter II Neoplasms,Leiomyoma of uterus,NCR1,Natural cytotoxicity triggering receptor 1,11759,170,1.17 [0.81-1.69],0.3902116957598517
Chapter II Neoplasms,Leiomyoma of uterus,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,10273,150,0.93 [0.58-1.49],0.7548206212543374
Chapter II Neoplasms,Leiomyoma of uterus,NCS1,Neuronal calcium sensor 1,11889,169,1.54 [0.96-2.48],0.0764908271634036
Chapter II Neoplasms,Leiomyoma of uterus,NDRG1,Protein NDRG1,11512,163,0.99 [0.80-1.21],0.9069666318547006
Chapter II Neoplasms,Leiomyoma of uterus,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,10278,147,1.26 [1.06-1.49],0.0075651237243561
Chapter II Neoplasms,Leiomyoma of uterus,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,10023,145,0.95 [0.60-1.50],0.8158772643964414
Chapter II Neoplasms,Leiomyoma of uterus,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,10273,150,0.88 [0.73-1.05],0.1448907934069413
Chapter II Neoplasms,Leiomyoma of uterus,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",11526,160,1.21 [1.05-1.39],0.009598469943945
Chapter II Neoplasms,Leiomyoma of uterus,NEB,Nebulin,10002,147,1.47 [1.10-1.96],0.0087255833378976
Chapter II Neoplasms,Leiomyoma of uterus,NECAP2,Adaptin ear-binding coat-associated protein 2,10002,147,0.97 [0.77-1.23],0.7890718423148214
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN1,Nectin-1,10039,145,1.08 [0.67-1.76],0.7479985972608705
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN2,Nectin-2,11779,169,0.98 [0.62-1.56],0.9369302906076752
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN4,Nectin-4,11855,167,1.34 [0.89-2.04],0.1642329075346666
Chapter II Neoplasms,Leiomyoma of uterus,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,10039,145,1.22 [0.87-1.72],0.243658297048233
Chapter II Neoplasms,Leiomyoma of uterus,NEDD9,Enhancer of filamentation 1,10039,145,1.18 [0.76-1.84],0.4615749281627419
Chapter II Neoplasms,Leiomyoma of uterus,NEFL,Neurofilament light polypeptide,11473,163,1.21 [0.88-1.66],0.2488242641597018
Chapter II Neoplasms,Leiomyoma of uterus,NEK7,Serine/threonine-protein kinase Nek7,10166,144,0.97 [0.78-1.20],0.7755195224494367
Chapter II Neoplasms,Leiomyoma of uterus,NELL1,Protein kinase C-binding protein NELL1,11855,167,0.82 [0.60-1.13],0.2218482698736317
Chapter II Neoplasms,Leiomyoma of uterus,NELL2,Protein kinase C-binding protein NELL2,11854,170,0.84 [0.51-1.36],0.4691309607648688
Chapter II Neoplasms,Leiomyoma of uterus,NENF,Neudesin,10278,147,1.16 [1.04-1.30],0.0082639763748372
Chapter II Neoplasms,Leiomyoma of uterus,NEO1,Neogenin,10311,147,1.37 [0.68-2.72],0.3772462212304412
Chapter II Neoplasms,Leiomyoma of uterus,NEXN,Nexilin,10335,147,0.95 [0.76-1.20],0.6826075941689875
Chapter II Neoplasms,Leiomyoma of uterus,NFASC,Neurofascin,11910,170,1.09 [0.67-1.79],0.7214537693117555
Chapter II Neoplasms,Leiomyoma of uterus,NFAT5,Nuclear factor of activated T-cells 5,10039,145,1.05 [0.88-1.26],0.5839604023939576
Chapter II Neoplasms,Leiomyoma of uterus,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",11777,170,0.97 [0.83-1.12],0.635159231351371
Chapter II Neoplasms,Leiomyoma of uterus,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",11555,165,0.97 [0.76-1.24],0.8164803721305085
Chapter II Neoplasms,Leiomyoma of uterus,NFE2,Transcription factor NF-E2 45 kDa subunit,10091,145,0.99 [0.80-1.22],0.9045752698128252
Chapter II Neoplasms,Leiomyoma of uterus,NFIC,Nuclear factor 1 C-type,10311,147,1.29 [1.01-1.66],0.0442025981980688
Chapter II Neoplasms,Leiomyoma of uterus,NFKB1,Nuclear factor NF-kappa-B p105 subunit,10002,147,1.03 [0.83-1.29],0.7710458783257421
Chapter II Neoplasms,Leiomyoma of uterus,NFKB2,Nuclear factor NF-kappa-B p100 subunit,10166,144,0.95 [0.70-1.29],0.756078219541521
Chapter II Neoplasms,Leiomyoma of uterus,NFKBIE,NF-kappa-B inhibitor epsilon,11526,160,0.95 [0.71-1.28],0.7543778014222657
Chapter II Neoplasms,Leiomyoma of uterus,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",10273,150,0.97 [0.83-1.14],0.7461303729685443
Chapter II Neoplasms,Leiomyoma of uterus,NFX1,Transcriptional repressor NF-X1,10002,147,1.16 [0.93-1.46],0.1884597143955708
Chapter II Neoplasms,Leiomyoma of uterus,NFYA,Nuclear transcription factor Y subunit alpha,10002,147,1.32 [0.95-1.83],0.0975897745368143
Chapter II Neoplasms,Leiomyoma of uterus,NGF,Beta-nerve growth factor,11718,168,1.73 [0.54-5.55],0.3588398893660023
Chapter II Neoplasms,Leiomyoma of uterus,NGFR,Tumor necrosis factor receptor superfamily member 16,10334,150,1.43 [0.90-2.27],0.1266744517066308
Chapter II Neoplasms,Leiomyoma of uterus,NGRN,Neugrin,10317,147,0.97 [0.47-2.00],0.9350183217483024
Chapter II Neoplasms,Leiomyoma of uterus,NHLRC3,NHL repeat-containing protein 3,9878,144,0.82 [0.49-1.37],0.4439434514668877
Chapter II Neoplasms,Leiomyoma of uterus,NID1,Nidogen-1,11807,169,0.86 [0.61-1.21],0.3801881451246071
Chapter II Neoplasms,Leiomyoma of uterus,NID2,Nidogen-2,11808,165,0.97 [0.80-1.16],0.7146100913902138
Chapter II Neoplasms,Leiomyoma of uterus,NINJ1,Ninjurin-1,11526,160,1.04 [0.81-1.34],0.7564084222343059
Chapter II Neoplasms,Leiomyoma of uterus,NIT1,Deaminated glutathione amidase,10091,145,1.06 [0.75-1.48],0.7552094859208013
Chapter II Neoplasms,Leiomyoma of uterus,NIT2,Omega-amidase NIT2,10294,148,1.10 [0.88-1.36],0.4093743829068574
Chapter II Neoplasms,Leiomyoma of uterus,NLGN1,Neuroligin-1,10056,144,0.95 [0.75-1.22],0.7050850737179007
Chapter II Neoplasms,Leiomyoma of uterus,NLGN2,Neuroligin-2,9978,146,1.09 [0.81-1.48],0.5560162005516139
Chapter II Neoplasms,Leiomyoma of uterus,NME1,Nucleoside diphosphate kinase A,10039,145,1.45 [0.73-2.88],0.2884435322379154
Chapter II Neoplasms,Leiomyoma of uterus,NME3,Nucleoside diphosphate kinase 3,11817,169,1.46 [0.87-2.44],0.1534121208895154
Chapter II Neoplasms,Leiomyoma of uterus,NMI,N-myc-interactor,10244,147,0.99 [0.79-1.24],0.9419589330927014
Chapter II Neoplasms,Leiomyoma of uterus,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,11718,168,0.89 [0.73-1.09],0.2489680362560877
Chapter II Neoplasms,Leiomyoma of uterus,NMRK2,Nicotinamide riboside kinase 2,9961,142,0.98 [0.67-1.45],0.925978460081664
Chapter II Neoplasms,Leiomyoma of uterus,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,10311,147,1.04 [0.83-1.30],0.7270715598662141
Chapter II Neoplasms,Leiomyoma of uterus,NOMO1,Nodal modulator 1,11808,165,0.76 [0.42-1.37],0.3619314391160293
Chapter II Neoplasms,Leiomyoma of uterus,NOP56,Nucleolar protein 56,10002,147,1.15 [1.03-1.30],0.0175548038561542
Chapter II Neoplasms,Leiomyoma of uterus,NOS1,"Nitric oxide synthase, brain",11512,163,1.08 [0.81-1.44],0.5948927384440823
Chapter II Neoplasms,Leiomyoma of uterus,NOS2,"Nitric oxide synthase, inducible",10002,147,1.09 [0.74-1.61],0.6629905524288573
Chapter II Neoplasms,Leiomyoma of uterus,NOS3,"Nitric oxide synthase, endothelial",11512,163,1.13 [0.89-1.43],0.329142318832671
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH1,Neurogenic locus notch homolog protein 1,11938,171,0.93 [0.39-2.23],0.8682286013381243
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH2,Neurogenic locus notch homolog protein 2,10347,149,0.84 [0.39-1.82],0.6644913022174452
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH3,Neurogenic locus notch homolog protein 3,11938,171,0.82 [0.55-1.22],0.3300723423511887
Chapter II Neoplasms,Leiomyoma of uterus,NPC2,NPC intracellular cholesterol transporter 2,10157,144,1.38 [0.87-2.17],0.1679409557097639
Chapter II Neoplasms,Leiomyoma of uterus,NPDC1,Neural proliferation differentiation and control protein 1,11802,169,1.25 [0.82-1.89],0.3004613572002307
Chapter II Neoplasms,Leiomyoma of uterus,NPHS1,Nephrin,10039,145,0.54 [0.33-0.90],0.0176387781558968
Chapter II Neoplasms,Leiomyoma of uterus,NPHS2,Podocin,10039,145,1.06 [0.92-1.22],0.422727668525258
Chapter II Neoplasms,Leiomyoma of uterus,NPL,N-acetylneuraminate lyase,10334,150,1.42 [1.02-1.98],0.0362485036864039
Chapter II Neoplasms,Leiomyoma of uterus,NPPB,Natriuretic peptides B,11560,165,1.08 [0.97-1.20],0.1592336196322223
Chapter II Neoplasms,Leiomyoma of uterus,NPPC,C-type natriuretic peptide,11777,170,1.07 [0.78-1.45],0.6831691657501353
Chapter II Neoplasms,Leiomyoma of uterus,NPR1,Atrial natriuretic peptide receptor 1,10002,147,1.12 [0.76-1.64],0.5634822484589508
Chapter II Neoplasms,Leiomyoma of uterus,NPTN,Neuroplastin,11526,160,0.99 [0.83-1.18],0.8775031620923386
Chapter II Neoplasms,Leiomyoma of uterus,NPTX1,Neuronal pentraxin-1,11808,165,0.97 [0.68-1.40],0.8816417317586577
Chapter II Neoplasms,Leiomyoma of uterus,NPTX2,Neuronal pentraxin-2,10347,149,0.91 [0.55-1.49],0.706489744975922
Chapter II Neoplasms,Leiomyoma of uterus,NPTXR,Neuronal pentraxin receptor,11802,169,1.02 [0.68-1.52],0.9376014323827626
Chapter II Neoplasms,Leiomyoma of uterus,NPY,Pro-neuropeptide Y,11889,169,1.16 [0.93-1.43],0.181055885519292
Chapter II Neoplasms,Leiomyoma of uterus,NRCAM,Neuronal cell adhesion molecule,11802,169,1.09 [0.67-1.75],0.7369360449619167
Chapter II Neoplasms,Leiomyoma of uterus,NRGN,Neurogranin,10335,147,1.00 [0.84-1.19],0.964964252569324
Chapter II Neoplasms,Leiomyoma of uterus,NRN1,Neuritin,10311,147,1.22 [0.86-1.73],0.2560282103711844
Chapter II Neoplasms,Leiomyoma of uterus,NRP1,Neuropilin-1,11871,169,0.89 [0.54-1.44],0.6223812580241443
Chapter II Neoplasms,Leiomyoma of uterus,NRP2,Neuropilin-2,11808,165,1.08 [0.67-1.73],0.7635550439994234
Chapter II Neoplasms,Leiomyoma of uterus,NRTN,Neurturin,11555,165,0.80 [0.60-1.07],0.1358788733987538
Chapter II Neoplasms,Leiomyoma of uterus,NRXN3,Neurexin-3,10056,144,0.91 [0.57-1.45],0.6799347637392651
Chapter II Neoplasms,Leiomyoma of uterus,NSFL1C,NSFL1 cofactor p47,11892,170,0.99 [0.81-1.21],0.9226960973927674
Chapter II Neoplasms,Leiomyoma of uterus,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",10334,150,1.07 [0.86-1.32],0.5478875158263217
Chapter II Neoplasms,Leiomyoma of uterus,NT5C1A,Cytosolic 5'-nucleotidase 1A,10317,147,1.66 [1.17-2.36],0.0042561512276684
Chapter II Neoplasms,Leiomyoma of uterus,NT5C3A,Cytosolic 5'-nucleotidase 3A,11764,170,0.94 [0.80-1.09],0.411421727287617
Chapter II Neoplasms,Leiomyoma of uterus,NT5E,5'-nucleotidase,11855,167,1.12 [0.89-1.40],0.3228785998365034
Chapter II Neoplasms,Leiomyoma of uterus,NTF3,Neurotrophin-3,11777,170,1.00 [0.69-1.46],0.994149456856284
Chapter II Neoplasms,Leiomyoma of uterus,NTF4,Neurotrophin-4,11526,160,0.90 [0.61-1.32],0.5972509621535758
Chapter II Neoplasms,Leiomyoma of uterus,NTRK2,BDNF/NT-3 growth factors receptor,11802,169,0.65 [0.38-1.11],0.1162192778990256
Chapter II Neoplasms,Leiomyoma of uterus,NTRK3,NT-3 growth factor receptor,11892,170,1.00 [0.54-1.87],0.9907810846773448
Chapter II Neoplasms,Leiomyoma of uterus,NTproBNP,N-terminal prohormone of brain natriuretic peptide,11802,169,1.12 [0.98-1.27],0.0879742185988274
Chapter II Neoplasms,Leiomyoma of uterus,NUB1,NEDD8 ultimate buster 1,11777,170,1.02 [0.86-1.20],0.8391888489643717
Chapter II Neoplasms,Leiomyoma of uterus,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,10278,147,1.17 [1.02-1.35],0.0231597875307444
Chapter II Neoplasms,Leiomyoma of uterus,NUCB2,Nucleobindin-2,11867,169,1.03 [0.71-1.49],0.8897957902190957
Chapter II Neoplasms,Leiomyoma of uterus,NUDC,Nuclear migration protein nudC,11910,170,0.93 [0.75-1.16],0.5340721317835233
Chapter II Neoplasms,Leiomyoma of uterus,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,10091,145,1.50 [0.92-2.42],0.1022452801721763
Chapter II Neoplasms,Leiomyoma of uterus,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,10002,147,1.12 [0.85-1.47],0.4215993892728115
Chapter II Neoplasms,Leiomyoma of uterus,NUDT16,U8 snoRNA-decapping enzyme,10254,150,1.05 [0.88-1.26],0.576680795529613
Chapter II Neoplasms,Leiomyoma of uterus,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],11744,167,0.94 [0.73-1.20],0.6189501178244192
Chapter II Neoplasms,Leiomyoma of uterus,NUDT5,ADP-sugar pyrophosphatase,11808,165,0.96 [0.73-1.27],0.7913127892767431
Chapter II Neoplasms,Leiomyoma of uterus,NUMB,Protein numb homolog,10039,145,1.10 [0.91-1.34],0.3278048043052813
Chapter II Neoplasms,Leiomyoma of uterus,NUP50,Nuclear pore complex protein Nup50,10002,147,1.02 [0.64-1.63],0.926757899919268
Chapter II Neoplasms,Leiomyoma of uterus,NXPE4,NXPE family member 4,10002,147,0.73 [0.43-1.24],0.2442963681462488
Chapter II Neoplasms,Leiomyoma of uterus,NXPH1,Neurexophilin-1,11512,163,1.06 [0.73-1.53],0.7709467313913478
Chapter II Neoplasms,Leiomyoma of uterus,NXPH3,Neurexophilin-3,10039,145,1.07 [0.62-1.83],0.8169789847594396
Chapter II Neoplasms,Leiomyoma of uterus,OBP2B,Odorant-binding protein 2b,11686,167,1.17 [0.94-1.47],0.1564256662241417
Chapter II Neoplasms,Leiomyoma of uterus,OCLN,Occludin,10311,147,1.26 [0.89-1.78],0.1930442695676771
Chapter II Neoplasms,Leiomyoma of uterus,ODAM,Odontogenic ameloblast-associated protein,11496,163,0.86 [0.66-1.11],0.2374038941586485
Chapter II Neoplasms,Leiomyoma of uterus,OFD1,Oral-facial-digital syndrome 1 protein,10166,144,0.97 [0.75-1.24],0.7829212383892864
Chapter II Neoplasms,Leiomyoma of uterus,OGA,Protein O-GlcNAcase,10273,150,1.07 [0.86-1.34],0.5456012296601802
Chapter II Neoplasms,Leiomyoma of uterus,OGFR,Opioid growth factor receptor,11744,167,0.97 [0.64-1.47],0.8950987579636487
Chapter II Neoplasms,Leiomyoma of uterus,OGN,Mimecan,11808,165,1.34 [0.97-1.86],0.075659614016292
Chapter II Neoplasms,Leiomyoma of uterus,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,10166,144,1.16 [0.94-1.44],0.1619605391404823
Chapter II Neoplasms,Leiomyoma of uterus,OLFM4,Olfactomedin-4,9750,141,0.90 [0.79-1.03],0.1245271265701944
Chapter II Neoplasms,Leiomyoma of uterus,OLR1,Oxidized low-density lipoprotein receptor 1,11695,167,0.94 [0.74-1.20],0.6299145587860412
Chapter II Neoplasms,Leiomyoma of uterus,OMD,Osteomodulin,11854,170,1.05 [0.77-1.43],0.7798316424522597
Chapter II Neoplasms,Leiomyoma of uterus,OMG,Oligodendrocyte-myelin glycoprotein,11744,167,0.99 [0.80-1.22],0.9072316039275432
Chapter II Neoplasms,Leiomyoma of uterus,OMP,Olfactory marker protein,9978,146,1.02 [0.74-1.39],0.9163609361859456
Chapter II Neoplasms,Leiomyoma of uterus,OPHN1,Oligophrenin-1,10317,147,1.03 [0.89-1.20],0.691685281890745
Chapter II Neoplasms,Leiomyoma of uterus,OPLAH,5-oxoprolinase,10091,145,1.14 [0.90-1.44],0.2705568003795828
Chapter II Neoplasms,Leiomyoma of uterus,OPTC,Opticin,11744,167,0.76 [0.55-1.06],0.1084543946037142
Chapter II Neoplasms,Leiomyoma of uterus,ORM1,Alpha-1-acid glycoprotein 1,10317,149,1.15 [0.53-2.53],0.7222684244881796
Chapter II Neoplasms,Leiomyoma of uterus,OSBPL2,Oxysterol-binding protein-related protein 2,10317,147,0.82 [0.53-1.27],0.370679706156665
Chapter II Neoplasms,Leiomyoma of uterus,OSCAR,Osteoclast-associated immunoglobulin-like receptor,11817,169,1.10 [0.74-1.64],0.6464011539957452
Chapter II Neoplasms,Leiomyoma of uterus,OSM,Oncostatin-M,11730,169,0.96 [0.80-1.17],0.7145232809224202
Chapter II Neoplasms,Leiomyoma of uterus,OSMR,Oncostatin-M-specific receptor subunit beta,11871,169,0.65 [0.34-1.26],0.2048246489696509
Chapter II Neoplasms,Leiomyoma of uterus,OSTN,Osteocrin,10056,144,0.84 [0.55-1.29],0.4302693193437722
Chapter II Neoplasms,Leiomyoma of uterus,OTOA,Otoancorin,9978,146,0.98 [0.73-1.32],0.9022427057282528
Chapter II Neoplasms,Leiomyoma of uterus,OTUD6B,Deubiquitinase OTUD6B,10273,150,1.04 [0.80-1.36],0.7760057009138108
Chapter II Neoplasms,Leiomyoma of uterus,OTUD7B,OTU domain-containing protein 7B,10311,147,1.13 [0.88-1.45],0.3445967133600582
Chapter II Neoplasms,Leiomyoma of uterus,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",10091,145,0.94 [0.74-1.19],0.5972630962792282
Chapter II Neoplasms,Leiomyoma of uterus,OXT,Oxytocin-neurophysin 1,11892,170,1.01 [0.91-1.12],0.8574373914909947
Chapter II Neoplasms,Leiomyoma of uterus,P4HB,Protein disulfide-isomerase,11757,166,1.09 [0.76-1.57],0.62485391395644
Chapter II Neoplasms,Leiomyoma of uterus,PACS2,Phosphofurin acidic cluster sorting protein 2,10002,147,1.13 [0.88-1.46],0.3346928637022014
Chapter II Neoplasms,Leiomyoma of uterus,PADI2,Protein-arginine deiminase type-2,11555,165,1.01 [0.79-1.29],0.9393935552999244
Chapter II Neoplasms,Leiomyoma of uterus,PADI4,Protein-arginine deiminase type-4,11496,163,1.03 [0.86-1.23],0.774648662009179
Chapter II Neoplasms,Leiomyoma of uterus,PAEP,Glycodelin,11718,168,1.16 [0.98-1.37],0.0922465256984187
Chapter II Neoplasms,Leiomyoma of uterus,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,10311,147,1.15 [1.03-1.28],0.0108552825651964
Chapter II Neoplasms,Leiomyoma of uterus,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",10166,144,0.95 [0.68-1.32],0.7523782156119877
Chapter II Neoplasms,Leiomyoma of uterus,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,11560,165,0.94 [0.73-1.21],0.6552885248011242
Chapter II Neoplasms,Leiomyoma of uterus,PAGR1,PAXIP1-associated glutamate-rich protein 1,10091,145,1.09 [0.78-1.54],0.6167156048597617
Chapter II Neoplasms,Leiomyoma of uterus,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,9943,142,1.18 [0.88-1.58],0.2798148644019063
Chapter II Neoplasms,Leiomyoma of uterus,PAK4,Serine/threonine-protein kinase PAK 4,11512,163,0.94 [0.74-1.19],0.6276915448254279
Chapter II Neoplasms,Leiomyoma of uterus,PALLD,Palladin,10039,145,0.89 [0.59-1.37],0.6059441608818245
Chapter II Neoplasms,Leiomyoma of uterus,PALM,Paralemmin-1,10212,149,1.24 [0.74-2.07],0.4124169294513605
Chapter II Neoplasms,Leiomyoma of uterus,PALM2,Paralemmin-2,10317,147,1.49 [0.99-2.24],0.0532766082461195
Chapter II Neoplasms,Leiomyoma of uterus,PALM3,Paralemmin-3,10002,147,1.21 [1.03-1.42],0.0201943002632032
Chapter II Neoplasms,Leiomyoma of uterus,PAM,Peptidyl-glycine alpha-amidating monooxygenase,11879,170,1.14 [0.70-1.88],0.5909099678394332
Chapter II Neoplasms,Leiomyoma of uterus,PAMR1,Inactive serine protease PAMR1,11808,165,0.80 [0.48-1.34],0.4024567852808357
Chapter II Neoplasms,Leiomyoma of uterus,PAPPA,Pappalysin-1,11555,165,1.02 [0.75-1.39],0.8904271263375935
Chapter II Neoplasms,Leiomyoma of uterus,PARD3,Partitioning defective 3 homolog,10166,144,1.05 [0.85-1.29],0.6700884470009867
Chapter II Neoplasms,Leiomyoma of uterus,PARK7,Parkinson disease protein 7,11808,165,1.01 [0.78-1.31],0.95586840852127
Chapter II Neoplasms,Leiomyoma of uterus,PARP1,Poly [ADP-ribose] polymerase 1,11777,170,1.14 [0.93-1.40],0.1919182294438925
Chapter II Neoplasms,Leiomyoma of uterus,PAXX,Protein PAXX,10128,146,1.05 [0.74-1.49],0.7720986153042786
Chapter II Neoplasms,Leiomyoma of uterus,PBK,Lymphokine-activated killer T-cell-originated protein kinase,9961,142,0.98 [0.57-1.67],0.927223578805549
Chapter II Neoplasms,Leiomyoma of uterus,PBLD,Phenazine biosynthesis-like domain-containing protein,11512,163,1.11 [0.84-1.46],0.4521250485883006
Chapter II Neoplasms,Leiomyoma of uterus,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,10273,150,0.96 [0.56-1.65],0.8910820475167857
Chapter II Neoplasms,Leiomyoma of uterus,PCARE,Photoreceptor cilium actin regulator,9978,146,1.07 [0.91-1.27],0.4193939984816731
Chapter II Neoplasms,Leiomyoma of uterus,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,10114,146,0.97 [0.68-1.38],0.8618033038982259
Chapter II Neoplasms,Leiomyoma of uterus,PCBP2,Poly(rC)-binding protein 2,10311,147,1.19 [0.96-1.49],0.1167363300306668
Chapter II Neoplasms,Leiomyoma of uterus,PCDH1,Protocadherin-1,11871,170,1.11 [0.61-2.02],0.724860443952137
Chapter II Neoplasms,Leiomyoma of uterus,PCDH12,Protocadherin-12,10311,147,2.26 [1.26-4.05],0.0063040250946312
Chapter II Neoplasms,Leiomyoma of uterus,PCDH17,Protocadherin-17,11802,169,1.18 [0.81-1.73],0.3833219197243016
Chapter II Neoplasms,Leiomyoma of uterus,PCDH7,Protocadherin-7,10273,150,1.08 [0.71-1.65],0.7281050396920478
Chapter II Neoplasms,Leiomyoma of uterus,PCDH9,Protocadherin-9,10273,150,0.67 [0.42-1.07],0.0910250035316711
Chapter II Neoplasms,Leiomyoma of uterus,PCDHB15,Protocadherin beta-15,10278,147,1.30 [0.89-1.89],0.1759595195918625
Chapter II Neoplasms,Leiomyoma of uterus,PCNA,Proliferating cell nuclear antigen,9961,142,1.05 [0.82-1.35],0.6913853415501752
Chapter II Neoplasms,Leiomyoma of uterus,PCSK7,Proprotein convertase subtilisin/kexin type 7,10278,147,1.17 [0.85-1.61],0.337121729981613
Chapter II Neoplasms,Leiomyoma of uterus,PCSK9,Proprotein convertase subtilisin/kexin type 9,11938,171,0.67 [0.48-0.95],0.0230693682330213
Chapter II Neoplasms,Leiomyoma of uterus,PCYT2,Ethanolamine-phosphate cytidylyltransferase,10273,150,0.95 [0.77-1.17],0.6098741527323022
Chapter II Neoplasms,Leiomyoma of uterus,PDAP1,28 kDa heat- and acid-stable phosphoprotein,10334,150,0.97 [0.83-1.15],0.7485750846990862
Chapter II Neoplasms,Leiomyoma of uterus,PDCD1,Programmed cell death protein 1,11870,169,0.98 [0.73-1.33],0.9131811838399678
Chapter II Neoplasms,Leiomyoma of uterus,PDCD1LG2,Programmed cell death 1 ligand 2,11744,167,0.97 [0.63-1.50],0.8931657438836145
Chapter II Neoplasms,Leiomyoma of uterus,PDCD5,Programmed cell death protein 5,11892,170,1.03 [0.81-1.30],0.8179744314105108
Chapter II Neoplasms,Leiomyoma of uterus,PDCD6,Programmed cell death protein 6,11802,169,1.12 [0.90-1.40],0.2991244544306504
Chapter II Neoplasms,Leiomyoma of uterus,PDCL2,Phosducin-like protein 2,9961,142,0.93 [0.68-1.27],0.6326770595948139
Chapter II Neoplasms,Leiomyoma of uterus,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",9961,142,1.27 [1.03-1.56],0.0277487116406389
Chapter II Neoplasms,Leiomyoma of uterus,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",10002,147,1.09 [0.86-1.39],0.4838707634140686
Chapter II Neoplasms,Leiomyoma of uterus,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",10128,146,0.95 [0.81-1.11],0.508928557989361
Chapter II Neoplasms,Leiomyoma of uterus,PDGFA,Platelet-derived growth factor subunit A,11938,171,0.94 [0.78-1.13],0.4942339134194646
Chapter II Neoplasms,Leiomyoma of uterus,PDGFB,Platelet-derived growth factor subunit B,11854,170,0.98 [0.83-1.14],0.7731437719593959
Chapter II Neoplasms,Leiomyoma of uterus,PDGFC,Platelet-derived growth factor C,11526,160,0.78 [0.48-1.28],0.3322493600037807
Chapter II Neoplasms,Leiomyoma of uterus,PDGFRA,Platelet-derived growth factor receptor alpha,11802,169,0.92 [0.57-1.49],0.7427643771182351
Chapter II Neoplasms,Leiomyoma of uterus,PDGFRB,Platelet-derived growth factor receptor beta,11938,171,0.84 [0.57-1.24],0.3802122080552037
Chapter II Neoplasms,Leiomyoma of uterus,PDIA2,Protein disulfide-isomerase A2,9961,142,1.17 [0.83-1.64],0.3714878244961942
Chapter II Neoplasms,Leiomyoma of uterus,PDIA3,Protein disulfide-isomerase A3,10128,146,1.09 [0.59-2.04],0.7810025442725458
Chapter II Neoplasms,Leiomyoma of uterus,PDIA4,Protein disulfide-isomerase A4,10347,149,1.08 [0.83-1.40],0.5525108109352255
Chapter II Neoplasms,Leiomyoma of uterus,PDIA5,Protein disulfide-isomerase A5,9961,142,1.08 [0.84-1.39],0.5262607887951334
Chapter II Neoplasms,Leiomyoma of uterus,PDLIM5,PDZ and LIM domain protein 5,10311,147,1.03 [0.90-1.18],0.6740901995945784
Chapter II Neoplasms,Leiomyoma of uterus,PDLIM7,PDZ and LIM domain protein 7,11854,170,1.01 [0.90-1.12],0.8919100463322874
Chapter II Neoplasms,Leiomyoma of uterus,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",11526,160,0.85 [0.62-1.16],0.3044553726105078
Chapter II Neoplasms,Leiomyoma of uterus,PDRG1,p53 and DNA damage-regulated protein 1,10056,144,1.02 [0.76-1.36],0.8969092089171737
Chapter II Neoplasms,Leiomyoma of uterus,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,9961,142,1.06 [0.82-1.36],0.6569222318984042
Chapter II Neoplasms,Leiomyoma of uterus,PDZD2,PDZ domain-containing protein 2,10002,147,1.04 [0.81-1.35],0.7343890260655082
Chapter II Neoplasms,Leiomyoma of uterus,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,10039,145,1.31 [0.94-1.83],0.1065272546314815
Chapter II Neoplasms,Leiomyoma of uterus,PEAR1,Platelet endothelial aggregation receptor 1,11938,171,0.99 [0.54-1.80],0.9626761916538518
Chapter II Neoplasms,Leiomyoma of uterus,PEBP1,Phosphatidylethanolamine-binding protein 1,11808,165,1.00 [0.79-1.27],0.9826909463277176
Chapter II Neoplasms,Leiomyoma of uterus,PECAM1,Platelet endothelial cell adhesion molecule,11808,165,0.79 [0.50-1.25],0.3064654224972379
Chapter II Neoplasms,Leiomyoma of uterus,PECR,Peroxisomal trans-2-enoyl-CoA reductase,10091,145,1.21 [0.75-1.96],0.4310485023039121
Chapter II Neoplasms,Leiomyoma of uterus,PENK,Proenkephalin-A,10128,146,1.49 [0.95-2.32],0.0806910167636334
Chapter II Neoplasms,Leiomyoma of uterus,PEPD,Xaa-Pro dipeptidase,10335,147,1.10 [0.60-2.01],0.7553454850864209
Chapter II Neoplasms,Leiomyoma of uterus,PER3,Period circadian protein homolog 3,10039,145,0.96 [0.84-1.10],0.5909749316621791
Chapter II Neoplasms,Leiomyoma of uterus,PF4,Platelet factor 4,10274,147,1.05 [0.89-1.23],0.5519658863921795
Chapter II Neoplasms,Leiomyoma of uterus,PFDN2,Prefoldin subunit 2,11512,163,1.02 [0.80-1.31],0.8792070223778679
Chapter II Neoplasms,Leiomyoma of uterus,PFDN4,Prefoldin subunit 4,9961,142,1.21 [0.92-1.59],0.1811574177671956
Chapter II Neoplasms,Leiomyoma of uterus,PFDN6,Prefoldin subunit 6,10056,144,0.88 [0.67-1.16],0.3594256321868898
Chapter II Neoplasms,Leiomyoma of uterus,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",11717,167,1.06 [0.89-1.27],0.4961294659198269
Chapter II Neoplasms,Leiomyoma of uterus,PGA4,Pepsin A-4,10335,147,1.24 [1.01-1.53],0.042832342810288
Chapter II Neoplasms,Leiomyoma of uterus,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",10334,150,0.92 [0.69-1.24],0.595065061549048
Chapter II Neoplasms,Leiomyoma of uterus,PGF,Placenta growth factor,11910,170,1.12 [0.64-1.94],0.6917756542320853
Chapter II Neoplasms,Leiomyoma of uterus,PGLYRP1,Peptidoglycan recognition protein 1,11893,170,0.80 [0.57-1.11],0.1803748906958223
Chapter II Neoplasms,Leiomyoma of uterus,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,10220,149,0.70 [0.42-1.16],0.1674145062267108
Chapter II Neoplasms,Leiomyoma of uterus,PGLYRP4,Peptidoglycan recognition protein 4,10002,147,1.00 [0.78-1.29],0.9936577619312752
Chapter II Neoplasms,Leiomyoma of uterus,PGM2,Phosphoglucomutase-2,10056,144,0.84 [0.60-1.15],0.276524477855815
Chapter II Neoplasms,Leiomyoma of uterus,PGR,Progesterone receptor,10039,145,1.11 [0.97-1.27],0.1343091702560016
Chapter II Neoplasms,Leiomyoma of uterus,PHACTR2,Phosphatase and actin regulator 2,10311,147,1.02 [0.89-1.17],0.7832009403160862
Chapter II Neoplasms,Leiomyoma of uterus,PHLDB1,Pleckstrin homology-like domain family B member 1,10273,150,1.03 [0.77-1.39],0.8223542392523366
Chapter II Neoplasms,Leiomyoma of uterus,PHLDB2,Pleckstrin homology-like domain family B member 2,9961,142,1.12 [0.96-1.29],0.1415263535526649
Chapter II Neoplasms,Leiomyoma of uterus,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,11718,168,0.97 [0.61-1.54],0.892140237169942
Chapter II Neoplasms,Leiomyoma of uterus,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,10128,146,0.87 [0.59-1.29],0.4931433256886424
Chapter II Neoplasms,Leiomyoma of uterus,PI16,Peptidase inhibitor 16,10335,147,0.71 [0.39-1.32],0.2823963609406763
Chapter II Neoplasms,Leiomyoma of uterus,PI3,Elafin,11646,167,0.96 [0.74-1.24],0.7413767780648634
Chapter II Neoplasms,Leiomyoma of uterus,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",10311,147,1.02 [0.83-1.25],0.8552537871551654
Chapter II Neoplasms,Leiomyoma of uterus,PIGR,Polymeric immunoglobulin receptor,11647,164,1.00 [0.67-1.50],0.9894147389618722
Chapter II Neoplasms,Leiomyoma of uterus,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,11777,170,0.88 [0.70-1.10],0.2508807394242429
Chapter II Neoplasms,Leiomyoma of uterus,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,11808,165,1.26 [0.77-2.08],0.3541421982808981
Chapter II Neoplasms,Leiomyoma of uterus,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,10039,145,1.15 [0.88-1.51],0.3029243499695043
Chapter II Neoplasms,Leiomyoma of uterus,PILRA,Paired immunoglobulin-like type 2 receptor alpha,11808,165,0.83 [0.60-1.15],0.2555308098944713
Chapter II Neoplasms,Leiomyoma of uterus,PILRB,Paired immunoglobulin-like type 2 receptor beta,11802,169,0.87 [0.69-1.09],0.2279511141404022
Chapter II Neoplasms,Leiomyoma of uterus,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,10128,146,0.92 [0.73-1.15],0.446832653285076
Chapter II Neoplasms,Leiomyoma of uterus,PITHD1,PITH domain-containing protein 1,9943,142,1.14 [0.96-1.34],0.1246726703532441
Chapter II Neoplasms,Leiomyoma of uterus,PKD1,Polycystin-1,10334,150,1.10 [0.60-2.02],0.7469258782653818
Chapter II Neoplasms,Leiomyoma of uterus,PKD2,Polycystin-2,10002,147,1.07 [0.81-1.39],0.6431373277288559
Chapter II Neoplasms,Leiomyoma of uterus,PKLR,Pyruvate kinase PKLR,11820,169,1.01 [0.83-1.24],0.8931205056105559
Chapter II Neoplasms,Leiomyoma of uterus,PKN3,Serine/threonine-protein kinase N3,10166,144,1.17 [0.96-1.42],0.1185112809358516
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G10,Group 10 secretory phospholipase A2,11718,168,1.01 [0.81-1.27],0.9015366702919704
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G15,Phospholipase A2 group XV,11855,167,1.21 [0.71-2.04],0.483225421823912
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G1B,Phospholipase A2,11921,171,1.16 [0.85-1.59],0.3367889628232094
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G2A,"Phospholipase A2, membrane associated",11752,169,0.92 [0.72-1.18],0.5254364260354888
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G4A,Cytosolic phospholipase A2,11854,170,0.99 [0.84-1.15],0.8522181867420788
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G7,Platelet-activating factor acetylhydrolase,11808,165,1.24 [0.81-1.89],0.3278630665439779
Chapter II Neoplasms,Leiomyoma of uterus,PLAT,Tissue-type plasminogen activator,11905,170,0.97 [0.74-1.28],0.8410591765782514
Chapter II Neoplasms,Leiomyoma of uterus,PLAU,Urokinase-type plasminogen activator,11808,165,1.16 [0.73-1.82],0.5318167393698428
Chapter II Neoplasms,Leiomyoma of uterus,PLAUR,Urokinase plasminogen activator surface receptor,11721,168,1.37 [0.82-2.28],0.2250874520653132
Chapter II Neoplasms,Leiomyoma of uterus,PLB1,"Phospholipase B1, membrane-associated",10317,147,1.09 [0.83-1.42],0.5352446694768898
Chapter II Neoplasms,Leiomyoma of uterus,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",10039,145,0.90 [0.61-1.34],0.6137967400219323
Chapter II Neoplasms,Leiomyoma of uterus,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",10317,147,1.05 [0.89-1.24],0.5529372447873702
Chapter II Neoplasms,Leiomyoma of uterus,PLEKHO1,Pleckstrin homology domain-containing family O member 1,10317,147,1.02 [0.81-1.28],0.8560962966890441
Chapter II Neoplasms,Leiomyoma of uterus,PLG,Plasminogen,10084,146,1.27 [0.60-2.69],0.5346478555388475
Chapter II Neoplasms,Leiomyoma of uterus,PLIN1,Perilipin-1,11512,163,1.35 [0.95-1.92],0.0990180820271972
Chapter II Neoplasms,Leiomyoma of uterus,PLIN3,Perilipin-3,11802,169,0.87 [0.63-1.20],0.3991189526005178
Chapter II Neoplasms,Leiomyoma of uterus,PLPBP,Pyridoxal phosphate homeostasis protein,11802,169,0.91 [0.75-1.12],0.3859056302804848
Chapter II Neoplasms,Leiomyoma of uterus,PLSCR3,Phospholipid scramblase 3,10297,146,0.87 [0.66-1.14],0.3041252644241681
Chapter II Neoplasms,Leiomyoma of uterus,PLTP,Phospholipid transfer protein,11907,170,0.86 [0.58-1.28],0.4650102625398171
Chapter II Neoplasms,Leiomyoma of uterus,PLXDC1,Plexin domain-containing protein 1,11526,160,0.91 [0.58-1.44],0.6883946305199089
Chapter II Neoplasms,Leiomyoma of uterus,PLXDC2,Plexin domain-containing protein 2,10317,147,1.16 [0.67-2.03],0.5972331134659352
Chapter II Neoplasms,Leiomyoma of uterus,PLXNA4,Plexin-A4,11777,170,0.86 [0.73-1.01],0.0661704875972913
Chapter II Neoplasms,Leiomyoma of uterus,PLXNB2,Plexin-B2,11880,170,0.51 [0.28-0.92],0.026215985427333
Chapter II Neoplasms,Leiomyoma of uterus,PLXNB3,Plexin-B3,11769,169,0.89 [0.66-1.19],0.4227505603528959
Chapter II Neoplasms,Leiomyoma of uterus,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,11732,166,1.01 [0.94-1.09],0.7629976065156127
Chapter II Neoplasms,Leiomyoma of uterus,PMCH,Pro-MCH,10002,147,0.94 [0.76-1.15],0.5425339640429011
Chapter II Neoplasms,Leiomyoma of uterus,PMM2,Phosphomannomutase 2,10002,147,1.09 [0.83-1.41],0.5415431261152186
Chapter II Neoplasms,Leiomyoma of uterus,PMS1,PMS1 protein homolog 1,10056,144,1.04 [0.77-1.42],0.7816761129348072
Chapter II Neoplasms,Leiomyoma of uterus,PMVK,Phosphomevalonate kinase,11490,163,1.03 [0.90-1.18],0.6356934118238019
Chapter II Neoplasms,Leiomyoma of uterus,PNLIP,Pancreatic triacylglycerol lipase,10335,147,1.21 [0.94-1.56],0.1290967667736181
Chapter II Neoplasms,Leiomyoma of uterus,PNLIPRP1,Inactive pancreatic lipase-related protein 1,10317,147,1.17 [0.96-1.43],0.12722605200255
Chapter II Neoplasms,Leiomyoma of uterus,PNLIPRP2,Pancreatic lipase-related protein 2,11797,169,1.03 [0.98-1.09],0.1959347744225862
Chapter II Neoplasms,Leiomyoma of uterus,PNMA1,Paraneoplastic antigen Ma1,10091,145,0.90 [0.68-1.21],0.4988628894582125
Chapter II Neoplasms,Leiomyoma of uterus,PNMA2,Paraneoplastic antigen Ma2,9978,146,1.28 [0.93-1.78],0.1350631996063284
Chapter II Neoplasms,Leiomyoma of uterus,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",11555,165,0.97 [0.85-1.10],0.6251337389892189
Chapter II Neoplasms,Leiomyoma of uterus,PODXL,Podocalyxin,11744,167,1.38 [0.56-3.40],0.4855697975605009
Chapter II Neoplasms,Leiomyoma of uterus,PODXL2,Podocalyxin-like protein 2,11855,167,1.18 [0.72-1.93],0.5036039612787231
Chapter II Neoplasms,Leiomyoma of uterus,POF1B,Protein POF1B,10039,145,1.07 [0.77-1.49],0.6840037037106803
Chapter II Neoplasms,Leiomyoma of uterus,POLR2A,DNA-directed RNA polymerase II subunit RPB1,10039,145,0.73 [0.41-1.31],0.2920447784822381
Chapter II Neoplasms,Leiomyoma of uterus,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",11744,167,1.42 [1.04-1.93],0.0289637649430858
Chapter II Neoplasms,Leiomyoma of uterus,POMC,Pro-opiomelanocortin,10091,145,0.86 [0.68-1.08],0.1975982246462301
Chapter II Neoplasms,Leiomyoma of uterus,PON1,Serum paraoxonase/arylesterase 1,10335,147,0.91 [0.51-1.65],0.7653918062518797
Chapter II Neoplasms,Leiomyoma of uterus,PON2,Serum paraoxonase/arylesterase 2,11560,165,1.33 [0.90-1.97],0.1491303589283823
Chapter II Neoplasms,Leiomyoma of uterus,PON3,Serum paraoxonase/lactonase 3,11854,170,0.90 [0.56-1.44],0.6686733709793373
Chapter II Neoplasms,Leiomyoma of uterus,POSTN,Periostin,10347,149,1.05 [0.69-1.60],0.8309566838070521
Chapter II Neoplasms,Leiomyoma of uterus,PPBP,Platelet basic protein,10282,147,0.98 [0.81-1.18],0.8223395473405682
Chapter II Neoplasms,Leiomyoma of uterus,PPCDC,Phosphopantothenoylcysteine decarboxylase,11892,170,0.95 [0.71-1.27],0.7245772497325906
Chapter II Neoplasms,Leiomyoma of uterus,PPIB,Peptidyl-prolyl cis-trans isomerase B,11822,169,0.97 [0.83-1.12],0.6396948634172087
Chapter II Neoplasms,Leiomyoma of uterus,PPIE,Peptidyl-prolyl cis-trans isomerase E,10166,144,1.13 [0.91-1.40],0.2668443330548526
Chapter II Neoplasms,Leiomyoma of uterus,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",10347,149,1.00 [0.78-1.28],0.9925936618514298
Chapter II Neoplasms,Leiomyoma of uterus,PPL,Periplakin,10039,145,1.39 [0.92-2.12],0.1207857275516265
Chapter II Neoplasms,Leiomyoma of uterus,PPM1A,Protein phosphatase 1A,11526,160,1.02 [0.65-1.58],0.9427135964432082
Chapter II Neoplasms,Leiomyoma of uterus,PPM1B,Protein phosphatase 1B,10039,145,1.06 [0.83-1.37],0.6329004098740725
Chapter II Neoplasms,Leiomyoma of uterus,PPM1F,Protein phosphatase 1F,10334,150,1.07 [0.79-1.45],0.655937815548435
Chapter II Neoplasms,Leiomyoma of uterus,PPME1,Protein phosphatase methylesterase 1,11744,167,1.03 [0.83-1.29],0.7651593550292858
Chapter II Neoplasms,Leiomyoma of uterus,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,10278,147,1.03 [0.85-1.24],0.7947493195997226
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,11855,167,0.99 [0.86-1.14],0.8684154028444449
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,10166,144,1.03 [0.83-1.27],0.8193859017198901
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,10311,147,1.06 [0.88-1.28],0.5479867468858546
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,10311,147,1.24 [0.86-1.79],0.2525230631037645
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R2,Protein phosphatase inhibitor 2,11802,169,0.98 [0.83-1.17],0.8582739713803949
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R9B,Neurabin-2,11910,170,1.03 [0.89-1.19],0.6719667530718763
Chapter II Neoplasms,Leiomyoma of uterus,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,10273,150,1.03 [0.90-1.17],0.7189524901496239
Chapter II Neoplasms,Leiomyoma of uterus,PPP3R1,Calcineurin subunit B type 1,11718,168,1.00 [0.71-1.39],0.9878154247958868
Chapter II Neoplasms,Leiomyoma of uterus,PPT1,Palmitoyl-protein thioesterase 1,10056,144,1.02 [0.83-1.25],0.8563264592976575
Chapter II Neoplasms,Leiomyoma of uterus,PPY,Pancreatic prohormone,11812,166,1.04 [0.91-1.19],0.5246703667472625
Chapter II Neoplasms,Leiomyoma of uterus,PQBP1,Polyglutamine-binding protein 1,11526,160,1.11 [0.89-1.39],0.3350400043660864
Chapter II Neoplasms,Leiomyoma of uterus,PRAME,Melanoma antigen preferentially expressed in tumors,9961,142,0.98 [0.52-1.85],0.9529983759300412
Chapter II Neoplasms,Leiomyoma of uterus,PRAP1,Proline-rich acidic protein 1,10347,149,1.21 [0.83-1.77],0.3149676900842727
Chapter II Neoplasms,Leiomyoma of uterus,PRC1,Protein regulator of cytokinesis 1,10278,147,1.16 [0.88-1.53],0.2812835924937814
Chapter II Neoplasms,Leiomyoma of uterus,PRCP,Lysosomal Pro-X carboxypeptidase,11877,170,0.64 [0.41-1.00],0.047686059029405
Chapter II Neoplasms,Leiomyoma of uterus,PRDX1,Peroxiredoxin-1,11488,165,0.96 [0.81-1.13],0.5966167512008596
Chapter II Neoplasms,Leiomyoma of uterus,PRDX2,Peroxiredoxin-2,10164,145,1.14 [0.90-1.45],0.2722005494194575
Chapter II Neoplasms,Leiomyoma of uterus,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",11555,165,1.00 [0.82-1.21],0.996704327994796
Chapter II Neoplasms,Leiomyoma of uterus,PRDX5,"Peroxiredoxin-5, mitochondrial",11910,170,1.02 [0.83-1.25],0.8657670652294152
Chapter II Neoplasms,Leiomyoma of uterus,PRDX6,Peroxiredoxin-6,11889,169,0.80 [0.63-1.01],0.0636736885372887
Chapter II Neoplasms,Leiomyoma of uterus,PREB,Prolactin regulatory element-binding protein,11555,165,1.13 [0.73-1.75],0.5818350771683323
Chapter II Neoplasms,Leiomyoma of uterus,PRELP,Prolargin,11797,169,1.14 [0.64-2.04],0.6549213809915668
Chapter II Neoplasms,Leiomyoma of uterus,PRG2,Bone marrow proteoglycan,10347,149,1.07 [0.80-1.44],0.6528180729585618
Chapter II Neoplasms,Leiomyoma of uterus,PRG3,Proteoglycan 3,10347,149,1.06 [0.77-1.45],0.7225901807023973
Chapter II Neoplasms,Leiomyoma of uterus,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,11555,165,0.90 [0.69-1.18],0.4538185904809899
Chapter II Neoplasms,Leiomyoma of uterus,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,10056,144,1.50 [0.99-2.28],0.056840161217293
Chapter II Neoplasms,Leiomyoma of uterus,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,11802,169,0.96 [0.82-1.13],0.6179745595972126
Chapter II Neoplasms,Leiomyoma of uterus,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,10299,147,1.05 [0.86-1.27],0.646384978407998
Chapter II Neoplasms,Leiomyoma of uterus,PRKCQ,Protein kinase C theta type,11555,165,1.20 [0.91-1.58],0.1948391151164374
Chapter II Neoplasms,Leiomyoma of uterus,PRKD2,Serine/threonine-protein kinase D2,10002,147,1.03 [0.74-1.43],0.8768611658071578
Chapter II Neoplasms,Leiomyoma of uterus,PRKG1,cGMP-dependent protein kinase 1,10128,146,0.98 [0.86-1.12],0.7745386785672055
Chapter II Neoplasms,Leiomyoma of uterus,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,11526,160,1.09 [0.89-1.34],0.4075395899603951
Chapter II Neoplasms,Leiomyoma of uterus,PRL,Prolactin,11892,170,0.99 [0.82-1.20],0.9454541255787186
Chapter II Neoplasms,Leiomyoma of uterus,PRND,Prion-like protein doppel,10317,147,1.59 [1.22-2.07],0.0006628463630753
Chapter II Neoplasms,Leiomyoma of uterus,PROC,Vitamin K-dependent protein C,11829,169,0.81 [0.46-1.43],0.4757649061687333
Chapter II Neoplasms,Leiomyoma of uterus,PROCR,Endothelial protein C receptor,10002,147,1.25 [0.88-1.76],0.2078225721935436
Chapter II Neoplasms,Leiomyoma of uterus,PROK1,Prokineticin-1,11777,170,0.94 [0.75-1.19],0.6260430098949239
Chapter II Neoplasms,Leiomyoma of uterus,PROS1,Vitamin K-dependent protein S,10353,149,0.68 [0.36-1.29],0.2347646651435621
Chapter II Neoplasms,Leiomyoma of uterus,PRR4,Proline-rich protein 4,10043,145,1.03 [0.82-1.30],0.7811814424260006
Chapter II Neoplasms,Leiomyoma of uterus,PRR5,Proline-rich protein 5,10039,145,0.91 [0.64-1.31],0.6190334347879773
Chapter II Neoplasms,Leiomyoma of uterus,PRRT3,Proline-rich transmembrane protein 3,10091,145,1.04 [0.69-1.58],0.8358516558000729
Chapter II Neoplasms,Leiomyoma of uterus,PRSS2,Trypsin-2,11855,169,1.26 [0.98-1.63],0.0753467211858847
Chapter II Neoplasms,Leiomyoma of uterus,PRSS22,Brain-specific serine protease 4,10039,145,0.92 [0.58-1.46],0.7215005807224028
Chapter II Neoplasms,Leiomyoma of uterus,PRSS27,Serine protease 27,11770,168,1.09 [0.78-1.53],0.5982128314336209
Chapter II Neoplasms,Leiomyoma of uterus,PRSS53,Serine protease 53,10317,147,1.31 [0.86-1.99],0.2055231497462928
Chapter II Neoplasms,Leiomyoma of uterus,PRSS8,Prostasin,11762,169,1.18 [0.85-1.64],0.3207005346031795
Chapter II Neoplasms,Leiomyoma of uterus,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,11512,163,1.02 [0.89-1.15],0.8106714470113454
Chapter II Neoplasms,Leiomyoma of uterus,PRTG,Protogenin,11889,169,1.46 [0.85-2.52],0.1707739447145445
Chapter II Neoplasms,Leiomyoma of uterus,PRTN3,Myeloblastin,11498,168,0.94 [0.71-1.25],0.6648979348831818
Chapter II Neoplasms,Leiomyoma of uterus,PRUNE2,Protein prune homolog 2,10166,144,1.19 [0.74-1.92],0.4803991647106792
Chapter II Neoplasms,Leiomyoma of uterus,PSAP,Prosaposin,10238,148,0.83 [0.47-1.47],0.5224411190076494
Chapter II Neoplasms,Leiomyoma of uterus,PSAPL1,Proactivator polypeptide-like 1,10273,150,1.03 [0.75-1.40],0.8673596667796194
Chapter II Neoplasms,Leiomyoma of uterus,PSCA,Prostate stem cell antigen,10273,150,1.00 [0.95-1.06],0.9260705165472316
Chapter II Neoplasms,Leiomyoma of uterus,PSG1,Pregnancy-specific beta-1-glycoprotein 1,11718,168,0.97 [0.87-1.08],0.5861506475135206
Chapter II Neoplasms,Leiomyoma of uterus,PSIP1,PC4 and SFRS1-interacting protein,11777,170,1.01 [0.81-1.25],0.9598347009880234
Chapter II Neoplasms,Leiomyoma of uterus,PSMA1,Proteasome subunit alpha type-1,11526,160,0.98 [0.71-1.34],0.8940349186360138
Chapter II Neoplasms,Leiomyoma of uterus,PSMC3,26S proteasome regulatory subunit 6A,9961,142,1.14 [0.69-1.90],0.6023051346460933
Chapter II Neoplasms,Leiomyoma of uterus,PSMD1,26S proteasome non-ATPase regulatory subunit 1,10311,147,0.99 [0.72-1.37],0.968716426832401
Chapter II Neoplasms,Leiomyoma of uterus,PSMD5,26S proteasome non-ATPase regulatory subunit 5,10056,144,1.04 [0.80-1.36],0.7723359472029832
Chapter II Neoplasms,Leiomyoma of uterus,PSMD9,26S proteasome non-ATPase regulatory subunit 9,11744,167,0.97 [0.76-1.24],0.8300069194061873
Chapter II Neoplasms,Leiomyoma of uterus,PSME1,Proteasome activator complex subunit 1,11700,168,1.09 [0.76-1.56],0.6557869511051433
Chapter II Neoplasms,Leiomyoma of uterus,PSME2,Proteasome activator complex subunit 2,11662,167,0.99 [0.68-1.44],0.9742924041057288
Chapter II Neoplasms,Leiomyoma of uterus,PSMG3,Proteasome assembly chaperone 3,11777,170,1.00 [0.77-1.29],0.9955182372824696
Chapter II Neoplasms,Leiomyoma of uterus,PSMG4,Proteasome assembly chaperone 4,10039,145,1.08 [0.82-1.41],0.5832405183639822
Chapter II Neoplasms,Leiomyoma of uterus,PSPN,Persephin,11777,170,0.98 [0.85-1.13],0.7791537262487206
Chapter II Neoplasms,Leiomyoma of uterus,PSRC1,Proline/serine-rich coiled-coil protein 1,11526,160,1.02 [0.80-1.30],0.8849925461827889
Chapter II Neoplasms,Leiomyoma of uterus,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,9768,140,1.02 [0.87-1.19],0.8284648444430238
Chapter II Neoplasms,Leiomyoma of uterus,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",11512,163,1.07 [0.67-1.70],0.7723052364610581
Chapter II Neoplasms,Leiomyoma of uterus,PTGDS,Prostaglandin-H2 D-isomerase,11705,166,1.21 [0.78-1.89],0.3904117170900801
Chapter II Neoplasms,Leiomyoma of uterus,PTGES2,Prostaglandin E synthase 2,9955,145,0.93 [0.69-1.25],0.6248539432527813
Chapter II Neoplasms,Leiomyoma of uterus,PTGR1,Prostaglandin reductase 1,10334,150,1.19 [0.99-1.43],0.0688932663301976
Chapter II Neoplasms,Leiomyoma of uterus,PTH,Parathyroid hormone,10056,144,1.22 [1.01-1.48],0.040285759675966
Chapter II Neoplasms,Leiomyoma of uterus,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,11777,170,1.19 [0.90-1.57],0.2124262918660481
Chapter II Neoplasms,Leiomyoma of uterus,PTK7,Inactive tyrosine-protein kinase 7,11512,163,1.30 [0.90-1.88],0.1616557763520041
Chapter II Neoplasms,Leiomyoma of uterus,PTN,Pleiotrophin,11560,165,0.99 [0.75-1.31],0.9574513704536594
Chapter II Neoplasms,Leiomyoma of uterus,PTP4A3,Protein tyrosine phosphatase type IVA 3,10039,145,1.26 [0.98-1.63],0.0748650078038671
Chapter II Neoplasms,Leiomyoma of uterus,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,11718,168,1.04 [0.87-1.23],0.6945902593193307
Chapter II Neoplasms,Leiomyoma of uterus,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,11831,169,0.97 [0.83-1.14],0.7271325266949827
Chapter II Neoplasms,Leiomyoma of uterus,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,10022,145,0.73 [0.45-1.19],0.2094407757978625
Chapter II Neoplasms,Leiomyoma of uterus,PTPRB,Receptor-type tyrosine-protein phosphatase beta,10334,150,1.02 [0.58-1.78],0.9508725107616114
Chapter II Neoplasms,Leiomyoma of uterus,PTPRC,Receptor-type tyrosine-protein phosphatase C,10347,149,0.93 [0.46-1.88],0.8467202716610432
Chapter II Neoplasms,Leiomyoma of uterus,PTPRF,Receptor-type tyrosine-protein phosphatase F,11938,171,0.72 [0.45-1.14],0.1621798488805236
Chapter II Neoplasms,Leiomyoma of uterus,PTPRH,Receptor-type tyrosine-protein phosphatase H,10273,150,1.17 [0.85-1.61],0.3465598759919548
Chapter II Neoplasms,Leiomyoma of uterus,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,10273,150,1.18 [0.59-2.37],0.6336541895220815
Chapter II Neoplasms,Leiomyoma of uterus,PTPRM,Receptor-type tyrosine-protein phosphatase mu,11764,170,0.53 [0.30-0.93],0.0281917699988032
Chapter II Neoplasms,Leiomyoma of uterus,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,11689,167,1.06 [0.70-1.60],0.7983790250548152
Chapter II Neoplasms,Leiomyoma of uterus,PTPRR,Receptor-type tyrosine-protein phosphatase R,10317,147,1.15 [0.74-1.79],0.5312530803645283
Chapter II Neoplasms,Leiomyoma of uterus,PTPRS,Receptor-type tyrosine-protein phosphatase S,11938,171,0.97 [0.55-1.69],0.9017158311229376
Chapter II Neoplasms,Leiomyoma of uterus,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,10334,150,1.10 [0.68-1.78],0.700792294891974
Chapter II Neoplasms,Leiomyoma of uterus,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,10128,146,0.98 [0.75-1.28],0.8780059383585885
Chapter II Neoplasms,Leiomyoma of uterus,PTS,6-pyruvoyl tetrahydrobiopterin synthase,11460,163,1.02 [0.79-1.31],0.8901369120273199
Chapter II Neoplasms,Leiomyoma of uterus,PTTG1,Securin,10166,144,1.06 [0.73-1.54],0.7557527100926303
Chapter II Neoplasms,Leiomyoma of uterus,PTX3,Pentraxin-related protein PTX3,11777,170,0.83 [0.64-1.08],0.1745174854973251
Chapter II Neoplasms,Leiomyoma of uterus,PVALB,Parvalbumin alpha,11823,169,1.07 [0.95-1.22],0.2592497934166952
Chapter II Neoplasms,Leiomyoma of uterus,PVR,Poliovirus receptor,11892,170,0.99 [0.68-1.44],0.9695858914843724
Chapter II Neoplasms,Leiomyoma of uterus,PXDNL,Peroxidasin-like protein,10278,147,0.89 [0.65-1.22],0.4675780645429286
Chapter II Neoplasms,Leiomyoma of uterus,PXN,Paxillin,11512,163,1.25 [0.98-1.58],0.0689280775774371
Chapter II Neoplasms,Leiomyoma of uterus,PYDC1,Pyrin domain-containing protein 1,10091,145,1.10 [0.76-1.59],0.6044913185115733
Chapter II Neoplasms,Leiomyoma of uterus,PYY,Peptide YY,10002,147,1.06 [0.91-1.25],0.4389490792165015
Chapter II Neoplasms,Leiomyoma of uterus,PZP,Pregnancy zone protein,10353,149,0.83 [0.64-1.08],0.1716118050137636
Chapter II Neoplasms,Leiomyoma of uterus,QDPR,Dihydropteridine reductase,11741,169,1.00 [0.73-1.37],0.9999346129775268
Chapter II Neoplasms,Leiomyoma of uterus,QPCT,Glutaminyl-peptide cyclotransferase,11828,169,0.55 [0.33-0.91],0.0210574298363841
Chapter II Neoplasms,Leiomyoma of uterus,QSOX1,Sulfhydryl oxidase 1,10149,148,1.15 [0.84-1.58],0.3752588341237688
Chapter II Neoplasms,Leiomyoma of uterus,RAB10,Ras-related protein Rab-10,10334,150,1.15 [0.87-1.53],0.3247845630202139
Chapter II Neoplasms,Leiomyoma of uterus,RAB11FIP3,Rab11 family-interacting protein 3,10334,150,0.99 [0.86-1.15],0.9387356351452424
Chapter II Neoplasms,Leiomyoma of uterus,RAB27B,Ras-related protein Rab-27B,10334,150,0.91 [0.75-1.10],0.3268185213301063
Chapter II Neoplasms,Leiomyoma of uterus,RAB2B,Ras-related protein Rab-2B,10278,147,1.03 [0.79-1.34],0.81692262195563
Chapter II Neoplasms,Leiomyoma of uterus,RAB33A,Ras-related protein Rab-33A,10002,147,1.05 [0.82-1.33],0.7100106453075268
Chapter II Neoplasms,Leiomyoma of uterus,RAB37,Ras-related protein Rab-37,11555,165,1.03 [0.88-1.22],0.6933533745034883
Chapter II Neoplasms,Leiomyoma of uterus,RAB39B,Ras-related protein Rab-39B,10002,147,0.91 [0.74-1.12],0.3874172519244817
Chapter II Neoplasms,Leiomyoma of uterus,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,9978,146,0.94 [0.69-1.27],0.6666938625234886
Chapter II Neoplasms,Leiomyoma of uterus,RAB44,Ras-related protein Rab-44,10278,147,1.26 [0.95-1.67],0.1053317471468346
Chapter II Neoplasms,Leiomyoma of uterus,RAB6A,Ras-related protein Rab-6A,11777,170,1.03 [0.78-1.36],0.8233323853352343
Chapter II Neoplasms,Leiomyoma of uterus,RAB6B,Ras-related protein Rab-6B,11512,163,0.87 [0.64-1.18],0.3769817535947841
Chapter II Neoplasms,Leiomyoma of uterus,RABEP1,Rab GTPase-binding effector protein 1,10128,146,0.93 [0.76-1.14],0.4897024147713213
Chapter II Neoplasms,Leiomyoma of uterus,RABEPK,Rab9 effector protein with kelch motifs,11526,160,0.94 [0.72-1.21],0.6147791865802945
Chapter II Neoplasms,Leiomyoma of uterus,RABGAP1L,Rab GTPase-activating protein 1-like,11555,165,0.99 [0.79-1.25],0.9350443672588786
Chapter II Neoplasms,Leiomyoma of uterus,RAC3,Ras-related C3 botulinum toxin substrate 3,10056,144,0.91 [0.70-1.17],0.4525310286200521
Chapter II Neoplasms,Leiomyoma of uterus,RAD23B,UV excision repair protein RAD23 homolog B,11526,160,0.93 [0.68-1.27],0.6637786802070402
Chapter II Neoplasms,Leiomyoma of uterus,RAD51,DNA repair protein RAD51 homolog 1,10166,144,0.87 [0.62-1.22],0.4318578681262018
Chapter II Neoplasms,Leiomyoma of uterus,RALB,Ras-related protein Ral-B,10039,145,1.08 [0.64-1.82],0.7847551987665646
Chapter II Neoplasms,Leiomyoma of uterus,RALY,RNA-binding protein Raly,10278,147,1.21 [0.92-1.60],0.1754571322824483
Chapter II Neoplasms,Leiomyoma of uterus,RANBP1,Ran-specific GTPase-activating protein,10091,145,1.07 [0.79-1.44],0.6624302725119027
Chapter II Neoplasms,Leiomyoma of uterus,RANBP2,E3 SUMO-protein ligase RanBP2,9978,146,1.55 [1.00-2.41],0.0516619329896232
Chapter II Neoplasms,Leiomyoma of uterus,RANGAP1,Ran GTPase-activating protein 1,11526,160,0.92 [0.68-1.26],0.6220437268683607
Chapter II Neoplasms,Leiomyoma of uterus,RAP1A,Ras-related protein Rap-1A,10039,145,0.98 [0.77-1.25],0.8819175331120426
Chapter II Neoplasms,Leiomyoma of uterus,RAPGEF2,Rap guanine nucleotide exchange factor 2,10166,144,0.94 [0.69-1.28],0.6749418816628252
Chapter II Neoplasms,Leiomyoma of uterus,RARRES1,Retinoic acid receptor responder protein 1,11526,160,0.93 [0.60-1.44],0.7578052226522412
Chapter II Neoplasms,Leiomyoma of uterus,RARRES2,Retinoic acid receptor responder protein 2,11871,169,0.86 [0.64-1.16],0.3240312843711463
Chapter II Neoplasms,Leiomyoma of uterus,RASA1,Ras GTPase-activating protein 1,11512,163,1.24 [0.84-1.81],0.2751599887793516
Chapter II Neoplasms,Leiomyoma of uterus,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,9961,142,0.83 [0.57-1.19],0.3092996499900606
Chapter II Neoplasms,Leiomyoma of uterus,RASSF2,Ras association domain-containing protein 2,11526,160,0.97 [0.75-1.25],0.8140695115607337
Chapter II Neoplasms,Leiomyoma of uterus,RBFOX3,RNA binding protein fox-1 homolog 3,10311,147,1.52 [1.09-2.11],0.012850598280304
Chapter II Neoplasms,Leiomyoma of uterus,RBKS,Ribokinase,11539,166,1.11 [0.85-1.45],0.4487688933457485
Chapter II Neoplasms,Leiomyoma of uterus,RBM17,Splicing factor 45,10311,147,1.02 [0.83-1.25],0.8757908125084763
Chapter II Neoplasms,Leiomyoma of uterus,RBM19,Probable RNA-binding protein 19,10002,147,1.23 [0.93-1.62],0.1564039650197092
Chapter II Neoplasms,Leiomyoma of uterus,RBM25,RNA-binding protein 25,9961,142,1.33 [0.97-1.81],0.074233236591048
Chapter II Neoplasms,Leiomyoma of uterus,RBP1,Retinol-binding protein 1,10056,144,1.15 [0.95-1.40],0.1468492834418071
Chapter II Neoplasms,Leiomyoma of uterus,RBP2,Retinol-binding protein 2,11744,167,0.94 [0.78-1.13],0.4888828452084871
Chapter II Neoplasms,Leiomyoma of uterus,RBP5,Retinol-binding protein 5,11744,167,0.97 [0.76-1.25],0.84182653887662
Chapter II Neoplasms,Leiomyoma of uterus,RBP7,Retinoid-binding protein 7,10273,150,1.01 [0.78-1.31],0.9428462038683634
Chapter II Neoplasms,Leiomyoma of uterus,RBPMS,RNA-binding protein with multiple splicing,10039,145,1.22 [1.02-1.46],0.0302150133767418
Chapter II Neoplasms,Leiomyoma of uterus,RBPMS2,RNA-binding protein with multiple splicing 2,10091,145,0.99 [0.84-1.15],0.8508038299160636
Chapter II Neoplasms,Leiomyoma of uterus,RCC1,Regulator of chromosome condensation,10278,147,1.04 [0.78-1.38],0.8027961144032634
Chapter II Neoplasms,Leiomyoma of uterus,RCOR1,REST corepressor 1,11560,165,0.86 [0.60-1.22],0.3909667523889077
Chapter II Neoplasms,Leiomyoma of uterus,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,10091,145,1.48 [0.66-3.35],0.3405164819267298
Chapter II Neoplasms,Leiomyoma of uterus,REEP4,Receptor expression-enhancing protein 4,10311,147,1.03 [0.80-1.33],0.7936244172009512
Chapter II Neoplasms,Leiomyoma of uterus,REG1A,Lithostathine-1-alpha,11725,169,1.11 [0.86-1.44],0.429816131835128
Chapter II Neoplasms,Leiomyoma of uterus,REG1B,Lithostathine-1-beta,11938,171,1.04 [0.83-1.31],0.7172802121046045
Chapter II Neoplasms,Leiomyoma of uterus,REG3A,Regenerating islet-derived protein 3-alpha,11938,171,0.95 [0.77-1.18],0.6691629148260364
Chapter II Neoplasms,Leiomyoma of uterus,REG3G,Regenerating islet-derived protein 3-gamma,10278,147,1.48 [1.06-2.08],0.0225201218881152
Chapter II Neoplasms,Leiomyoma of uterus,REG4,Regenerating islet-derived protein 4,11817,169,1.15 [0.88-1.51],0.3003392724912419
Chapter II Neoplasms,Leiomyoma of uterus,RELB,Transcription factor RelB,10039,145,1.23 [0.94-1.60],0.1288895175884417
Chapter II Neoplasms,Leiomyoma of uterus,RELT,Tumor necrosis factor receptor superfamily member 19L,11808,165,1.02 [0.62-1.67],0.9340663227258782
Chapter II Neoplasms,Leiomyoma of uterus,REN,Renin,11802,169,1.18 [1.00-1.38],0.0492597607225675
Chapter II Neoplasms,Leiomyoma of uterus,REPS1,RalBP1-associated Eps domain-containing protein 1,10039,145,1.19 [0.81-1.76],0.3807023994796016
Chapter II Neoplasms,Leiomyoma of uterus,REST,RE1-silencing transcription factor,9961,142,0.90 [0.55-1.45],0.6568955337114376
Chapter II Neoplasms,Leiomyoma of uterus,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,11744,167,0.83 [0.59-1.17],0.2906156821442976
Chapter II Neoplasms,Leiomyoma of uterus,RETN,Resistin,11785,169,0.70 [0.50-0.98],0.0385690422555925
Chapter II Neoplasms,Leiomyoma of uterus,REXO2,"Oligoribonuclease, mitochondrial",10002,147,0.89 [0.63-1.25],0.4939267354084991
Chapter II Neoplasms,Leiomyoma of uterus,RFC4,Replication factor C subunit 4,10278,147,1.41 [0.70-2.87],0.3385458204225233
Chapter II Neoplasms,Leiomyoma of uterus,RGCC,Regulator of cell cycle RGCC,10311,147,1.12 [0.91-1.38],0.2805024375338215
Chapter II Neoplasms,Leiomyoma of uterus,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,10166,144,1.20 [0.98-1.48],0.0773532661724397
Chapter II Neoplasms,Leiomyoma of uterus,RGMA,Repulsive guidance molecule A,11892,170,0.80 [0.52-1.24],0.3202400301113495
Chapter II Neoplasms,Leiomyoma of uterus,RGMB,RGM domain family member B,11892,170,1.11 [0.67-1.85],0.6880115926720175
Chapter II Neoplasms,Leiomyoma of uterus,RGS10,Regulator of G-protein signaling 10,10311,147,0.96 [0.74-1.26],0.7799452442951161
Chapter II Neoplasms,Leiomyoma of uterus,RGS8,Regulator of G-protein signaling 8,11555,165,1.10 [0.91-1.33],0.3028068848355235
Chapter II Neoplasms,Leiomyoma of uterus,RHOC,Rho-related GTP-binding protein RhoC,11645,168,0.99 [0.88-1.12],0.8733348765174
Chapter II Neoplasms,Leiomyoma of uterus,RICTOR,Rapamycin-insensitive companion of mTOR,10039,145,1.06 [0.79-1.42],0.6983942145399197
Chapter II Neoplasms,Leiomyoma of uterus,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,10128,146,1.13 [0.83-1.55],0.4398972242024389
Chapter II Neoplasms,Leiomyoma of uterus,RILP,Rab-interacting lysosomal protein,11847,169,0.94 [0.75-1.18],0.6012849712613465
Chapter II Neoplasms,Leiomyoma of uterus,RILPL2,RILP-like protein 2,10334,150,1.05 [0.89-1.23],0.5884819585530858
Chapter II Neoplasms,Leiomyoma of uterus,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,10002,147,0.94 [0.74-1.19],0.6203637153292146
Chapter II Neoplasms,Leiomyoma of uterus,RLN1,Prorelaxin H1,10311,147,1.24 [1.00-1.53],0.0520502859434067
Chapter II Neoplasms,Leiomyoma of uterus,RLN2,Prorelaxin H2,10107,145,0.99 [0.69-1.40],0.942098834989647
Chapter II Neoplasms,Leiomyoma of uterus,RNASE1,Ribonuclease pancreatic,10335,147,1.35 [0.80-2.26],0.2569713935237659
Chapter II Neoplasms,Leiomyoma of uterus,RNASE10,Inactive ribonuclease-like protein 10,10091,145,1.19 [0.88-1.60],0.2579101499141957
Chapter II Neoplasms,Leiomyoma of uterus,RNASE3,Eosinophil cationic protein,11749,168,0.91 [0.80-1.04],0.1705901946011986
Chapter II Neoplasms,Leiomyoma of uterus,RNASE4,Ribonuclease 4,9976,141,1.60 [0.96-2.64],0.0686235378999083
Chapter II Neoplasms,Leiomyoma of uterus,RNASE6,Ribonuclease K6,10253,145,1.09 [0.67-1.78],0.7298371134628052
Chapter II Neoplasms,Leiomyoma of uterus,RNASEH2A,Ribonuclease H2 subunit A,10311,147,1.11 [0.82-1.48],0.5043206155022908
Chapter II Neoplasms,Leiomyoma of uterus,RNASET2,Ribonuclease T2,11891,170,1.14 [0.70-1.85],0.5973308788130502
Chapter II Neoplasms,Leiomyoma of uterus,RNF149,E3 ubiquitin-protein ligase RNF149,10091,145,0.94 [0.56-1.58],0.8256804988338674
Chapter II Neoplasms,Leiomyoma of uterus,RNF168,E3 ubiquitin-protein ligase RNF168,10039,145,1.10 [0.75-1.61],0.6282149288010876
Chapter II Neoplasms,Leiomyoma of uterus,RNF31,E3 ubiquitin-protein ligase RNF31,10039,145,1.25 [0.87-1.81],0.2329290005803721
Chapter II Neoplasms,Leiomyoma of uterus,RNF4,E3 ubiquitin-protein ligase RNF4,10166,144,1.03 [0.82-1.30],0.7747487750634912
Chapter II Neoplasms,Leiomyoma of uterus,RNF41,E3 ubiquitin-protein ligase NRDP1,11526,160,1.01 [0.82-1.25],0.9208055542704604
Chapter II Neoplasms,Leiomyoma of uterus,RNF43,E3 ubiquitin-protein ligase RNF43,10166,144,1.08 [0.84-1.40],0.5367047424043061
Chapter II Neoplasms,Leiomyoma of uterus,RNF5,E3 ubiquitin-protein ligase RNF5,10091,145,0.98 [0.78-1.22],0.8489207662401648
Chapter II Neoplasms,Leiomyoma of uterus,ROBO1,Roundabout homolog 1,11817,169,0.80 [0.45-1.40],0.4337115254632354
Chapter II Neoplasms,Leiomyoma of uterus,ROBO2,Roundabout homolog 2,11892,170,1.23 [0.69-2.19],0.4841975626170155
Chapter II Neoplasms,Leiomyoma of uterus,ROBO4,Roundabout homolog 4,10091,145,1.12 [0.45-2.76],0.8069319524293552
Chapter II Neoplasms,Leiomyoma of uterus,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,11802,169,1.30 [0.85-1.99],0.2274126978301745
Chapter II Neoplasms,Leiomyoma of uterus,RP2,Protein XRP2,11744,167,0.91 [0.65-1.27],0.5624792816591668
Chapter II Neoplasms,Leiomyoma of uterus,RPA2,Replication protein A 32 kDa subunit,10039,145,1.21 [0.75-1.95],0.4444835463673494
Chapter II Neoplasms,Leiomyoma of uterus,RPE,Ribulose-phosphate 3-epimerase,10166,144,1.16 [0.93-1.43],0.1825318401160944
Chapter II Neoplasms,Leiomyoma of uterus,RPGR,X-linked retinitis pigmentosa GTPase regulator,10056,144,1.12 [0.79-1.57],0.5331640240031124
Chapter II Neoplasms,Leiomyoma of uterus,RPL14,60S ribosomal protein L14,10091,145,1.25 [0.88-1.79],0.2157538682523215
Chapter II Neoplasms,Leiomyoma of uterus,RPS10,40S ribosomal protein S10,10002,147,0.94 [0.63-1.40],0.7627714923114715
Chapter II Neoplasms,Leiomyoma of uterus,RRAS,Ras-related protein R-Ras,10056,144,1.01 [0.89-1.14],0.8807512439401055
Chapter II Neoplasms,Leiomyoma of uterus,RRM2,Ribonucleoside-diphosphate reductase subunit M2,11526,160,1.19 [0.97-1.45],0.0872062824299718
Chapter II Neoplasms,Leiomyoma of uterus,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,11526,160,1.01 [0.82-1.25],0.9239689992532656
Chapter II Neoplasms,Leiomyoma of uterus,RRP15,RRP15-like protein,9978,146,1.00 [0.85-1.19],0.9677634105981484
Chapter II Neoplasms,Leiomyoma of uterus,RSPO1,R-spondin-1,11718,168,1.24 [0.83-1.84],0.2941119606529705
Chapter II Neoplasms,Leiomyoma of uterus,RSPO3,R-spondin-3,11889,169,1.29 [0.81-2.05],0.292080474768889
Chapter II Neoplasms,Leiomyoma of uterus,RTBDN,Retbindin,11744,167,1.11 [0.69-1.78],0.664299368515934
Chapter II Neoplasms,Leiomyoma of uterus,RTKN2,Rhotekin-2,10002,147,1.01 [0.74-1.37],0.9617387021321292
Chapter II Neoplasms,Leiomyoma of uterus,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",10311,147,0.97 [0.82-1.15],0.733564012999413
Chapter II Neoplasms,Leiomyoma of uterus,RTN4R,Reticulon-4 receptor,11889,169,1.18 [0.80-1.73],0.4067116485392464
Chapter II Neoplasms,Leiomyoma of uterus,RUVBL1,RuvB-like 1,11526,160,1.05 [0.93-1.19],0.3937930948311875
Chapter II Neoplasms,Leiomyoma of uterus,RWDD1,RWD domain-containing protein 1,11892,170,1.00 [0.81-1.24],0.9907390144641542
Chapter II Neoplasms,Leiomyoma of uterus,RYR1,Ryanodine receptor 1,10002,147,1.28 [0.89-1.85],0.1804667462315534
Chapter II Neoplasms,Leiomyoma of uterus,S100A11,Protein S100-A11,11712,167,0.94 [0.70-1.27],0.7065822682783907
Chapter II Neoplasms,Leiomyoma of uterus,S100A12,Protein S100-A12,11629,166,0.93 [0.78-1.12],0.467859445350712
Chapter II Neoplasms,Leiomyoma of uterus,S100A13,Protein S100-A13,10039,145,1.08 [0.69-1.67],0.7440386239240608
Chapter II Neoplasms,Leiomyoma of uterus,S100A14,Protein S100-A14,10311,147,0.85 [0.64-1.14],0.2812718138234705
Chapter II Neoplasms,Leiomyoma of uterus,S100A16,Protein S100-A16,11496,163,0.95 [0.75-1.20],0.6720968136250245
Chapter II Neoplasms,Leiomyoma of uterus,S100A3,Protein S100-A3,10278,147,1.20 [0.92-1.56],0.1699729477363294
Chapter II Neoplasms,Leiomyoma of uterus,S100A4,Protein S100-A4,11855,167,1.01 [0.79-1.29],0.9230719984853392
Chapter II Neoplasms,Leiomyoma of uterus,S100G,Protein S100-G,10311,147,1.76 [1.29-2.41],0.0004185821865628
Chapter II Neoplasms,Leiomyoma of uterus,S100P,Protein S100-P,11560,165,0.96 [0.75-1.23],0.7481805665167683
Chapter II Neoplasms,Leiomyoma of uterus,SAA4,Serum amyloid A-4 protein,10353,149,1.17 [0.76-1.78],0.4782553094113901
Chapter II Neoplasms,Leiomyoma of uterus,SAFB2,Scaffold attachment factor B2,10311,147,1.10 [0.64-1.87],0.7351781573492111
Chapter II Neoplasms,Leiomyoma of uterus,SAG,S-arrestin,9978,146,1.34 [1.06-1.68],0.0127003230769007
Chapter II Neoplasms,Leiomyoma of uterus,SAMD9L,Sterile alpha motif domain-containing protein 9-like,11777,170,1.02 [0.85-1.23],0.8200237550838585
Chapter II Neoplasms,Leiomyoma of uterus,SAP18,Histone deacetylase complex subunit SAP18,10166,144,0.91 [0.72-1.15],0.4341444174425031
Chapter II Neoplasms,Leiomyoma of uterus,SARG,Specifically androgen-regulated gene protein,10285,150,1.07 [0.92-1.24],0.3755866089450361
Chapter II Neoplasms,Leiomyoma of uterus,SART1,U4/U6.U5 tri-snRNP-associated protein 1,10002,147,1.21 [0.85-1.72],0.299234733012693
Chapter II Neoplasms,Leiomyoma of uterus,SAT1,Diamine acetyltransferase 1,10002,147,1.11 [0.84-1.47],0.4445190045702651
Chapter II Neoplasms,Leiomyoma of uterus,SAT2,Thialysine N-epsilon-acetyltransferase,10166,144,1.07 [0.85-1.34],0.5834026600202404
Chapter II Neoplasms,Leiomyoma of uterus,SATB1,DNA-binding protein SATB1,10311,147,1.12 [0.68-1.86],0.647720686786261
Chapter II Neoplasms,Leiomyoma of uterus,SBSN,Suprabasin,10328,149,1.04 [0.66-1.64],0.8733908035776673
Chapter II Neoplasms,Leiomyoma of uterus,SCAMP3,Secretory carrier-associated membrane protein 3,11744,167,0.95 [0.80-1.11],0.5051199639513522
Chapter II Neoplasms,Leiomyoma of uterus,SCARA5,Scavenger receptor class A member 5,11892,170,0.97 [0.61-1.55],0.905090640232228
Chapter II Neoplasms,Leiomyoma of uterus,SCARB1,Scavenger receptor class B member 1,11512,163,1.15 [0.95-1.41],0.1545361599093575
Chapter II Neoplasms,Leiomyoma of uterus,SCARB2,Lysosome membrane protein 2,11507,166,1.24 [0.81-1.89],0.3226158020877667
Chapter II Neoplasms,Leiomyoma of uterus,SCARF1,Scavenger receptor class F member 1,11938,171,0.86 [0.62-1.19],0.3687647779433782
Chapter II Neoplasms,Leiomyoma of uterus,SCARF2,Scavenger receptor class F member 2,11892,170,0.85 [0.54-1.32],0.4636591645167305
Chapter II Neoplasms,Leiomyoma of uterus,SCG2,Secretogranin-2,11825,169,1.25 [0.82-1.89],0.2994255411715952
Chapter II Neoplasms,Leiomyoma of uterus,SCG3,Secretogranin-3,11817,169,0.96 [0.65-1.43],0.8390994520609555
Chapter II Neoplasms,Leiomyoma of uterus,SCGB1A1,Uteroglobin,11805,168,1.28 [0.99-1.65],0.0596397630456587
Chapter II Neoplasms,Leiomyoma of uterus,SCGB2A2,Mammaglobin-A,10002,147,1.49 [1.02-2.17],0.040832157547116
Chapter II Neoplasms,Leiomyoma of uterus,SCGB3A1,Secretoglobin family 3A member 1,10128,146,0.88 [0.47-1.63],0.6744772758867514
Chapter II Neoplasms,Leiomyoma of uterus,SCGB3A2,Secretoglobin family 3A member 2,11831,169,0.90 [0.77-1.06],0.22129675572651
Chapter II Neoplasms,Leiomyoma of uterus,SCGN,Secretagogin,11555,165,1.10 [0.81-1.49],0.544616123026709
Chapter II Neoplasms,Leiomyoma of uterus,SCIN,Adseverin,9978,146,0.88 [0.70-1.12],0.303055513838966
Chapter II Neoplasms,Leiomyoma of uterus,SCLY,Selenocysteine lyase,11847,169,0.98 [0.73-1.32],0.9117162625437024
Chapter II Neoplasms,Leiomyoma of uterus,SCN2A,Sodium channel protein type 2 subunit alpha,9978,146,1.16 [0.86-1.56],0.3308424228221482
Chapter II Neoplasms,Leiomyoma of uterus,SCN2B,Sodium channel subunit beta-2,10056,144,0.95 [0.55-1.64],0.8624675655662147
Chapter II Neoplasms,Leiomyoma of uterus,SCN3A,Sodium channel protein type 3 subunit alpha,10056,144,0.92 [0.58-1.46],0.7380970016645154
Chapter II Neoplasms,Leiomyoma of uterus,SCN3B,Sodium channel subunit beta-3,9978,146,1.21 [0.91-1.61],0.1949096522964795
Chapter II Neoplasms,Leiomyoma of uterus,SCN4B,Sodium channel subunit beta-4,10091,145,1.02 [0.70-1.48],0.9158929278545072
Chapter II Neoplasms,Leiomyoma of uterus,SCP2,Non-specific lipid-transfer protein,11526,160,0.95 [0.78-1.16],0.6122206299736115
Chapter II Neoplasms,Leiomyoma of uterus,SCPEP1,Retinoid-inducible serine carboxypeptidase,10045,143,1.04 [0.75-1.45],0.8177098353331137
Chapter II Neoplasms,Leiomyoma of uterus,SCRG1,Scrapie-responsive protein 1,10334,150,1.35 [0.77-2.34],0.291599375579966
Chapter II Neoplasms,Leiomyoma of uterus,SCRIB,Protein scribble homolog,10091,145,1.13 [0.96-1.32],0.1382178720528501
Chapter II Neoplasms,Leiomyoma of uterus,SCRN1,Secernin-1,11777,170,0.93 [0.72-1.19],0.5519906002847672
Chapter II Neoplasms,Leiomyoma of uterus,SCT,Secretin,10056,144,0.96 [0.68-1.35],0.7929874670266247
Chapter II Neoplasms,Leiomyoma of uterus,SDC1,Syndecan-1,11802,169,1.08 [0.76-1.54],0.6608299588636282
Chapter II Neoplasms,Leiomyoma of uterus,SDC4,Syndecan-4,11802,169,0.94 [0.70-1.26],0.6701182108294566
Chapter II Neoplasms,Leiomyoma of uterus,SDCCAG8,Serologically defined colon cancer antigen 8,10278,147,1.01 [0.88-1.16],0.9222741830537644
Chapter II Neoplasms,Leiomyoma of uterus,SDHB,Succinate dehydrogenase,10273,150,1.04 [0.83-1.30],0.7255926776772615
Chapter II Neoplasms,Leiomyoma of uterus,SDK2,Protein sidekick-2,10128,146,1.13 [0.76-1.69],0.5408340805979945
Chapter II Neoplasms,Leiomyoma of uterus,SEC31A,Protein transport protein Sec31A,10091,145,1.02 [0.83-1.27],0.8296402743623723
Chapter II Neoplasms,Leiomyoma of uterus,SEL1L,Protein sel-1 homolog 1,10091,145,0.96 [0.59-1.57],0.8787234293688934
Chapter II Neoplasms,Leiomyoma of uterus,SELE,E-selectin,11938,171,0.86 [0.66-1.12],0.2746479062374671
Chapter II Neoplasms,Leiomyoma of uterus,SELENOP,Selenoprotein P,10353,149,1.56 [0.83-2.93],0.1701849587770476
Chapter II Neoplasms,Leiomyoma of uterus,SELL,L-selectin,10353,149,1.17 [0.60-2.30],0.6443015905626721
Chapter II Neoplasms,Leiomyoma of uterus,SELP,P-selectin,11855,169,0.89 [0.70-1.13],0.3235065967743535
Chapter II Neoplasms,Leiomyoma of uterus,SELPLG,P-selectin glycoprotein ligand 1,11777,170,0.98 [0.60-1.60],0.9238872390011944
Chapter II Neoplasms,Leiomyoma of uterus,SEMA3F,Semaphorin-3F,11802,169,1.00 [0.59-1.68],0.9957309834327114
Chapter II Neoplasms,Leiomyoma of uterus,SEMA3G,Semaphorin-3G,10128,146,1.15 [0.80-1.65],0.4598642926553991
Chapter II Neoplasms,Leiomyoma of uterus,SEMA4C,Semaphorin-4C,11744,167,1.16 [0.72-1.87],0.5337861517626119
Chapter II Neoplasms,Leiomyoma of uterus,SEMA4D,Semaphorin-4D,11892,170,0.73 [0.46-1.14],0.1667977459282493
Chapter II Neoplasms,Leiomyoma of uterus,SEMA6C,Semaphorin-6C,10039,145,1.22 [0.69-2.18],0.496658516705673
Chapter II Neoplasms,Leiomyoma of uterus,SEMA7A,Semaphorin-7A,11905,170,1.38 [0.87-2.18],0.1700857527171553
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN3,Neuronal-specific septin-3,10311,147,1.08 [0.88-1.33],0.4503709823467017
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN7,Septin-7,10166,144,1.03 [0.77-1.36],0.8555574212875949
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN8,Septin-8,10304,147,1.17 [0.73-1.90],0.5111086737031285
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN9,Septin-9,11744,167,1.35 [0.89-2.07],0.160592058459685
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA1,Alpha-1-antitrypsin,10147,145,0.71 [0.09-5.34],0.7371284085956002
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA11,Serpin A11,11938,171,1.13 [0.81-1.58],0.4823039589525082
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA12,Serpin A12,11432,164,1.01 [0.89-1.15],0.8287008590304787
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA3,Alpha-1-antichymotrypsin,10300,149,0.57 [0.19-1.71],0.3163843507210666
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA4,Kallistatin,10158,147,1.63 [0.84-3.15],0.1476521073650292
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA5,Plasma serine protease inhibitor,10199,147,1.19 [0.76-1.88],0.4419095917994051
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA6,Corticosteroid-binding globulin,10353,149,1.00 [0.37-2.68],0.9985791279226924
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA7,Thyroxine-binding globulin,10353,149,1.02 [0.44-2.38],0.9554739830937172
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA9,Serpin A9,11684,167,1.02 [0.85-1.24],0.8043092183416796
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB1,Leukocyte elastase inhibitor,11767,165,0.97 [0.83-1.13],0.6743758544403119
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB5,Serpin B5,11560,165,1.14 [0.86-1.51],0.3703784252604455
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB6,Serpin B6,11856,170,1.01 [0.80-1.27],0.9347523774566644
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB8,Serpin B8,11910,170,0.96 [0.76-1.22],0.7637461979559997
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB9,Serpin B9,11718,168,1.09 [0.72-1.65],0.6907610393647111
Chapter II Neoplasms,Leiomyoma of uterus,SERPINC1,Antithrombin-III,10332,149,0.57 [0.20-1.64],0.2974932844234359
Chapter II Neoplasms,Leiomyoma of uterus,SERPIND1,Heparin cofactor 2,10332,149,0.93 [0.52-1.67],0.8086234570634205
Chapter II Neoplasms,Leiomyoma of uterus,SERPINE1,Plasminogen activator inhibitor 1,11938,171,0.88 [0.73-1.08],0.2269675296311517
Chapter II Neoplasms,Leiomyoma of uterus,SERPINE2,Glia-derived nexin,10334,150,0.98 [0.77-1.25],0.8945429047667416
Chapter II Neoplasms,Leiomyoma of uterus,SERPINF1,Pigment epithelium-derived factor,10197,147,1.41 [0.79-2.53],0.2436680738740467
Chapter II Neoplasms,Leiomyoma of uterus,SERPINF2,Alpha-2-antiplasmin,10159,147,0.42 [0.13-1.32],0.1369423373420806
Chapter II Neoplasms,Leiomyoma of uterus,SERPING1,Plasma protease C1 inhibitor,10332,149,0.84 [0.35-2.00],0.6915733733989528
Chapter II Neoplasms,Leiomyoma of uterus,SERPINH1,Serpin H1,10166,144,1.09 [0.97-1.24],0.1532157667507546
Chapter II Neoplasms,Leiomyoma of uterus,SERPINI1,Neuroserpin,10112,145,0.67 [0.39-1.15],0.1489267409535491
Chapter II Neoplasms,Leiomyoma of uterus,SERPINI2,Serpin I2,10273,150,1.28 [0.98-1.67],0.0693551548969087
Chapter II Neoplasms,Leiomyoma of uterus,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,11512,163,1.04 [0.84-1.29],0.6992266152248439
Chapter II Neoplasms,Leiomyoma of uterus,SETMAR,Histone-lysine N-methyltransferase SETMAR,11682,167,0.84 [0.52-1.34],0.4623881560146935
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6,Seizure protein 6 homolog,10056,144,0.80 [0.47-1.36],0.4140351230804261
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6L,Seizure 6-like protein,11855,167,0.82 [0.49-1.35],0.4257068290767941
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6L2,Seizure 6-like protein 2,11744,167,0.85 [0.46-1.56],0.5939494936810277
Chapter II Neoplasms,Leiomyoma of uterus,SF3B4,Splicing factor 3B subunit 4,11744,167,1.00 [0.83-1.20],0.99843300154438
Chapter II Neoplasms,Leiomyoma of uterus,SFRP1,Secreted frizzled-related protein 1,11693,167,1.00 [0.73-1.37],0.9903096026546604
Chapter II Neoplasms,Leiomyoma of uterus,SFRP4,Secreted frizzled-related protein 4,10128,146,1.28 [0.85-1.91],0.2316383513946485
Chapter II Neoplasms,Leiomyoma of uterus,SFTPA1,Pulmonary surfactant-associated protein A1,11526,160,1.02 [0.81-1.30],0.8593519280795117
Chapter II Neoplasms,Leiomyoma of uterus,SFTPA2,Pulmonary surfactant-associated protein A2,11526,160,0.76 [0.56-1.02],0.0711499624631039
Chapter II Neoplasms,Leiomyoma of uterus,SFTPD,Pulmonary surfactant-associated protein D,11802,169,1.07 [0.87-1.31],0.5374059563995133
Chapter II Neoplasms,Leiomyoma of uterus,SGSH,N-sulphoglucosamine sulphohydrolase,10132,146,1.11 [0.85-1.45],0.4383390542329826
Chapter II Neoplasms,Leiomyoma of uterus,SH2B3,SH2B adapter protein 3,11526,160,1.01 [0.87-1.17],0.8987223490462163
Chapter II Neoplasms,Leiomyoma of uterus,SH2D1A,SH2 domain-containing protein 1A,11777,170,1.10 [0.88-1.38],0.4194014361351774
Chapter II Neoplasms,Leiomyoma of uterus,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,9978,146,1.08 [0.85-1.38],0.5301574643589106
Chapter II Neoplasms,Leiomyoma of uterus,SH3BP1,SH3 domain-binding protein 1,10273,150,1.26 [0.95-1.67],0.1082250661792508
Chapter II Neoplasms,Leiomyoma of uterus,SH3GL3,Endophilin-A3,10114,144,1.02 [0.84-1.24],0.8447313189330865
Chapter II Neoplasms,Leiomyoma of uterus,SH3GLB2,Endophilin-B2,10317,147,1.13 [0.90-1.43],0.3007546806768972
Chapter II Neoplasms,Leiomyoma of uterus,SHBG,Sex hormone-binding globulin,10335,147,0.89 [0.67-1.19],0.4376587204549641
Chapter II Neoplasms,Leiomyoma of uterus,SHC1,SHC-transforming protein 1,9961,142,1.13 [1.00-1.27],0.059383174143816
Chapter II Neoplasms,Leiomyoma of uterus,SHD,SH2 domain-containing adapter protein D,9975,147,1.04 [0.87-1.23],0.6846417568045814
Chapter II Neoplasms,Leiomyoma of uterus,SHH,Sonic hedgehog protein,10039,145,0.85 [0.58-1.25],0.4160403783306776
Chapter II Neoplasms,Leiomyoma of uterus,SHISA5,Protein shisa-5,10347,149,1.46 [0.88-2.42],0.1445236741364209
Chapter II Neoplasms,Leiomyoma of uterus,SHMT1,"Serine hydroxymethyltransferase, cytosolic",11831,169,1.08 [0.92-1.26],0.3481465887180052
Chapter II Neoplasms,Leiomyoma of uterus,SHPK,Sedoheptulokinase,10166,144,1.06 [0.73-1.53],0.755296623410225
Chapter II Neoplasms,Leiomyoma of uterus,SIAE,Sialate O-acetylesterase,11836,167,0.87 [0.65-1.18],0.3785482079445669
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC1,Sialoadhesin,11854,170,1.05 [0.77-1.43],0.7689030040142911
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC10,Sialic acid-binding Ig-like lectin 10,11777,170,1.06 [0.71-1.58],0.7669994853806281
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC15,Sialic acid-binding Ig-like lectin 15,11512,163,1.02 [0.86-1.21],0.7804764172328046
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC5,Sialic acid-binding Ig-like lectin 5,11808,165,0.99 [0.88-1.11],0.8311492460139022
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC6,Sialic acid-binding Ig-like lectin 6,11889,169,1.10 [0.73-1.64],0.6498658409977942
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC7,Sialic acid-binding Ig-like lectin 7,11802,169,0.95 [0.57-1.57],0.8319869654474793
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC8,Sialic acid-binding Ig-like lectin 8,10091,145,1.18 [0.82-1.68],0.3775442395313156
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC9,Sialic acid-binding Ig-like lectin 9,11869,169,0.84 [0.53-1.33],0.4496581445038321
Chapter II Neoplasms,Leiomyoma of uterus,SIL1,Nucleotide exchange factor SIL1,10091,145,0.86 [0.50-1.51],0.608864575598025
Chapter II Neoplasms,Leiomyoma of uterus,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,11836,169,0.97 [0.76-1.22],0.7759518819289837
Chapter II Neoplasms,Leiomyoma of uterus,SIRPB1,Signal-regulatory protein beta-1,11786,169,0.98 [0.73-1.32],0.9091191478411492
Chapter II Neoplasms,Leiomyoma of uterus,SIRT1,NAD-dependent protein deacetylase sirtuin-1,10039,145,1.14 [0.97-1.34],0.1072753974686493
Chapter II Neoplasms,Leiomyoma of uterus,SIRT2,NAD-dependent protein deacetylase sirtuin-2,11744,167,1.02 [0.88-1.20],0.769871163317612
Chapter II Neoplasms,Leiomyoma of uterus,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",11512,163,1.10 [0.87-1.39],0.4331390401470952
Chapter II Neoplasms,Leiomyoma of uterus,SIT1,Signaling threshold-regulating transmembrane adapter 1,11555,165,0.96 [0.75-1.24],0.774366057767887
Chapter II Neoplasms,Leiomyoma of uterus,SKAP1,Src kinase-associated phosphoprotein 1,11699,167,1.05 [0.87-1.26],0.6395335987067106
Chapter II Neoplasms,Leiomyoma of uterus,SKAP2,Src kinase-associated phosphoprotein 2,11854,170,0.94 [0.82-1.06],0.3115309239563291
Chapter II Neoplasms,Leiomyoma of uterus,SKIV2L,Helicase SKI2W,10002,147,1.33 [0.96-1.83],0.0878322591324444
Chapter II Neoplasms,Leiomyoma of uterus,SLA2,Src-like-adapter 2,10311,147,1.03 [0.89-1.21],0.6698489337442288
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF1,Signaling lymphocytic activation molecule,11555,165,0.82 [0.66-1.01],0.0662565496448368
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF6,SLAM family member 6,11526,160,0.80 [0.55-1.18],0.2638754662470842
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF7,SLAM family member 7,11777,170,0.84 [0.67-1.07],0.1553926375222543
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF8,SLAM family member 8,11526,160,0.96 [0.74-1.24],0.7332406586224185
Chapter II Neoplasms,Leiomyoma of uterus,SLC12A2,Solute carrier family 12 member 2,10002,147,1.22 [0.76-1.94],0.4056406848801913
Chapter II Neoplasms,Leiomyoma of uterus,SLC13A1,Solute carrier family 13 member 1,10278,147,1.19 [0.97-1.45],0.0915405807176134
Chapter II Neoplasms,Leiomyoma of uterus,SLC16A1,Monocarboxylate transporter 1,11512,163,0.89 [0.69-1.15],0.3781041328158496
Chapter II Neoplasms,Leiomyoma of uterus,SLC1A4,Neutral amino acid transporter A,10056,144,1.01 [0.74-1.38],0.953823787425048
Chapter II Neoplasms,Leiomyoma of uterus,SLC27A4,Long-chain fatty acid transport protein 4,11512,163,1.03 [0.83-1.27],0.7974598538410266
Chapter II Neoplasms,Leiomyoma of uterus,SLC28A1,Sodium/nucleoside cotransporter 1,9961,142,1.26 [1.02-1.55],0.0305401636082027
Chapter II Neoplasms,Leiomyoma of uterus,SLC34A3,Sodium-dependent phosphate transport protein 2C,9961,142,1.14 [0.87-1.51],0.3471316666800348
Chapter II Neoplasms,Leiomyoma of uterus,SLC39A14,Zinc transporter ZIP14,11512,163,0.99 [0.65-1.50],0.960982219185143
Chapter II Neoplasms,Leiomyoma of uterus,SLC39A5,Zinc transporter ZIP5,11777,170,1.28 [1.08-1.53],0.0045841543589069
Chapter II Neoplasms,Leiomyoma of uterus,SLC44A4,Choline transporter-like protein 4,10056,144,1.06 [0.86-1.30],0.6083518754802608
Chapter II Neoplasms,Leiomyoma of uterus,SLC4A1,Band 3 anion transport protein,10347,149,0.98 [0.71-1.37],0.9284642323003118
Chapter II Neoplasms,Leiomyoma of uterus,SLC51B,Organic solute transporter subunit beta,10002,147,1.02 [0.84-1.24],0.8402302674667338
Chapter II Neoplasms,Leiomyoma of uterus,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,10128,146,1.02 [0.85-1.24],0.8020287727579666
Chapter II Neoplasms,Leiomyoma of uterus,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,10273,150,1.25 [1.00-1.57],0.0528717573925572
Chapter II Neoplasms,Leiomyoma of uterus,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",9961,142,1.12 [0.86-1.45],0.4066569959520985
Chapter II Neoplasms,Leiomyoma of uterus,SLIT2,Slit homolog 2 protein,11512,163,1.17 [0.92-1.50],0.2038678602708035
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK1,SLIT and NTRK-like protein 1,10039,145,0.84 [0.51-1.40],0.5092646496931942
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK2,SLIT and NTRK-like protein 2,11889,169,1.13 [0.79-1.61],0.5083593566602327
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK6,SLIT and NTRK-like protein 6,11560,165,1.12 [0.75-1.67],0.5912101826061731
Chapter II Neoplasms,Leiomyoma of uterus,SLK,STE20-like serine/threonine-protein kinase,10166,144,1.09 [0.91-1.29],0.3549233177003534
Chapter II Neoplasms,Leiomyoma of uterus,SLMAP,Sarcolemmal membrane-associated protein,10273,150,1.00 [0.83-1.20],0.97654597113493
Chapter II Neoplasms,Leiomyoma of uterus,SLURP1,Secreted Ly-6/uPAR-related protein 1,10269,148,1.21 [0.84-1.72],0.3039298399267743
Chapter II Neoplasms,Leiomyoma of uterus,SMAD1,Mothers against decapentaplegic homolog 1,11526,160,1.11 [0.94-1.32],0.2185119628137432
Chapter II Neoplasms,Leiomyoma of uterus,SMAD2,Mothers against decapentaplegic homolog 2,10278,147,1.13 [0.90-1.41],0.3047495002148223
Chapter II Neoplasms,Leiomyoma of uterus,SMAD3,Mothers against decapentaplegic homolog 3,10278,147,1.06 [0.78-1.44],0.7007878019007616
Chapter II Neoplasms,Leiomyoma of uterus,SMAD5,Mothers against decapentaplegic homolog 5,11744,167,0.68 [0.35-1.32],0.2534937300828158
Chapter II Neoplasms,Leiomyoma of uterus,SMARCA2,Probable global transcription activator SNF2L2,11512,163,0.85 [0.69-1.05],0.1246607318689464
Chapter II Neoplasms,Leiomyoma of uterus,SMC3,Structural maintenance of chromosomes protein 3,9961,142,1.33 [1.08-1.63],0.0071163446125358
Chapter II Neoplasms,Leiomyoma of uterus,SMNDC1,Survival of motor neuron-related-splicing factor 30,10273,150,1.13 [0.89-1.43],0.3199630452155918
Chapter II Neoplasms,Leiomyoma of uterus,SMOC1,SPARC-related modular calcium-binding protein 1,11889,169,1.03 [0.68-1.55],0.8906853132080715
Chapter II Neoplasms,Leiomyoma of uterus,SMOC2,SPARC-related modular calcium-binding protein 2,11854,170,1.27 [0.89-1.81],0.1876420267052966
Chapter II Neoplasms,Leiomyoma of uterus,SMPD1,Sphingomyelin phosphodiesterase,11837,169,0.87 [0.65-1.17],0.3654481479446246
Chapter II Neoplasms,Leiomyoma of uterus,SMPD3,Sphingomyelin phosphodiesterase 3,10039,145,1.23 [0.98-1.55],0.0802932296493128
Chapter II Neoplasms,Leiomyoma of uterus,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,11843,170,0.97 [0.78-1.20],0.764188851383464
Chapter II Neoplasms,Leiomyoma of uterus,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,10278,147,0.93 [0.75-1.17],0.549037063737706
Chapter II Neoplasms,Leiomyoma of uterus,SMS,Spermine synthase,9978,146,1.10 [0.88-1.38],0.4098372304588977
Chapter II Neoplasms,Leiomyoma of uterus,SMTN,Smoothelin,10305,147,0.97 [0.82-1.14],0.6789385318967622
Chapter II Neoplasms,Leiomyoma of uterus,SNAP23,Synaptosomal-associated protein 23,11802,169,0.94 [0.80-1.09],0.4002447077179711
Chapter II Neoplasms,Leiomyoma of uterus,SNAP25,Synaptosomal-associated protein 25,9978,146,0.87 [0.61-1.23],0.4201923973030164
Chapter II Neoplasms,Leiomyoma of uterus,SNAP29,Synaptosomal-associated protein 29,11855,167,0.98 [0.85-1.15],0.840144561152684
Chapter II Neoplasms,Leiomyoma of uterus,SNAPIN,SNARE-associated protein Snapin,10311,147,1.04 [0.79-1.37],0.7816277483166915
Chapter II Neoplasms,Leiomyoma of uterus,SNCA,Alpha-synuclein,10128,146,1.02 [0.88-1.18],0.7843860365433077
Chapter II Neoplasms,Leiomyoma of uterus,SNCG,Gamma-synuclein,11718,168,0.99 [0.81-1.22],0.9577640126529756
Chapter II Neoplasms,Leiomyoma of uterus,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",10091,145,0.94 [0.58-1.52],0.8054509329695192
Chapter II Neoplasms,Leiomyoma of uterus,SNRPB2,U2 small nuclear ribonucleoprotein B'',10317,147,1.20 [0.90-1.59],0.2170142697918994
Chapter II Neoplasms,Leiomyoma of uterus,SNU13,NHP2-like protein 1,10002,147,1.20 [0.98-1.46],0.0722242286091199
Chapter II Neoplasms,Leiomyoma of uterus,SNX15,Sorting nexin-15,10128,146,1.21 [0.91-1.61],0.1921130347101896
Chapter II Neoplasms,Leiomyoma of uterus,SNX18,Sorting nexin-18,10273,150,0.94 [0.65-1.35],0.725863180136618
Chapter II Neoplasms,Leiomyoma of uterus,SNX2,Sorting nexin-2,10278,147,1.13 [0.94-1.36],0.1793611904422915
Chapter II Neoplasms,Leiomyoma of uterus,SNX5,Sorting nexin-5,10091,145,1.51 [0.93-2.43],0.0943692961317292
Chapter II Neoplasms,Leiomyoma of uterus,SNX9,Sorting nexin-9,11802,169,0.98 [0.80-1.19],0.8096019189315768
Chapter II Neoplasms,Leiomyoma of uterus,SOD1,Superoxide dismutase [Cu-Zn],11583,166,1.08 [0.81-1.43],0.6088138581072875
Chapter II Neoplasms,Leiomyoma of uterus,SOD2,"Superoxide dismutase [Mn], mitochondrial",11808,165,1.03 [0.71-1.48],0.8831312246967237
Chapter II Neoplasms,Leiomyoma of uterus,SOD3,Extracellular superoxide dismutase,10335,147,1.04 [0.80-1.36],0.7480419108778762
Chapter II Neoplasms,Leiomyoma of uterus,SORBS1,Sorbin and SH3 domain-containing protein 1,10311,147,1.54 [1.21-1.95],0.0003573793626883
Chapter II Neoplasms,Leiomyoma of uterus,SORCS2,VPS10 domain-containing receptor SorCS2,11526,160,1.34 [0.92-1.96],0.1289723344354706
Chapter II Neoplasms,Leiomyoma of uterus,SORD,Sorbitol dehydrogenase,11834,169,0.96 [0.78-1.17],0.6663579040931519
Chapter II Neoplasms,Leiomyoma of uterus,SORT1,Sortilin,11779,169,0.82 [0.56-1.20],0.3094339848860471
Chapter II Neoplasms,Leiomyoma of uterus,SOST,Sclerostin,11779,169,0.79 [0.56-1.13],0.2035268387931155
Chapter II Neoplasms,Leiomyoma of uterus,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,10056,144,0.80 [0.55-1.15],0.2272260168218011
Chapter II Neoplasms,Leiomyoma of uterus,SOX2,Transcription factor SOX-2,10289,146,2.36 [1.29-4.29],0.0050655127830772
Chapter II Neoplasms,Leiomyoma of uterus,SOX9,Transcription factor SOX-9,10056,144,0.95 [0.52-1.71],0.8549786442155322
Chapter II Neoplasms,Leiomyoma of uterus,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,10311,147,1.32 [0.81-2.14],0.2669617878553162
Chapter II Neoplasms,Leiomyoma of uterus,SPAG1,Sperm-associated antigen 1,10311,147,1.20 [0.94-1.52],0.1375729098090422
Chapter II Neoplasms,Leiomyoma of uterus,SPARC,SPARC,11855,167,0.98 [0.81-1.19],0.8669709590146367
Chapter II Neoplasms,Leiomyoma of uterus,SPARCL1,SPARC-like protein 1,11815,169,0.98 [0.60-1.59],0.923803878241176
Chapter II Neoplasms,Leiomyoma of uterus,SPART,Spartin,10128,146,1.02 [0.83-1.26],0.8374976980275555
Chapter II Neoplasms,Leiomyoma of uterus,SPESP1,Sperm equatorial segment protein 1,10334,150,1.12 [0.66-1.91],0.6649117452358078
Chapter II Neoplasms,Leiomyoma of uterus,SPINK1,Serine protease inhibitor Kazal-type 1,11808,165,1.09 [0.80-1.49],0.5824354753789573
Chapter II Neoplasms,Leiomyoma of uterus,SPINK2,Serine protease inhibitor Kazal-type 2,10128,146,1.02 [0.67-1.53],0.937798865091495
Chapter II Neoplasms,Leiomyoma of uterus,SPINK4,Serine protease inhibitor Kazal-type 4,11777,170,1.19 [0.98-1.44],0.0717255085291749
Chapter II Neoplasms,Leiomyoma of uterus,SPINK5,Serine protease inhibitor Kazal-type 5,11808,165,1.28 [0.84-1.96],0.2578706176241944
Chapter II Neoplasms,Leiomyoma of uterus,SPINK6,Serine protease inhibitor Kazal-type 6,11889,169,1.11 [0.86-1.43],0.4293884504628739
Chapter II Neoplasms,Leiomyoma of uterus,SPINK8,Serine protease inhibitor Kazal-type 8,10002,147,1.44 [1.13-1.84],0.0037713936093468
Chapter II Neoplasms,Leiomyoma of uterus,SPINT1,Kunitz-type protease inhibitor 1,11779,164,0.97 [0.55-1.72],0.9196484967744916
Chapter II Neoplasms,Leiomyoma of uterus,SPINT2,Kunitz-type protease inhibitor 2,11854,170,1.00 [0.72-1.38],0.9922247861215444
Chapter II Neoplasms,Leiomyoma of uterus,SPINT3,Kunitz-type protease inhibitor 3,10273,150,1.07 [0.95-1.21],0.2753417112192799
Chapter II Neoplasms,Leiomyoma of uterus,SPOCK1,Testican-1,11718,168,0.54 [0.31-0.93],0.0276988373156407
Chapter II Neoplasms,Leiomyoma of uterus,SPON1,Spondin-1,11817,169,0.91 [0.60-1.40],0.6779135481076292
Chapter II Neoplasms,Leiomyoma of uterus,SPON2,Spondin-2,11744,169,1.09 [0.74-1.62],0.6559499963955848
Chapter II Neoplasms,Leiomyoma of uterus,SPP1,Osteopontin,11926,171,1.21 [0.91-1.60],0.1838484538098173
Chapter II Neoplasms,Leiomyoma of uterus,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",10039,145,1.35 [0.97-1.87],0.0759070906986705
Chapter II Neoplasms,Leiomyoma of uterus,SPRING1,SREBP regulating gene protein,9961,142,1.36 [1.12-1.65],0.0016443709311432
Chapter II Neoplasms,Leiomyoma of uterus,SPRR1B,Cornifin-B,10166,144,1.02 [0.84-1.24],0.8332231033850738
Chapter II Neoplasms,Leiomyoma of uterus,SPRR3,Small proline-rich protein 3,10317,147,1.25 [1.02-1.54],0.0332914039420424
Chapter II Neoplasms,Leiomyoma of uterus,SPRY2,Protein sprouty homolog 2,11555,165,0.96 [0.83-1.12],0.6376659497904569
Chapter II Neoplasms,Leiomyoma of uterus,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",9978,146,1.21 [0.78-1.87],0.3885423164876821
Chapter II Neoplasms,Leiomyoma of uterus,SPTLC1,Serine palmitoyltransferase 1,10317,147,1.03 [0.68-1.55],0.9056874244261424
Chapter II Neoplasms,Leiomyoma of uterus,SRC,Proto-oncogene tyrosine-protein kinase Src,11832,167,1.00 [0.89-1.12],0.948486429106049
Chapter II Neoplasms,Leiomyoma of uterus,SRP14,Signal recognition particle 14 kDa protein,11744,167,1.03 [0.82-1.29],0.7979915524433632
Chapter II Neoplasms,Leiomyoma of uterus,SRPK2,SRSF protein kinase 2,11777,170,0.98 [0.83-1.15],0.7715331387110579
Chapter II Neoplasms,Leiomyoma of uterus,SRPX,Sushi repeat-containing protein SRPX,10334,150,1.33 [0.83-2.14],0.2284785699825339
Chapter II Neoplasms,Leiomyoma of uterus,SSB,Lupus La protein,11512,163,1.05 [0.83-1.33],0.6750509332945855
Chapter II Neoplasms,Leiomyoma of uterus,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",10039,145,1.13 [0.75-1.72],0.552489444092706
Chapter II Neoplasms,Leiomyoma of uterus,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,11779,169,1.00 [0.87-1.13],0.947360837322509
Chapter II Neoplasms,Leiomyoma of uterus,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,11855,169,0.78 [0.56-1.09],0.1458089409375353
Chapter II Neoplasms,Leiomyoma of uterus,SSH3,Protein phosphatase Slingshot homolog 3,9961,142,1.14 [0.66-1.97],0.6329172981208466
Chapter II Neoplasms,Leiomyoma of uterus,SSNA1,Sjoegren syndrome nuclear autoantigen 1,10273,150,1.12 [0.83-1.50],0.4584787133176993
Chapter II Neoplasms,Leiomyoma of uterus,ST13,Hsc70-interacting protein,10128,146,1.01 [0.76-1.34],0.9285421533164008
Chapter II Neoplasms,Leiomyoma of uterus,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",11744,167,1.03 [0.73-1.44],0.8686278567064545
Chapter II Neoplasms,Leiomyoma of uterus,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",11938,171,0.65 [0.40-1.05],0.0802952143702099
Chapter II Neoplasms,Leiomyoma of uterus,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",10039,145,1.16 [0.85-1.58],0.344289631310099
Chapter II Neoplasms,Leiomyoma of uterus,STAB2,Stabilin-2,10347,149,0.88 [0.51-1.52],0.6525325466032239
Chapter II Neoplasms,Leiomyoma of uterus,STAM,Signal transducing adapter molecule 1,10278,147,1.06 [0.71-1.58],0.7809399731667647
Chapter II Neoplasms,Leiomyoma of uterus,STAMBP,STAM-binding protein,11699,167,1.02 [0.82-1.27],0.8427484956619603
Chapter II Neoplasms,Leiomyoma of uterus,STAT2,Signal transducer and activator of transcription 2,10039,145,1.08 [0.88-1.34],0.4587471852729347
Chapter II Neoplasms,Leiomyoma of uterus,STAT5B,Signal transducer and activator of transcription 5B,11744,167,1.01 [0.92-1.12],0.7966172724772771
Chapter II Neoplasms,Leiomyoma of uterus,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,9961,142,1.31 [1.08-1.59],0.0052790063676605
Chapter II Neoplasms,Leiomyoma of uterus,STC1,Stanniocalcin-1,11892,170,1.06 [0.77-1.46],0.7320798912011554
Chapter II Neoplasms,Leiomyoma of uterus,STC2,Stanniocalcin-2,11794,165,1.27 [0.73-2.22],0.3936045036543321
Chapter II Neoplasms,Leiomyoma of uterus,STEAP4,Metalloreductase STEAP4,9978,146,1.03 [0.84-1.26],0.7863217928735455
Chapter II Neoplasms,Leiomyoma of uterus,STIP1,Stress-induced-phosphoprotein 1,11793,165,0.98 [0.80-1.21],0.8789721032514349
Chapter II Neoplasms,Leiomyoma of uterus,STK11,Serine/threonine-protein kinase STK11,11560,165,1.00 [0.83-1.21],0.9964900235653266
Chapter II Neoplasms,Leiomyoma of uterus,STK24,Serine/threonine-protein kinase 24,11512,163,1.01 [0.80-1.26],0.9504050790589724
Chapter II Neoplasms,Leiomyoma of uterus,STK4,Serine/threonine-protein kinase 4,11802,169,0.97 [0.83-1.14],0.699639185432192
Chapter II Neoplasms,Leiomyoma of uterus,STOML2,"Stomatin-like protein 2, mitochondrial",9961,142,1.12 [0.96-1.32],0.158492103107769
Chapter II Neoplasms,Leiomyoma of uterus,STX16,Syntaxin-16,11526,160,1.00 [0.79-1.27],0.9966248931707306
Chapter II Neoplasms,Leiomyoma of uterus,STX1B,Syntaxin-1B,10056,144,1.02 [0.69-1.52],0.903987955884328
Chapter II Neoplasms,Leiomyoma of uterus,STX3,Syntaxin-3,10317,147,1.41 [1.03-1.93],0.0332282921209341
Chapter II Neoplasms,Leiomyoma of uterus,STX4,Syntaxin-4,11744,167,1.05 [0.85-1.31],0.6379632574230747
Chapter II Neoplasms,Leiomyoma of uterus,STX5,Syntaxin-5,10039,145,0.92 [0.61-1.38],0.6753935682541403
Chapter II Neoplasms,Leiomyoma of uterus,STX6,Syntaxin-6,11526,160,0.91 [0.73-1.14],0.4239292784080408
Chapter II Neoplasms,Leiomyoma of uterus,STX7,Syntaxin-7,10039,145,0.86 [0.62-1.19],0.3575222864349381
Chapter II Neoplasms,Leiomyoma of uterus,STX8,Syntaxin-8,11777,170,0.89 [0.67-1.19],0.4387760550939745
Chapter II Neoplasms,Leiomyoma of uterus,STXBP1,Syntaxin-binding protein 1,10311,147,1.09 [0.89-1.35],0.4000791823466261
Chapter II Neoplasms,Leiomyoma of uterus,STXBP3,Syntaxin-binding protein 3,11526,160,1.00 [0.73-1.38],0.9878899941017156
Chapter II Neoplasms,Leiomyoma of uterus,SUGP1,SURP and G-patch domain-containing protein 1,10273,150,0.98 [0.66-1.45],0.9154193936740896
Chapter II Neoplasms,Leiomyoma of uterus,SUGT1,Protein SGT1 homolog,11526,160,1.03 [0.86-1.23],0.7664209785658088
Chapter II Neoplasms,Leiomyoma of uterus,SULT1A1,Sulfotransferase 1A1,11892,170,0.96 [0.86-1.07],0.4500364122108862
Chapter II Neoplasms,Leiomyoma of uterus,SULT2A1,Bile salt sulfotransferase,11777,170,1.11 [0.88-1.41],0.3842614219162477
Chapter II Neoplasms,Leiomyoma of uterus,SUMF1,Formylglycine-generating enzyme,10039,145,0.78 [0.57-1.09],0.1434571118963046
Chapter II Neoplasms,Leiomyoma of uterus,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,11892,170,0.92 [0.71-1.19],0.516034397280585
Chapter II Neoplasms,Leiomyoma of uterus,SUOX,"Sulfite oxidase, mitochondrial",10311,147,1.39 [1.12-1.73],0.0026410447048524
Chapter II Neoplasms,Leiomyoma of uterus,SUSD1,Sushi domain-containing protein 1,11560,165,0.71 [0.54-0.94],0.017974636850044
Chapter II Neoplasms,Leiomyoma of uterus,SUSD2,Sushi domain-containing protein 2,11808,165,1.24 [0.79-1.95],0.3532393913116012
Chapter II Neoplasms,Leiomyoma of uterus,SUSD4,Sushi domain-containing protein 4,10278,147,1.10 [0.77-1.56],0.5914278157924835
Chapter II Neoplasms,Leiomyoma of uterus,SUSD5,Sushi domain-containing protein 5,10063,146,0.93 [0.59-1.48],0.7665935336659495
Chapter II Neoplasms,Leiomyoma of uterus,SV2A,Synaptic vesicle glycoprotein 2A,10056,144,1.10 [0.86-1.41],0.4303754309224065
Chapter II Neoplasms,Leiomyoma of uterus,SWAP70,Switch-associated protein 70,10273,150,0.91 [0.57-1.45],0.678001027052446
Chapter II Neoplasms,Leiomyoma of uterus,SYAP1,Synapse-associated protein 1,10128,146,0.93 [0.70-1.24],0.6174091976387596
Chapter II Neoplasms,Leiomyoma of uterus,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,9978,146,0.98 [0.74-1.29],0.8630483973518198
Chapter II Neoplasms,Leiomyoma of uterus,SYT1,Synaptotagmin-1,10317,147,0.97 [0.65-1.46],0.8938082033965911
Chapter II Neoplasms,Leiomyoma of uterus,SYTL4,Synaptotagmin-like protein 4,10334,150,0.92 [0.74-1.14],0.4327116536006562
Chapter II Neoplasms,Leiomyoma of uterus,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,10166,144,1.01 [0.87-1.18],0.9016546336599756
Chapter II Neoplasms,Leiomyoma of uterus,TACC3,Transforming acidic coiled-coil-containing protein 3,11744,167,0.99 [0.88-1.11],0.8539872410933347
Chapter II Neoplasms,Leiomyoma of uterus,TACSTD2,Tumor-associated calcium signal transducer 2,10451,142,0.82 [0.49-1.38],0.4541213796482815
Chapter II Neoplasms,Leiomyoma of uterus,TADA3,Transcriptional adapter 3,10278,147,1.20 [0.80-1.79],0.3716214951725576
Chapter II Neoplasms,Leiomyoma of uterus,TAFA5,Chemokine-like protein TAFA-5,11744,167,1.50 [1.04-2.15],0.0287380079822762
Chapter II Neoplasms,Leiomyoma of uterus,TAGLN3,Transgelin-3,9961,142,1.06 [0.82-1.36],0.6708787209494097
Chapter II Neoplasms,Leiomyoma of uterus,TALDO1,Transaldolase,10295,148,1.04 [0.73-1.48],0.836663243206733
Chapter II Neoplasms,Leiomyoma of uterus,TANK,TRAF family member-associated NF-kappa-B activator,11555,165,1.03 [0.84-1.26],0.7940872670860959
Chapter II Neoplasms,Leiomyoma of uterus,TAP1,Antigen peptide transporter 1,10166,144,0.98 [0.75-1.28],0.8662471880042256
Chapter II Neoplasms,Leiomyoma of uterus,TARBP2,RISC-loading complex subunit TARBP2,11512,163,1.01 [0.84-1.20],0.9554936212327308
Chapter II Neoplasms,Leiomyoma of uterus,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",10056,144,0.90 [0.72-1.13],0.3718234098426511
Chapter II Neoplasms,Leiomyoma of uterus,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",10278,147,1.17 [0.79-1.73],0.4447686711450719
Chapter II Neoplasms,Leiomyoma of uterus,TAX1BP1,Tax1-binding protein 1,10317,147,0.92 [0.72-1.18],0.5137000396492949
Chapter II Neoplasms,Leiomyoma of uterus,TBC1D17,TBC1 domain family member 17,11512,163,1.03 [0.77-1.38],0.857302463264562
Chapter II Neoplasms,Leiomyoma of uterus,TBC1D23,TBC1 domain family member 23,11744,167,0.96 [0.82-1.12],0.5701286649226449
Chapter II Neoplasms,Leiomyoma of uterus,TBC1D5,TBC1 domain family member 5,11777,170,0.90 [0.75-1.07],0.2372767385433995
Chapter II Neoplasms,Leiomyoma of uterus,TBCA,Tubulin-specific chaperone A,10128,146,0.99 [0.82-1.19],0.90289628176532
Chapter II Neoplasms,Leiomyoma of uterus,TBCB,Tubulin-folding cofactor B,11718,168,1.02 [0.89-1.17],0.793851070251027
Chapter II Neoplasms,Leiomyoma of uterus,TBCC,Tubulin-specific chaperone C,11718,168,1.03 [0.87-1.23],0.6970981573743512
Chapter II Neoplasms,Leiomyoma of uterus,TBL1X,F-box-like/WD repeat-containing protein TBL1X,11526,160,0.97 [0.82-1.15],0.7418457615380895
Chapter II Neoplasms,Leiomyoma of uterus,TBR1,T-box brain protein 1,10056,144,1.00 [0.72-1.40],0.9927174537031388
Chapter II Neoplasms,Leiomyoma of uterus,TCL1A,T-cell leukemia/lymphoma protein 1A,11702,168,0.96 [0.84-1.11],0.5943394202619556
Chapter II Neoplasms,Leiomyoma of uterus,TCL1B,T-cell leukemia/lymphoma protein 1B,11560,165,0.94 [0.78-1.14],0.5391206492016778
Chapter II Neoplasms,Leiomyoma of uterus,TCN1,Transcobalamin-1,10110,143,0.84 [0.52-1.36],0.4730916552848682
Chapter II Neoplasms,Leiomyoma of uterus,TCN2,Transcobalamin-2,11926,171,1.07 [0.69-1.65],0.7788812124890955
Chapter II Neoplasms,Leiomyoma of uterus,TCOF1,Treacle protein,10334,150,1.24 [0.79-1.94],0.3500432987251294
Chapter II Neoplasms,Leiomyoma of uterus,TCP11,T-complex protein 11 homolog,10166,144,0.75 [0.52-1.07],0.1125414943506321
Chapter II Neoplasms,Leiomyoma of uterus,TCTN3,Tectonic-3,10334,150,1.41 [0.83-2.41],0.2083829625169232
Chapter II Neoplasms,Leiomyoma of uterus,TDGF1,Teratocarcinoma-derived growth factor 1,11512,163,1.02 [0.93-1.12],0.7066886003367807
Chapter II Neoplasms,Leiomyoma of uterus,TDO2,"Tryptophan 2,3-dioxygenase",10056,144,0.82 [0.51-1.30],0.3936815900739404
Chapter II Neoplasms,Leiomyoma of uterus,TDP1,Tyrosyl-DNA phosphodiesterase 1,10278,147,1.19 [0.98-1.44],0.0828699212705363
Chapter II Neoplasms,Leiomyoma of uterus,TDRKH,Tudor and KH domain-containing protein,11512,163,1.01 [0.86-1.19],0.882613872350355
Chapter II Neoplasms,Leiomyoma of uterus,TEF,Thyrotroph embryonic factor,10002,147,0.96 [0.66-1.41],0.8511032398385829
Chapter II Neoplasms,Leiomyoma of uterus,TEK,Angiopoietin-1 receptor,11855,167,1.33 [0.71-2.52],0.3736074937940415
Chapter II Neoplasms,Leiomyoma of uterus,TERF1,Telomeric repeat-binding factor 1,10039,145,1.13 [0.69-1.87],0.627857544425235
Chapter II Neoplasms,Leiomyoma of uterus,TET2,Methylcytosine dioxygenase TET2,10138,143,0.96 [0.81-1.13],0.6072199404098064
Chapter II Neoplasms,Leiomyoma of uterus,TEX101,Testis-expressed protein 101,10056,144,0.86 [0.57-1.30],0.4695320897050131
Chapter II Neoplasms,Leiomyoma of uterus,TEX33,Testis-expressed protein 33,10166,144,1.09 [0.75-1.59],0.6445047884187591
Chapter II Neoplasms,Leiomyoma of uterus,TF,Serotransferrin,10353,149,0.93 [0.45-1.93],0.843308994715541
Chapter II Neoplasms,Leiomyoma of uterus,TFAP2A,Transcription factor AP-2-alpha,9978,146,0.91 [0.69-1.21],0.5173143757376091
Chapter II Neoplasms,Leiomyoma of uterus,TFF1,Trefoil factor 1,11745,164,1.01 [0.85-1.19],0.9513869573837116
Chapter II Neoplasms,Leiomyoma of uterus,TFF2,Trefoil factor 2,11831,169,1.22 [0.97-1.54],0.0951684278802432
Chapter II Neoplasms,Leiomyoma of uterus,TFF3,Trefoil factor 3,11789,168,1.13 [0.85-1.52],0.3943385822430816
Chapter II Neoplasms,Leiomyoma of uterus,TFPI,Tissue factor pathway inhibitor,11774,168,0.51 [0.32-0.82],0.0055113062975929
Chapter II Neoplasms,Leiomyoma of uterus,TFPI2,Tissue factor pathway inhibitor 2,11821,166,0.86 [0.58-1.28],0.4508786590751882
Chapter II Neoplasms,Leiomyoma of uterus,TFRC,Transferrin receptor protein 1,11852,169,1.09 [0.76-1.56],0.6556443408604611
Chapter II Neoplasms,Leiomyoma of uterus,TG,Thyroglobulin,10278,147,1.09 [0.97-1.23],0.1503800238573933
Chapter II Neoplasms,Leiomyoma of uterus,TGFA,Protransforming growth factor alpha,11777,170,0.87 [0.64-1.17],0.3561997333194315
Chapter II Neoplasms,Leiomyoma of uterus,TGFB1,Transforming growth factor beta-1 proprotein,11894,170,1.05 [0.74-1.51],0.7731661918695691
Chapter II Neoplasms,Leiomyoma of uterus,TGFB2,Transforming growth factor beta-2 proprotein,10278,147,1.09 [0.82-1.45],0.5602306710165503
Chapter II Neoplasms,Leiomyoma of uterus,TGFBI,Transforming growth factor-beta-induced protein ig-h3,11733,168,0.79 [0.47-1.31],0.358777231893852
Chapter II Neoplasms,Leiomyoma of uterus,TGFBR1,TGF-beta receptor type-1,10039,145,1.15 [0.56-2.35],0.7047484822150314
Chapter II Neoplasms,Leiomyoma of uterus,TGFBR2,TGF-beta receptor type-2,11855,167,1.22 [0.82-1.83],0.3247972919816321
Chapter II Neoplasms,Leiomyoma of uterus,TGFBR3,Transforming growth factor beta receptor type 3,11938,171,1.37 [0.90-2.10],0.1390895100716243
Chapter II Neoplasms,Leiomyoma of uterus,TGM2,Protein-glutamine gamma-glutamyltransferase 2,11786,169,1.04 [0.87-1.24],0.6832921094596689
Chapter II Neoplasms,Leiomyoma of uterus,TGOLN2,Trans-Golgi network integral membrane protein 2,10335,147,1.08 [0.60-1.94],0.8094069353398673
Chapter II Neoplasms,Leiomyoma of uterus,THAP12,52 kDa repressor of the inhibitor of the protein kinase,9943,142,0.85 [0.69-1.05],0.1401682818512174
Chapter II Neoplasms,Leiomyoma of uterus,THBD,Thrombomodulin,11802,169,0.87 [0.53-1.43],0.5894268674097038
Chapter II Neoplasms,Leiomyoma of uterus,THBS2,Thrombospondin-2,11808,165,1.07 [0.74-1.56],0.7156847386886918
Chapter II Neoplasms,Leiomyoma of uterus,THBS4,Thrombospondin-4,11807,169,1.11 [0.82-1.50],0.4875565679421364
Chapter II Neoplasms,Leiomyoma of uterus,THOP1,Thimet oligopeptidase,11733,169,0.94 [0.60-1.47],0.7766757953471465
Chapter II Neoplasms,Leiomyoma of uterus,THPO,Thrombopoietin,11560,165,0.84 [0.58-1.20],0.3287262402776402
Chapter II Neoplasms,Leiomyoma of uterus,THRAP3,Thyroid hormone receptor-associated protein 3,10002,147,1.06 [0.93-1.20],0.3989279270098016
Chapter II Neoplasms,Leiomyoma of uterus,THSD1,Thrombospondin type-1 domain-containing protein 1,9956,144,1.04 [0.65-1.67],0.869212639619652
Chapter II Neoplasms,Leiomyoma of uterus,THTPA,Thiamine-triphosphatase,10265,147,1.05 [0.87-1.26],0.6126174770319246
Chapter II Neoplasms,Leiomyoma of uterus,THY1,Thy-1 membrane glycoprotein,11892,170,1.53 [0.96-2.41],0.0709872539701657
Chapter II Neoplasms,Leiomyoma of uterus,TIA1,Nucleolysin TIA-1 isoform p40,11422,165,1.02 [0.91-1.15],0.7233335329213797
Chapter II Neoplasms,Leiomyoma of uterus,TIE1,Tyrosine-protein kinase receptor Tie-1,11938,171,0.89 [0.65-1.21],0.4585833338764734
Chapter II Neoplasms,Leiomyoma of uterus,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",11493,162,1.09 [0.82-1.46],0.542331537507312
Chapter II Neoplasms,Leiomyoma of uterus,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,10166,144,0.69 [0.43-1.12],0.1322752428294929
Chapter II Neoplasms,Leiomyoma of uterus,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,11855,169,0.88 [0.64-1.20],0.4076303137495727
Chapter II Neoplasms,Leiomyoma of uterus,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,10334,150,1.07 [0.73-1.57],0.7127464174946057
Chapter II Neoplasms,Leiomyoma of uterus,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,10317,147,0.96 [0.80-1.16],0.6899135300379824
Chapter II Neoplasms,Leiomyoma of uterus,TIMP1,Metalloproteinase inhibitor 1,11680,166,0.81 [0.49-1.33],0.4043803983477365
Chapter II Neoplasms,Leiomyoma of uterus,TIMP2,Metalloproteinase inhibitor 2,10334,150,1.15 [0.69-1.92],0.5843685446194136
Chapter II Neoplasms,Leiomyoma of uterus,TIMP3,Metalloproteinase inhibitor 3,11854,170,0.99 [0.90-1.10],0.8681268505034988
Chapter II Neoplasms,Leiomyoma of uterus,TIMP4,Metalloproteinase inhibitor 4,11808,165,0.76 [0.53-1.07],0.1157529275893403
Chapter II Neoplasms,Leiomyoma of uterus,TINAGL1,Tubulointerstitial nephritis antigen-like,11760,169,1.15 [0.62-2.13],0.6585946523606334
Chapter II Neoplasms,Leiomyoma of uterus,TJAP1,Tight junction-associated protein 1,11855,167,1.00 [0.84-1.18],0.9585831135802906
Chapter II Neoplasms,Leiomyoma of uterus,TJP3,Tight junction protein ZO-3,9978,146,1.12 [0.78-1.60],0.5532593032084607
Chapter II Neoplasms,Leiomyoma of uterus,TK1,"Thymidine kinase, cytosolic",10166,144,1.17 [0.84-1.62],0.3476554919384282
Chapter II Neoplasms,Leiomyoma of uterus,TLR1,Toll-like receptor 1,10039,145,1.12 [0.63-2.01],0.7000496037303547
Chapter II Neoplasms,Leiomyoma of uterus,TLR2,Toll-like receptor 2,10166,144,1.17 [0.59-2.32],0.6569648020253994
Chapter II Neoplasms,Leiomyoma of uterus,TLR3,Toll-like receptor 3,11910,170,0.97 [0.78-1.21],0.8074021850020374
Chapter II Neoplasms,Leiomyoma of uterus,TLR4,Toll-like receptor 4,10039,145,1.18 [0.68-2.04],0.5493220400070269
Chapter II Neoplasms,Leiomyoma of uterus,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,10056,144,0.93 [0.68-1.26],0.6300199328998596
Chapter II Neoplasms,Leiomyoma of uterus,TMED1,Transmembrane emp24 domain-containing protein 1,10166,144,1.11 [0.85-1.46],0.4386840979249865
Chapter II Neoplasms,Leiomyoma of uterus,TMED10,Transmembrane emp24 domain-containing protein 10,10002,147,1.23 [0.97-1.57],0.0838928022169305
Chapter II Neoplasms,Leiomyoma of uterus,TMED4,Transmembrane emp24 domain-containing protein 4,10002,147,0.97 [0.73-1.29],0.8331886816116715
Chapter II Neoplasms,Leiomyoma of uterus,TMED8,Protein TMED8,10273,150,1.02 [0.87-1.19],0.8429561424476046
Chapter II Neoplasms,Leiomyoma of uterus,TMEM106A,Transmembrane protein 106A,10278,147,1.00 [0.80-1.25],0.9921088533231373
Chapter II Neoplasms,Leiomyoma of uterus,TMEM132A,Transmembrane protein 132A,10091,145,1.12 [0.87-1.44],0.3809809389408534
Chapter II Neoplasms,Leiomyoma of uterus,TMEM25,Transmembrane protein 25,10311,147,0.97 [0.68-1.38],0.8706912503382709
Chapter II Neoplasms,Leiomyoma of uterus,TMOD4,Tropomodulin-4,9961,142,1.14 [0.78-1.66],0.4930375634672319
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS11B,Transmembrane protease serine 11B,9978,146,1.06 [0.88-1.29],0.532020250447526
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS11D,Transmembrane protease serine 11D,10304,147,1.06 [0.72-1.56],0.7618405656997426
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS15,Enteropeptidase,11744,167,1.13 [0.97-1.31],0.1205707716408374
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS5,Transmembrane protease serine 5,11668,166,0.84 [0.58-1.20],0.3264324776976615
Chapter II Neoplasms,Leiomyoma of uterus,TMSB10,Thymosin beta-10,11808,165,1.05 [0.87-1.27],0.6150088685930155
Chapter II Neoplasms,Leiomyoma of uterus,TNC,Tenascin,11855,169,0.71 [0.53-0.94],0.0187373766935601
Chapter II Neoplasms,Leiomyoma of uterus,TNF,Tumor necrosis factor,11539,165,0.99 [0.70-1.40],0.9502804006113904
Chapter II Neoplasms,Leiomyoma of uterus,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,10273,150,0.99 [0.70-1.40],0.9486288521875452
Chapter II Neoplasms,Leiomyoma of uterus,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,11555,165,0.93 [0.64-1.36],0.7130433569785108
Chapter II Neoplasms,Leiomyoma of uterus,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,10128,146,0.91 [0.71-1.18],0.4972356629607919
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,11718,168,0.99 [0.65-1.52],0.9606631559673716
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,11718,168,0.99 [0.68-1.44],0.963942450259056
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,11836,169,0.85 [0.65-1.10],0.2153231942112434
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,11910,170,0.98 [0.69-1.38],0.888369684682683
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,11797,169,0.77 [0.47-1.25],0.2847200635097419
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,11855,167,1.37 [0.94-2.00],0.1005097544763577
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,11817,169,1.04 [0.71-1.54],0.8267339456732039
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,11555,165,0.95 [0.68-1.32],0.7567667944897927
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,11817,169,1.00 [0.63-1.57],0.9832809147576104
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,10128,146,0.75 [0.51-1.10],0.13600387386603
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,11889,169,1.38 [0.92-2.08],0.1173292931064458
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,11808,165,1.04 [0.65-1.67],0.8555735373859865
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,11808,165,0.98 [0.68-1.42],0.9342550606513096
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,11892,170,0.92 [0.56-1.52],0.7446074776808647
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,11894,170,1.18 [0.85-1.65],0.3270331811961052
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,11718,168,0.90 [0.70-1.16],0.4361347726807484
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,11892,170,0.95 [0.70-1.27],0.7100359380557406
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,11718,168,1.17 [0.86-1.58],0.3285130919846183
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF10,Tumor necrosis factor ligand superfamily member 10,11910,170,1.06 [0.62-1.82],0.8237620418461769
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF11,Tumor necrosis factor ligand superfamily member 11,11777,170,1.14 [0.91-1.43],0.240286325241303
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF12,Tumor necrosis factor ligand superfamily member 12,11910,170,0.88 [0.55-1.42],0.603248252559492
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF13,Tumor necrosis factor ligand superfamily member 13,11854,170,1.33 [0.80-2.20],0.2718014644191424
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,11922,170,0.99 [0.61-1.62],0.9783358300163966
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF14,Tumor necrosis factor ligand superfamily member 14,11718,168,1.02 [0.80-1.29],0.8980668499906445
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF8,Tumor necrosis factor ligand superfamily member 8,10347,149,0.78 [0.50-1.22],0.2822987773213047
Chapter II Neoplasms,Leiomyoma of uterus,TNIP1,TNFAIP3-interacting protein 1,10317,147,0.93 [0.78-1.12],0.4462104364034526
Chapter II Neoplasms,Leiomyoma of uterus,TNN,Tenascin-N,10347,149,0.87 [0.61-1.25],0.4597934116658196
Chapter II Neoplasms,Leiomyoma of uterus,TNNI3,"Troponin I, cardiac muscle",11560,165,1.17 [0.98-1.40],0.0840753692758178
Chapter II Neoplasms,Leiomyoma of uterus,TNPO1,Transportin-1,10166,144,1.37 [0.97-1.94],0.0748583202169435
Chapter II Neoplasms,Leiomyoma of uterus,TNR,Tenascin-R,11718,168,0.74 [0.53-1.02],0.0649367243484731
Chapter II Neoplasms,Leiomyoma of uterus,TNXB,Tenascin-X,11808,165,1.12 [0.64-1.95],0.6877539471652645
Chapter II Neoplasms,Leiomyoma of uterus,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,10334,150,0.98 [0.80-1.20],0.8627957405078361
Chapter II Neoplasms,Leiomyoma of uterus,TOP1,DNA topoisomerase 1,10273,150,1.04 [0.90-1.21],0.5938712808547228
Chapter II Neoplasms,Leiomyoma of uterus,TOP1MT,"DNA topoisomerase I, mitochondrial",9961,142,1.23 [0.95-1.61],0.1209532309725069
Chapter II Neoplasms,Leiomyoma of uterus,TOP2B,DNA topoisomerase 2-beta,10039,145,1.05 [0.86-1.28],0.6581795537498127
Chapter II Neoplasms,Leiomyoma of uterus,TOR1AIP1,Torsin-1A-interacting protein 1,10091,145,1.18 [0.90-1.55],0.2285634576825418
Chapter II Neoplasms,Leiomyoma of uterus,TP53,Cellular tumor antigen p53,11526,160,1.13 [0.81-1.58],0.477101428974453
Chapter II Neoplasms,Leiomyoma of uterus,TP53BP1,TP53-binding protein 1,10039,145,1.10 [0.92-1.31],0.2841317085566405
Chapter II Neoplasms,Leiomyoma of uterus,TP53I3,Quinone oxidoreductase PIG3,9910,143,1.12 [0.82-1.51],0.4787840453961693
Chapter II Neoplasms,Leiomyoma of uterus,TP53INP1,Tumor protein p53-inducible nuclear protein 1,11560,165,1.17 [0.82-1.67],0.3942213186117957
Chapter II Neoplasms,Leiomyoma of uterus,TP73,Tumor protein p73,10056,144,0.90 [0.57-1.44],0.6734174031940277
Chapter II Neoplasms,Leiomyoma of uterus,TPBGL,Trophoblast glycoprotein-like,10056,144,1.18 [0.83-1.67],0.3594902788100266
Chapter II Neoplasms,Leiomyoma of uterus,TPD52L2,Tumor protein D54,10128,146,1.01 [0.87-1.18],0.8618001320484943
Chapter II Neoplasms,Leiomyoma of uterus,TPK1,Thiamin pyrophosphokinase 1,10334,150,0.77 [0.43-1.38],0.3797628068297757
Chapter II Neoplasms,Leiomyoma of uterus,TPM3,Tropomyosin alpha-3 chain,10002,147,1.30 [0.93-1.82],0.1195479742478216
Chapter II Neoplasms,Leiomyoma of uterus,TPMT,Thiopurine S-methyltransferase,11526,160,1.02 [0.85-1.24],0.8109974477918501
Chapter II Neoplasms,Leiomyoma of uterus,TPP1,Tripeptidyl-peptidase 1,11712,165,0.86 [0.62-1.20],0.3868654314395505
Chapter II Neoplasms,Leiomyoma of uterus,TPPP2,Tubulin polymerization-promoting protein family member 2,10166,144,1.15 [0.98-1.36],0.0910196281212545
Chapter II Neoplasms,Leiomyoma of uterus,TPPP3,Tubulin polymerization-promoting protein family member 3,11512,163,1.04 [0.74-1.46],0.8418837779747408
Chapter II Neoplasms,Leiomyoma of uterus,TPR,Nucleoprotein TPR,10002,147,1.08 [0.81-1.45],0.5857015487649639
Chapter II Neoplasms,Leiomyoma of uterus,TPRKB,EKC/KEOPS complex subunit TPRKB,9961,142,1.02 [0.80-1.31],0.8516620279700651
Chapter II Neoplasms,Leiomyoma of uterus,TPSAB1,Tryptase alpha/beta-1,11894,170,1.11 [0.86-1.44],0.4330335001037846
Chapter II Neoplasms,Leiomyoma of uterus,TPSD1,Tryptase delta,10311,147,1.05 [0.71-1.57],0.7963932064827788
Chapter II Neoplasms,Leiomyoma of uterus,TPSG1,Tryptase gamma,10039,145,1.81 [1.13-2.89],0.0136122440929168
Chapter II Neoplasms,Leiomyoma of uterus,TPT1,Translationally-controlled tumor protein,11555,165,0.97 [0.77-1.21],0.7544320995922206
Chapter II Neoplasms,Leiomyoma of uterus,TRAF2,TNF receptor-associated factor 2,11777,170,0.96 [0.79-1.16],0.6544125777998787
Chapter II Neoplasms,Leiomyoma of uterus,TRAF3,"TNF receptor-associated factor 3, Isoform 2",10039,145,1.01 [0.65-1.56],0.9636267712083983
Chapter II Neoplasms,Leiomyoma of uterus,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,10002,147,1.21 [0.92-1.59],0.1836171028773799
Chapter II Neoplasms,Leiomyoma of uterus,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,10166,144,1.08 [0.91-1.28],0.3939231275908016
Chapter II Neoplasms,Leiomyoma of uterus,TREH,Trehalase,10347,149,1.00 [0.81-1.23],0.9934566132160876
Chapter II Neoplasms,Leiomyoma of uterus,TREM2,Triggering receptor expressed on myeloid cells 2,11797,169,1.10 [0.84-1.44],0.4870596999064167
Chapter II Neoplasms,Leiomyoma of uterus,TREML1,Trem-like transcript 1 protein,10335,147,0.99 [0.74-1.34],0.9552570467963968
Chapter II Neoplasms,Leiomyoma of uterus,TREML2,Trem-like transcript 2 protein,11808,165,0.96 [0.63-1.45],0.8417399133294444
Chapter II Neoplasms,Leiomyoma of uterus,TRIAP1,TP53-regulated inhibitor of apoptosis 1,11889,169,0.99 [0.80-1.24],0.9487116956782532
Chapter II Neoplasms,Leiomyoma of uterus,TRIM21,E3 ubiquitin-protein ligase TRIM21,11777,170,0.96 [0.81-1.12],0.5807428548158163
Chapter II Neoplasms,Leiomyoma of uterus,TRIM24,Transcription intermediary factor 1-alpha,10146,144,1.04 [0.82-1.34],0.7277794542693958
Chapter II Neoplasms,Leiomyoma of uterus,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,10273,150,1.02 [0.89-1.18],0.7494550116421639
Chapter II Neoplasms,Leiomyoma of uterus,TRIM26,Tripartite motif-containing protein 26,9961,142,1.02 [0.77-1.35],0.8744014209897002
Chapter II Neoplasms,Leiomyoma of uterus,TRIM40,E3 ubiquitin ligase TRIM40,10056,144,0.85 [0.67-1.07],0.1680827371702822
Chapter II Neoplasms,Leiomyoma of uterus,TRIM5,Tripartite motif-containing protein 5,11777,170,0.97 [0.83-1.14],0.7510136456162132
Chapter II Neoplasms,Leiomyoma of uterus,TRIM58,E3 ubiquitin-protein ligase TRIM58,10278,147,1.04 [0.87-1.25],0.671361670975742
Chapter II Neoplasms,Leiomyoma of uterus,TRPV3,Transient receptor potential cation channel subfamily V member 3,10002,147,0.82 [0.56-1.18],0.2850876956583972
Chapter II Neoplasms,Leiomyoma of uterus,TSC1,Hamartin,10039,145,1.06 [0.86-1.31],0.5594723796456796
Chapter II Neoplasms,Leiomyoma of uterus,TSC22D1,TSC22 domain family protein 1,10311,147,0.97 [0.77-1.23],0.8148360194767696
Chapter II Neoplasms,Leiomyoma of uterus,TSHB,Thyrotropin subunit beta,11802,169,0.99 [0.85-1.16],0.8956311089780132
Chapter II Neoplasms,Leiomyoma of uterus,TSLP,Thymic stromal lymphopoietin,11560,165,0.83 [0.64-1.08],0.1667792152948073
Chapter II Neoplasms,Leiomyoma of uterus,TSNAX,Translin-associated protein X,10002,147,1.50 [1.03-2.19],0.0351877269053229
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN1,Tetraspanin-1,11560,165,1.57 [1.05-2.34],0.0284396845900363
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN15,Tetraspanin-15,10002,147,1.05 [0.77-1.42],0.7618482165993425
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN7,Tetraspanin-7,9978,146,0.97 [0.81-1.17],0.7508329440536817
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN8,Tetraspanin-8,10273,150,0.88 [0.76-1.02],0.0859949785465271
Chapter II Neoplasms,Leiomyoma of uterus,TSPYL1,Testis-specific Y-encoded-like protein 1,10039,145,1.11 [0.76-1.62],0.6027863268988454
Chapter II Neoplasms,Leiomyoma of uterus,TST,Thiosulfate sulfurtransferase,11487,162,1.13 [0.94-1.35],0.2025963337817349
Chapter II Neoplasms,Leiomyoma of uterus,TTF2,Transcription termination factor 2,10056,144,1.05 [0.76-1.45],0.7605336141275287
Chapter II Neoplasms,Leiomyoma of uterus,TTN,Titin,10002,147,1.28 [1.06-1.54],0.0110051244283778
Chapter II Neoplasms,Leiomyoma of uterus,TTR,Transthyretin,10236,149,1.58 [0.84-2.99],0.1565730451280562
Chapter II Neoplasms,Leiomyoma of uterus,TUBB3,Tubulin beta-3 chain,9978,146,1.02 [0.58-1.81],0.9379366159993808
Chapter II Neoplasms,Leiomyoma of uterus,TWF2,Twinfilin-2,10347,149,1.06 [0.88-1.28],0.5339972083508389
Chapter II Neoplasms,Leiomyoma of uterus,TXK,Tyrosine-protein kinase TXK,10166,144,0.95 [0.77-1.18],0.6634500627862958
Chapter II Neoplasms,Leiomyoma of uterus,TXLNA,Alpha-taxilin,11718,168,1.02 [0.87-1.19],0.8002230884429815
Chapter II Neoplasms,Leiomyoma of uterus,TXN,Thioredoxin,10165,143,1.16 [0.84-1.60],0.3724374363795115
Chapter II Neoplasms,Leiomyoma of uterus,TXNDC15,Thioredoxin domain-containing protein 15,11855,167,1.35 [0.82-2.20],0.2331820793312334
Chapter II Neoplasms,Leiomyoma of uterus,TXNDC5,Thioredoxin domain-containing protein 5,11892,170,0.96 [0.78-1.18],0.7161864131529665
Chapter II Neoplasms,Leiomyoma of uterus,TXNDC9,Thioredoxin domain-containing protein 9,10317,147,0.99 [0.73-1.33],0.926004169496485
Chapter II Neoplasms,Leiomyoma of uterus,TXNL1,Thioredoxin-like protein 1,9957,145,1.12 [0.97-1.29],0.116005823140667
Chapter II Neoplasms,Leiomyoma of uterus,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",11808,165,1.00 [0.74-1.35],0.9771971708343732
Chapter II Neoplasms,Leiomyoma of uterus,TYMP,Thymidine phosphorylase,11720,167,0.99 [0.80-1.22],0.9069271970182896
Chapter II Neoplasms,Leiomyoma of uterus,TYRO3,Tyrosine-protein kinase receptor TYRO3,11802,169,0.68 [0.42-1.10],0.1188205323938165
Chapter II Neoplasms,Leiomyoma of uterus,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",10039,145,0.92 [0.72-1.18],0.5221288695948256
Chapter II Neoplasms,Leiomyoma of uterus,UBAC1,Ubiquitin-associated domain-containing protein 1,11744,167,1.02 [0.70-1.50],0.9067036836995808
Chapter II Neoplasms,Leiomyoma of uterus,UBE2B,Ubiquitin-conjugating enzyme E2 B,10278,147,1.75 [1.11-2.76],0.016338448819868
Chapter II Neoplasms,Leiomyoma of uterus,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,10334,150,1.10 [0.85-1.42],0.4752410354817084
Chapter II Neoplasms,Leiomyoma of uterus,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,10039,145,1.07 [0.82-1.40],0.6099917048288584
Chapter II Neoplasms,Leiomyoma of uterus,UBQLN3,Ubiquilin-3,10002,147,0.97 [0.68-1.38],0.8582996691535734
Chapter II Neoplasms,Leiomyoma of uterus,UBXN1,UBX domain-containing protein 1,10128,146,1.01 [0.80-1.27],0.9646288574167308
Chapter II Neoplasms,Leiomyoma of uterus,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,10273,150,1.02 [0.91-1.14],0.7602514454741317
Chapter II Neoplasms,Leiomyoma of uterus,UGDH,UDP-glucose 6-dehydrogenase,10002,147,1.19 [1.05-1.35],0.0082893739047497
Chapter II Neoplasms,Leiomyoma of uterus,UHRF2,E3 ubiquitin-protein ligase UHRF2,10002,147,1.35 [1.01-1.80],0.0413728606068514
Chapter II Neoplasms,Leiomyoma of uterus,ULBP2,UL16-binding protein 2,11718,168,1.00 [0.69-1.43],0.985477777434788
Chapter II Neoplasms,Leiomyoma of uterus,UMOD,Uromodulin,11907,170,0.88 [0.69-1.12],0.2926992057093065
Chapter II Neoplasms,Leiomyoma of uterus,UNC5D,Netrin receptor UNC5D,10039,145,0.91 [0.48-1.70],0.7585077247022549
Chapter II Neoplasms,Leiomyoma of uterus,UNC79,Protein unc-79 homolog,9961,142,1.21 [0.94-1.57],0.1372534727536113
Chapter II Neoplasms,Leiomyoma of uterus,UNG,Uracil-DNA glycosylase,10278,147,1.57 [1.05-2.36],0.0291291576032199
Chapter II Neoplasms,Leiomyoma of uterus,UPB1,Beta-ureidopropionase,10334,150,1.01 [0.85-1.20],0.944532860450444
Chapter II Neoplasms,Leiomyoma of uterus,UPK3A,Uroplakin-3a,9978,146,1.12 [0.84-1.51],0.4435411864466807
Chapter II Neoplasms,Leiomyoma of uterus,UPK3BL1,Uroplakin-3b-like protein 1,10143,143,0.92 [0.67-1.26],0.6009553090629094
Chapter II Neoplasms,Leiomyoma of uterus,UROD,Uroporphyrinogen decarboxylase,10128,146,1.07 [0.85-1.34],0.576861878004145
Chapter II Neoplasms,Leiomyoma of uterus,UROS,Uroporphyrinogen-III synthase,10056,144,1.02 [0.81-1.27],0.884409033329976
Chapter II Neoplasms,Leiomyoma of uterus,USO1,General vesicular transport factor p115,11744,167,1.01 [0.87-1.17],0.9148163247402822
Chapter II Neoplasms,Leiomyoma of uterus,USP25,Ubiquitin carboxyl-terminal hydrolase 25,10278,147,1.08 [0.87-1.35],0.4757167040502473
Chapter II Neoplasms,Leiomyoma of uterus,USP28,Ubiquitin carboxyl-terminal hydrolase 28,10317,147,1.26 [0.87-1.81],0.2200243873870252
Chapter II Neoplasms,Leiomyoma of uterus,USP47,Ubiquitin carboxyl-terminal hydrolase 47,10002,147,0.92 [0.75-1.12],0.4011934773093547
Chapter II Neoplasms,Leiomyoma of uterus,USP8,Ubiquitin carboxyl-terminal hydrolase 8,11560,165,1.02 [0.89-1.18],0.751541690145997
Chapter II Neoplasms,Leiomyoma of uterus,UXS1,UDP-glucuronic acid decarboxylase 1,11526,160,1.10 [0.85-1.41],0.4735022686211816
Chapter II Neoplasms,Leiomyoma of uterus,VAMP5,Vesicle-associated membrane protein 5,11560,165,1.01 [0.80-1.29],0.9148109072744788
Chapter II Neoplasms,Leiomyoma of uterus,VAMP8,Vesicle-associated membrane protein 8,10039,145,0.98 [0.82-1.18],0.8672513524687362
Chapter II Neoplasms,Leiomyoma of uterus,VASH1,Tubulinyl-Tyr carboxypeptidase 1,11777,170,0.99 [0.84-1.17],0.8960659770321432
Chapter II Neoplasms,Leiomyoma of uterus,VASN,Vasorin,11628,165,0.88 [0.52-1.47],0.622875003745265
Chapter II Neoplasms,Leiomyoma of uterus,VASP,Vasodilator-stimulated phosphoprotein,10335,147,1.02 [0.82-1.27],0.8326400011372441
Chapter II Neoplasms,Leiomyoma of uterus,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,11744,167,0.65 [0.32-1.31],0.2256333901439726
Chapter II Neoplasms,Leiomyoma of uterus,VAV3,Guanine nucleotide exchange factor VAV3,9978,146,1.01 [0.86-1.19],0.8575790675204247
Chapter II Neoplasms,Leiomyoma of uterus,VCAM1,Vascular cell adhesion protein 1,11829,169,0.87 [0.52-1.45],0.5972969234454495
Chapter II Neoplasms,Leiomyoma of uterus,VCAN,Versican core protein,11892,170,0.84 [0.54-1.31],0.4387846074501641
Chapter II Neoplasms,Leiomyoma of uterus,VCPKMT,Protein-lysine methyltransferase METTL21D,9961,142,1.06 [0.88-1.26],0.5544971455101126
Chapter II Neoplasms,Leiomyoma of uterus,VEGFA,Vascular endothelial growth factor A,11870,170,1.00 [0.79-1.25],0.9660449472465832
Chapter II Neoplasms,Leiomyoma of uterus,VEGFB,Vascular endothelial growth factor B,10039,145,0.93 [0.53-1.63],0.7876647292278972
Chapter II Neoplasms,Leiomyoma of uterus,VEGFC,Vascular endothelial growth factor C,11855,167,0.97 [0.76-1.23],0.7931559106782571
Chapter II Neoplasms,Leiomyoma of uterus,VEGFD,Vascular endothelial growth factor D,11887,170,1.36 [0.91-2.02],0.1290893769644796
Chapter II Neoplasms,Leiomyoma of uterus,VGF,Neurosecretory protein VGF,10311,147,1.43 [0.87-2.34],0.1563504016788034
Chapter II Neoplasms,Leiomyoma of uterus,VIM,Vimentin,11560,165,1.06 [0.93-1.20],0.3848744507740235
Chapter II Neoplasms,Leiomyoma of uterus,VIPR1,Vasoactive intestinal polypeptide receptor 1,10091,145,1.21 [0.64-2.27],0.5532232626707325
Chapter II Neoplasms,Leiomyoma of uterus,VIT,Vitrin,10334,150,1.51 [1.01-2.26],0.0430046489297999
Chapter II Neoplasms,Leiomyoma of uterus,VMO1,Vitelline membrane outer layer protein 1 homolog,11744,167,1.22 [0.99-1.51],0.0654475161176926
Chapter II Neoplasms,Leiomyoma of uterus,VNN1,Pantetheinase,10335,147,0.94 [0.76-1.16],0.5541626958758813
Chapter II Neoplasms,Leiomyoma of uterus,VNN2,Vascular non-inflammatory molecule 2,11744,167,0.96 [0.71-1.29],0.7844098603854378
Chapter II Neoplasms,Leiomyoma of uterus,VPS28,Vacuolar protein sorting-associated protein 28 homolog,10166,144,0.99 [0.77-1.26],0.9141379792426496
Chapter II Neoplasms,Leiomyoma of uterus,VPS37A,Vacuolar protein sorting-associated protein 37A,11744,167,1.08 [0.91-1.28],0.3936138374629707
Chapter II Neoplasms,Leiomyoma of uterus,VPS4B,Vacuolar protein sorting-associated protein 4B,10278,147,1.07 [0.90-1.26],0.4474522987638537
Chapter II Neoplasms,Leiomyoma of uterus,VPS53,Vacuolar protein sorting-associated protein 53 homolog,11744,167,1.05 [0.88-1.25],0.6157845420477257
Chapter II Neoplasms,Leiomyoma of uterus,VSIG10,V-set and immunoglobulin domain-containing protein 10,10278,147,0.80 [0.48-1.31],0.3717665395370454
Chapter II Neoplasms,Leiomyoma of uterus,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,10002,147,1.24 [0.78-1.97],0.3600254115376652
Chapter II Neoplasms,Leiomyoma of uterus,VSIG2,V-set and immunoglobulin domain-containing protein 2,10278,147,1.27 [1.01-1.60],0.0399542086372637
Chapter II Neoplasms,Leiomyoma of uterus,VSIG4,V-set and immunoglobulin domain-containing protein 4,11794,165,1.13 [0.81-1.58],0.4771114580852996
Chapter II Neoplasms,Leiomyoma of uterus,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,11781,169,0.91 [0.73-1.14],0.4269650018024471
Chapter II Neoplasms,Leiomyoma of uterus,VSNL1,Visinin-like protein 1,10317,147,1.11 [0.73-1.67],0.6263958224926616
Chapter II Neoplasms,Leiomyoma of uterus,VSTM1,V-set and transmembrane domain-containing protein 1,11512,163,1.07 [0.81-1.42],0.6167768399533147
Chapter II Neoplasms,Leiomyoma of uterus,VSTM2B,V-set and transmembrane domain-containing protein 2B,10166,144,1.69 [1.33-2.14],1.470895380984886e-05
Chapter II Neoplasms,Leiomyoma of uterus,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,11560,165,0.98 [0.77-1.25],0.8960804548514141
Chapter II Neoplasms,Leiomyoma of uterus,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,11892,170,1.00 [0.83-1.20],0.9612671266559344
Chapter II Neoplasms,Leiomyoma of uterus,VTCN1,V-set domain-containing T-cell activation inhibitor 1,11526,160,1.11 [0.70-1.74],0.6682972226015125
Chapter II Neoplasms,Leiomyoma of uterus,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,10128,146,0.91 [0.69-1.21],0.5264820936720425
Chapter II Neoplasms,Leiomyoma of uterus,VWA1,von Willebrand factor A domain-containing protein 1,11867,169,0.57 [0.41-0.80],0.0011829637910459
Chapter II Neoplasms,Leiomyoma of uterus,VWA5A,von Willebrand factor A domain-containing protein 5A,9961,142,1.03 [0.85-1.26],0.7495652878546328
Chapter II Neoplasms,Leiomyoma of uterus,VWC2,Brorin,11684,166,1.61 [1.13-2.29],0.0077636634981229
Chapter II Neoplasms,Leiomyoma of uterus,VWC2L,von Willebrand factor C domain-containing protein 2-like,10311,147,1.13 [0.84-1.52],0.4336455110951769
Chapter II Neoplasms,Leiomyoma of uterus,VWF,von Willebrand factor,11938,171,0.96 [0.80-1.16],0.6763321665529579
Chapter II Neoplasms,Leiomyoma of uterus,WARS,"Tryptophan--tRNA ligase, cytoplasmic",11808,165,0.91 [0.63-1.31],0.6196555810025007
Chapter II Neoplasms,Leiomyoma of uterus,WAS,Wiskott-Aldrich syndrome protein,11555,165,1.13 [0.93-1.37],0.2280855376794303
Chapter II Neoplasms,Leiomyoma of uterus,WASF1,Wiskott-Aldrich syndrome protein family member 1,11560,165,0.97 [0.84-1.13],0.7179052778162789
Chapter II Neoplasms,Leiomyoma of uterus,WASF3,Wiskott-Aldrich syndrome protein family member 3,11512,163,0.99 [0.84-1.17],0.9027294465121308
Chapter II Neoplasms,Leiomyoma of uterus,WASHC3,WASH complex subunit 3,10317,147,0.94 [0.76-1.17],0.5854996775184791
Chapter II Neoplasms,Leiomyoma of uterus,WASL,Neural Wiskott-Aldrich syndrome protein,10039,145,0.89 [0.67-1.18],0.4164228476935134
Chapter II Neoplasms,Leiomyoma of uterus,WDR46,WD repeat-containing protein 46,10278,147,1.21 [0.80-1.81],0.3630738297959281
Chapter II Neoplasms,Leiomyoma of uterus,WFDC1,WAP four-disulfide core domain protein 1,10060,147,1.21 [1.00-1.48],0.0538280760376368
Chapter II Neoplasms,Leiomyoma of uterus,WFDC12,WAP four-disulfide core domain protein 12,11876,169,1.09 [0.88-1.34],0.4306338579143008
Chapter II Neoplasms,Leiomyoma of uterus,WFDC2,WAP four-disulfide core domain protein 2,11215,157,1.54 [1.11-2.13],0.0090660804227125
Chapter II Neoplasms,Leiomyoma of uterus,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",11682,167,1.11 [0.79-1.54],0.5542769495772519
Chapter II Neoplasms,Leiomyoma of uterus,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",11817,169,1.85 [1.27-2.71],0.0015091983543178
Chapter II Neoplasms,Leiomyoma of uterus,WIF1,Wnt inhibitory factor 1,11889,169,1.04 [0.70-1.53],0.859010695579201
Chapter II Neoplasms,Leiomyoma of uterus,WNT9A,Protein Wnt-9a,11555,165,1.31 [0.82-2.10],0.2580207767275864
Chapter II Neoplasms,Leiomyoma of uterus,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,11718,168,1.04 [0.81-1.34],0.7777322176573807
Chapter II Neoplasms,Leiomyoma of uterus,XCL1,Lymphotactin,11889,169,1.03 [0.81-1.31],0.8310327531130638
Chapter II Neoplasms,Leiomyoma of uterus,XG,Glycoprotein Xg,11882,169,1.20 [0.78-1.85],0.4106413502562566
Chapter II Neoplasms,Leiomyoma of uterus,XIAP,E3 ubiquitin-protein ligase XIAP,10039,145,1.08 [0.82-1.42],0.6025976975358518
Chapter II Neoplasms,Leiomyoma of uterus,XPNPEP2,Xaa-Pro aminopeptidase 2,11855,167,1.08 [0.92-1.27],0.3322071870522821
Chapter II Neoplasms,Leiomyoma of uterus,XRCC4,DNA repair protein XRCC4,11512,163,1.20 [0.85-1.69],0.2961124098832542
Chapter II Neoplasms,Leiomyoma of uterus,YAP1,Transcriptional coactivator YAP1,10317,147,1.13 [0.64-1.99],0.6708781004925015
Chapter II Neoplasms,Leiomyoma of uterus,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",10273,150,1.00 [0.90-1.12],0.9436782525402464
Chapter II Neoplasms,Leiomyoma of uterus,YES1,Tyrosine-protein kinase Yes,11744,167,0.99 [0.87-1.11],0.8153371292086302
Chapter II Neoplasms,Leiomyoma of uterus,YJU2,Splicing factor YJU2,10278,147,1.31 [0.85-2.04],0.2227963099041111
Chapter II Neoplasms,Leiomyoma of uterus,YOD1,Ubiquitin thioesterase OTU1,10002,147,1.20 [0.94-1.53],0.1481513472683736
Chapter II Neoplasms,Leiomyoma of uterus,YTHDF3,YTH domain-containing family protein 3,11555,165,1.01 [0.85-1.19],0.9331668181362034
Chapter II Neoplasms,Leiomyoma of uterus,YWHAQ,14-3-3 protein theta,10128,146,1.01 [0.81-1.25],0.9429227175465658
Chapter II Neoplasms,Leiomyoma of uterus,YY1,Transcriptional repressor protein YY1,10039,145,0.96 [0.55-1.69],0.8980250242529194
Chapter II Neoplasms,Leiomyoma of uterus,ZBP1,Z-DNA-binding protein 1,10039,145,1.15 [0.80-1.65],0.4447068651879025
Chapter II Neoplasms,Leiomyoma of uterus,ZBTB16,Zinc finger and BTB domain-containing protein 16,11526,160,1.06 [0.88-1.29],0.5273098696854077
Chapter II Neoplasms,Leiomyoma of uterus,ZBTB17,Zinc finger and BTB domain-containing protein 17,11560,165,0.92 [0.65-1.30],0.645595457302431
Chapter II Neoplasms,Leiomyoma of uterus,ZCCHC8,Zinc finger CCHC domain-containing protein 8,10002,147,1.07 [0.84-1.36],0.5750609541347869
Chapter II Neoplasms,Leiomyoma of uterus,ZFYVE19,Abscission/NoCut checkpoint regulator,10273,150,1.04 [0.87-1.23],0.6958781853765152
Chapter II Neoplasms,Leiomyoma of uterus,ZHX2,Zinc fingers and homeoboxes protein 2,10317,147,0.95 [0.58-1.58],0.8533544586088914
Chapter II Neoplasms,Leiomyoma of uterus,ZNF174,Zinc finger protein 174,10039,145,1.28 [0.92-1.77],0.1496934171219134
Chapter II Neoplasms,Leiomyoma of uterus,ZNF75D,Zinc finger protein 75D,10166,144,0.95 [0.73-1.24],0.7277788298509995
Chapter II Neoplasms,Leiomyoma of uterus,ZNF830,Zinc finger protein 830,10278,147,1.07 [0.88-1.29],0.5061791101203476
Chapter II Neoplasms,Leiomyoma of uterus,ZNRD2,Protein ZNRD2,10273,150,0.85 [0.67-1.07],0.1694082923626247
Chapter II Neoplasms,Leiomyoma of uterus,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,10278,147,0.87 [0.64-1.18],0.3646607501459127
Chapter II Neoplasms,Leiomyoma of uterus,ZP3,Zona pellucida sperm-binding protein 3,10091,145,1.01 [0.95-1.07],0.7302448720899195
Chapter II Neoplasms,Leiomyoma of uterus,ZP4,Zona pellucida sperm-binding protein 4,9961,142,0.90 [0.54-1.49],0.6705535875230805
Chapter II Neoplasms,Leiomyoma of uterus,ZPR1,Zinc finger protein ZPR1,9978,146,1.09 [0.94-1.26],0.2450400939067278
